Genetic	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
copper	NN	B-Disease
toxicosis	NN	I-Disease
locus	NN	O
in	IN	O
Bedlington	NNP	O
terriers	NNS	O
to	TO	O
dog	NN	O
chromosome	NN	O
10	CD	O
,	,	O
in	IN	O
a	DT	O
region	NN	O
syntenic	JJ	O
to	TO	O
human	JJ	O
chromosome	NN	O
region	NN	O
2p13-p16	JJ	O
.	.	O

Abnormal	JJ	O
hepatic	JJ	B-Disease
copper	NN	I-Disease
accumulation	NN	I-Disease
is	VBZ	O
recognized	VBN	O
as	IN	O
an	DT	O
inherited	VBN	B-Disease
disorder	NN	I-Disease
in	IN	O
man	NN	O
,	,	O
mouse	NN	O
,	,	O
rat	NN	O
and	CC	O
dog	NN	O
.	.	O

The	DT	O
major	JJ	O
cause	NN	O
of	IN	O
hepatic	JJ	B-Disease
copper	NN	I-Disease
accumulation	NN	I-Disease
in	IN	O
man	NN	O
is	VBZ	O
a	DT	O
dysfunctional	JJ	O
ATP7B	NN	O
gene	NN	O
,	,	O
causing	VBG	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
WD	NN	B-Disease
)	-RRB-	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
ATP7B	NN	O
genes	NNS	O
have	VBP	O
also	RB	O
been	VBN	O
demonstrated	VBN	O
in	IN	O
mouse	NN	O
and	CC	O
rat	NN	O
.	.	O

The	DT	O
ATP7B	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
excluded	VBN	O
in	IN	O
the	DT	O
much	JJ	O
rarer	JJR	O
human	JJ	O
copper	NN	B-Disease
overload	NN	I-Disease
disease	NN	O
non-Indian	JJ	B-Disease
childhood	NN	I-Disease
cirrhosis	NN	I-Disease
,	,	O
indicating	VBG	O
genetic	JJ	O
heterogeneity	NN	O
.	.	O

By	IN	O
investigating	VBG	O
the	DT	O
common	JJ	O
autosomal	JJ	O
recessive	JJ	O
copper	NN	B-Disease
toxicosis	NN	I-Disease
(	-LRB-	O
CT	NN	B-Disease
)	-RRB-	O
in	IN	O
Bedlington	NNP	O
terriers	NNS	O
,	,	O
we	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
new	JJ	O
locus	NN	O
involved	VBN	O
in	IN	O
progressive	JJ	O
liver	NN	B-Disease
disease	NN	I-Disease
.	.	O

We	PRP	O
examined	VBD	O
whether	IN	O
the	DT	O
WD	NN	B-Disease
gene	NN	O
ATP7B	NN	O
was	VBD	O
also	RB	O
causative	JJ	O
for	IN	O
CT	NN	B-Disease
by	IN	O
investigating	VBG	O
the	DT	O
chromosomal	JJ	O
co-localization	NN	O
of	IN	O
ATP7B	NN	O
and	CC	O
C04107	NN	O
,	,	O
using	VBG	O
fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
(	-LRB-	O
FISH	NN	O
)	-RRB-	O
.	.	O

C04107	NN	O
is	VBZ	O
an	DT	O
anonymous	JJ	O
microsatellite	NN	O
marker	NN	O
closely	RB	O
linked	VBN	O
to	TO	O
CT	NNP	B-Disease
.	.	O

However	RB	O
,	,	O
BAC	NN	O
clones	NNS	O
containing	VBG	O
ATP7B	NN	O
and	CC	O
C04107	NN	O
mapped	VBD	O
to	TO	O
the	DT	O
canine	JJ	O
chromosome	NN	O
regions	NNS	O
CFA22q11	NN	O
and	CC	O
CFA10q26	NN	O
,	,	O
respectively	RB	O
,	,	O
demonstrating	VBG	O
that	IN	O
WD	NNP	B-Disease
can	MD	O
not	RB	O
be	VB	O
homologous	JJ	O
to	TO	O
CT	NNP	B-Disease
.	.	O

The	DT	O
copper	NN	O
transport	NN	O
genes	NNS	O
CTR1	NN	O
and	CC	O
CTR2	NN	O
were	VBD	O
also	RB	O
excluded	VBN	O
as	IN	O
candidate	NN	O
genes	NNS	O
for	IN	O
CT	NN	B-Disease
since	IN	O
they	PRP	O
both	DT	O
mapped	VBN	O
to	TO	O
canine	JJ	O
chromosome	NN	O
region	NN	O
CFA11q22	NN	O
.	.	O

2-22	CD	O
.	.	O

5	CD	O
.	.	O

A	DT	O
transcribed	VBN	O
sequence	NN	O
identified	VBN	O
from	IN	O
the	DT	O
C04107-containing	JJ	O
BAC	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homologous	JJ	O
to	TO	O
a	DT	O
gene	NN	O
expressed	VBN	O
from	IN	O
human	JJ	O
chromosome	NN	O
2p13-p16	NN	O
,	,	O
a	DT	O
region	NN	O
devoid	JJ	O
of	IN	O
any	DT	O
positional	JJ	O
candidate	NN	O
genes	NNS	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
in	IN	O
205	CD	O
families	NNS	O
:	:	O
extended	VBN	O
genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
FAP	NN	B-Disease
and	CC	O
evidence	NN	O
for	IN	O
the	DT	O
role	NN	O
of	IN	O
APC	NN	B-Disease
amino	NN	O
acid	NN	O
changes	NNS	O
in	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
predisposition	NN	O
.	.	O

BACKGROUND/AIMS	NN	O
The	DT	O
development	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
and	CC	O
a	DT	O
variable	JJ	O
range	NN	O
of	IN	O
extracolonic	JJ	O
manifestations	NNS	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
the	DT	O
dominant	JJ	O
inheritance	NN	O
of	IN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
mutations	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
direct	JJ	O
mutation	NN	O
analysis	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
was	VBD	O
performed	VBN	O
to	TO	O
determine	VB	O
genotype-phenotype	JJ	O
correlations	NNS	O
for	IN	O
nine	CD	O
extracolonic	JJ	O
manifestations	NNS	O
and	CC	O
to	TO	O
investigate	VB	O
the	DT	O
incidence	NN	O
of	IN	O
APC	NN	B-Disease
mutations	NNS	O
in	IN	O
non-FAP	JJ	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

METHODS	NNS	O
The	DT	O
APC	NN	B-Disease
gene	NN	O
was	VBD	O
analysed	VBN	O
in	IN	O
190	CD	O
unrelated	JJ	O
FAP	NN	B-Disease
and	CC	O
15	CD	O
non-FAP	JJ	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
patients	NNS	O
using	VBG	O
denaturing	VBG	O
gradient	NN	O
gel	NN	O
electrophoresis	NN	O
,	,	O
the	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
,	,	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

RESULTS	NNS	O
Chain	VBP	O
terminating	VBG	O
signals	NNS	O
were	VBD	O
only	RB	O
identified	VBN	O
in	IN	O
patients	NNS	O
belonging	VBG	O
to	TO	O
the	DT	O
FAP	NN	B-Disease
group	NN	O
(	-LRB-	O
105	CD	O
patients	NNS	O
)	-RRB-	O
.	.	O

Amino	NN	O
acid	NN	O
changes	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
four	CD	O
patients	NNS	O
,	,	O
three	CD	O
of	IN	O
whom	WP	O
belonged	VBD	O
to	TO	O
the	DT	O
non-FAP	JJ	O
group	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
patients	NNS	O
.	.	O

Genotype-phenotype	JJ	O
correlations	NNS	O
identified	VBD	O
significant	JJ	O
differences	NNS	O
in	IN	O
the	DT	O
nature	NN	O
of	IN	O
certain	JJ	O
extracolonic	JJ	O
manifestations	NNS	O
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
belonging	VBG	O
to	TO	O
three	CD	O
mutation	NN	O
subgroups	NNS	O
.	.	O

CONCLUSIONS	NNS	O
Extended	VBN	O
genotype-phenotype	JJ	O
correlations	NNS	O
made	VBN	O
in	IN	O
this	DT	O
study	NN	O
may	MD	O
have	VB	O
the	DT	O
potential	JJ	O
to	TO	O
determine	VB	O
the	DT	O
most	RBS	O
appropriate	JJ	O
surveillance	NN	O
and	CC	O
prophylactic	NN	O
treatment	NN	O
regimens	NNS	O
for	IN	O
those	DT	O
patients	NNS	O
with	IN	O
mutations	NNS	O
associated	VBN	O
with	IN	O
life	NN	O
threatening	JJ	O
conditions	NNS	O
.	.	O

This	DT	O
study	NN	O
also	RB	O
provided	VBD	O
evidence	NN	O
for	IN	O
the	DT	O
pathological	JJ	O
nature	NN	O
of	IN	O
amino	NN	O
acid	NN	O
changes	NNS	O
in	IN	O
APC	NN	O
associated	VBN	O
with	IN	O
both	CC	O
FAP	NN	B-Disease
and	CC	O
non-FAP	JJ	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
patients	NNS	O
.	.	O

.	.	O

A	DT	O
European	JJ	O
multicenter	JJ	O
study	NN	O
of	IN	O
phenylalanine	NN	B-Disease
hydroxylase	NN	I-Disease
deficiency	NN	I-Disease
:	:	O
classification	NN	O
of	IN	O
105	CD	O
mutations	NNS	O
and	CC	O
a	DT	O
general	JJ	O
system	NN	O
for	IN	O
genotype-based	JJ	O
prediction	NN	O
of	IN	O
metabolic	JJ	O
phenotype	NN	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
and	CC	O
mild	JJ	B-Disease
hyperphenylalaninemia	NN	I-Disease
(	-LRB-	O
MHP	NN	B-Disease
)	-RRB-	O
are	VBP	O
allelic	JJ	B-Disease
disorders	NNS	I-Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

Previous	JJ	O
studies	NNS	O
have	VBP	O
suggested	VBN	O
that	IN	O
the	DT	O
highly	RB	O
variable	JJ	O
metabolic	JJ	O
phenotypes	NNS	O
of	IN	O
PAH	NN	B-Disease
deficiency	NN	I-Disease
correlate	VBP	O
with	IN	O
PAH	NN	O
genotypes	NNS	O
.	.	O

We	PRP	O
identified	VBD	O
both	CC	O
causative	JJ	O
mutations	NNS	O
in	IN	O
686	CD	O
patients	NNS	O
from	IN	O
seven	CD	O
European	JJ	O
centers	NNS	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
phenotypic	JJ	O
characteristics	NNS	O
of	IN	O
297	CD	O
functionally	RB	O
hemizygous	JJ	O
patients	NNS	O
,	,	O
105	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
assigned	VBN	O
to	TO	O
one	CD	O
of	IN	O
four	CD	O
arbitrary	JJ	O
phenotype	NN	O
categories	NNS	O
.	.	O

We	PRP	O
proposed	VBD	O
and	CC	O
tested	VBD	O
a	DT	O
simple	JJ	O
model	NN	O
for	IN	O
correlation	NN	O
between	IN	O
genotype	NN	O
and	CC	O
phenotypic	JJ	O
outcome	NN	O
.	.	O

The	DT	O
observed	VBN	O
phenotype	NN	O
matched	VBD	O
the	DT	O
predicted	VBN	O
phenotype	NN	O
in	IN	O
79	CD	O
%	NN	O
of	IN	O
the	DT	O
cases	NNS	O
,	,	O
and	CC	O
in	IN	O
only	RB	O
5	CD	O
of	IN	O
184	CD	O
patients	NNS	O
was	VBD	O
the	DT	O
observed	VBN	O
phenotype	NN	O
more	JJR	O
than	IN	O
one	CD	O
category	NN	O
away	RB	O
from	IN	O
that	DT	O
expected	VBN	O
.	.	O

Among	IN	O
the	DT	O
seven	CD	O
contributing	VBG	O
centers	NNS	O
,	,	O
the	DT	O
proportion	NN	O
of	IN	O
patients	NNS	O
for	IN	O
whom	WP	O
the	DT	O
observed	VBN	O
phenotype	NN	O
did	VBD	O
not	RB	O
match	VB	O
the	DT	O
predicted	VBN	O
phenotype	NN	O
was	VBD	O
4	CD	O
%	NN	O
-23	CD	O
%	NN	O
(	-LRB-	O
P	NN	O
<	JJR	O
.	.	O

0001	NN	O
)	-RRB-	O
,	,	O
suggesting	VBG	O
that	IN	O
differences	NNS	O
in	IN	O
methods	NNS	O
used	VBN	O
for	IN	O
mutation	NN	O
detection	NN	O
or	CC	O
phenotype	NN	O
classification	NN	O
may	MD	O
account	VB	O
for	IN	O
a	DT	O
considerable	JJ	O
proportion	NN	O
of	IN	O
genotype-phenotype	JJ	O
inconsistencies	NNS	O
.	.	O

Our	PRP$	O
data	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
PAH-mutation	NN	O
genotype	NN	O
is	VBZ	O
the	DT	O
main	JJ	O
determinant	NN	O
of	IN	O
metabolic	JJ	O
phenotype	NN	O
in	IN	O
most	JJS	O
patients	NNS	O
with	IN	O
PAH	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
the	DT	O
classification	NN	O
of	IN	O
105	CD	O
PAH	NN	O
mutations	NNS	O
may	MD	O
allow	VB	O
the	DT	O
prediction	NN	O
of	IN	O
the	DT	O
biochemical	JJ	O
phenotype	NN	O
in	IN	O
>	JJR	O
10	CD	O
,	,	O
000	CD	O
genotypes	NNS	O
,	,	O
which	WDT	O
may	MD	O
be	VB	O
useful	JJ	O
for	IN	O
the	DT	O
management	NN	O
of	IN	O
hyperphenylalaninemia	NN	B-Disease
in	IN	O
newborns	NNS	O
.	.	O

Disruption	NN	O
of	IN	O
splicing	NN	O
regulated	VBN	O
by	IN	O
a	DT	O
CUG-binding	JJ	O
protein	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
CTG	NNP	O
expansion	NN	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
gene	NN	O
.	.	O

One	CD	O
model	NN	O
of	IN	O
DM	NN	B-Disease
pathogenesis	NN	O
suggests	VBZ	O
that	IN	O
RNAs	NNS	O
from	IN	O
the	DT	O
expanded	VBN	O
allele	NN	O
create	VB	O
a	DT	O
gain-of-function	NN	O
mutation	NN	O
by	IN	O
the	DT	O
inappropriate	JJ	O
binding	NN	O
of	IN	O
proteins	NNS	O
to	TO	O
the	DT	O
CUG	NN	O
repeats	NNS	O
.	.	O

Data	NNS	O
presented	VBN	O
here	RB	O
indicate	VBP	O
that	IN	O
the	DT	O
conserved	VBN	O
heterogeneous	JJ	O
nuclear	JJ	O
ribonucleoprotein	NN	O
,	,	O
CUG-binding	JJ	O
protein	NN	O
(	-LRB-	O
CUG-BP	NN	O
)	-RRB-	O
,	,	O
may	MD	O
mediate	VB	O
the	DT	O
trans-dominant	JJ	O
effect	NN	O
of	IN	O
the	DT	O
RNA	NN	O
.	.	O

CUG-BP	NN	O
was	VBD	O
found	VBN	O
to	TO	O
bind	VB	O
to	TO	O
the	DT	O
human	JJ	O
cardiac	JJ	O
troponin	NN	O
T	NN	O
(	-LRB-	O
cTNT	NN	O
)	-RRB-	O
pre-messenger	JJ	O
RNA	NN	O
and	CC	O
regulate	VB	O
its	PRP$	O
alternative	JJ	O
splicing	NN	O
.	.	O

Splicing	NN	O
of	IN	O
cTNT	NN	O
was	VBD	O
disrupted	VBN	O
in	IN	O
DM	NN	B-Disease
striated	VBD	O
muscle	NN	O
and	CC	O
in	IN	O
normal	JJ	O
cells	NNS	O
expressing	VBG	O
transcripts	NNS	O
that	WDT	O
contain	VBP	O
CUG	NN	O
repeats	NNS	O
.	.	O

Altered	JJ	O
expression	NN	O
of	IN	O
genes	NNS	O
regulated	VBN	O
posttranscriptionally	RB	O
by	IN	O
CUG-BP	NN	O
therefore	RB	O
may	MD	O
contribute	VB	O
to	TO	O
DM	NN	B-Disease
pathogenesis	NN	O
.	.	O

.	.	O

Maternal	JJ	B-Disease
disomy	NN	I-Disease
and	CC	O
Prader-Willi	NN	B-Disease
syndrome	NN	I-Disease
consistent	JJ	O
with	IN	O
gamete	NN	O
complementation	NN	O
in	IN	O
a	DT	O
case	NN	O
of	IN	O
familial	JJ	O
translocation	NN	O
(	-LRB-	O
3	CD	O
;	:	O
15	CD	O
)	-RRB-	O
(	-LRB-	O
p25	NN	O
;	:	O
q11	NN	O
.2	NN	O
)	-RRB-	O
.	.	O

Maternal	JJ	B-Disease
uniparental	JJ	I-Disease
disomy	NN	I-Disease
(	-LRB-	I-Disease
UPD	NN	I-Disease
)	-RRB-	I-Disease
for	IN	I-Disease
chromosome	NN	I-Disease
15	CD	I-Disease
is	VBZ	O
responsible	JJ	O
for	IN	O
an	DT	O
estimated	JJ	O
30	CD	O
%	NN	O
of	IN	O
cases	NNS	O
of	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
an	DT	O
unusual	JJ	O
case	NN	O
of	IN	O
maternal	JJ	B-Disease
disomy	NN	I-Disease
15	CD	I-Disease
in	IN	O
PWS	NNP	B-Disease
that	WDT	O
is	VBZ	O
most	RBS	O
consistent	JJ	O
with	IN	O
adjacent-1	NN	O
segregation	NN	O
of	IN	O
a	DT	O
paternal	JJ	O
t	NN	O
(	-LRB-	O
3	CD	O
;	:	O
15	CD	O
)	-RRB-	O
(	-LRB-	O
p25	NN	O
;	:	O
q11	NN	O
.	.	O

2	LS	O
)	-RRB-	O
with	IN	O
simultaneous	JJ	O
maternal	JJ	O
meiotic	JJ	O
nondisjunction	NN	O
for	IN	O
chromosome	NN	O
15	CD	O
.	.	O

The	DT	O
patient	NN	O
(	-LRB-	O
J.	NNP	O
B.	NNP	O
)	-RRB-	O
,	,	O
a	DT	O
17-year-old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
PWS	NN	B-Disease
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
47	CD	O
chromosomes	NNS	O
with	IN	O
a	DT	O
supernumerary	NN	O
,	,	O
paternal	JJ	O
der	NN	O
(	-LRB-	O
15	CD	O
)	-RRB-	O
consisting	VBG	O
of	IN	O
the	DT	O
short	JJ	O
arm	NN	O
and	CC	O
the	DT	O
proximal	JJ	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
15	CD	O
,	,	O
and	CC	O
distal	JJ	O
chromosome	NN	O
arm	NN	O
3p	NN	O
.	.	O

The	DT	O
t	NN	O
(	-LRB-	O
3	CD	O
;	:	O
15	CD	O
)	-RRB-	O
was	VBD	O
present	JJ	O
in	IN	O
the	DT	O
balanced	JJ	O
state	NN	O
in	IN	O
the	DT	O
patients	NNS	O
father	NN	O
and	CC	O
a	DT	O
sister	NN	O
.	.	O

Fluorescent	JJ	O
in	FW	O
situ	FW	O
hybridization	NN	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
the	DT	O
PWS	NN	B-Disease
critical	JJ	O
region	NN	O
resided	VBD	O
on	IN	O
the	DT	O
derivative	NN	O
chromosome	NN	O
3	CD	O
and	CC	O
that	IN	O
there	EX	O
was	VBD	O
no	DT	O
deletion	NN	O
of	IN	O
the	DT	O
PWS	NN	B-Disease
region	NN	O
on	IN	O
the	DT	O
normal	JJ	O
pair	NN	O
of	IN	O
15s	NNS	O
present	JJ	O
in	IN	O
J.	NNP	O
B.	NNP	O
Methylation	NN	O
analysis	NN	O
at	IN	O
exon	NN	O
alpha	NN	O
of	IN	O
the	DT	O
small	JJ	O
nuclear	JJ	O
ribonucleoprotein-associated	JJ	O
polypeptide	NN	O
N	NN	O
(	-LRB-	O
SNRPN	NN	O
)	-RRB-	O
gene	NN	O
showed	VBD	O
a	DT	O
pattern	NN	O
characteristic	NN	O
of	IN	O
only	RB	O
the	DT	O
maternal	JJ	O
chromosome	NN	O
15	CD	O
in	IN	O
J.	NNP	O
B.	NNP	O
Maternal	NNP	B-Disease
disomy	NN	I-Disease
was	VBD	O
confirmed	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
analysis	NN	O
of	IN	O
microsatellite	NN	O
repeats	NNS	O
at	IN	O
the	DT	O
gamma-aminobutyric	JJ	O
acid	NN	O
receptor	NN	O
beta3	NN	O
subunit	NN	O
(	-LRB-	O
GABRB3	NN	O
)	-RRB-	O
locus	NN	O
.	.	O

A	DT	O
niece	NN	O
(	-LRB-	O
B.	NNP	O
B.	NNP	O
)	-RRB-	O
with	IN	O
45	CD	O
chromosomes	NNS	O
and	CC	O
the	DT	O
derivative	JJ	O
3	CD	O
but	CC	O
without	IN	O
the	DT	O
der	NN	O
(	-LRB-	O
15	CD	O
)	-RRB-	O
demonstrated	VBD	O
a	DT	O
phenotype	NN	O
consistent	JJ	O
with	IN	O
that	DT	O
reported	VBN	O
for	IN	O
haploinsufficiency	NN	O
of	IN	O
distal	JJ	O
3	CD	O
p.	NN	O
Uniparental	JJ	B-Disease
disomy	NN	I-Disease
associated	VBN	O
with	IN	O
unbalanced	JJ	O
segregation	NN	O
of	IN	O
non-Robertsonian	JJ	O
translocations	NNS	O
has	VBZ	O
been	VBN	O
reported	VBN	O
previously	RB	O
but	CC	O
has	VBZ	O
not	RB	O
,	,	O
to	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
been	VBN	O
observed	VBN	O
in	IN	O
a	DT	O
case	NN	O
of	IN	O
PWS	NNP	B-Disease
.	.	O

Furthermore	RB	O
,	,	O
our	PRP$	O
findings	NNS	O
are	VBP	O
best	RB	O
interpreted	VBN	O
as	IN	O
true	JJ	O
gamete	NN	O
complementation	NN	O
resulting	VBG	O
in	IN	O
maternal	JJ	B-Disease
UPD	NNP	I-Disease
15	CD	I-Disease
and	CC	O
PWS	NNP	B-Disease

Segregation	NN	O
distortion	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disease	NN	I-Disease
which	WDT	O
,	,	O
in	IN	O
the	DT	O
typical	JJ	O
pedigree	NN	O
,	,	O
shows	VBZ	O
a	DT	O
three	CD	O
generation	NN	O
anticipation	NN	O
cascade	NN	O
.	.	O

This	DT	O
results	VBZ	O
in	IN	O
infertility	NN	B-Disease
and	CC	O
congenital	JJ	B-Disease
myotonic	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
CDM	NN	B-Disease
)	-RRB-	O
with	IN	O
the	DT	O
disappearance	NN	O
of	IN	O
DM	NN	B-Disease
in	IN	O
that	DT	O
pedigree	NN	O
.	.	O

The	DT	O
concept	NN	O
of	IN	O
segregation	NN	O
distortion	NN	O
,	,	O
where	WRB	O
there	EX	O
is	VBZ	O
preferential	JJ	O
transmission	NN	O
of	IN	O
the	DT	O
larger	JJR	O
allele	NN	O
at	IN	O
the	DT	O
DM	NN	B-Disease
locus	NN	O
,	,	O
has	VBZ	O
been	VBN	O
put	VBN	O
forward	RB	O
to	TO	O
explain	VB	O
partially	RB	O
the	DT	O
maintenance	NN	O
of	IN	O
DM	NN	B-Disease
in	IN	O
the	DT	O
population	NN	O
.	.	O

In	IN	O
a	DT	O
survey	NN	O
of	IN	O
DM	NN	B-Disease
in	IN	O
Northern	JJ	O
Ireland	NNP	O
,	,	O
59	CD	O
pedigrees	NNS	O
were	VBD	O
ascertained	VBN	O
.	.	O

Sibships	NNS	O
where	WRB	O
the	DT	O
status	NN	O
of	IN	O
all	PDT	O
the	DT	O
members	NNS	O
had	VBD	O
been	VBN	O
identified	VBN	O
were	VBD	O
examined	VBN	O
to	TO	O
determine	VB	O
the	DT	O
transmission	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
expansion	NN	O
from	IN	O
affected	VBN	O
parents	NNS	O
to	TO	O
their	PRP$	O
offspring	NN	O
.	.	O

Where	WRB	O
the	DT	O
transmitting	VBG	O
parent	NN	O
was	VBD	O
male	JJ	O
,	,	O
58	CD	O
.	.	O

3	CD	O
%	NN	O
of	IN	O
the	DT	O
offspring	NN	O
were	VBD	O
affected	VBN	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
case	NN	O
of	IN	O
a	DT	O
female	JJ	O
transmitting	VBG	O
parent	NN	O
,	,	O
68	CD	O
.	.	O

7	CD	O
%	NN	O
were	VBD	O
affected	VBN	O
.	.	O

Studies	NNS	O
on	IN	O
meiotic	JJ	O
drive	NN	O
in	IN	O
DM	NN	B-Disease
have	VBP	O
shown	VBN	O
increased	VBN	O
transmission	NN	O
of	IN	O
the	DT	O
larger	JJR	O
allele	NN	O
at	IN	O
the	DT	O
DM	NN	B-Disease
locus	NN	O
in	IN	O
non-DM	JJ	O
heterozygotes	NNS	O
for	IN	O
CTGn	NN	O
.	.	O

This	DT	O
study	NN	O
provides	VBZ	O
further	JJ	O
evidence	NN	O
that	IN	O
the	DT	O
DM	NN	B-Disease
expansion	NN	O
tends	VBZ	O
to	TO	O
be	VB	O
transmitted	VBN	O
preferentially	RB	O
.	.	O

Ataxia-telangiectasia	NN	B-Disease
:	:	O
identification	NN	O
and	CC	O
detection	NN	O
of	IN	O
founder-effect	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
in	IN	O
ethnic	JJ	O
populations	NNS	O
.	.	O

To	TO	O
facilitate	VB	O
the	DT	O
evaluation	NN	O
of	IN	O
ATM	NNP	O
heterozygotes	NNS	O
for	IN	O
susceptibility	NN	O
to	TO	O
other	JJ	O
diseases	NNS	O
,	,	O
such	JJ	O
as	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
,	,	O
we	PRP	O
have	VBP	O
attempted	VBN	O
to	TO	O
define	VB	O
the	DT	O
most	RBS	O
common	JJ	O
mutations	NNS	O
and	CC	O
their	PRP$	O
frequencies	NNS	O
in	IN	O
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
homozygotes	NNS	O
from	IN	O
10	CD	O
ethnic	JJ	O
populations	NNS	O
.	.	O

Both	DT	O
genomic	JJ	O
mutations	NNS	O
and	CC	O
their	PRP$	O
effects	NNS	O
on	IN	O
cDNA	NN	O
were	VBD	O
characterized	VBN	O
.	.	O

Protein-truncation	JJ	O
testing	NN	O
of	IN	O
the	DT	O
entire	JJ	O
ATM	NNP	O
cDNA	NN	O
detected	VBD	O
92	CD	O
(	-LRB-	O
66	CD	O
%	NN	O
)	-RRB-	O
truncating	JJ	O
mutations	NNS	O
in	IN	O
140	CD	O
mutant	JJ	O
alleles	NNS	O
screened	VBN	O
.	.	O

The	DT	O
haplotyping	NN	O
of	IN	O
patients	NNS	O
with	IN	O
identical	JJ	O
mutations	NNS	O
indicates	VBZ	O
that	IN	O
almost	RB	O
all	DT	O
of	IN	O
these	DT	O
represent	VBP	O
common	JJ	O
ancestry	NN	O
and	CC	O
that	IN	O
very	RB	O
few	JJ	O
spontaneously	RB	O
recurring	VBG	O
ATM	NNP	O
mutations	NNS	O
exist	VBP	O
.	.	O

Assays	NNS	O
requiring	VBG	O
minimal	JJ	O
amounts	NNS	O
of	IN	O
genomic	JJ	O
DNA	NN	O
were	VBD	O
designed	VBN	O
to	TO	O
allow	VB	O
rapid	JJ	O
screening	NN	O
for	IN	O
common	JJ	O
ethnic	JJ	O
mutations	NNS	O
.	.	O

These	DT	O
rapid	JJ	O
assays	NNS	O
detected	VBD	O
mutations	NNS	O
in	IN	O
76	CD	O
%	NN	O
of	IN	O
Costa	JJ	O
Rican	JJ	O
patients	NNS	O
(	-LRB-	O
3	CD	O
)	-RRB-	O
,	,	O
50	CD	O
%	NN	O
of	IN	O
Norwegian	JJ	O
patients	NNS	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
,	,	O
25	CD	O
%	NN	O
of	IN	O
Polish	JJ	O
patients	NNS	O
(	-LRB-	O
4	CD	O
)	-RRB-	O
,	,	O
and	CC	O
14	CD	O
%	NN	O
of	IN	O
Italian	JJ	O
patients	NNS	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
patients	NNS	O
of	IN	O
Amish/Mennonite	NN	O
and	CC	O
Irish	JJ	O
English	JJ	O
backgrounds	NNS	O
.	.	O

Additional	JJ	O
mutations	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
Japanese	JJ	O
,	,	O
Utah	NNP	O
Mormon	NNP	O
,	,	O
and	CC	O
African	JJ	O
American	JJ	O
patients	NNS	O
.	.	O

These	DT	O
assays	NNS	O
should	MD	O
facilitate	VB	O
screening	NN	O
for	IN	O
A-T	NN	B-Disease
heterozygotes	NNS	O
in	IN	O
the	DT	O
populations	NNS	O
studied	VBN	O
.	.	O

.	.	O

Constitutional	NNP	O
RB1-gene	JJ	O
mutations	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
isolated	VBN	O
unilateral	JJ	B-Disease
retinoblastoma	NN	I-Disease
.	.	O

In	IN	O
most	JJS	O
patients	NNS	O
with	IN	O
isolated	VBN	O
unilateral	JJ	B-Disease
retinoblastoma	NN	I-Disease
,	,	O
tumor	NN	B-Disease
development	NN	O
is	VBZ	O
initiated	VBN	O
by	IN	O
somatic	JJ	O
inactivation	NN	O
of	IN	O
both	CC	O
alleles	NNS	O
of	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
.	.	O

However	RB	O
,	,	O
some	DT	O
of	IN	O
these	DT	O
patients	NNS	O
can	MD	O
transmit	VB	O
retinoblastoma	NN	B-Disease
predisposition	NN	O
to	TO	O
their	PRP$	O
offspring	NN	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
frequency	NN	O
and	CC	O
nature	NN	O
of	IN	O
constitutional	JJ	O
RB1-gene	JJ	O
mutations	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
isolated	VBN	O
unilateral	JJ	B-Disease
retinoblastoma	NN	I-Disease
,	,	O
we	PRP	O
analyzed	VBD	O
DNA	NN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
and	CC	O
from	IN	O
tumor	NN	B-Disease
tissue	NN	O
.	.	O

The	DT	O
analysis	NN	O
of	IN	O
tumors	NNS	B-Disease
from	IN	O
54	CD	O
(	-LRB-	O
71	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
76	CD	O
informative	JJ	O
patients	NNS	O
showed	VBD	O
loss	NN	O
of	IN	O
constitutional	JJ	O
heterozygosity	NN	O
(	-LRB-	O
LOH	NN	O
)	-RRB-	O
at	IN	O
intragenic	JJ	O
loci	NNS	O
.	.	O

Three	CD	O
of	IN	O
13	CD	O
uninformative	JJ	O
patients	NNS	O
had	VBD	O
constitutional	JJ	O
deletions	NNS	O
.	.	O

For	IN	O
39	CD	O
randomly	RB	O
selected	VBN	O
tumors	NNS	B-Disease
,	,	O
SSCP	NN	O
,	,	O
hetero-duplex	JJ	O
analysis	NN	O
,	,	O
sequencing	NN	O
,	,	O
and	CC	O
Southern	NN	O
blot	NN	O
analysis	NN	O
were	VBD	O
used	VBN	O
to	TO	O
identify	VB	O
mutations	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
21	CD	O
(	-LRB-	O
91	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
23	CD	O
tumors	NNS	B-Disease
with	IN	O
LOH	NN	O
.	.	O

In	IN	O
6	CD	O
(	-LRB-	O
38	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
16	CD	O
tumors	NNS	B-Disease
without	IN	O
LOH	NNP	O
,	,	O
one	CD	O
mutation	NN	O
was	VBD	O
detected	VBN	O
,	,	O
and	CC	O
in	IN	O
9	CD	O
(	-LRB-	O
56	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
tumors	NNS	B-Disease
without	IN	O
LOH	NNP	O
,	,	O
both	DT	O
mutations	NNS	O
were	VBD	O
found	VBN	O
.	.	O

Thus	RB	O
,	,	O
a	DT	O
total	NN	O
of	IN	O
45	CD	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
tumors	NNS	B-Disease
of	IN	O
36	CD	O
patients	NNS	O
.	.	O

Thirty-nine	CD	O
of	IN	O
the	DT	O
mutations-including	JJ	O
34	CD	O
small	JJ	O
mutations	NNS	O
,	,	O
2	CD	O
large	JJ	O
structural	JJ	O
alterations	NNS	O
,	,	O
and	CC	O
hypermethylation	NN	O
in	IN	O
3	CD	O
tumors-were	NN	O
not	RB	O
detected	VBN	O
in	IN	O
the	DT	O
corresponding	JJ	O
peripheral	JJ	O
blood	NN	O
DNA	NN	O
.	.	O

In	IN	O
6	CD	O
(	-LRB-	O
17	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
36	CD	O
patients	NNS	O
,	,	O
a	DT	O
mutation	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
constitutional	JJ	O
DNA	NN	O
,	,	O
and	CC	O
1	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
reduced	VBN	O
expressivity	NN	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
a	DT	O
constitutional	JJ	O
mutation	NN	O
was	VBD	O
not	RB	O
associated	VBN	O
with	IN	O
an	DT	O
early	JJ	O
age	NN	O
at	IN	O
treatment	NN	O
.	.	O

In	IN	O
1	CD	O
patient	NN	O
,	,	O
somatic	JJ	O
mosaicism	NN	O
was	VBD	O
demonstrated	VBN	O
by	IN	O
molecular	JJ	O
analysis	NN	O
of	IN	O
DNA	NN	O
and	CC	O
RNA	NN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
.	.	O

In	IN	O
2	CD	O
patients	NNS	O
without	IN	O
a	DT	O
detectable	JJ	O
mutation	NN	O
in	IN	O
peripheral	JJ	O
blood	NN	O
,	,	O
mosaicism	NN	O
was	VBD	O
suggested	VBN	O
because	IN	O
1	CD	O
of	IN	O
the	DT	O
patients	NNS	O
showed	VBD	O
multifocal	JJ	O
tumors	NNS	B-Disease
and	CC	O
the	DT	O
other	JJ	O
later	JJ	O
developed	VBD	O
bilateral	JJ	B-Disease
retinoblastoma	NN	I-Disease
.	.	O

In	IN	O
conclusion	NN	O
,	,	O
our	PRP$	O
results	NNS	O
emphasize	VBP	O
that	IN	O
the	DT	O
manifestation	NN	O
and	CC	O
transmissibility	NN	O
of	IN	O
retinoblastoma	NN	B-Disease
depend	VBP	O
on	IN	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
first	JJ	O
mutation	NN	O
,	,	O
its	PRP$	O
time	NN	O
in	IN	O
development	NN	O
,	,	O
and	CC	O
the	DT	O
number	NN	O
and	CC	O
types	NNS	O
of	IN	O
cells	NNS	O
that	WDT	O
are	VBP	O
affected	VBN	O
.	.	O

.	.	O

Missense	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
most	RBS	O
ancient	JJ	O
residues	NNS	O
of	IN	O
the	DT	O
PAX6	NN	O
paired	JJ	O
domain	NN	O
underlie	VBP	O
a	DT	O
spectrum	NN	O
of	IN	O
human	JJ	O
congenital	JJ	B-Disease
eye	NN	I-Disease
malformations	NNS	I-Disease
.	.	O

Mutations	NNS	O
of	IN	O
the	DT	O
human	JJ	O
PAX6	NN	O
gene	NN	O
underlie	VBP	O
aniridia	NN	B-Disease
(	-LRB-	O
congenital	JJ	B-Disease
absence	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
iris	NN	I-Disease
)	-RRB-	O
,	,	O
a	DT	O
rare	JJ	O
dominant	JJ	O
malformation	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
eye	NN	I-Disease
.	.	O

The	DT	O
spectrum	NN	O
of	IN	O
PAX6	NN	O
mutations	NNS	O
in	IN	O
aniridia	NN	B-Disease
patients	NNS	O
is	VBZ	O
highly	RB	O
biased	VBN	O
,	,	O
with	IN	O
92	CD	O
%	NN	O
of	IN	O
all	DT	O
reported	VBN	O
mutations	NNS	O
leading	VBG	O
to	TO	O
premature	JJ	O
truncation	NN	O
of	IN	O
the	DT	O
protein	NN	O
(	-LRB-	O
nonsense	NN	O
,	,	O
splicing	NN	O
,	,	O
insertions	NNS	O
and	CC	O
deletions	NNS	O
)	-RRB-	O
and	CC	O
just	RB	O
2	CD	O
%	NN	O
leading	VBG	O
to	TO	O
substitution	NN	O
of	IN	O
one	CD	O
amino	NN	O
acid	NN	O
by	IN	O
another	DT	O
(	-LRB-	O
missense	NN	O
)	-RRB-	O
.	.	O

The	DT	O
extraordinary	JJ	O
conservation	NN	O
of	IN	O
the	DT	O
PAX6	NN	O
protein	NN	O
at	IN	O
the	DT	O
amino	NN	O
acid	NN	O
level	NN	O
amongst	IN	O
vertebrates	NNS	O
predicts	VBZ	O
that	IN	O
pathological	JJ	O
missense	NN	O
mutations	NNS	O
should	MD	O
in	IN	O
fact	NN	O
be	VB	O
common	JJ	O
even	RB	O
though	IN	O
they	PRP	O
are	VBP	O
hardly	RB	O
ever	RB	O
seen	VBN	O
in	IN	O
aniridia	NN	B-Disease
patients	NNS	O
.	.	O

This	DT	O
indicates	VBZ	O
that	IN	O
there	EX	O
is	VBZ	O
a	DT	O
heavy	JJ	O
ascertainment	NN	O
bias	NN	O
in	IN	O
the	DT	O
selection	NN	O
of	IN	O
patients	NNS	O
for	IN	O
PAX6	NN	O
mutation	NN	O
analysis	NN	O
and	CC	O
that	IN	O
the	DT	O
missing	VBG	O
PAX6	NN	O
missense	NN	O
mutations	NNS	O
frequently	RB	O
may	MD	O
underlie	VB	O
phenotypes	NNS	O
distinct	JJ	O
from	IN	O
textbook	NN	O
aniridia	NN	B-Disease
.	.	O

Here	RB	O
we	PRP	O
present	VBP	O
four	CD	O
novel	JJ	O
PAX6	NN	O
missense	NN	O
mutations	NNS	O
,	,	O
two	CD	O
in	IN	O
association	NN	O
with	IN	O
atypical	JJ	O
phenotypes	NNS	O
ectopia	JJ	B-Disease
pupillae	NN	I-Disease
(	-LRB-	O
displaced	JJ	B-Disease
pupils	NNS	I-Disease
)	-RRB-	O
and	CC	O
congenital	JJ	B-Disease
nystagmus	NN	I-Disease
(	-LRB-	O
searching	VBG	B-Disease
gaze	VBP	I-Disease
)	-RRB-	O
,	,	O
and	CC	O
two	CD	O
in	IN	O
association	NN	O
with	IN	O
more	JJR	O
recognizable	JJ	O
aniridia	NN	B-Disease
phenotypes	NNS	O
.	.	O

Strikingly	RB	O
,	,	O
all	DT	O
four	CD	O
mutations	NNS	O
are	VBP	O
located	JJ	O
within	IN	O
the	DT	O
PAX6	NN	O
paired	JJ	O
domain	NN	O
and	CC	O
affect	VB	O
amino	NN	O
acids	NNS	O
which	WDT	O
are	VBP	O
highly	RB	O
conserved	VBN	O
in	IN	O
all	DT	O
known	VBN	O
paired	JJ	O
domain	NN	O
proteins	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
support	VBP	O
the	DT	O
hypothesis	NN	O
that	IN	O
the	DT	O
under-representation	NN	O
of	IN	O
missense	NN	O
mutations	NNS	O
is	VBZ	O
caused	VBN	O
by	IN	O
ascertainment	NN	O
bias	NN	O
and	CC	O
suggest	VBP	O
that	IN	O
a	DT	O
substantial	JJ	O
burden	NN	O
of	IN	O
PAX6	NN	B-Disease
-	:	I-Disease
related	JJ	I-Disease
disease	NN	I-Disease
remains	VBZ	O
to	TO	O
be	VB	O
uncovered	VBN	O
.	.	O

.	.	O

Somatic	JJ	O
instability	NN	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
mice	NNS	O
transgenic	JJ	O
for	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
region	NN	O
is	VBZ	O
age	NN	O
dependent	JJ	O
but	CC	O
not	RB	O
correlated	VBD	O
to	TO	O
the	DT	O
relative	JJ	O
intertissue	NN	O
transcription	NN	O
levels	NNS	O
and	CC	O
proliferative	JJ	O
capacities	NNS	O
.	.	O

A	DT	O
(	-LRB-	O
CTG	NNP	O
)	-RRB-	O
nexpansion	NN	O
in	IN	O
the	DT	O
3-untranslated	JJ	O
region	NN	O
(	-LRB-	O
UTR	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
DM	NN	O
protein	NN	O
kinase	NN	O
gene	NN	O
(	-LRB-	O
DMPK	NN	O
)	-RRB-	O
is	VBZ	O
responsible	JJ	O
for	IN	O
causing	VBG	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
.	.	O

Major	JJ	O
instability	NN	O
,	,	O
with	IN	O
very	RB	O
large	JJ	O
expansions	NNS	O
between	IN	O
generations	NNS	O
and	CC	O
high	JJ	O
levels	NNS	O
of	IN	O
somatic	JJ	O
mosaicism	NN	O
,	,	O
is	VBZ	O
observed	VBN	O
in	IN	O
patients	NNS	O
.	.	O

There	EX	O
is	VBZ	O
a	DT	O
good	JJ	O
correlation	NN	O
between	IN	O
repeat	NN	O
size	NN	O
(	-LRB-	O
at	IN	O
least	JJS	O
in	IN	O
leucocytes	NNS	O
)	-RRB-	O
,	,	O
clinical	JJ	O
severity	NN	O
and	CC	O
age	NN	O
of	IN	O
onset	NN	O
.	.	O

The	DT	O
trinucleotide	JJ	O
repeat	NN	O
instability	NN	O
mechanisms	NNS	O
involved	VBN	O
in	IN	O
DM	NN	B-Disease
and	CC	O
other	JJ	O
human	JJ	O
genetic	JJ	B-Disease
diseases	NNS	I-Disease
are	VBP	O
unknown	JJ	O
.	.	O

We	PRP	O
studied	VBD	O
somatic	JJ	O
instability	NN	O
by	IN	O
measuring	VBG	O
the	DT	O
CTG	NNP	O
repeat	NN	O
length	NN	O
at	IN	O
several	JJ	O
ages	NNS	O
in	IN	O
various	JJ	O
tissues	NNS	O
of	IN	O
transgenic	JJ	O
mice	NNS	O
carrying	VBG	O
a	DT	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
55expansion	NN	O
surrounded	VBN	O
by	IN	O
45	CD	O
kb	NN	O
of	IN	O
the	DT	O
human	JJ	O
DM	NN	B-Disease
region	NN	O
,	,	O
using	VBG	O
small-pool	JJ	O
PCR	NN	O
.	.	O

These	DT	O
mice	NNS	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
reproduce	VB	O
the	DT	O
intergenerational	JJ	O
and	CC	O
somatic	JJ	O
instability	NN	O
of	IN	O
the	DT	O
55	CD	O
CTG	NNP	O
repeat	NN	O
suggesting	VBG	O
that	IN	O
surrounding	VBG	O
sequences	NNS	O
and	CC	O
the	DT	O
chromatin	NN	O
environment	NN	O
are	VBP	O
involved	VBN	O
in	IN	O
instability	NN	O
mechanisms	NNS	O
.	.	O

As	IN	O
observed	VBN	O
in	IN	O
some	DT	O
of	IN	O
the	DT	O
tissues	NNS	O
of	IN	O
DM	NN	B-Disease
patients	NNS	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	O
tendency	NN	O
for	IN	O
repeat	NN	O
length	NN	O
and	CC	O
somatic	JJ	O
mosaicism	NN	O
to	TO	O
increase	VB	O
with	IN	O
the	DT	O
age	NN	O
of	IN	O
the	DT	O
mouse	NN	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
observed	VBD	O
no	DT	O
correlation	NN	O
between	IN	O
the	DT	O
somatic	JJ	O
mutation	NN	O
rate	NN	O
and	CC	O
tissue	NN	O
proliferation	NN	O
capacity	NN	O
.	.	O

The	DT	O
somatic	JJ	O
mutation	NN	O
rates	NNS	O
in	IN	O
different	JJ	O
tissues	NNS	O
were	VBD	O
also	RB	O
not	RB	O
correlated	VBN	O
to	TO	O
the	DT	O
relative	JJ	O
inter-tissue	JJ	O
difference	NN	O
in	IN	O
transcriptional	JJ	O
levels	NNS	O
of	IN	O
the	DT	O
three	CD	O
genes	NNS	O
(	-LRB-	O
DMAHP	NN	O
,	,	O
DMPK	NN	O
and	CC	O
59	CD	O
)	-RRB-	O
surrounding	VBG	O
the	DT	O
repeat	NN	O
.	.	O

.	.	O

ATM	NNP	O
mutations	NNS	O
and	CC	O
phenotypes	NNS	O
in	IN	O
ataxia-telangiectasia	JJ	B-Disease
families	NNS	O
in	IN	O
the	DT	O
British	JJ	O
Isles	NNP	O
:	:	O
expression	NN	O
of	IN	O
mutant	JJ	O
ATM	NNP	O
and	CC	O
the	DT	O
risk	NN	O
of	IN	O
leukemia	NN	B-Disease
,	,	O
lymphoma	NN	B-Disease
,	,	O
and	CC	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
report	VBP	O
the	DT	O
spectrum	NN	O
of	IN	O
59	CD	O
ATM	NNP	O
mutations	NNS	O
observed	VBN	O
in	IN	O
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
patients	NNS	O
in	IN	O
the	DT	O
British	JJ	O
Isles	NNP	O
.	.	O

Of	IN	O
51	CD	O
ATM	NNP	O
mutations	NNS	O
identified	VBN	O
in	IN	O
families	NNS	O
native	JJ	O
to	TO	O
the	DT	O
British	JJ	O
Isles	NNP	O
,	,	O
11	CD	O
were	VBD	O
founder	NN	O
mutations	NNS	O
,	,	O
and	CC	O
2	CD	O
of	IN	O
these	DT	O
11	CD	O
conferred	VBD	O
a	DT	O
milder	JJR	O
clinical	JJ	O
phenotype	NN	O
with	IN	O
respect	NN	O
to	TO	O
both	DT	O
cerebellar	JJ	B-Disease
degeneration	NN	I-Disease
and	CC	O
cellular	JJ	O
features	NNS	O
.	.	O

We	PRP	O
report	VBP	O
,	,	O
in	IN	O
two	CD	O
A-T	JJ	B-Disease
families	NNS	O
,	,	O
an	DT	O
ATM	NNP	O
mutation	NN	O
(	-LRB-	O
7271T	NN	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
that	WDT	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
in	IN	O
both	CC	O
homozygotes	NNS	O
and	CC	O
heterozygotes	NNS	O
(	-LRB-	O
relative	JJ	O
risk	NN	O
12	CD	O
.	.	O

7	CD	O
;	:	O
P	NN	O
=	JJ	O
.	.	O

0025	CD	O
)	-RRB-	O
,	,	O
although	IN	O
there	EX	O
is	VBZ	O
a	DT	O
less	RBR	O
severe	JJ	O
A-T	NN	B-Disease
phenotype	NN	O
in	IN	O
terms	NNS	O
of	IN	O
the	DT	O
degree	NN	O
of	IN	O
cerebellar	NN	B-Disease
degeneration	NN	I-Disease
.	.	O

This	DT	O
mutation	NN	O
(	-LRB-	O
7271T	NN	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
also	RB	O
allows	VBZ	O
expression	NN	O
of	IN	O
full-length	JJ	O
ATM	NNP	O
protein	NN	O
at	IN	O
a	DT	O
level	NN	O
comparable	JJ	O
with	IN	O
that	DT	O
in	IN	O
unaffected	JJ	O
individuals	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
18	CD	O
A-T	NN	B-Disease
patients	NNS	O
,	,	O
in	IN	O
15	CD	O
families	NNS	O
,	,	O
who	WP	O
developed	VBD	O
leukemia	NN	B-Disease
,	,	O
lymphoma	NN	B-Disease
,	,	O
preleukemic	JJ	O
T-cell	NN	O
proliferation	NN	O
,	,	O
or	CC	O
Hodgkin	NN	B-Disease
lymphoma	NN	I-Disease
,	,	O
mostly	RB	O
in	IN	O
childhood	NN	O
.	.	O

A	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
ATM	NNP	O
mutation	NN	O
types	NNS	O
,	,	O
including	VBG	O
missense	NN	O
mutations	NNS	O
and	CC	O
in-frame	RB	O
deletions	NNS	O
,	,	O
were	VBD	O
seen	VBN	O
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
25	CD	O
%	NN	O
of	IN	O
all	DT	O
A-T	NN	B-Disease
patients	NNS	O
carried	VBD	O
in-frame	RB	O
deletions	NNS	O
or	CC	O
missense	NN	O
mutations	NNS	O
,	,	O
many	JJ	O
of	IN	O
which	WDT	O
were	VBD	O
also	RB	O
associated	VBN	O
with	IN	O
expression	NN	O
of	IN	O
mutant	JJ	O
ATM	NNP	O
protein	NN	O
.	.	O

Low	JJ	O
frequency	NN	O
of	IN	O
BRCA1	NN	O
germline	NN	O
mutations	NNS	O
in	IN	O
45	CD	O
German	JJ	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
we	PRP	O
investigated	VBD	O
45	CD	O
German	JJ	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
for	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
.	.	O

We	PRP	O
identified	VBD	O
four	CD	O
germline	NN	O
mutations	NNS	O
in	IN	O
three	CD	O
breast	NN	B-Disease
cancer	NN	I-Disease
families	NNS	O
and	CC	O
in	IN	O
one	CD	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
family	NN	O
.	.	O

among	IN	O
these	DT	O
were	VBD	O
one	CD	O
frameshift	NN	O
mutation	NN	O
,	,	O
one	CD	O
nonsense	NN	O
mutation	NN	O
,	,	O
one	CD	O
novel	JJ	O
splice	NN	O
site	NN	O
mutation	NN	O
,	,	O
and	CC	O
one	CD	O
missense	NN	O
mutation	NN	O
.	.	O

The	DT	O
missense	NN	O
mutation	NN	O
was	VBD	O
also	RB	O
found	VBN	O
in	IN	O
2	CD	O
.	.	O

8	CD	O
%	NN	O
of	IN	O
the	DT	O
general	JJ	O
population	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
it	PRP	O
is	VBZ	O
not	RB	O
disease	NN	O
associated	VBN	O
.	.	O

The	DT	O
average	JJ	O
age	NN	O
of	IN	O
disease	NN	O
onset	NN	O
in	IN	O
those	DT	O
families	NNS	O
harbouring	VBG	O
causative	JJ	O
mutations	NNS	O
was	VBD	O
between	IN	O
32	CD	O
.	.	O

3	CD	O
and	CC	O
37	CD	O
.	.	O

4	CD	O
years	NNS	O
,	,	O
whereas	IN	O
the	DT	O
family	NN	O
harbouring	VBG	O
the	DT	O
missense	NN	O
mutation	NN	O
had	VBD	O
an	DT	O
average	JJ	O
age	NN	O
of	IN	O
onset	NN	O
of	IN	O
51	CD	O
.	.	O

2	CD	O
years	NNS	O
.	.	O

These	DT	O
findings	NNS	O
show	VBP	O
that	IN	O
BRCA1	NN	O
is	VBZ	O
implicated	VBN	O
in	IN	O
a	DT	O
small	JJ	O
fraction	NN	O
of	IN	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
suggesting	VBG	O
the	DT	O
involvement	NN	O
of	IN	O
another	DT	O
susceptibility	NN	O
gene	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O

Oral	JJ	O
contraceptives	NNS	O
and	CC	O
the	DT	O
risk	NN	O
of	IN	O
hereditary	JJ	B-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

Hereditary	JJ	B-Disease
Ovarian	JJ	I-Disease
Cancer	NN	I-Disease
Clinical	JJ	O
Study	NNP	O
Group	NNP	O
.	.	O

BACKGROUND	NN	O
Women	NNS	O
with	IN	O
mutations	NNS	O
in	IN	O
either	CC	O
the	DT	O
BRCA1	NN	O
or	CC	O
the	DT	O
BRCA2	NN	O
gene	NN	O
have	VBP	O
a	DT	O
high	JJ	O
lifetime	NN	O
risk	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Oral	JJ	O
contraceptives	NNS	O
protect	VBP	O
against	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
in	IN	O
general	JJ	O
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
known	VBN	O
whether	IN	O
they	PRP	O
also	RB	O
protect	VBP	O
against	IN	O
hereditary	JJ	B-Disease
forms	NNS	I-Disease
of	IN	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

METHODS	NNS	O
We	PRP	O
enrolled	VBD	O
207	CD	O
women	NNS	O
with	IN	O
hereditary	JJ	B-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
and	CC	O
161	CD	O
of	IN	O
their	PRP$	O
sisters	NNS	O
as	IN	O
controls	NNS	O
in	IN	O
a	DT	O
case-control	JJ	O
study	NN	O
.	.	O

All	PDT	O
the	DT	O
patients	NNS	O
carried	VBD	O
a	DT	O
pathogenic	JJ	O
mutation	NN	O
in	IN	O
either	CC	O
BRCA1	NN	O
(	-LRB-	O
179	CD	O
women	NNS	O
)	-RRB-	O
or	CC	O
BRCA2	NN	O
(	-LRB-	O
28	CD	O
women	NNS	O
)	-RRB-	O
.	.	O

The	DT	O
control	NN	O
women	NNS	O
were	VBD	O
enrolled	VBN	O
regardless	RB	O
of	IN	O
whether	IN	O
or	CC	O
not	RB	O
they	PRP	O
had	VBD	O
either	CC	O
mutation	NN	O
.	.	O

Lifetime	NN	O
histories	NNS	O
of	IN	O
oral-contraceptive	JJ	O
use	NN	O
were	VBD	O
obtained	VBN	O
by	IN	O
interview	NN	O
or	CC	O
by	IN	O
written	VBN	O
questionnaire	NN	O
and	CC	O
were	VBD	O
compared	VBN	O
between	IN	O
patients	NNS	O
and	CC	O
control	JJ	O
women	NNS	O
,	,	O
after	IN	O
adjustment	NN	O
for	IN	O
year	NN	O
of	IN	O
birth	NN	O
and	CC	O
parity	NN	O
.	.	O

RESULTS	NNS	O
The	DT	O
adjusted	JJ	O
odds	NNS	O
ratio	NN	O
for	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
associated	VBN	O
with	IN	O
any	DT	O
past	JJ	O
use	NN	O
of	IN	O
oral	JJ	O
contraceptives	NNS	O
was	VBD	O
0	CD	O
.	.	O

5	CD	O
(	-LRB-	O
95	CD	O
percent	NN	O
confidence	NN	O
interval	NN	O
,	,	O
0	CD	O
.	.	O

3	CD	O
to	TO	O
0	CD	O
.	.	O

8	CD	O
)	-RRB-	O
.	.	O

The	DT	O
risk	NN	O
decreased	VBD	O
with	IN	O
increasing	VBG	O
duration	NN	O
of	IN	O
use	NN	O
(	-LRB-	O
P	NN	O
for	IN	O
trend	NN	O
,	,	O
<	JJR	O
0	CD	O
.	.	O

001	CD	O
)	-RRB-	O
;	:	O
use	NN	O
for	IN	O
six	CD	O
or	CC	O
more	JJR	O
years	NNS	O
was	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
60	CD	O
percent	NN	O
reduction	NN	O
in	IN	O
risk	NN	O
.	.	O

Oral-contraceptive	JJ	O
use	NN	O
protected	VBN	O
against	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
both	CC	O
for	IN	O
carriers	NNS	O
of	IN	O
the	DT	O
BRCA1	NN	O
mutation	NN	O
(	-LRB-	O
odds	NNS	O
ratio	NN	O
,	,	O
0	CD	O
.	.	O

5	CD	O
;	:	O
95	CD	O
percent	NN	O
confidence	NN	O
interval	NN	O
,	,	O
0	CD	O
.	.	O

3	CD	O
to	TO	O
0	CD	O
.	.	O

9	CD	O
)	-RRB-	O
and	CC	O
for	IN	O
carriers	NNS	O
of	IN	O
the	DT	O
BRCA2	NN	O
mutation	NN	O
(	-LRB-	O
odds	NNS	O
ratio	NN	O
,	,	O
0	CD	O
.	.	O

4	CD	O
;	:	O
95	CD	O
percent	NN	O
confidence	NN	O
interval	NN	O
,	,	O
0	CD	O
.	.	O

2	CD	O
to	TO	O
1	CD	O
.	.	O

1	LS	O
)	-RRB-	O
.	.	O

CONCLUSIONS	NNS	O
Oral-contraceptive	JJ	O
use	NN	O
may	MD	O
reduce	VB	O
the	DT	O
risk	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
in	IN	O
women	NNS	O
with	IN	O
pathogenic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
or	CC	O
BRCA2	NN	O
gene	NN	O

Founder	NN	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
mutations	NNS	O
in	IN	O
French	JJ	O
Canadian	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
four	CD	O
mutations	NNS	O
in	IN	O
each	DT	O
of	IN	O
the	DT	O
breast	NN	B-Disease
cancer-susceptibility	NN	O
genes	NNS	O
,	,	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
,	,	O
in	IN	O
French	JJ	O
Canadian	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
and	CC	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
from	IN	O
Quebec	NNP	O
.	.	O

To	TO	O
identify	VB	O
founder	NN	O
effects	NNS	O
,	,	O
we	PRP	O
examined	VBD	O
independently	RB	O
ascertained	VBN	O
French	JJ	O
Canadian	JJ	O
cancer	NN	B-Disease
families	NNS	O
for	IN	O
the	DT	O
distribution	NN	O
of	IN	O
these	DT	O
eight	CD	O
mutations	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
41	CD	O
of	IN	O
97	CD	O
families	NNS	O
.	.	O

Six	CD	O
of	IN	O
eight	CD	O
mutations	NNS	O
were	VBD	O
observed	VBN	O
at	IN	O
least	JJS	O
twice	RB	O
.	.	O

The	DT	O
BRCA1	NN	O
C4446T	NN	O
mutation	NN	O
was	VBD	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
found	VBN	O
,	,	O
followed	VBN	O
by	IN	O
the	DT	O
BRCA2	NN	O
8765delAG	NN	O
mutation	NN	O
.	.	O

Together	RB	O
,	,	O
these	DT	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
28	CD	O
of	IN	O
41	CD	O
families	NNS	O
identified	VBN	O
to	TO	O
have	VB	O
a	DT	O
mutation	NN	O
.	.	O

The	DT	O
odds	NNS	O
of	IN	O
detection	NN	O
of	IN	O
any	DT	O
of	IN	O
the	DT	O
four	CD	O
BRCA1	NN	O
mutations	NNS	O
was	VBD	O
18	CD	O
.	.	O

7x	RB	O
greater	JJR	O
if	IN	O
one	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
were	VBD	O
also	RB	O
present	JJ	O
in	IN	O
the	DT	O
family	NN	O
.	.	O

The	DT	O
odds	NNS	O
of	IN	O
detection	NN	O
of	IN	O
any	DT	O
of	IN	O
the	DT	O
four	CD	O
BRCA2	NN	O
mutations	NNS	O
was	VBD	O
5	CD	O
.	.	O

3x	RB	O
greater	JJR	O
if	IN	O
there	EX	O
were	VBD	O
at	IN	O
least	JJS	O
five	CD	O
cases	NNS	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
in	IN	O
the	DT	O
family	NN	O
.	.	O

Interestingly	RB	O
,	,	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
breast	NN	B-Disease
cancer	NN	I-Disease
case	NN	O
<	JJR	O
36	CD	O
years	NNS	O
of	IN	O
age	NN	O
was	VBD	O
strongly	RB	O
predictive	JJ	O
of	IN	O
the	DT	O
presence	NN	O
of	IN	O
any	DT	O
of	IN	O
the	DT	O
eight	CD	O
mutations	NNS	O
screened	VBN	O
.	.	O

Carriers	NNS	O
of	IN	O
the	DT	O
same	JJ	O
mutation	NN	O
,	,	O
from	IN	O
different	JJ	O
families	NNS	O
,	,	O
shared	VBD	O
similar	JJ	O
haplotypes	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
mutant	JJ	O
alleles	NNS	O
were	VBD	O
likely	JJ	O
to	TO	O
be	VB	O
identical	JJ	O
by	IN	O
descent	NN	O
for	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
founder	NN	O
population	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
common	JJ	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
mutations	NNS	O
will	MD	O
facilitate	VB	O
carrier	NN	O
detection	NN	O
in	IN	O
French	JJ	O
Canadian	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
and	CC	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

Truncation	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
transactivation	NN	O
region	NN	O
of	IN	O
PAX6	NN	O
result	NN	O
in	IN	O
dominant-negative	JJ	O
mutants	NNS	O
.	.	O

PAX6	NN	O
is	VBZ	O
a	DT	O
transcription	NN	O
factor	NN	O
with	IN	O
two	CD	O
DNA-binding	JJ	O
domains	NNS	O
(	-LRB-	O
paired	JJ	O
box	NN	O
and	CC	O
homeobox	NN	O
)	-RRB-	O
and	CC	O
a	DT	O
proline-serine-threonine	NN	O
(	-LRB-	O
PST	NN	O
)	-RRB-	O
-	:	O
rich	JJ	O
transactivation	NN	O
domain	NN	O
.	.	O

PAX6	NN	O
regulates	VBZ	O
eye	NN	O
development	NN	O
in	IN	O
animals	NNS	O
ranging	VBG	O
from	IN	O
jellyfish	NN	O
to	TO	O
Drosophila	FW	O
to	TO	O
humans	NNS	O
.	.	O

Heterozygous	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
PAX6	NN	O
gene	NN	O
result	NN	O
in	IN	O
various	JJ	O
phenotypes	NNS	O
,	,	O
including	VBG	O
aniridia	NN	B-Disease
,	,	O
Peters	NNP	B-Disease
anomaly	RB	I-Disease
,	,	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
keratitis	NN	I-Disease
,	,	O
and	CC	O
familial	JJ	B-Disease
foveal	NN	I-Disease
dysplasia	NN	I-Disease
.	.	O

It	PRP	O
is	VBZ	O
believed	VBN	O
that	IN	O
the	DT	O
mutated	VBN	O
allele	NN	O
of	IN	O
PAX6	NN	O
produces	VBZ	O
an	DT	O
inactive	JJ	O
protein	NN	O
and	CC	O
aniridia	NN	B-Disease
is	VBZ	O
caused	VBN	O
due	JJ	O
to	TO	O
genetic	JJ	O
haploinsufficiency	NN	O
.	.	O

However	RB	O
,	,	O
several	JJ	O
truncation	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
to	TO	O
occur	VB	O
in	IN	O
the	DT	O
C-terminal	JJ	O
half	NN	O
of	IN	O
PAX6	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Aniridia	NN	B-Disease
resulting	VBG	O
in	IN	O
mutant	JJ	O
proteins	NNS	O
that	WDT	O
retain	VBP	O
the	DT	O
DNA-binding	JJ	O
domains	NNS	O
but	CC	O
have	VBP	O
lost	VBN	O
most	JJS	O
of	IN	O
the	DT	O
transactivation	NN	O
domain	NN	O
.	.	O

It	PRP	O
is	VBZ	O
not	RB	O
clear	JJ	O
whether	IN	O
such	JJ	O
mutants	NNS	O
really	RB	O
behave	VBP	O
as	IN	O
loss-of-function	JJ	O
mutants	NNS	O
as	IN	O
predicted	VBN	O
by	IN	O
haploinsufficiency	NN	O
.	.	O

Contrary	JJ	O
to	TO	O
this	DT	O
theory	NN	O
,	,	O
our	PRP$	O
data	NNS	O
showed	VBD	O
that	IN	O
these	DT	O
mutants	NNS	O
are	VBP	O
dominant-negative	JJ	O
in	IN	O
transient	JJ	O
transfection	NN	O
assays	NNS	O
when	WRB	O
they	PRP	O
are	VBP	O
coexpressed	VBN	O
with	IN	O
wild-type	JJ	O
PAX6	NN	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
the	DT	O
dominant-negative	JJ	O
effects	NNS	O
result	VBP	O
from	IN	O
the	DT	O
enhanced	VBN	O
DNA	NN	O
binding	NN	O
ability	NN	O
of	IN	O
these	DT	O
mutants	NNS	O
.	.	O

Kinetic	JJ	O
studies	NNS	O
of	IN	O
binding	NN	O
and	CC	O
dissociation	NN	O
revealed	VBD	O
that	IN	O
various	JJ	O
truncation	NN	O
mutants	NNS	O
have	VBP	O
3-5-fold	RB	O
higher	JJR	O
affinity	NN	O
to	TO	O
various	JJ	O
DNA-binding	JJ	O
sites	NNS	O
when	WRB	O
compared	VBN	O
with	IN	O
the	DT	O
wild-type	JJ	O
PAX6	NN	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
a	DT	O
new	JJ	O
insight	NN	O
into	IN	O
the	DT	O
role	NN	O
of	IN	O
mutant	JJ	O
PAX6	NN	O
in	IN	O
causing	VBG	O
aniridia	NN	B-Disease
.	.	O

.	.	O

Crystal	NNP	O
structure	NN	O
of	IN	O
the	DT	O
hemochromatosis	NN	B-Disease
protein	NN	O
HFE	NN	O
and	CC	O
characterization	NN	O
of	IN	O
its	PRP$	O
interaction	NN	O
with	IN	O
transferrin	NN	O
receptor	NN	O
.	.	O

HFE	NN	O
is	VBZ	O
an	DT	O
MHC-related	JJ	O
protein	NN	O
that	WDT	O
is	VBZ	O
mutated	VBN	O
in	IN	O
the	DT	O
iron-overload	JJ	B-Disease
disease	NN	I-Disease
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
.	.	O

HFE	NN	O
binds	VBZ	O
to	TO	O
transferrin	NN	O
receptor	NN	O
(	-LRB-	O
TfR	NN	O
)	-RRB-	O
and	CC	O
reduces	VBZ	O
its	PRP$	O
affinity	NN	O
for	IN	O
iron-loaded	JJ	O
transferrin	NN	O
,	,	O
implicating	VBG	O
HFE	NN	O
in	IN	O
iron	NN	O
metabolism	NN	O
.	.	O

The	DT	O
2	CD	O
.	.	O

6	CD	O
A	NN	O
crystal	NN	O
structure	NN	O
of	IN	O
HFE	NN	O
reveals	VBZ	O
the	DT	O
locations	NNS	O
of	IN	O
hemochromatosis	NN	B-Disease
mutations	NNS	O
and	CC	O
a	DT	O
patch	NN	O
of	IN	O
histidines	NNS	O
that	WDT	O
could	MD	O
be	VB	O
involved	VBN	O
in	IN	O
pH-dependent	JJ	O
interactions	NNS	O
.	.	O

We	PRP	O
also	RB	O
demonstrate	VBP	O
that	IN	O
soluble	JJ	O
TfR	NN	O
and	CC	O
HFE	NN	O
bind	VBP	O
tightly	RB	O
at	IN	O
the	DT	O
basic	JJ	O
pH	NN	O
of	IN	O
the	DT	O
cell	NN	O
surface	NN	O
,	,	O
but	CC	O
not	RB	O
at	IN	O
the	DT	O
acidic	JJ	O
pH	NN	O
of	IN	O
intracellular	JJ	O
vesicles	NNS	O
.	.	O

TfR	NN	O
HFE	NN	O
stoichiometry	NN	O
(	-LRB-	O
2	CD	O
1	LS	O
)	-RRB-	O
differs	VBZ	O
from	IN	O
TfR	NN	O
transferrin	NN	O
stoichiometry	NN	O
(	-LRB-	O
2	CD	O
2	LS	O
)	-RRB-	O
,	,	O
implying	VBG	O
a	DT	O
different	JJ	O
mode	NN	O
of	IN	O
binding	NN	O
for	IN	O
HFE	NN	O
and	CC	O
transferrin	NN	O
to	TO	O
TfR	NN	O
,	,	O
consistent	JJ	O
with	IN	O
our	PRP$	O
demonstration	NN	O
that	IN	O
HFE	NN	O
,	,	O
transferrin	NN	O
,	,	O
and	CC	O
TfR	NN	O
form	VBP	O
a	DT	O
ternary	JJ	O
complex	NN	O
.	.	O

Stable	JJ	O
interaction	NN	O
between	IN	O
the	DT	O
products	NNS	O
of	IN	O
the	DT	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
tumor	NN	B-Disease
suppressor	NN	O
genes	NNS	O
in	IN	O
mitotic	JJ	O
and	CC	O
meiotic	JJ	O
cells	NNS	O
.	.	O

BRCA1	NN	O
and	CC	O
BRCA2	NN	O
account	NN	O
for	IN	O
most	JJS	O
cases	NNS	O
of	IN	O
familial	JJ	O
,	,	O
early	JJ	O
onset	NN	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
and	CC	O
encode	VBP	O
products	NNS	O
that	WDT	O
each	DT	O
interact	VBP	O
with	IN	O
hRAD51	NN	O
.	.	O

Results	NNS	O
presented	VBN	O
here	RB	O
show	VBP	O
that	IN	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
coexist	VBP	O
in	IN	O
a	DT	O
biochemical	JJ	O
complex	NN	O
and	CC	O
colocalize	VB	O
in	IN	O
subnuclear	JJ	O
foci	NNS	O
in	IN	O
somatic	JJ	O
cells	NNS	O
and	CC	O
on	IN	O
the	DT	O
axial	JJ	O
elements	NNS	O
of	IN	O
developing	VBG	O
synaptonemal	JJ	O
complexes	NNS	O
.	.	O

Like	IN	O
BRCA1	NN	O
and	CC	O
RAD51	NN	O
,	,	O
BRCA2	NN	O
relocates	VBZ	O
to	TO	O
PCNA	NN	O
+	CC	O
replication	NN	O
sites	NNS	O
following	VBG	O
exposure	NN	O
of	IN	O
S	NN	O
phase	NN	O
cells	NNS	O
to	TO	O
hydroxyurea	NN	O
or	CC	O
UV	NN	O
irradiation	NN	O
.	.	O

Thus	RB	O
,	,	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
participate	VBP	O
,	,	O
together	RB	O
,	,	O
in	IN	O
a	DT	O
pathway	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
associated	VBN	O
with	IN	O
the	DT	O
activation	NN	O
of	IN	O
double-strand	JJ	O
break	NN	O
repair	NN	O
and/or	CC	O
homologous	JJ	O
recombination	NN	O
.	.	O

Dysfunction	NN	O
of	IN	O
this	DT	O
pathway	NN	O
may	MD	O
be	VB	O
a	DT	O
general	JJ	O
phenomenon	NN	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
cases	NNS	O
of	IN	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

.	.	O

A	DT	O
novel	JJ	O
Arg362Ser	NN	O
mutation	NN	O
in	IN	O
the	DT	O
sterol	NN	O
27-hydroxylase	JJ	O
gene	NN	O
(	-LRB-	O
CYP27	NN	O
)	-RRB-	O
:	:	O
its	PRP$	O
effects	NNS	O
on	IN	O
pre-mRNA	NN	O
splicing	NN	O
and	CC	O
enzyme	NN	O
activity	NN	O
.	.	O

A	DT	O
novel	JJ	O
C	NN	O
to	TO	O
A	DT	O
mutation	NN	O
in	IN	O
the	DT	O
sterol	NN	O
27-hydroxylase	JJ	O
gene	NN	O
(	-LRB-	O
CYP27	NN	O
)	-RRB-	O
was	VBD	O
identified	VBN	O
by	IN	O
sequencing	NN	O
amplified	VBD	O
CYP27	NN	O
gene	NN	O
products	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
(	-LRB-	O
CTX	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
mutation	NN	O
changed	VBD	O
the	DT	O
adrenodoxin	NN	O
cofactor	NN	O
binding	NN	O
residue	NN	O
362Arg	NN	O
to	TO	O
362Ser	NN	O
(	-LRB-	O
CGT	NN	O
362Arg	NN	O
to	TO	O
AGT	NNP	O
362Ser	NN	O
)	-RRB-	O
,	,	O
and	CC	O
was	VBD	O
responsible	JJ	O
for	IN	O
deficiency	NN	O
in	IN	O
the	DT	O
sterol	NN	O
27-hydroxylase	JJ	O
activity	NN	O
,	,	O
as	IN	O
confirmed	VBN	O
by	IN	O
expression	NN	O
of	IN	O
mutant	JJ	O
cDNA	NN	O
into	IN	O
COS-1	NN	O
cells	NNS	O
.	.	O

Quantitative	JJ	O
analysis	NN	O
showed	VBD	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
CYP27	NN	O
gene	NN	O
mRNA	NN	O
in	IN	O
the	DT	O
patient	NN	O
represented	VBD	O
52	CD	O
.	.	O

5	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
level	NN	O
.	.	O

As	IN	O
the	DT	O
mutation	NN	O
occurred	VBD	O
at	IN	O
the	DT	O
penultimate	NN	O
nucleotide	NN	O
of	IN	O
exon	NN	O
6	CD	O
(	-LRB-	O
-2	CD	O
position	NN	O
of	IN	O
exon	NN	O
6-intron	NN	O
6	CD	O
splice	NN	O
site	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
we	PRP	O
hypothesized	VBD	O
that	IN	O
the	DT	O
mutation	NN	O
may	MD	O
partially	RB	O
affect	VB	O
the	DT	O
normal	JJ	O
splicing	NN	O
efficiency	NN	O
in	IN	O
exon	NN	O
6	CD	O
and	CC	O
cause	VB	O
alternative	JJ	O
splicing	NN	O
elsewhere	RB	O
,	,	O
which	WDT	O
resulted	VBD	O
in	IN	O
decreased	VBN	O
transcript	NN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

Transfection	NN	O
of	IN	O
constructed	VBN	O
minigenes	NNS	O
,	,	O
with	IN	O
or	CC	O
without	IN	O
the	DT	O
mutation	NN	O
,	,	O
into	IN	O
COS-1	NN	O
cells	NNS	O
confirmed	VBD	O
that	IN	O
the	DT	O
mutant	JJ	O
minigene	NN	O
was	VBD	O
responsible	JJ	O
for	IN	O
a	DT	O
mRNA	NN	O
species	NNS	O
alternatively	RB	O
spliced	VBN	O
at	IN	O
an	DT	O
activated	VBN	O
cryptic	JJ	O
5	CD	O
splice	NN	O
site	NN	O
88	CD	O
bp	NN	O
upstream	RB	O
from	IN	O
the	DT	O
3	CD	O
end	NN	O
of	IN	O
exon	NN	O
6	CD	O
.	.	O

Our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
C	NN	O
to	TO	O
A	DT	O
mutation	NN	O
at	IN	O
the	DT	O
penultimate	NN	O
nucleotide	NN	O
of	IN	O
exon	NN	O
6	CD	O
of	IN	O
the	DT	O
CYP27	NN	O
gene	NN	O
not	RB	O
only	RB	O
causes	VBZ	O
the	DT	O
deficiency	NN	B-Disease
in	IN	I-Disease
the	DT	I-Disease
sterol	NN	I-Disease
27-hydroxylase	JJ	I-Disease
activity	NN	I-Disease
,	,	O
but	CC	O
also	RB	O
partially	RB	O
leads	VBZ	O
to	TO	O
alternative	JJ	O
pre-mRNA	NN	O
splicing	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

To	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
regarding	VBG	O
effects	NNS	O
on	IN	O
pre-mRNA	NN	O
splicing	NN	O
of	IN	O
a	DT	O
mutation	NN	O
at	IN	O
the	DT	O
-2	CD	O
position	NN	O
of	IN	O
a	DT	O
5	CD	O
splice	NN	O
site	NN	O
.	.	O

A	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
adrenoleukodystrophy	NN	B-Disease
with	IN	O
a	DT	O
codon	NN	O
291	CD	O
deletion	NN	O
:	:	O
a	DT	O
clinical	JJ	O
,	,	O
biochemical	JJ	O
,	,	O
pathological	JJ	O
,	,	O
and	CC	O
genetic	JJ	O
report	NN	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
with	IN	O
a	DT	O
three	CD	O
base	NN	O
pair	NN	O
deletion	NN	O
(	-LRB-	O
delGAG	NN	O
291	CD	O
)	-RRB-	O
in	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
.	.	O

A	DT	O
variety	NN	O
of	IN	O
phenotypes	NNS	O
were	VBD	O
observed	VBN	O
within	IN	O
this	DT	O
family	NN	O
.	.	O

While	IN	O
the	DT	O
proband	NN	O
(	-LRB-	O
patient	NN	O
1	CD	O
)	-RRB-	O
was	VBD	O
classified	VBN	O
as	IN	O
having	VBG	O
a	DT	O
rare	JJ	O
intermediate	JJ	O
type	NN	O
of	IN	O
adult	JJ	O
cerebral	JJ	O
and	CC	O
cerebello-brain	JJ	O
stem	NN	O
forms	NNS	O
,	,	O
his	PRP$	O
younger	JJR	O
brother	NN	O
(	-LRB-	O
patient	NN	O
2	CD	O
)	-RRB-	O
and	CC	O
nephew	NN	O
(	-LRB-	O
patient	NN	O
3	CD	O
)	-RRB-	O
had	VBD	O
a	DT	O
childhood	NN	O
ALD	NN	B-Disease
type	NN	O
.	.	O

Another	DT	O
nephew	NN	O
(	-LRB-	O
patient	NN	O
4	CD	O
)	-RRB-	O
of	IN	O
patient	NN	O
1	CD	O
was	VBD	O
classified	VBN	O
as	IN	O
having	VBG	O
an	DT	O
adolescent	JJ	O
form	NN	O
.	.	O

The	DT	O
tau	NN	O
level	NN	O
in	IN	O
the	DT	O
cerebrospinal	JJ	O
fluid	NN	O
(	-LRB-	O
CSF	NN	O
)	-RRB-	O
in	IN	O
patient	NN	O
1	CD	O
was	VBD	O
as	RB	O
high	JJ	O
as	IN	O
that	DT	O
of	IN	O
patients	NNS	O
with	IN	O
Alzheimers	NNS	B-Disease
disease	NN	I-Disease
(	-LRB-	O
AD	NN	B-Disease
)	-RRB-	O
.	.	O

His	PRP$	O
brain	NN	O
magnetic	JJ	O
resonance	NN	O
image	NN	O
(	-LRB-	O
MRI	NNP	O
)	-RRB-	O
showed	VBD	O
abnormalities	NNS	B-Disease
in	IN	I-Disease
the	DT	I-Disease
bilateral	JJ	I-Disease
cerebellar	NN	I-Disease
hemispheres	NNS	I-Disease
and	CC	O
brain	NN	O
stem	NN	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
the	DT	O
cerebral	JJ	O
white	JJ	O
matter	NN	O
,	,	O
where	WRB	O
marked	JJ	O
reductions	NNS	O
of	IN	O
the	DT	O
cerebral	JJ	O
blood	NN	O
flow	NN	O
and	CC	O
oxygen	NN	O
metabolism	NN	O
were	VBD	O
clearly	RB	O
demonstrated	VBN	O
by	IN	O
positron	JJ	O
emission	NN	O
tomography	NN	O
(	-LRB-	O
PET	NN	O
)	-RRB-	O
.	.	O

In	IN	O
patients	NNS	O
2	CD	O
and	CC	O
3	CD	O
,	,	O
the	DT	O
autopsy	NN	O
findings	NNS	O
showed	VBD	O
massive	JJ	O
demyelination	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
cerebral	JJ	I-Disease
white	JJ	I-Disease
matter	NN	I-Disease
with	IN	O
sparing	NN	O
of	IN	O
the	DT	O
U-fibers	NNS	O
,	,	O
compatible	JJ	O
with	IN	O
the	DT	O
findings	NNS	O
of	IN	O
childhood	NN	O
ALD	NN	B-Disease
.	.	O

Oleic	JJ	O
and	CC	O
erucic	JJ	O
acids	NNS	O
(	-LRB-	O
Lorenzos	NNP	O
Oil	NNP	O
)	-RRB-	O
were	VBD	O
administered	VBN	O
to	TO	O
patients	NNS	O
1	CD	O
and	CC	O
4	CD	O
,	,	O
but	CC	O
sufficient	JJ	O
effectiveness	NN	O
was	VBD	O
not	RB	O
obtained	VBN	O
.	.	O

The	DT	O
findings	NNS	O
in	IN	O
this	DT	O
family	NN	O
suggest	VBP	O
that	IN	O
delGAG291	NN	O
is	VBZ	O
part	NN	O
of	IN	O
the	DT	O
cause	NN	O
of	IN	O
Japanese	JJ	O
ALD	NN	B-Disease
with	IN	O
phenotypic	JJ	O
variations	NNS	O
.	.	O

Moreover	RB	O
,	,	O
although	IN	O
the	DT	O
scale	NN	O
of	IN	O
the	DT	O
study	NN	O
is	VBZ	O
limited	VBN	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	O
possibility	NN	O
that	IN	O
PET	NN	O
can	MD	O
detect	VB	O
an	DT	O
insidious	JJ	B-Disease
lesion	NN	I-Disease
which	WDT	O
is	VBZ	O
undetectable	JJ	O
by	IN	O
computed	JJ	O
tomogram	NN	O
(	-LRB-	O
CT	NN	O
)	-RRB-	O
or	CC	O
MRI	NNP	O
analysis	NN	O
,	,	O
and	CC	O
that	IN	O
the	DT	O
higher	JJR	O
level	NN	O
of	IN	O
tau	NN	O
reflects	VBZ	O
the	DT	O
process	NN	O
of	IN	O
neuronal	JJ	B-Disease
degeneration	NN	I-Disease
in	IN	O
ALD	NNP	B-Disease
.	.	O

Lorenzos	NNP	O
Oil	NNP	O
should	MD	O
be	VB	O
given	VBN	O
in	IN	O
the	DT	O
early	JJ	O
stage	NN	O
.	.	O

.	.	O

Two	CD	O
frequent	JJ	O
missense	NN	O
mutations	NNS	O
in	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Pendred	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
early	JJ	O
childhood	NN	O
deafness	NN	B-Disease
and	CC	O
goiter	NN	B-Disease
.	.	O

A	DT	O
century	NN	O
after	IN	O
its	PRP$	O
recognition	NN	O
as	IN	O
a	DT	O
syndrome	NN	O
by	IN	O
Vaughan	NNP	O
Pendred	NNP	O
,	,	O
the	DT	O
disease	NN	O
gene	NN	O
(	-LRB-	O
PDS	NN	O
)	-RRB-	O
was	VBD	O
mapped	VBN	O
to	TO	O
chromosome	NN	O
7q22-q31	NN	O
.	.	O

1	CD	O
and	CC	O
,	,	O
recently	RB	O
,	,	O
found	VBN	O
to	TO	O
encode	VB	O
a	DT	O
putative	JJ	O
sulfate	NN	O
transporter	NN	O
.	.	O

We	PRP	O
performed	VBD	O
mutation	NN	O
analysis	NN	O
of	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
in	IN	O
patients	NNS	O
from	IN	O
14	CD	O
Pendred	JJ	B-Disease
families	NNS	O
originating	VBG	O
from	IN	O
seven	CD	O
countries	NNS	O
and	CC	O
identified	VBD	O
all	DT	O
mutations	NNS	O
.	.	O

The	DT	O
mutations	NNS	O
include	VBP	O
three	CD	O
single	JJ	O
base	NN	O
deletions	NNS	O
,	,	O
one	CD	O
splice	NN	O
site	NN	O
mutation	NN	O
and	CC	O
10	CD	O
missense	NN	O
mutations	NNS	O
.	.	O

One	CD	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
L236P	NN	O
)	-RRB-	O
was	VBD	O
found	VBN	O
in	IN	O
a	DT	O
homozygous	JJ	O
state	NN	O
in	IN	O
two	CD	O
consanguineous	JJ	O
families	NNS	O
and	CC	O
in	IN	O
a	DT	O
heterozygous	JJ	O
state	NN	O
in	IN	O
five	CD	O
additional	JJ	O
non-consanguineous	JJ	O
families	NNS	O
.	.	O

Another	DT	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
T416P	NN	O
)	-RRB-	O
was	VBD	O
found	VBN	O
in	IN	O
a	DT	O
homozygous	JJ	O
state	NN	O
in	IN	O
one	CD	O
family	NN	O
and	CC	O
in	IN	O
a	DT	O
heterozygous	JJ	O
state	NN	O
in	IN	O
four	CD	O
families	NNS	O
.	.	O

Pendred	JJ	B-Disease
patients	NNS	O
in	IN	O
three	CD	O
non-consanguineous	JJ	O
families	NNS	O
were	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
compound	JJ	O
heterozygotes	NNS	O
for	IN	O
L236P	NN	O
and	CC	O
T416P	NN	O
.	.	O

In	IN	O
total	NN	O
,	,	O
one	CD	O
or	CC	O
both	DT	O
of	IN	O
these	DT	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
nine	CD	O
of	IN	O
the	DT	O
14	CD	O
families	NNS	O
analyzed	VBN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
two	CD	O
frequent	JJ	O
PDS	NN	B-Disease
mutations	NNS	O
will	MD	O
facilitate	VB	O
the	DT	O
molecular	JJ	O
diagnosis	NN	O
of	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Aspartylglucosaminuria	NN	B-Disease
among	IN	O
Palestinian	JJ	O
Arabs	NNPS	O
.	.	O

Aspartylglucosaminuria	NN	B-Disease
(	-LRB-	O
AGU	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
rare	JJ	O
disorder	NN	B-Disease
of	IN	I-Disease
glycoprotein	NN	I-Disease
metabolism	NN	I-Disease
caused	VBN	O
by	IN	O
the	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
lysosomal	JJ	I-Disease
enzyme	NN	I-Disease
aspartylglucosaminidase	NN	I-Disease
(	-LRB-	O
AGA	NN	O
)	-RRB-	O
.	.	O

AGU	NNP	B-Disease
is	VBZ	O
inherited	VBN	O
as	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
and	CC	O
occurs	VBZ	O
with	IN	O
a	DT	O
high	JJ	O
frequency	NN	O
in	IN	O
Finland	NNP	O
because	IN	O
of	IN	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

While	IN	O
very	RB	O
few	JJ	O
patients	NNS	O
with	IN	O
AGU	NN	B-Disease
have	VBP	O
been	VBN	O
reported	VBN	O
from	IN	O
non-Finnish	JJ	O
origin	NN	O
,	,	O
we	PRP	O
diagnosed	VBD	O
the	DT	O
disorder	NN	O
in	IN	O
8	CD	O
patients	NNS	O
originating	VBG	O
from	IN	O
3	CD	O
unrelated	JJ	O
families	NNS	O
,	,	O
all	DT	O
Palestinian	JJ	O
Arabs	NNPS	O
from	IN	O
the	DT	O
region	NN	O
of	IN	O
Jerusalem	NNP	O
.	.	O

The	DT	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
AGU	NNP	B-Disease
is	VBZ	O
often	RB	O
difficult	JJ	O
,	,	O
in	IN	O
particular	JJ	O
early	JJ	O
in	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
disease	NN	O
,	,	O
and	CC	O
most	JJS	O
of	IN	O
the	DT	O
patients	NNS	O
are	VBP	O
diagnosed	VBN	O
after	IN	O
the	DT	O
age	NN	O
of	IN	O
5	CD	O
years	NNS	O
.	.	O

However	RB	O
,	,	O
since	IN	O
these	DT	O
patients	NNS	O
excrete	VBP	O
early	RB	O
large	JJ	O
amounts	NNS	O
of	IN	O
aspartylglucosamine	NN	O
in	IN	O
urine	NN	O
,	,	O
biochemical	JJ	O
screening	NN	O
is	VBZ	O
easy	JJ	O
by	IN	O
urine	NN	O
chromatography	NN	O
.	.	O

.	.	O

Mutation	NN	O
spectrum	NN	O
and	CC	O
genotype-phenotype	NN	O
analyses	NNS	O
in	IN	O
Cowden	NNP	B-Disease
disease	NN	I-Disease
and	CC	O
Bannayan-Zonana	NN	B-Disease
syndrome	NN	I-Disease
,	,	O
two	CD	O
hamartoma	NN	B-Disease
syndromes	NNS	I-Disease
with	IN	O
germline	NN	O
PTEN	NN	O
mutation	NN	O
.	.	O

The	DT	O
tumour	NN	B-Disease
suppressor	NN	O
gene	NN	O
PTEN	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
10q23	NN	O
.	.	O

3	CD	O
and	CC	O
encodes	VBZ	O
a	DT	O
403	CD	O
amino	NN	O
acid	NN	O
dual	JJ	O
specificity	NN	O
phosphatase	NN	O
(	-LRB-	O
protein	NN	O
tyrosine	NN	O
phosphatase	NN	O
;	:	O
PTPase	NN	O
)	-RRB-	O
,	,	O
was	VBD	O
shown	VBN	O
recently	RB	O
to	TO	O
play	VB	O
a	DT	O
broad	JJ	O
role	NN	O
in	IN	O
human	JJ	O
malignancy	NN	B-Disease
.	.	O

Somatic	JJ	O
PTEN	NN	O
deletions	NNS	O
and	CC	O
mutations	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
sporadic	JJ	B-Disease
breast	NN	I-Disease
,	,	I-Disease
brain	NN	I-Disease
,	,	I-Disease
prostate	NN	I-Disease
and	CC	I-Disease
kidney	NN	I-Disease
cancer	NN	I-Disease
cell	NN	O
lines	NNS	O
and	CC	O
in	IN	O
several	JJ	O
primary	JJ	O
tumours	NNS	B-Disease
such	JJ	O
as	IN	O
endometrial	JJ	B-Disease
carcinomas	NNS	I-Disease
,	,	O
malignant	JJ	B-Disease
melanoma	NN	I-Disease
and	CC	O
thyroid	NN	B-Disease
tumours	NNS	I-Disease
.	.	O

In	IN	O
addition	NN	O
,	,	O
PTEN	NN	O
was	VBD	O
identified	VBN	O
as	IN	O
the	DT	O
susceptibility	NN	O
gene	NN	O
for	IN	O
two	CD	O
hamartoma	NN	B-Disease
syndromes	NNS	I-Disease
Cowden	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
CD	NN	B-Disease
;	:	O
MIM	NNP	O
158350	CD	O
)	-RRB-	O
and	CC	O
Bannayan-Zonana	NNP	B-Disease
(	-LRB-	I-Disease
BZS	NNP	I-Disease
)	-RRB-	I-Disease
or	CC	I-Disease
Ruvalcaba-Riley-Smith	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
MIM	NNP	O
153480	CD	O
)	-RRB-	O
.	.	O

Constitutive	JJ	O
DNA	NN	O
from	IN	O
37	CD	O
CD	NNP	B-Disease
families	NNS	O
and	CC	O
seven	CD	O
BZS	NNS	B-Disease
families	NNS	O
was	VBD	O
screened	VBN	O
for	IN	O
germline	NN	O
PTEN	NN	O
mutations	NNS	O
.	.	O

PTEN	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
30	CD	O
of	IN	O
37	CD	O
(	-LRB-	O
81	CD	O
%	NN	O
)	-RRB-	O
CD	NN	B-Disease
families	NNS	O
,	,	O
including	VBG	O
missense	NN	O
and	CC	O
nonsense	NN	O
point	NN	O
mutations	NNS	O
,	,	O
deletions	NNS	O
,	,	O
insertions	NNS	O
,	,	O
a	DT	O
deletion/insertion	NN	O
and	CC	O
splice	NN	O
site	NN	O
mutations	NNS	O
.	.	O

These	DT	O
mutations	NNS	O
were	VBD	O
scattered	VBN	O
over	IN	O
the	DT	O
entire	JJ	O
length	NN	O
of	IN	O
PTEN	NNP	O
,	,	O
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
the	DT	O
first	JJ	O
,	,	O
fourth	JJ	O
and	CC	O
last	JJ	O
exons	NNS	O
.	.	O

A	DT	O
hot	JJ	O
spot	NN	O
for	IN	O
PTEN	NN	O
mutation	NN	O
in	IN	O
CD	NNP	B-Disease
was	VBD	O
identified	VBN	O
in	IN	O
exon	NN	O
5	CD	O
that	WDT	O
contains	VBZ	O
the	DT	O
PTPase	NN	O
core	NN	O
motif	NN	O
,	,	O
with	IN	O
13	CD	O
of	IN	O
30	CD	O
(	-LRB-	O
43	CD	O
%	NN	O
)	-RRB-	O
CD	NN	B-Disease
mutations	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
exon	NN	O
.	.	O

Seven	CD	O
of	IN	O
30	CD	O
(	-LRB-	O
23	CD	O
%	NN	O
)	-RRB-	O
were	VBD	O
within	IN	O
the	DT	O
core	NN	O
motif	NN	O
,	,	O
the	DT	O
majority	NN	O
(	-LRB-	O
five	CD	O
of	IN	O
seven	CD	O
)	-RRB-	O
of	IN	O
which	WDT	O
were	VBD	O
missense	NN	O
mutations	NNS	O
,	,	O
possibly	RB	O
pointing	VBG	O
to	TO	O
the	DT	O
functional	JJ	O
significance	NN	O
of	IN	O
this	DT	O
region	NN	O
.	.	O

Germline	NN	O
PTEN	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
four	CD	O
of	IN	O
seven	CD	O
(	-LRB-	O
57	CD	O
%	NN	O
)	-RRB-	O
BZS	NN	B-Disease
families	NNS	O
studied	VBN	O
.	.	O

Interestingly	RB	O
,	,	O
none	NN	O
of	IN	O
these	DT	O
mutations	NNS	O
was	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
PTPase	NN	O
core	NN	O
motif	NN	O
.	.	O

It	PRP	O
is	VBZ	O
also	RB	O
worthy	JJ	O
of	IN	O
note	NN	O
that	IN	O
a	DT	O
single	JJ	O
nonsense	NN	O
point	NN	O
mutation	NN	O
,	,	O
R233X	NN	O
,	,	O
was	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
germline	NN	O
DNA	NN	O
from	IN	O
two	CD	O
unrelated	JJ	O
CD	NNP	B-Disease
families	NNS	O
and	CC	O
one	CD	O
BZS	NN	B-Disease
family	NN	O
.	.	O

Genotype-phenotype	JJ	O
studies	NNS	O
were	VBD	O
not	RB	O
performed	VBN	O
on	IN	O
this	DT	O
small	JJ	O
group	NN	O
of	IN	O
BZS	NNP	B-Disease
families	NNS	O
.	.	O

However	RB	O
,	,	O
genotype-phenotype	JJ	O
analysis	NN	O
inthe	NN	O
group	NN	O
of	IN	O
CD	NNP	B-Disease
families	NNS	O
revealed	VBD	O
two	CD	O
possible	JJ	O
associations	NNS	O
worthy	JJ	O
of	IN	O
follow-up	NN	O
in	IN	O
independent	JJ	O
analyses	NNS	O
.	.	O

The	DT	O
first	JJ	O
was	VBD	O
an	DT	O
association	NN	O
noted	VBD	O
in	IN	O
the	DT	O
group	NN	O
of	IN	O
CD	NNP	B-Disease
families	NNS	O
with	IN	O
breast	NN	B-Disease
disease	NN	I-Disease
.	.	O

A	DT	O
correlation	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
the	DT	O
presence/absence	NN	O
of	IN	O
a	DT	O
PTEN	NN	O
mutation	NN	O
and	CC	O
the	DT	O
type	NN	O
of	IN	O
breast	NN	O
involvement	NN	O
(	-LRB-	O
unaffected	JJ	O
versus	CC	O
benign	JJ	O
versus	CC	O
malignant	JJ	O
)	-RRB-	O
.	.	O

Specifically	RB	O
and	CC	O
more	RBR	O
directly	RB	O
,	,	O
an	DT	O
association	NN	O
was	VBD	O
also	RB	O
observed	VBN	O
between	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
PTEN	NN	O
mutation	NN	O
and	CC	O
malignant	JJ	B-Disease
breast	NN	I-Disease
disease	NN	I-Disease
.	.	O

Secondly	RB	O
,	,	O
there	EX	O
appeared	VBD	O
to	TO	O
be	VB	O
an	DT	O
interdependent	JJ	O
association	NN	O
between	IN	O
mutations	NNS	O
upstream	JJ	O
and	CC	O
within	IN	O
the	DT	O
PTPase	NN	O
core	NN	O
motif	NN	O
,	,	O
the	DT	O
core	NN	O
motif	NN	O
containing	VBG	O
the	DT	O
majority	NN	O
of	IN	O
missense	NN	O
mutations	NNS	O
,	,	O
and	CC	O
the	DT	O
involvement	NN	O
of	IN	O
all	DT	O
major	JJ	O
organ	NN	O
systems	NNS	O
(	-LRB-	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
thyroid	NN	O
,	,	O
breast	NN	O
,	,	O
skin	NN	O
and	CC	O
gastrointestinal	JJ	O
tract	NN	O
)	-RRB-	O
.	.	O

However	RB	O
,	,	O
these	DT	O
observations	NNS	O
would	MD	O
need	VB	O
to	TO	O
be	VB	O
confirmed	VBN	O
by	IN	O
studying	VBG	O
a	DT	O
larger	JJR	O
number	NN	O
of	IN	O
CD	NNP	B-Disease
families	NNS	O
.	.	O

I1307K	CD	O
APC	NN	O
and	CC	O
hMLH1	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
non-Jewish	JJ	O
family	NN	O
with	IN	O
hereditary	JJ	B-Disease
non-polyposis	JJ	I-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
French	JJ	O
Canadian	JJ	O
hereditary	JJ	B-Disease
non-polyposis	JJ	I-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
(	-LRB-	O
HNPCC	NN	B-Disease
)	-RRB-	O
kindred	NN	O
which	WDT	O
carries	VBZ	O
a	DT	O
novel	JJ	O
truncating	JJ	O
mutation	NN	O
in	IN	O
hMLH1	NN	O
.	.	O

Interestingly	RB	O
,	,	O
the	DT	O
I1307K	NN	O
APC	NN	O
polymorphism	NN	O
,	,	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
,	,	O
is	VBZ	O
also	RB	O
present	JJ	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

The	DT	O
I1307K	NN	O
polymorphism	NN	O
has	VBZ	O
previously	RB	O
only	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
individuals	NNS	O
of	IN	O
self-reported	JJ	O
Ashkenazi	NNP	O
Jewish	NNP	O
origins	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
in	IN	O
this	DT	O
family	NN	O
,	,	O
there	EX	O
appears	VBZ	O
to	TO	O
be	VB	O
no	DT	O
relationship	NN	O
between	IN	O
the	DT	O
I1307K	NN	O
polymorphism	NN	O
and	CC	O
the	DT	O
presence	NN	O
or	CC	O
absence	NN	O
of	IN	O
cancer	NN	B-Disease
.	.	O

.	.	O

Wilms	NN	B-Disease
'	POS	I-Disease
tumor	NN	I-Disease
1	CD	O
and	CC	O
Dax-1	NN	O
modulate	VBP	O
the	DT	O
orphan	NN	O
nuclear	JJ	O
receptor	NN	O
SF-1	NN	O
in	IN	O
sex-specific	JJ	O
gene	NN	O
expression	NN	O
.	.	O

Products	NNPS	O
of	IN	O
steroidogenic	JJ	O
factor	NN	O
1	CD	O
(	-LRB-	O
SF-1	NN	O
)	-RRB-	O
and	CC	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
1	CD	O
(	-LRB-	O
WT1	NN	O
)	-RRB-	O
genes	NNS	O
are	VBP	O
essential	JJ	O
for	IN	O
mammalian	JJ	O
gonadogenesis	NN	O
prior	RB	O
to	TO	O
sexual	JJ	O
differentiation	NN	O
.	.	O

In	IN	O
males	NNS	O
,	,	O
SF-1	NN	O
participates	VBZ	O
in	IN	O
sexual	JJ	O
development	NN	O
by	IN	O
regulating	VBG	O
expression	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
hormone	NN	O
Mullerian	JJ	O
inhibiting	VBG	O
substance	NN	O
(	-LRB-	O
MIS	NN	O
)	-RRB-	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
WT1	NN	O
-	:	O
KTS	NN	O
isoforms	NNS	O
associate	VBP	O
and	CC	O
synergize	VBP	O
with	IN	O
SF-1	NN	O
to	TO	O
promote	VB	O
MIS	NN	O
expression	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
WT1	NN	O
missense	NN	O
mutations	NNS	O
,	,	O
associated	VBN	O
with	IN	O
male	JJ	B-Disease
pseudohermaphroditism	NN	I-Disease
in	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
fail	VBP	O
to	TO	O
synergize	VB	O
with	IN	O
SF-1	NN	O
.	.	O

Additionally	RB	O
,	,	O
the	DT	O
X-linked	JJ	O
,	,	O
candidate	NN	O
dosage-sensitive	JJ	O
sex-reversal	JJ	O
gene	NN	O
,	,	O
Dax-1	NN	O
,	,	O
antagonizes	VBZ	O
synergy	NN	O
between	IN	O
SF-1	NN	O
and	CC	O
WT1	NN	O
,	,	O
most	RBS	O
likely	RB	O
through	IN	O
a	DT	O
direct	JJ	O
interaction	NN	O
with	IN	O
SF-1	NN	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
WT1	NN	O
and	CC	O
Dax-1	NN	O
functionally	RB	O
oppose	VBP	O
each	DT	O
other	JJ	O
in	IN	O
testis	NN	O
development	NN	O
by	IN	O
modulating	VBG	O
SF-1-mediated	JJ	O
transactivation	NN	O
.	.	O

.	.	O

Ethnic	JJ	O
differences	NNS	O
in	IN	O
the	DT	O
HFE	NN	O
codon	NN	O
282	CD	O
(	-LRB-	O
Cys/Tyr	NN	O
)	-RRB-	O
polymorphism	NN	O
.	.	O

Recent	JJ	O
studies	NNS	O
have	VBP	O
shown	VBN	O
that	IN	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
(	-LRB-	O
HH	NN	B-Disease
)	-RRB-	O
is	VBZ	O
likely	JJ	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
homozygosity	NN	O
for	IN	O
a	DT	O
Cys282Tyr	NN	O
mutation	NN	O
in	IN	O
the	DT	O
HFE	NN	O
gene	NN	O
located	JJ	O
4	CD	O
.	.	O

5	CD	O
Mb	NN	O
telomeric	JJ	O
to	TO	O
HLA-A	NN	O
.	.	O

Population	NNP	O
studies	NNS	O
of	IN	O
this	DT	O
polymorphism	NN	O
are	VBP	O
facilitated	VBN	O
by	IN	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
Cys282Tyr	NN	O
mutation	NN	O
creates	VBZ	O
a	DT	O
Rsal	JJ	O
restriction	NN	O
site	NN	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
codon	NN	O
282	CD	O
(	-LRB-	O
Cys/Tyr	NN	O
)	-RRB-	O
polymorphism	NN	O
in	IN	O
different	JJ	O
ethnic	JJ	O
groups	NNS	O
.	.	O

In	IN	O
agreement	NN	O
with	IN	O
previous	JJ	O
observations	NNS	O
the	DT	O
Tyr	NNP	O
allele	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
rare	JJ	O
or	CC	O
absent	JJ	O
in	IN	O
Asiatic	NNP	O
(	-LRB-	O
Indian	NNP	O
,	,	O
Chinese	NNP	O
)	-RRB-	O
populations	NNS	O
.	.	O

The	DT	O
highest	JJS	O
allele	NN	O
frequency	NN	O
(	-LRB-	O
7	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
was	VBD	O
found	VBN	O
in	IN	O
Swedes	NNS	O
.	.	O

Saamis	FW	O
(	-LRB-	O
2	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
Mordvinians	NNS	O
(	-LRB-	O
1	CD	O
.	.	O

8	CD	O
%	NN	O
)	-RRB-	O
had	VBD	O
significantly	RB	O
lower	JJR	O
frequencies	NNS	O
of	IN	O
the	DT	O
Tyr	NNP	O
allele	NN	O
.	.	O

Comparisons	NNS	O
with	IN	O
allele	NN	O
frequencies	NNS	O
based	VBN	O
on	IN	O
prevalence	NN	O
estimates	NNS	O
of	IN	O
HH	NN	B-Disease
showed	VBD	O
some	DT	O
disagreements	NNS	O
with	IN	O
the	DT	O
RFLP	NN	O
data	NNS	O
,	,	O
particularly	RB	O
in	IN	O
Finns	NNS	O
.	.	O

The	DT	O
newly	RB	O
described	VBN	O
HFE	NN	O
marker	NN	O
provides	VBZ	O
a	DT	O
new	JJ	O
approach	NN	O
to	TO	O
the	DT	O
screening	NN	O
of	IN	O
HH	NN	B-Disease
as	RB	O
well	RB	O
as	IN	O
studies	NNS	O
of	IN	O
the	DT	O
relationship	NN	O
between	IN	O
the	DT	O
HFE	NNP	O
Tyr	NNP	O
allele	NN	O
and	CC	O
different	JJ	O
disorders	NNS	O
including	VBG	O
cancer	NN	B-Disease

Risk	NN	O
reversals	NNS	O
in	IN	O
predictive	JJ	O
testing	NN	O
for	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
first	JJ	O
predictive	JJ	O
testing	NN	O
for	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
was	VBD	O
based	VBN	O
on	IN	O
analysis	NN	O
of	IN	O
linked	VBN	O
polymorphic	JJ	O
DNA	NN	O
markers	NNS	O
to	TO	O
estimate	VB	O
the	DT	O
likelihood	NN	O
of	IN	O
inheriting	VBG	O
the	DT	O
mutation	NN	O
for	IN	O
HD	NN	B-Disease
.	.	O

Limits	NNS	O
to	TO	O
accuracy	NN	O
included	VBD	O
recombination	NN	O
between	IN	O
the	DT	O
DNA	NN	O
markers	NNS	O
and	CC	O
the	DT	O
mutation	NN	O
,	,	O
pedigree	NN	O
structure	NN	O
,	,	O
and	CC	O
whether	IN	O
DNA	NN	O
samples	NNS	O
were	VBD	O
available	JJ	O
from	IN	O
family	NN	O
members	NNS	O
.	.	O

With	IN	O
direct	JJ	O
tests	NNS	O
for	IN	O
the	DT	O
HD	NN	B-Disease
mutation	NN	O
,	,	O
we	PRP	O
have	VBP	O
assessed	VBN	O
the	DT	O
accuracy	NN	O
of	IN	O
results	NNS	O
obtained	VBN	O
by	IN	O
linkage	NN	O
approaches	NNS	O
when	WRB	O
requested	VBN	O
to	TO	O
do	VB	O
so	RB	O
by	IN	O
the	DT	O
test	NN	O
individuals	NNS	O
.	.	O

For	IN	O
six	CD	O
such	JJ	O
individuals	NNS	O
,	,	O
there	EX	O
was	VBD	O
significant	JJ	O
disparity	NN	O
between	IN	O
the	DT	O
tests	NNS	O
.	.	O

Three	CD	O
went	VBD	O
from	IN	O
a	DT	O
decreased	VBN	O
risk	NN	O
to	TO	O
an	DT	O
increased	VBN	O
risk	NN	O
,	,	O
while	IN	O
in	IN	O
another	DT	O
three	CD	O
the	DT	O
risk	NN	O
was	VBD	O
decreased	VBN	O
.	.	O

Knowledge	NN	O
of	IN	O
the	DT	O
potential	JJ	O
reasons	NNS	O
for	IN	O
these	DT	O
changes	NNS	O
in	IN	O
results	NNS	O
and	CC	O
impact	NN	O
of	IN	O
these	DT	O
risk	NN	O
reversals	NNS	O
on	IN	O
both	DT	O
patients	NNS	O
and	CC	O
the	DT	O
counseling	NN	O
team	NN	O
can	MD	O
assist	VB	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
strategies	NNS	O
for	IN	O
the	DT	O
prevention	NN	O
and	CC	O
,	,	O
where	WRB	O
necessary	JJ	O
,	,	O
management	NN	O
of	IN	O
a	DT	O
risk	NN	O
reversal	NN	O
in	IN	O
any	DT	O
predictive	JJ	O
testing	NN	O
program	NN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
three	CD	O
novel	JJ	O
mutations	NNS	O
and	CC	O
a	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
the	DT	O
Arg778Leu	NN	O
mutation	NN	O
in	IN	O
Korean	JJ	O
patients	NNS	O
with	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
.	.	O

Four	CD	O
mutations	NNS	O
--	:	O
R778L	NN	O
,	,	O
A874V	NN	O
,	,	O
L1083F	NN	O
,	,	O
and	CC	O
2304delC	NN	O
--	:	O
in	IN	O
the	DT	O
copper-transporting	JJ	O
enzyme	NN	O
,	,	O
P-type	JJ	O
ATPase	NN	O
(	-LRB-	O
ATP7B	NN	O
)	-RRB-	O
,	,	O
were	VBD	O
identified	VBN	O
in	IN	O
Korean	JJ	O
Patients	NNS	O
with	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
.	.	O

Arg778Leu	NN	O
,	,	O
the	DT	O
most	RBS	O
frequently	RB	O
reported	VBN	O
mutation	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
,	,	O
was	VBD	O
found	VBN	O
in	IN	O
six	CD	O
of	IN	O
eight	CD	O
unrelated	JJ	O
patients	NNS	O
studied	VBN	O
,	,	O
an	DT	O
allele	NN	O
frequency	NN	O
of	IN	O
37	CD	O
.	.	O

5	CD	O
%	NN	O
,	,	O
which	WDT	O
is	VBZ	O
considerably	RB	O
higher	JJR	O
than	IN	O
those	DT	O
in	IN	O
other	JJ	O
Asian	JJ	O
populations	NNS	O
.	.	O

The	DT	O
novel	JJ	O
single	JJ	O
nucleotide	NN	O
deletion	NN	O
,	,	O
2304delC	NN	O
,	,	O
was	VBD	O
found	VBN	O
in	IN	O
one	CD	O
patient	NN	O
.	.	O

Since	IN	O
a	DT	O
mutation	NN	O
at	IN	O
cDNA	NN	O
nucleotide	NN	O
2302	CD	O
(	-LRB-	O
2302insC	NN	O
)	-RRB-	O
had	VBD	O
been	VBN	O
previously	RB	O
described	VBN	O
,	,	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
ATP7B	NN	O
gene	NN	O
may	MD	O
be	VB	O
susceptible	JJ	O
to	TO	O
gene	NN	O
rearrangements	NNS	O
causing	VBG	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
.	.	O

Determination	NN	O
of	IN	O
the	DT	O
genomic	JJ	O
structure	NN	O
of	IN	O
the	DT	O
COL4A4	NN	O
gene	NN	O
and	CC	O
of	IN	O
novel	JJ	O
mutations	NNS	O
causing	VBG	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
Alport	NNP	I-Disease
syndrome	NN	I-Disease
.	.	O

Autosomal	JJ	B-Disease
recessive	JJ	I-Disease
Alport	NNP	I-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
progressive	JJ	O
hematuric	JJ	B-Disease
glomerulonephritis	NN	I-Disease
characterized	VBN	O
by	IN	O
glomerular	JJ	B-Disease
basement	NN	I-Disease
membrane	NN	I-Disease
abnormalities	NNS	I-Disease
and	CC	O
associated	VBN	O
with	IN	O
mutations	NNS	O
in	IN	O
either	CC	O
the	DT	O
COL4A3	NN	O
or	CC	O
the	DT	O
COL4A4	NN	O
gene	NN	O
,	,	O
which	WDT	O
encode	VBP	O
the	DT	O
alpha3	NN	O
and	CC	O
alpha4	NN	O
type	NN	O
IV	CD	O
collagen	NN	O
chains	NNS	O
,	,	O
respectively	RB	O
.	.	O

To	TO	O
date	NN	O
,	,	O
mutation	NN	O
screening	NN	O
in	IN	O
the	DT	O
two	CD	O
genes	NNS	O
has	VBZ	O
been	VBN	O
hampered	VBN	O
by	IN	O
the	DT	O
lack	NN	O
of	IN	O
genomic	JJ	O
structure	NN	O
information	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
complete	JJ	O
characterization	NN	O
of	IN	O
the	DT	O
48	CD	O
exons	NNS	O
of	IN	O
the	DT	O
COL4A4	NN	O
gene	NN	O
,	,	O
a	DT	O
comprehensive	JJ	O
gene	NN	O
screen	NN	O
,	,	O
and	CC	O
the	DT	O
subsequent	JJ	O
detection	NN	O
of	IN	O
10	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
eight	CD	O
patients	NNS	O
diagnosed	VBD	O
with	IN	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
Alport	NNP	I-Disease
syndrome	NN	I-Disease
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
identified	VBD	O
a	DT	O
glycine	NN	O
to	TO	O
alanine	NN	O
substitution	NN	O
in	IN	O
the	DT	O
collagenous	JJ	O
domain	NN	O
that	WDT	O
is	VBZ	O
apparently	RB	O
silent	JJ	O
in	IN	O
the	DT	O
heterozygous	JJ	O
carriers	NNS	O
,	,	O
in	IN	O
11	CD	O
.	.	O

5	CD	O
%	NN	O
of	IN	O
all	DT	O
control	NN	O
individuals	NNS	O
,	,	O
and	CC	O
in	IN	O
one	CD	O
control	NN	O
individual	JJ	O
homozygous	JJ	O
for	IN	O
this	DT	O
glycine	NN	O
substitution	NN	O
.	.	O

There	EX	O
has	VBZ	O
been	VBN	O
no	DT	O
previous	JJ	O
finding	NN	O
of	IN	O
a	DT	O
glycine	NN	O
substitution	NN	O
that	WDT	O
is	VBZ	O
not	RB	O
associated	VBN	O
with	IN	O
any	DT	O
obvious	JJ	O
phenotype	NN	O
in	IN	O
homozygous	JJ	O
individuals	NNS	O
.	.	O

A	DT	O
gene	NN	O
encoding	VBG	O
a	DT	O
transmembrane	NN	O
protein	NN	O
is	VBZ	O
mutated	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
diabetes	NN	B-Disease
mellitus	NN	I-Disease
and	CC	O
optic	JJ	B-Disease
atrophy	NN	I-Disease
(	-LRB-	O
Wolfram	NN	B-Disease
syndrome	NN	I-Disease
)	-RRB-	O
.	.	O

Wolfram	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WFS	NN	B-Disease
;	:	O
OMIM	NNP	O
222300	CD	O
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
neurodegenerative	JJ	I-Disease
disorder	NN	I-Disease
defined	VBN	O
by	IN	O
young-onset	JJ	O
non-immune	JJ	O
insulin-dependent	JJ	B-Disease
diabetes	NN	I-Disease
mellitus	NN	I-Disease
and	CC	O
progressive	JJ	O
optic	JJ	B-Disease
atrophy	NN	I-Disease
.	.	O

Linkage	NN	O
to	TO	O
markers	NNS	O
on	IN	O
chromosome	NN	O
4p	NN	O
was	VBD	O
confirmed	VBN	O
in	IN	O
five	CD	O
families	NNS	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
meiotic	JJ	O
recombinants	NNS	O
and	CC	O
disease-associated	JJ	O
haplotypes	NNS	O
,	,	O
the	DT	O
WFS	NNP	B-Disease
gene	NN	O
was	VBD	O
localized	JJ	O
to	TO	O
a	DT	O
BAC/P1	NN	O
contig	NN	O
of	IN	O
less	JJR	O
than	IN	O
250	CD	O
kb	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
(	-LRB-	O
WFS1	NN	O
)	-RRB-	O
encoding	VBG	O
a	DT	O
putative	JJ	O
transmembrane	NN	O
protein	NN	O
were	VBD	O
found	VBN	O
in	IN	O
all	DT	O
affected	VBN	O
individuals	NNS	O
in	IN	O
six	CD	O
WFS	NNS	B-Disease
families	NNS	O
,	,	O
and	CC	O
these	DT	O
mutations	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
the	DT	O
disease	NN	O
phenotype	NN	O
.	.	O

WFS1	NN	O
appears	VBZ	O
to	TO	O
function	VB	O
in	IN	O
survival	NN	O
of	IN	O
islet	NN	O
beta-cells	NNS	O
and	CC	O
neurons	NNS	O
.	.	O

.	.	O

Molecular	JJ	O
defects	NNS	O
leading	VBG	O
to	TO	O
human	JJ	O
complement	NN	B-Disease
component	NN	I-Disease
C6	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
an	DT	O
African-American	JJ	O
family	NN	O
.	.	O

Complement	NN	B-Disease
component	NN	I-Disease
C6	NN	I-Disease
deficiency	NN	I-Disease
(	-LRB-	O
C6D	NN	B-Disease
)	-RRB-	O
was	VBD	O
diagnosed	VBN	O
in	IN	O
a	DT	O
16-year-old	JJ	O
African-American	JJ	O
male	NN	O
with	IN	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
.	.	O

The	DT	O
patients	NNS	O
father	NN	O
and	CC	O
two	CD	O
brothers	NNS	O
also	RB	O
had	VBD	O
C6D	NN	B-Disease
,	,	O
but	CC	O
gave	VBD	O
no	DT	O
history	NN	O
of	IN	O
meningitis	NN	B-Disease
or	CC	O
other	JJ	O
neisserial	JJ	B-Disease
infection	NN	I-Disease
.	.	O

By	IN	O
using	VBG	O
exon-specific	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
/	:	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
as	IN	O
a	DT	O
screening	JJ	O
step	NN	O
and	CC	O
nucleotide	NN	O
sequencing	NN	O
of	IN	O
target	NN	O
exons	NNS	O
,	,	O
we	PRP	O
determined	VBD	O
that	IN	O
the	DT	O
proband	NN	O
was	VBD	O
a	DT	O
compound	NN	O
heterozygote	NN	O
for	IN	O
two	CD	O
C6	NN	O
gene	NN	O
mutations	NNS	O
.	.	O

The	DT	O
first	JJ	O
,	,	O
1195delC	JJ	O
located	JJ	O
in	IN	O
exon	NN	O
7	CD	O
,	,	O
is	VBZ	O
a	DT	O
novel	JJ	O
mutation	NN	O
,	,	O
while	IN	O
the	DT	O
second	JJ	O
,	,	O
1936delG	NN	O
in	IN	O
exon	NN	O
12	CD	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
before	IN	O
to	TO	O
cause	VB	O
C6D	NN	B-Disease
in	IN	O
an	DT	O
unrelated	JJ	O
African-American	JJ	O
individual	NN	O
.	.	O

Both	DT	O
mutations	NNS	O
result	VBP	O
in	IN	O
premature	JJ	O
termination	NN	O
codons	NNS	O
and	CC	O
C6	NN	O
null	JJ	O
alleles	NNS	O
.	.	O

Allele-specific	JJ	O
PCR	NN	O
indicated	VBD	O
that	IN	O
the	DT	O
probands	NNS	O
two	CD	O
brothers	NNS	O
also	RB	O
inherited	VBD	O
the	DT	O
1195delC	NN	O
mutation	NN	O
from	IN	O
their	PRP$	O
heterozygous	JJ	O
mother	NN	O
and	CC	O
the	DT	O
1936delG	NN	O
mutation	NN	O
from	IN	O
their	PRP$	O
homozygous	JJ	O
father	NN	O
.	.	O

.	.	O

Sperm	NN	O
DNA	NN	O
analysis	NN	O
in	IN	O
a	DT	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
premutation	NN	O
carrier	NN	O
suggests	VBZ	O
both	CC	O
meiotic	JJ	O
and	CC	O
mitotic	JJ	O
expansion	NN	O
in	IN	O
the	DT	O
FRDA	NN	B-Disease
gene	NN	O
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
is	VBZ	O
usually	RB	O
caused	VBN	O
by	IN	O
an	DT	O
expansion	NN	O
of	IN	O
a	DT	O
GAA	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
intron	NN	O
1	CD	O
of	IN	O
the	DT	O
FRDA	NN	B-Disease
gene	NN	O
.	.	O

Occasionally	RB	O
,	,	O
a	DT	O
fully	RB	O
expanded	VBN	O
allele	NN	O
has	VBZ	O
been	VBN	O
found	VBN	O
to	TO	O
arise	VB	O
from	IN	O
a	DT	O
premutation	NN	O
of	IN	O
100	CD	O
or	CC	O
less	JJR	O
triplet	NN	O
repeats	NNS	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
sperm	NN	O
DNA	NN	O
of	IN	O
a	DT	O
premutation	NN	O
carrier	NN	O
.	.	O

This	DT	O
mans	VBZ	O
leucocyte	NN	O
DNA	NN	O
showed	VBD	O
one	CD	O
normal	JJ	O
allele	NN	O
and	CC	O
one	CD	O
allele	NN	O
of	IN	O
approximately	RB	O
100	CD	O
repeats	NNS	O
.	.	O

His	PRP$	O
sperm	NN	O
showed	VBD	O
an	DT	O
expanded	VBN	O
allele	NN	O
in	IN	O
a	DT	O
tight	JJ	O
range	NN	O
centering	VBG	O
on	IN	O
a	DT	O
size	NN	O
of	IN	O
approximately	RB	O
320	CD	O
trinucleotide	NN	O
repeats	NNS	O
.	.	O

His	PRP$	O
affected	JJ	O
son	NN	O
has	VBZ	O
repeat	NN	O
sizes	NNS	O
of	IN	O
1040	CD	O
and	CC	O
540	CD	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
expansion	NN	O
occurs	VBZ	O
in	IN	O
two	CD	O
stages	NNS	O
,	,	O
the	DT	O
first	JJ	O
during	IN	O
meiosis	NN	O
followed	VBN	O
by	IN	O
a	DT	O
second	JJ	O
mitotic	JJ	O
expansion	NN	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
in	IN	O
all	DT	O
informative	JJ	O
carrier	NN	O
father	NN	O
to	TO	O
affected	VBN	O
child	NN	O
transmissions	NNS	O
,	,	O
with	IN	O
the	DT	O
notable	JJ	O
exception	NN	O
of	IN	O
the	DT	O
premutation	NN	O
carrier	NN	O
,	,	O
the	DT	O
expansion	NN	O
size	NN	O
decreases	VBZ	O
.	.	O

.	.	O

Eye	NNP	B-Disease
movement	NN	I-Disease
abnormalities	NNS	I-Disease
correlate	VBP	O
with	IN	O
genotype	NN	O
in	IN	O
autosomal	JJ	O
dominant	JJ	O
cerebellar	NN	B-Disease
ataxia	NN	I-Disease
type	NN	I-Disease
I	CD	I-Disease
.	.	O

We	PRP	O
compared	VBD	O
horizontal	JJ	O
eye	NN	O
movements	NNS	O
(	-LRB-	O
visually	RB	O
guided	VBN	O
saccades	NNS	O
,	,	O
antisaccades	NNS	O
,	,	O
and	CC	O
smooth	VB	O
pursuit	NN	O
)	-RRB-	O
in	IN	O
control	JJ	O
subjects	NNS	O
(	-LRB-	O
n	NN	O
=	JJ	O
14	CD	O
)	-RRB-	O
and	CC	O
patients	NNS	O
with	IN	O
three	CD	O
forms	NNS	O
of	IN	O
autosomal	JJ	O
dominant	JJ	O
cerebellar	NN	B-Disease
ataxias	NN	I-Disease
type	NN	I-Disease
I	CD	I-Disease
spinocerebellar	NN	B-Disease
ataxias	NN	I-Disease
1	CD	I-Disease
and	CC	I-Disease
2	CD	I-Disease
(	-LRB-	O
SCA1	NN	B-Disease
,	,	O
n	NN	O
=	JJ	O
11	CD	O
;	:	O
SCA2	NN	B-Disease
,	,	O
n	NN	O
=	JJ	O
10	CD	O
)	-RRB-	O
and	CC	O
SCA3/Machado-Joseph	JJ	O
disease	NN	B-Disease
(	-LRB-	O
MJD	NN	B-Disease
)	-RRB-	O
(	-LRB-	O
n	NN	O
=	JJ	O
16	CD	O
)	-RRB-	O
.	.	O

In	IN	O
SCA1	NN	B-Disease
,	,	O
saccade	NN	O
amplitude	NN	O
was	VBD	O
significantly	RB	O
increased	VBN	O
,	,	O
resulting	VBG	O
in	IN	O
hypermetria	NN	B-Disease
.	.	O

The	DT	O
smooth	JJ	O
pursuit	NN	O
gain	NN	O
was	VBD	O
decreased	VBN	O
.	.	O

In	IN	O
SCA2	NN	B-Disease
,	,	O
saccade	NN	O
velocity	NN	O
was	VBD	O
markedly	RB	O
decreased	VBN	O
.	.	O

The	DT	O
percentage	NN	O
of	IN	O
errors	NNS	O
in	IN	O
antisaccades	NNS	O
was	VBD	O
greatly	RB	O
increased	VBN	O
and	CC	O
was	VBD	O
significantly	RB	O
correlated	VBN	O
with	IN	O
age	NN	O
at	IN	O
disease	NN	O
onset	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
a	DT	O
correlation	NN	O
between	IN	O
smooth	JJ	O
pursuit	NN	O
gain	NN	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
trinucleotide	NN	O
repeats	NNS	O
was	VBD	O
found	VBN	O
.	.	O

In	IN	O
SCA3	NN	B-Disease
,	,	O
gaze-evoked	JJ	B-Disease
nystagmus	NN	I-Disease
was	VBD	O
often	RB	O
present	JJ	O
as	IN	O
was	VBD	O
saccade	JJ	O
hypometria	NN	O
and	CC	O
smooth	JJ	O
pursuit	NN	O
gain	NN	O
was	VBD	O
markedly	RB	O
decreased	VBN	O
.	.	O

Three	CD	O
major	JJ	O
criteria	NNS	O
,	,	O
saccade	JJ	O
amplitude	NN	O
,	,	O
saccade	NN	O
velocity	NN	O
,	,	O
and	CC	O
presence	NN	O
of	IN	O
gaze-evoked	JJ	B-Disease
nystagmus	NN	I-Disease
,	,	O
permitted	VBD	O
the	DT	O
correct	JJ	O
assignment	NN	O
of	IN	O
90	CD	O
%	NN	O
of	IN	O
the	DT	O
SCA1	NN	B-Disease
,	,	O
90	CD	O
%	NN	O
of	IN	O
the	DT	O
SCA2	NN	B-Disease
,	,	O
and	CC	O
93	CD	O
%	NN	O
of	IN	O
the	DT	O
patients	NNS	O
with	IN	O
SCA3	NN	B-Disease
to	TO	O
their	PRP$	O
genetically	RB	O
confirmed	VBN	O
patient	NN	O
group	NN	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
may	MD	O
help	VB	O
orient	JJ	O
diagnoses	NNS	O
of	IN	O
SCA1	NN	B-Disease
,	,	O
SCA2	NN	B-Disease
,	,	O
and	CC	O
SCA3	NN	B-Disease
at	IN	O
early	JJ	O
clinical	JJ	O
stages	NNS	O
of	IN	O
the	DT	O
diseases	NNS	O
.	.	O

.	.	O

Clustering	NN	O
of	IN	O
missense	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
ataxia-telangiectasia	NN	B-Disease
gene	NN	O
in	IN	O
a	DT	O
sporadic	JJ	B-Disease
T-cell	NN	I-Disease
leukaemia	NN	I-Disease
.	.	O

Ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
recessive	JJ	B-Disease
multi-system	JJ	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
at	IN	O
11q22-q23	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

3	LS	O
)	-RRB-	O
.	.	O

The	DT	O
risk	NN	O
of	IN	O
cancer	NN	B-Disease
,	,	O
especially	RB	O
lymphoid	JJ	B-Disease
neoplasias	NNS	I-Disease
,	,	O
is	VBZ	O
substantially	RB	O
elevated	JJ	O
in	IN	O
A-T	NN	B-Disease
patients	NNS	O
and	CC	O
has	VBZ	O
long	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
chromosomal	JJ	O
instability	NN	O
.	.	O

By	IN	O
analysing	VBG	O
tumour	NN	B-Disease
DNA	NN	O
from	IN	O
patients	NNS	O
with	IN	O
sporadic	JJ	B-Disease
T-cell	NN	I-Disease
prolymphocytic	JJ	I-Disease
leukaemia	NN	I-Disease
(	-LRB-	O
T-PLL	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
rare	JJ	O
clonal	JJ	B-Disease
malignancy	NN	I-Disease
with	IN	O
similarities	NNS	O
to	TO	O
a	DT	O
mature	JJ	B-Disease
T-cell	NN	I-Disease
leukaemia	NN	I-Disease
seen	VBN	O
in	IN	O
A-T	NN	B-Disease
,	,	O
we	PRP	O
demonstrate	VBP	O
a	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
ATM	NNP	O
mutations	NNS	O
in	IN	O
T-PLL	NN	B-Disease
.	.	O

In	IN	O
marked	JJ	O
contrast	NN	O
to	TO	O
the	DT	O
ATM	NNP	O
mutation	NN	O
pattern	NN	O
in	IN	O
A-T	NN	B-Disease
,	,	O
the	DT	O
most	RBS	O
frequent	JJ	O
nucleotide	NN	O
changes	NNS	O
in	IN	O
this	DT	O
leukaemia	NN	B-Disease
were	VBD	O
missense	NN	O
mutations	NNS	O
.	.	O

These	DT	O
clustered	VBN	O
in	IN	O
the	DT	O
region	NN	O
corresponding	VBG	O
to	TO	O
the	DT	O
kinase	NN	O
domain	NN	O
,	,	O
which	WDT	O
is	VBZ	O
highly	RB	O
conserved	VBN	O
in	IN	O
ATM-related	JJ	O
proteins	NNS	O
in	IN	O
mouse	NN	O
,	,	O
yeast	NN	O
and	CC	O
Drosophila	NN	O
.	.	O

The	DT	O
resulting	VBG	O
amino-acid	JJ	O
substitutions	NNS	O
are	VBP	O
predicted	VBN	O
to	TO	O
interfere	VB	O
with	IN	O
ATP	NN	O
binding	NN	O
or	CC	O
substrate	NN	O
recognition	NN	O
.	.	O

Two	CD	O
of	IN	O
seventeen	CD	O
mutated	VBN	O
T-PLL	NN	B-Disease
samples	NNS	O
had	VBD	O
a	DT	O
previously	RB	O
reported	VBN	O
A-T	NN	B-Disease
allele	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
no	DT	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
p53	NN	O
gene	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
tumour	NN	B-Disease
suppressor	NN	O
is	VBZ	O
not	RB	O
frequently	RB	O
altered	VBN	O
in	IN	O
this	DT	O
leukaemia	NN	B-Disease
.	.	O

Occasional	JJ	O
missense	NN	O
mutations	NNS	O
in	IN	O
ATM	NNP	O
were	VBD	O
also	RB	O
found	VBN	O
in	IN	O
tumour	NN	B-Disease
DNA	NN	O
from	IN	O
patients	NNS	O
with	IN	O
B-cell	NN	B-Disease
non-Hodgkins	JJ	I-Disease
lymphomas	NNS	I-Disease
(	-LRB-	O
B-NHL	NN	B-Disease
)	-RRB-	O
and	CC	O
a	DT	O
B-NHL	NN	B-Disease
cell	NN	O
line	NN	O
.	.	O

The	DT	O
evidence	NN	O
of	IN	O
a	DT	O
significant	JJ	O
proportion	NN	O
of	IN	O
loss-of-function	JJ	O
mutations	NNS	O
and	CC	O
a	DT	O
complete	JJ	O
absence	NN	O
of	IN	O
the	DT	O
normal	JJ	O
copy	NN	O
of	IN	O
ATM	NNP	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
mutated	VBN	O
tumours	NNS	B-Disease
establishes	VBZ	O
somatic	JJ	O
inactivation	NN	O
of	IN	O
this	DT	O
gene	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
sporadic	JJ	B-Disease
T-PLL	NN	I-Disease
and	CC	O
suggests	VBZ	O
that	IN	O
ATM	NNP	O
acts	VBZ	O
as	IN	O
a	DT	O
tumour	NN	B-Disease
suppressor	NN	O
.	.	O

As	IN	O
constitutional	JJ	O
DNA	NN	O
was	VBD	O
not	RB	O
available	JJ	O
,	,	O
a	DT	O
putative	JJ	O
hereditary	JJ	O
predisposition	NN	O
to	TO	O
T-PLL	NN	B-Disease
will	MD	O
require	VB	O
further	JJ	O
investigation	NN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
a	DT	O
novel	JJ	O
nonsense	NN	O
mutation	NN	O
and	CC	O
a	DT	O
missense	NN	O
substitution	NN	O
in	IN	O
the	DT	O
vasopressin-neurophysin	NN	O
II	CD	O
gene	NN	O
in	IN	O
two	CD	O
Spanish	JJ	O
kindreds	NNS	O
with	IN	O
familial	JJ	B-Disease
neurohypophyseal	NN	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
.	.	O

Familial	JJ	B-Disease
neurohypophyseal	NN	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
(	-LRB-	O
FNDI	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disease	NN	I-Disease
caused	VBN	O
by	IN	O
deficiency	NN	O
in	IN	O
the	DT	O
antidiuretic	JJ	O
hormone	NN	O
arginine	NN	O
vasopressin	NN	O
(	-LRB-	O
AVP	NN	O
)	-RRB-	O
encoded	VBN	O
by	IN	O
the	DT	O
AVP-neurophysin	NN	O
II	CD	O
(	-LRB-	O
AVP-NPII	NN	O
)	-RRB-	O
gene	NN	O
on	IN	O
chromosome	NN	O
20p13	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
analyzed	VBD	O
two	CD	O
families	NNS	O
with	IN	O
FNDI	NN	B-Disease
using	VBG	O
direct	JJ	O
automated	VBN	O
fluorescent	JJ	O
,	,	O
solid	JJ	O
phase	NN	O
,	,	O
single-stranded	JJ	O
DNA	NN	O
sequencing	NN	O
of	IN	O
PCR-amplified	JJ	O
AVP-NPII	NN	O
DNA	NN	O
.	.	O

In	IN	O
one	CD	O
of	IN	O
the	DT	O
families	NNS	O
,	,	O
affected	VBD	O
individuals	NNS	O
presented	VBD	O
a	DT	O
novel	JJ	O
nonsense	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
3	CD	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
consisting	VBG	O
in	IN	O
a	DT	O
G	NN	O
to	TO	O
T	NN	O
transition	NN	O
at	IN	O
nucleotide	NN	O
2101	CD	O
,	,	O
which	WDT	O
produces	VBZ	O
a	DT	O
stop	NN	O
signal	NN	O
in	IN	O
codon	NN	O
82	CD	O
(	-LRB-	O
Glu	NN	O
)	-RRB-	O
of	IN	O
NPII	NN	O
.	.	O

The	DT	O
premature	JJ	O
termination	NN	O
eliminates	VBZ	O
part	NN	O
of	IN	O
the	DT	O
C-terminal	JJ	O
domain	NN	O
of	IN	O
NPII	NN	O
,	,	O
including	VBG	O
a	DT	O
cysteine	NN	O
residue	NN	O
in	IN	O
position	NN	O
85	CD	O
,	,	O
which	WDT	O
could	MD	O
be	VB	O
involved	VBN	O
in	IN	O
the	DT	O
correct	JJ	O
folding	JJ	O
of	IN	O
the	DT	O
prohormone	NN	O
.	.	O

In	IN	O
the	DT	O
second	JJ	O
family	NN	O
,	,	O
a	DT	O
G279A	NN	O
substitution	NN	O
at	IN	O
position	NN	O
-1	CD	O
of	IN	O
the	DT	O
signal	NN	O
peptide	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
all	DT	O
affected	VBN	O
individuals	NNS	O
.	.	O

This	DT	O
missense	NN	O
mutation	NN	O
,	,	O
which	WDT	O
replaces	VBZ	O
Ala	NN	O
with	IN	O
Thr	NN	O
,	,	O
is	VBZ	O
frequent	JJ	O
among	IN	O
FNDI	NN	B-Disease
patients	NNS	O
and	CC	O
is	VBZ	O
thought	VBN	O
to	TO	O
reduce	VB	O
the	DT	O
efficiency	NN	O
of	IN	O
cleavage	NN	O
by	IN	O
signal	NN	O
peptidases	NNS	O
.	.	O

.	.	O

Cloning	NN	O
of	IN	O
a	DT	O
novel	JJ	O
member	NN	O
of	IN	O
the	DT	O
low-density	JJ	O
lipoprotein	NN	O
receptor	NN	O
family	NN	O
.	.	O

A	DT	O
gene	NN	O
encoding	VBG	O
a	DT	O
novel	JJ	O
transmembrane	NN	O
protein	NN	O
was	VBD	O
identified	VBN	O
by	IN	O
DNA	NN	O
sequence	NN	O
analysis	NN	O
within	IN	O
the	DT	O
insulin-dependent	JJ	B-Disease
diabetes	NN	I-Disease
mellitus	NN	I-Disease
(	-LRB-	O
IDDM	NN	B-Disease
)	-RRB-	O
locus	NN	O
IDDM4	NN	O
on	IN	O
chromosome	NN	O
11q13	NN	O
.	.	O

Based	VBN	O
on	IN	O
its	PRP$	O
chromosomal	JJ	O
position	NN	O
,	,	O
this	DT	O
gene	NN	O
is	VBZ	O
a	DT	O
candidate	NN	O
for	IN	O
conferring	VBG	O
susceptibility	NN	O
to	TO	O
diabetes	NN	B-Disease
.	.	O

The	DT	O
gene	NN	O
,	,	O
termed	VBN	O
low-density	NN	O
lipoprotein	NN	O
receptor	NN	O
related	JJ	O
protein	NN	O
5	CD	O
(	-LRB-	O
LRP5	NN	O
)	-RRB-	O
,	,	O
encodes	VBZ	O
a	DT	O
protein	NN	O
of	IN	O
1615	CD	O
amino	NN	O
acids	NNS	O
that	WDT	O
contains	VBZ	O
conserved	VBN	O
modules	NNS	O
which	WDT	O
are	VBP	O
characteristic	JJ	O
of	IN	O
the	DT	O
low-density	JJ	O
lipoprotein	NN	O
(	-LRB-	O
LDL	NN	O
)	-RRB-	O
receptor	NN	O
family	NN	O
.	.	O

These	DT	O
modules	NNS	O
include	VBP	O
a	DT	O
putative	JJ	O
signal	NN	O
peptide	NN	O
for	IN	O
protein	NN	O
export	NN	O
,	,	O
four	CD	O
epidermal	JJ	O
growth	NN	O
factor	NN	O
(	-LRB-	O
EGF	NN	O
)	-RRB-	O
repeats	NNS	O
with	IN	O
associated	VBN	O
spacer	NN	O
domains	NNS	O
,	,	O
three	CD	O
LDL-receptor	NN	O
(	-LRB-	O
LDLR	NN	O
)	-RRB-	O
repeats	NNS	O
,	,	O
a	DT	O
single	JJ	O
transmembrane	NN	O
spanning	VBG	O
domain	NN	O
,	,	O
and	CC	O
a	DT	O
cytoplasmic	JJ	O
domain	NN	O
.	.	O

The	DT	O
encoded	VBN	O
protein	NN	O
has	VBZ	O
a	DT	O
unique	JJ	O
organization	NN	O
of	IN	O
EGF	NN	O
and	CC	O
LDLR	NN	O
repeats	NNS	O
;	:	O
therefore	RB	O
,	,	O
LRP5	NN	O
likely	JJ	O
represents	VBZ	O
a	DT	O
new	JJ	O
category	NN	O
of	IN	O
the	DT	O
LDLR	NN	O
family	NN	O
.	.	O

Both	CC	O
human	JJ	O
and	CC	O
mouse	NN	O
LRP5	NN	O
cDNAs	NNS	O
have	VBP	O
been	VBN	O
isolated	VBN	O
and	CC	O
the	DT	O
encoded	VBN	O
mature	JJ	O
proteins	NNS	O
are	VBP	O
95	CD	O
%	NN	O
identical	JJ	O
,	,	O
indicating	VBG	O
a	DT	O
high	JJ	O
degree	NN	O
of	IN	O
evolutionary	JJ	O
conservation	NN	O
.	.	O

.	.	O

ATM	NNP	O
germline	NN	O
mutations	NNS	O
in	IN	O
classical	JJ	O
ataxia-telangiectasia	NN	B-Disease
patients	NNS	O
in	IN	O
the	DT	O
Dutch	JJ	O
population	NN	O
.	.	O

Germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
the	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
our	PRP$	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
ATM	NNP	O
mutation	NN	O
spectrum	NN	O
in	IN	O
19	CD	O
classical	JJ	O
A-T	NN	B-Disease
patients	NNS	O
,	,	O
including	VBG	O
some	DT	O
immigrant	JJ	O
populations	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
12	CD	O
of	IN	O
Dutch	JJ	O
ethnic	JJ	O
origin	NN	O
.	.	O

Both	CC	O
the	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
(	-LRB-	O
PTT	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
restriction	NN	O
endonuclease	NN	O
fingerprinting	NN	O
(	-LRB-	O
REF	NN	O
)	-RRB-	O
method	NN	O
were	VBD	O
used	VBN	O
and	CC	O
compared	VBN	O
for	IN	O
their	PRP$	O
detection	NN	O
efficiency	NN	O
,	,	O
identifying	VBG	O
76	CD	O
%	NN	O
and	CC	O
60	CD	O
%	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
,	,	O
respectively	RB	O
.	.	O

Most	JJS	O
patients	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
compound	JJ	O
heterozygote	NN	O
.	.	O

Seventeen	CD	O
mutations	NNS	O
were	VBD	O
distinct	JJ	O
,	,	O
of	IN	O
which	WDT	O
10	CD	O
were	VBD	O
not	RB	O
reported	VBN	O
previously	RB	O
.	.	O

Mutations	NNS	O
are	VBP	O
small	JJ	O
deletions	NNS	O
or	CC	O
point	NN	O
mutations	NNS	O
frequently	RB	O
affecting	VBG	O
splice	NN	O
sites	NNS	O
.	.	O

Moreover	RB	O
,	,	O
a	DT	O
16	CD	O
.	.	O

7-kb	JJ	O
genomic	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
3	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
most	RBS	O
likely	RB	O
a	DT	O
result	NN	O
of	IN	O
recombination	NN	O
between	IN	O
two	CD	O
LINE	NN	O
elements	NNS	O
,	,	O
was	VBD	O
identified	VBN	O
.	.	O

The	DT	O
most	RBS	O
frequently	RB	O
found	VBN	O
mutation	NN	O
,	,	O
identified	VBN	O
in	IN	O
three	CD	O
unrelated	JJ	O
Turkish	JJ	O
A-T	NN	B-Disease
individuals	NNS	O
,	,	O
was	VBD	O
previously	RB	O
described	VBN	O
to	TO	O
be	VB	O
a	DT	O
Turkish	JJ	O
A-T	NN	B-Disease
founder	NN	O
mutation	NN	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
a	DT	O
founder	NN	O
mutation	NN	O
among	IN	O
relatively	RB	O
small	JJ	O
ethnic	JJ	O
population	NN	O
groups	NNS	O
in	IN	O
Western	NNP	O
Europe	NNP	O
could	MD	O
indicate	VB	O
a	DT	O
high	JJ	O
carrier	NN	O
frequency	NN	O
in	IN	O
such	JJ	O
communities	NNS	O
.	.	O

In	IN	O
patients	NNS	O
of	IN	O
Dutch	JJ	O
ethnic	JJ	O
origin	NN	O
,	,	O
however	RB	O
,	,	O
no	DT	O
significant	JJ	O
founder	NN	O
effect	NN	O
could	MD	O
be	VB	O
identified	VBN	O
.	.	O

The	DT	O
observed	VBN	O
genetic	JJ	O
heterogeneity	NN	O
including	VBG	O
the	DT	O
relative	JJ	O
high	JJ	O
percentage	NN	O
of	IN	O
splice-site	JJ	O
mutations	NNS	O
had	VBD	O
no	DT	O
reflection	NN	O
on	IN	O
the	DT	O
phenotype	NN	O
.	.	O

All	DT	O
patients	NNS	O
manifested	VBN	O
classical	JJ	O
A-T	NN	B-Disease
and	CC	O
increased	VBD	O
cellular	JJ	O
radioresistant	JJ	O
DNA	NN	O
synthesis	NN	O
.	.	O

Diagnosis	NN	O
of	IN	O
hemochromatosis	NN	B-Disease
.	.	O

If	IN	O
untreated	JJ	O
,	,	O
hemochromatosis	NN	B-Disease
can	MD	O
cause	VB	O
serious	JJ	O
illness	NN	O
and	CC	O
early	JJ	B-Disease
death	NN	I-Disease
,	,	O
but	CC	O
the	DT	O
disease	NN	O
is	VBZ	O
still	RB	O
substantially	RB	O
under-diagnosed	JJ	O
.	.	O

The	DT	O
cornerstone	NN	O
of	IN	O
screening	NN	O
and	CC	O
case	NN	O
detection	NN	O
is	VBZ	O
the	DT	O
measurement	NN	O
of	IN	O
serum	NN	O
transferrin	NN	O
saturation	NN	O
and	CC	O
the	DT	O
serum	NN	O
ferritin	NN	O
level	NN	O
.	.	O

Once	RB	O
the	DT	O
diagnosis	NN	O
is	VBZ	O
suspected	VBN	O
,	,	O
physicians	NNS	O
must	MD	O
use	VB	O
serum	NN	O
ferritin	NN	O
levels	NNS	O
and	CC	O
hepatic	JJ	O
iron	NN	O
stores	NNS	O
on	IN	O
liver	NN	O
biopsy	NN	O
specimens	NNS	O
to	TO	O
assess	VB	O
patients	NNS	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
iron	NN	B-Disease
overload	NN	I-Disease
.	.	O

Liver	NN	O
biopsy	NN	O
is	VBZ	O
also	RB	O
used	VBN	O
to	TO	O
establish	VB	O
the	DT	O
presence	NN	O
or	CC	O
absence	NN	O
of	IN	O
cirrhosis	NN	B-Disease
,	,	O
which	WDT	O
can	MD	O
affect	VB	O
prognosis	NN	O
and	CC	O
management	NN	O
.	.	O

A	DT	O
DNA-based	JJ	O
test	NN	O
for	IN	O
the	DT	O
HFE	NN	O
gene	NN	O
is	VBZ	O
commercially	RB	O
available	JJ	O
,	,	O
but	CC	O
its	PRP$	O
place	NN	O
in	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
hemochromatosis	NN	B-Disease
is	VBZ	O
still	RB	O
being	VBG	O
evaluated	VBN	O
.	.	O

Currently	RB	O
,	,	O
the	DT	O
most	RBS	O
useful	JJ	O
role	NN	O
for	IN	O
this	DT	O
test	NN	O
is	VBZ	O
in	IN	O
the	DT	O
detection	NN	O
of	IN	O
hemochromatosis	NN	B-Disease
in	IN	O
the	DT	O
family	NN	O
members	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
a	DT	O
proven	JJ	O
case	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

It	PRP	O
is	VBZ	O
crucial	JJ	O
to	TO	O
diagnose	VB	O
hemochromatosis	NN	B-Disease
before	IN	O
hepatic	JJ	B-Disease
cirrhosis	NN	I-Disease
develops	VBZ	O
because	IN	O
phlebotomy	NN	O
therapy	NN	O
can	MD	O
avert	VB	O
serious	JJ	O
chronic	JJ	O
disease	NN	O
and	CC	O
can	MD	O
even	RB	O
lead	VB	O
to	TO	O
normal	JJ	O
life	NN	O
expectancy	NN	O
.	.	O

.	.	O

PAX6	NN	O
mutations	NNS	O
reviewed	VBN	O
.	.	O

Mutations	NNS	O
in	IN	O
PAX6	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
human	JJ	O
aniridia	NN	B-Disease
and	CC	O
have	VBP	O
also	RB	O
been	VBN	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
Peters	NNP	B-Disease
anomaly	RB	I-Disease
,	,	O
with	IN	O
congenital	JJ	B-Disease
cataracts	NNS	I-Disease
,	,	O
with	IN	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
keratitis	NN	I-Disease
,	,	O
and	CC	O
with	IN	O
isolated	VBN	B-Disease
foveal	NN	I-Disease
hypoplasia	NN	I-Disease
.	.	O

No	DT	O
locus	NN	O
other	JJ	O
than	IN	O
chromosome	NN	O
11p13	NN	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
aniridia	NN	B-Disease
,	,	O
and	CC	O
PAX6	NN	O
is	VBZ	O
clearly	RB	O
the	DT	O
major	JJ	O
,	,	O
if	IN	O
not	RB	O
only	RB	O
,	,	O
gene	NN	O
responsible	JJ	O
.	.	O

Twenty-eight	CD	O
percent	NN	O
of	IN	O
identified	VBN	O
PAX6	NN	O
mutations	NNS	O
are	VBP	O
C-T	JJ	O
changes	NNS	O
at	IN	O
CpG	NN	O
dinucleotides	NNS	O
,	,	O
20	CD	O
%	NN	O
are	VBP	O
splicing	NN	O
errors	NNS	O
,	,	O
and	CC	O
more	JJR	O
than	IN	O
30	CD	O
%	NN	O
are	VBP	O
deletion	NN	O
or	CC	O
insertion	NN	O
events	NNS	O
.	.	O

There	EX	O
is	VBZ	O
a	DT	O
noticeably	RB	O
elevated	JJ	O
level	NN	O
of	IN	O
mutation	NN	O
in	IN	O
the	DT	O
paired	JJ	O
domain	NN	O
compared	VBN	O
with	IN	O
the	DT	O
rest	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Increased	VBN	O
mutation	NN	O
in	IN	O
the	DT	O
homeodomain	NN	O
is	VBZ	O
accounted	VBN	O
for	IN	O
by	IN	O
the	DT	O
hypermutable	JJ	O
CpG	NN	O
dinucleotide	NN	O
in	IN	O
codon	NN	O
240	CD	O
.	.	O

Very	RB	O
nearly	RB	O
all	DT	O
mutations	NNS	O
appear	VBP	O
to	TO	O
cause	VB	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
,	,	O
and	CC	O
more	JJR	O
than	IN	O
80	CD	O
%	NN	O
of	IN	O
exonic	JJ	O
substitutions	NNS	O
result	VBP	O
in	IN	O
nonsense	JJ	O
codons	NNS	O
.	.	O

In	IN	O
a	DT	O
gene	NN	O
with	IN	O
such	JJ	O
extraordinarily	RB	O
high	JJ	O
sequence	NN	O
conservation	NN	O
throughout	IN	O
evolution	NN	O
,	,	O
there	EX	O
are	VBP	O
presumed	JJ	O
undiscovered	JJ	O
missense	NN	O
mutations	NNS	O
,	,	O
these	DT	O
are	VBP	O
hypothesized	VBN	O
to	TO	O
exist	VB	O
in	IN	O
as-yet	RB	O
unidentified	JJ	O
phenotypes	NNS	O
.	.	O

.	.	O

Schwartz-Jampel	JJ	B-Disease
syndrome	NN	I-Disease
type	NN	I-Disease
2	CD	I-Disease
and	CC	O
Stuve-Wiedemann	NNP	B-Disease
syndrome	NN	I-Disease
:	:	O
a	DT	O
case	NN	O
for	IN	O
"	``	O
lumping	VBG	O
"	''	O
.	.	O

Recent	JJ	O
studies	NNS	O
demonstrated	VBD	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
genetically	RB	O
distinct	JJ	O
,	,	O
usually	RB	O
lethal	JJ	O
form	NN	O
of	IN	O
the	DT	O
Schwartz-Jampel	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
SJS	NN	B-Disease
)	-RRB-	O
of	IN	O
myotonia	NN	B-Disease
and	CC	O
skeletal	JJ	B-Disease
dysplasia	NN	I-Disease
,	,	O
which	WDT	O
we	PRP	O
called	VBD	O
SJS	NNP	B-Disease
type	NN	I-Disease
2	CD	I-Disease
.	.	O

This	DT	O
disorder	NN	O
is	VBZ	O
reminiscent	JJ	O
of	IN	O
another	DT	O
rare	JJ	O
condition	NN	O
,	,	O
the	DT	O
Stuve-Wiedemann	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
SWS	NN	B-Disease
)	-RRB-	O
,	,	O
which	WDT	O
comprises	VBZ	O
campomelia	NN	B-Disease
at	IN	O
birth	NN	O
with	IN	O
skeletal	JJ	B-Disease
dysplasia	NN	I-Disease
,	,	O
contractures	NNS	B-Disease
,	,	O
and	CC	O
early	JJ	B-Disease
death	NN	I-Disease
.	.	O

To	TO	O
test	VB	O
for	IN	O
possible	JJ	O
nosologic	JJ	O
identity	NN	O
between	IN	O
these	DT	O
disorders	NNS	O
,	,	O
we	PRP	O
reviewed	VBD	O
the	DT	O
literature	NN	O
and	CC	O
obtained	VBD	O
a	DT	O
follow-up	NN	O
of	IN	O
the	DT	O
only	JJ	O
two	CD	O
surviving	VBG	O
patients	NNS	O
,	,	O
one	CD	O
with	IN	O
SJS	NN	B-Disease
type	NN	I-Disease
2	CD	I-Disease
at	IN	O
age	NN	O
10	CD	O
years	NNS	O
and	CC	O
another	DT	O
with	IN	O
SWS	NN	B-Disease
at	IN	O
age	NN	O
7	CD	O
years	NNS	O
.	.	O

Patients	NNS	O
reported	VBD	O
as	IN	O
having	VBG	O
either	CC	O
neonatal	JJ	O
SJS	NN	B-Disease
or	CC	O
SWS	NN	B-Disease
presented	VBD	O
a	DT	O
combination	NN	O
of	IN	O
a	DT	O
severe	JJ	O
,	,	O
prenatal-onset	JJ	O
neuromuscular	JJ	B-Disease
disorder	NN	I-Disease
(	-LRB-	O
with	IN	O
congenital	JJ	B-Disease
joint	JJ	I-Disease
contractures	NNS	I-Disease
,	,	O
respiratory	JJ	O
and	CC	O
feeding	VBG	O
difficulties	NNS	O
,	,	O
tendency	NN	O
to	TO	O
hyperthermia	NN	B-Disease
,	,	O
and	CC	O
frequent	JJ	O
death	NN	O
in	IN	O
infancy	NN	O
)	-RRB-	O
with	IN	O
a	DT	O
distinct	JJ	O
campomelic-metaphyseal	JJ	B-Disease
skeletal	JJ	I-Disease
dysplasia	NN	I-Disease
.	.	O

The	DT	O
similarity	NN	O
of	IN	O
the	DT	O
clinical	JJ	O
and	CC	O
radiographic	JJ	O
findings	NNS	O
is	VBZ	O
so	RB	O
extensive	JJ	O
that	IN	O
these	DT	O
disorders	NNS	O
appear	VBP	O
to	TO	O
be	VB	O
a	DT	O
single	JJ	O
entity	NN	O
.	.	O

The	DT	O
follow-up	JJ	O
observation	NN	O
of	IN	O
an	DT	O
identical	JJ	O
and	CC	O
unique	JJ	O
pattern	NN	O
of	IN	O
progressive	JJ	O
bone	NN	B-Disease
dysplasia	NN	I-Disease
in	IN	O
the	DT	O
two	CD	O
patients	NNS	O
(	-LRB-	O
one	CD	O
with	IN	O
SJS	NN	B-Disease
type	NN	I-Disease
2	CD	I-Disease
,	,	O
one	CD	O
with	IN	O
SWS	NN	B-Disease
)	-RRB-	O
surviving	VBG	O
beyond	IN	O
infancy	NN	O
adds	VBZ	O
to	TO	O
the	DT	O
evidence	NN	O
in	IN	O
favor	NN	O
of	IN	O
identity	NN	O
.	.	O

The	DT	O
hypothesis	NN	O
that	IN	O
SWS	NNP	B-Disease
and	CC	O
SJS	NNP	B-Disease
type	NN	I-Disease
2	CD	I-Disease
are	VBP	O
the	DT	O
same	JJ	O
disorder	NN	O
should	MD	O
be	VB	O
testable	JJ	O
by	IN	O
molecular	JJ	O
methods	NNS	O
.	.	O

.	.	O

The	DT	O
185delAG	NN	O
BRCA1	NN	O
mutation	NN	O
originated	VBD	O
before	IN	O
the	DT	O
dispersion	NN	O
of	IN	O
Jews	NNPS	O
in	IN	O
the	DT	O
diaspora	NN	O
and	CC	O
is	VBZ	O
not	RB	O
limited	VBN	O
to	TO	O
Ashkenazim	NNP	O
.	.	O

The	DT	O
185delAG	NN	O
mutation	NN	O
in	IN	O
BRCA1	NN	O
is	VBZ	O
detected	VBN	O
in	IN	O
Ashkenazi	NNP	O
Jews	NNPS	O
both	CC	O
in	IN	O
familial	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
and	CC	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

All	DT	O
tested	VBN	O
Ashkenazi	NN	O
mutation	NN	O
carriers	NNS	O
share	VBP	O
the	DT	O
same	JJ	O
allelic	JJ	O
pattern	NN	O
at	IN	O
the	DT	O
BRCA1	NN	O
locus	NN	O
.	.	O

Our	PRP$	O
previous	JJ	O
study	NN	O
showed	VBD	O
that	IN	O
this	DT	O
Ashkenazi	NN	O
mutation	NN	O
also	RB	O
occurs	VBZ	O
in	IN	O
Iraqi	JJ	O
Jews	NNPS	O
with	IN	O
a	DT	O
similar	JJ	O
allelic	JJ	O
pattern	NN	O
.	.	O

We	PRP	O
extended	VBD	O
our	PRP$	O
analysis	NN	O
to	TO	O
other	JJ	O
non-Ashkenazi	JJ	O
subsets	NNS	O
354	CD	O
of	IN	O
Moroccan	JJ	O
origin	NN	O
,	,	O
200	CD	O
Yemenites	NNPS	O
and	CC	O
150	CD	O
Iranian	JJ	O
Jews	NNPS	O
.	.	O

Heteroduplex	JJ	O
analysis	NN	O
complemented	VBN	O
by	IN	O
direct	JJ	O
DNA	NN	O
sequencing	NN	O
of	IN	O
abnormally	RB	O
migrating	VBG	O
bands	NNS	O
were	VBD	O
employed	VBN	O
.	.	O

Four	CD	O
of	IN	O
Moroccan	JJ	O
origin	NN	O
(	-LRB-	O
1	CD	O
.	.	O

1	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
none	NN	O
of	IN	O
the	DT	O
Yemenites	NNPS	O
or	CC	O
Iranians	NNPS	O
was	VBD	O
a	DT	O
carrier	NN	O
of	IN	O
the	DT	O
185delAG	NN	O
mutation	NN	O
.	.	O

BRCA1	NN	O
allelic	JJ	O
patterns	NNS	O
were	VBD	O
determined	VBN	O
for	IN	O
four	CD	O
of	IN	O
these	DT	O
individuals	NNS	O
and	CC	O
for	IN	O
12	CD	O
additional	JJ	O
non-Ashkenazi	JJ	O
185delAG	NN	O
mutation	NN	O
carriers	NNS	O
who	WP	O
had	VBD	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Six	CD	O
non-Ashkenazi	JJ	O
individuals	NNS	O
shared	VBD	O
the	DT	O
common	JJ	O
Ashkenazi	NNP	O
haplotype	NN	O
,	,	O
four	CD	O
had	VBD	O
a	DT	O
closely	RB	O
related	JJ	O
pattern	NN	O
,	,	O
and	CC	O
the	DT	O
rest	NN	O
(	-LRB-	O
n	NN	O
=	JJ	O
6	CD	O
)	-RRB-	O
displayed	VBD	O
a	DT	O
distinct	JJ	O
BRCA1	NN	O
allelic	JJ	O
pattern	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
185delAG	NNP	O
BRCA1	NN	O
mutation	NN	O
occurs	VBZ	O
in	IN	O
some	DT	O
non-Ashkenazi	JJ	O
populations	NNS	O
at	IN	O
rates	NNS	O
comparable	JJ	O
with	IN	O
that	DT	O
of	IN	O
Ashkenazim	NNP	O
.	.	O

The	DT	O
majority	NN	O
of	IN	O
Jewish	JJ	O
185delAG	NN	O
mutation	NN	O
carriers	NNS	O
have	VBP	O
a	DT	O
common	JJ	O
allelic	JJ	O
pattern	NN	O
,	,	O
supporting	VBG	O
the	DT	O
founder	NN	O
effect	NN	O
notion	NN	O
,	,	O
but	CC	O
dating	VBG	O
the	DT	O
mutations	NNS	O
origin	NN	O
to	TO	O
an	DT	O
earlier	JJR	O
date	NN	O
than	IN	O
currently	RB	O
estimated	VBN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
different	JJ	O
allelic	JJ	O
pattern	NN	O
at	IN	O
the	DT	O
BRCA1	NN	O
locus	NN	O
even	RB	O
in	IN	O
some	DT	O
Jewish	JJ	O
mutation	NN	O
carriers	NNS	O
,	,	O
might	MD	O
suggest	VB	O
that	IN	O
the	DT	O
mutation	NN	O
arose	VBD	O
independently	RB	O
.	.	O

.	.	O

The	DT	O
RB1	NN	O
gene	NN	O
mutation	NN	O
in	IN	O
a	DT	O
child	NN	O
with	IN	O
ectopic	JJ	B-Disease
intracranial	JJ	I-Disease
retinoblastoma	NN	I-Disease
.	.	O

The	DT	O
RB1	NN	O
gene	NN	O
mutation	NN	O
was	VBD	O
investigated	VBN	O
in	IN	O
a	DT	O
child	NN	O
with	IN	O
ectopic	JJ	B-Disease
intracranial	JJ	I-Disease
retinoblastoma	NN	I-Disease
using	VBG	O
DNA	NN	O
obtained	VBN	O
from	IN	O
both	CC	O
the	DT	O
pineal	NN	B-Disease
and	CC	I-Disease
retinal	JJ	I-Disease
tumours	NNS	I-Disease
of	IN	O
the	DT	O
patient	NN	O
.	.	O

A	DT	O
nonsense	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
17	CD	O
(	-LRB-	O
codon	NN	O
556	CD	O
)	-RRB-	O
of	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
present	JJ	O
homozygously	RB	O
in	IN	O
both	CC	O
the	DT	O
retinal	JJ	B-Disease
and	CC	I-Disease
the	DT	I-Disease
pineal	NN	I-Disease
tumours	NNS	I-Disease
.	.	O

The	DT	O
same	JJ	O
mutation	NN	O
was	VBD	O
present	JJ	O
heterozygously	RB	O
in	IN	O
the	DT	O
DNA	NN	O
from	IN	O
the	DT	O
constitutional	JJ	O
cells	NNS	O
of	IN	O
the	DT	O
patient	NN	O
,	,	O
proving	VBG	O
it	PRP	O
to	TO	O
be	VB	O
of	IN	O
germline	NN	O
origin	NN	O
.	.	O

The	DT	O
initial	JJ	O
mutation	NN	O
was	VBD	O
shown	VBN	O
to	TO	O
have	VB	O
occurred	VBN	O
in	IN	O
the	DT	O
paternally	RB	O
derived	VBN	O
RB1	NN	O
allele	NN	O
.	.	O

The	DT	O
mutation	NN	O
is	VBZ	O
in	IN	O
an	DT	O
area	NN	O
of	IN	O
the	DT	O
gene	NN	O
that	WDT	O
encodes	VBZ	O
the	DT	O
protein-binding	JJ	O
region	NN	O
known	VBN	O
as	IN	O
the	DT	O
pocket	NN	O
region	NN	O
and	CC	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
other	JJ	O
cases	NNS	O
of	IN	O
retinoblastoma	NN	B-Disease
.	.	O

.	.	O

Genomic	JJ	O
structure	NN	O
of	IN	O
the	DT	O
human	JJ	O
congenital	JJ	B-Disease
chloride	NN	I-Disease
diarrhea	NN	I-Disease
(	-LRB-	O
CLD	NN	B-Disease
)	-RRB-	O
gene	NN	O
.	.	O

Congenital	JJ	B-Disease
chloride	NN	I-Disease
diarrhea	NN	I-Disease
(	-LRB-	O
CLD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
a	DT	O
gene	NN	O
which	WDT	O
encodes	VBZ	O
an	DT	O
intestinal	JJ	O
anion	NN	O
transporter	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
complete	JJ	O
genomic	JJ	O
organization	NN	O
of	IN	O
the	DT	O
human	JJ	O
CLD	NN	B-Disease
gene	NN	O
which	WDT	O
spans	VBZ	O
approximately	RB	O
39kb	JJ	O
,	,	O
and	CC	O
comprises	VBZ	O
21	CD	O
exons	NNS	O
.	.	O

All	DT	O
exon/intron	JJ	O
boundaries	NNS	O
conform	VB	O
to	TO	O
the	DT	O
GT/AG	NN	O
rule	NN	O
.	.	O

An	DT	O
analysis	NN	O
of	IN	O
the	DT	O
putative	JJ	O
promoter	NN	O
region	NN	O
sequence	NN	O
shows	VBZ	O
a	DT	O
putative	JJ	O
TATA	NN	O
box	NN	O
and	CC	O
predicts	VBZ	O
multiple	JJ	O
transcription	NN	O
factor	NN	O
binding	VBG	O
sites	NNS	O
.	.	O

The	DT	O
genomic	JJ	O
structure	NN	O
was	VBD	O
determined	VBN	O
using	VBG	O
DNA	NN	O
from	IN	O
several	JJ	O
sources	NNS	O
including	VBG	O
multiple	JJ	O
large-insert	JJ	O
libaries	NNS	O
and	CC	O
genomic	JJ	O
DNA	NN	O
from	IN	O
Finnish	JJ	O
CLD	NN	B-Disease
patients	NNS	O
and	CC	O
controls	NNS	O
.	.	O

Exon-specific	JJ	O
primers	NNS	O
developed	VBN	O
in	IN	O
this	DT	O
study	NN	O
will	MD	O
facilitate	VB	O
mutation	NN	O
screening	NN	O
studies	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
the	DT	O
disease	NN	O
.	.	O

Genomic	JJ	O
sequencing	NN	O
of	IN	O
a	DT	O
BAC	NN	O
clone	NN	O
H_RG364P16	NN	O
revealed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
another	DT	O
,	,	O
highly	RB	O
homologous	JJ	O
gene	NN	O
3	CD	O
of	IN	O
the	DT	O
CLD	NN	B-Disease
gene	NN	O
,	,	O
with	IN	O
a	DT	O
similar	JJ	O
genomic	JJ	O
structure	NN	O
,	,	O
recently	RB	O
identified	VBN	O
as	IN	O
the	DT	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
gene	NN	O
(	-LRB-	O
PDS	NN	B-Disease
)	-RRB-	O
.	.	O

.	.	O

Mutation	NN	O
analysis	NN	O
of	IN	O
UBE3A	NN	O
in	IN	O
Angelman	NNP	B-Disease
syndrome	NN	I-Disease
patients	NNS	O
.	.	O

Angelman	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
chromosome	NN	O
15q11-q13	NN	O
deletions	NNS	O
of	IN	O
maternal	JJ	O
origin	NN	O
,	,	O
by	IN	O
paternal	JJ	O
uniparental	JJ	B-Disease
disomy	NN	I-Disease
(	-LRB-	O
UPD	NN	B-Disease
)	-RRB-	O
15	CD	O
,	,	O
by	IN	O
imprinting	VBG	O
defects	NNS	O
,	,	O
and	CC	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
UBE3A	NN	O
gene	NN	O
.	.	O

UBE3A	NN	O
encodes	VBZ	O
a	DT	O
ubiquitin-protein	JJ	O
ligase	NN	O
and	CC	O
shows	VBZ	O
brain-specific	JJ	O
imprinting	VBG	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
UBE3A	NN	O
coding-region	NN	O
mutations	NNS	O
detected	VBN	O
by	IN	O
SSCP	NN	O
analysis	NN	O
in	IN	O
13	CD	O
AS	JJ	B-Disease
individuals	NNS	O
or	CC	O
families	NNS	O
.	.	O

Two	CD	O
identical	JJ	O
de	FW	O
novo	FW	O
5-bp	JJ	O
duplications	NNS	O
in	IN	O
exon	NN	O
16	CD	O
were	VBD	O
found	VBN	O
.	.	O

Among	IN	O
the	DT	O
other	JJ	O
11	CD	O
unique	JJ	O
mutations	NNS	O
,	,	O
8	CD	O
were	VBD	O
small	JJ	O
deletions	NNS	O
or	CC	O
insertions	NNS	O
predicted	VBN	O
to	TO	O
cause	VB	O
frameshifts	NNS	O
,	,	O
1	CD	O
was	VBD	O
a	DT	O
mutation	NN	O
to	TO	O
a	DT	O
stop	NN	O
codon	NN	O
,	,	O
1	CD	O
was	VBD	O
a	DT	O
missense	NN	O
mutation	NN	O
,	,	O
and	CC	O
1	CD	O
was	VBD	O
predicted	VBN	O
to	TO	O
cause	VB	O
insertion	NN	O
of	IN	O
an	DT	O
isoleucine	NN	O
in	IN	O
the	DT	O
hect	NN	O
domain	NN	O
of	IN	O
the	DT	O
UBE3A	NN	O
protein	NN	O
,	,	O
which	WDT	O
functions	VBZ	O
in	IN	O
E2	NN	O
binding	NN	O
and	CC	O
ubiquitin	NN	O
transfer	NN	O
.	.	O

Eight	CD	O
of	IN	O
the	DT	O
cases	NNS	O
were	VBD	O
familial	JJ	O
,	,	O
and	CC	O
five	CD	O
were	VBD	O
sporadic	JJ	O
.	.	O

In	IN	O
two	CD	O
familial	JJ	O
cases	NNS	O
and	CC	O
one	CD	O
sporadic	JJ	O
case	NN	O
,	,	O
mosaicism	NN	O
for	IN	O
UBE3A	NN	O
mutations	NNS	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
mother	NN	O
of	IN	O
three	CD	O
AS	JJ	B-Disease
sons	NNS	O
,	,	O
in	IN	O
the	DT	O
maternal	JJ	O
grandfather	NN	O
of	IN	O
two	CD	O
AS	JJ	B-Disease
first	JJ	O
cousins	NNS	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
mother	NN	O
of	IN	O
an	DT	O
AS	JJ	B-Disease
daughter	NN	O
.	.	O

The	DT	O
frequencies	NNS	O
with	IN	O
which	WDT	O
we	PRP	O
detected	VBD	O
mutations	NNS	O
were	VBD	O
5	CD	O
(	-LRB-	O
14	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
35	CD	O
in	IN	O
sporadic	JJ	O
cases	NNS	O
and	CC	O
8	CD	O
(	-LRB-	O
80	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
10	CD	O
in	IN	O
familial	JJ	O
cases	NNS	O
.	.	O

.	.	O

Autosomal	JJ	B-Disease
dominant	JJ	I-Disease
neurohypophyseal	JJ	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
associated	VBN	O
with	IN	O
a	DT	O
missense	NN	O
mutation	NN	O
encoding	VBG	O
Gly23	NN	O
--	:	O
>	JJR	O
Val	NN	O
in	IN	O
neurophysin	NN	O
II	CD	O
.	.	O

Autosomal	JJ	B-Disease
dominant	JJ	I-Disease
neurohypophyseal	JJ	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
(	-LRB-	O
ADNDI	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
inherited	VBN	B-Disease
disease	NN	I-Disease
caused	VBN	O
by	IN	O
progressive	JJ	O
degeneration	NN	O
of	IN	O
the	DT	O
magnocellular	JJ	O
neurons	NNS	O
of	IN	O
the	DT	O
hypothalamus	NN	O
leading	VBG	O
to	TO	O
decreased	VBN	O
ability	NN	O
to	TO	O
produce	VB	O
the	DT	O
hormone	NN	O
arginine	NN	O
vasopressin	NN	O
(	-LRB-	O
AVP	NN	O
)	-RRB-	O
.	.	O

Affected	VBN	O
individuals	NNS	O
are	VBP	O
not	RB	O
symptomatic	JJ	O
at	IN	O
birth	NN	O
,	,	O
but	CC	O
usually	RB	O
develop	VBP	O
diabetes	NN	B-Disease
insipidus	NNS	I-Disease
at	IN	O
1-6	CD	O
yr	NN	O
of	IN	O
age	NN	O
.	.	O

The	DT	O
genetic	JJ	O
locus	NN	O
of	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
the	DT	O
AVP-neurophysin	NN	O
II	CD	O
(	-LRB-	O
NPII	NN	O
)	-RRB-	O
gene	NN	O
,	,	O
and	CC	O
mutations	NNS	O
that	WDT	O
cause	VBP	O
ADNDI	NNP	B-Disease
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
both	CC	O
the	DT	O
signal	NN	O
peptide	NN	O
of	IN	O
the	DT	O
prepro-AVP-NPII	JJ	O
precursor	NN	O
and	CC	O
within	IN	O
NPII	NNP	O
itself	PRP	O
.	.	O

An	DT	O
affected	JJ	O
girl	NN	O
who	WP	O
presented	VBD	O
at	IN	O
9	CD	O
months	NNS	O
of	IN	O
age	NN	O
and	CC	O
her	PRP$	O
similarly	RB	O
affected	VBN	O
younger	JJR	O
brother	NN	O
and	CC	O
father	NN	O
were	VBD	O
all	DT	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
G1758	NN	O
--	:	O
>	JJR	O
T	NN	O
)	-RRB-	O
encoding	VBG	O
the	DT	O
amino	NN	O
acid	NN	O
substitution	NN	O
Gly23	NN	O
--	:	O
>	JJR	O
Val	NN	O
within	IN	O
NPII	NNP	O
.	.	O

The	DT	O
mutation	NN	O
was	VBD	O
confirmed	VBN	O
by	IN	O
restriction	NN	O
endonuclease	NN	O
analysis	NN	O
.	.	O

A	DT	O
T1-weighted	JJ	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
of	IN	O
the	DT	O
fathers	NNS	O
pituitary	JJ	O
gland	NN	O
demonstrates	VBZ	O
an	DT	O
attenuated	VBN	O
posterior	JJ	O
pituitary	JJ	O
bright	JJ	O
spot	NN	O
.	.	O

This	DT	O
mutation	NN	O
may	MD	O
be	VB	O
valuable	JJ	O
for	IN	O
developing	VBG	O
models	NNS	O
of	IN	O
dominantly	RB	B-Disease
inherited	VBN	I-Disease
neurodegeneration	NN	I-Disease
,	,	O
as	IN	O
the	DT	O
early	JJ	O
age	NN	O
of	IN	O
onset	NN	O
of	IN	O
symptoms	NNS	O
suggests	VBZ	O
that	IN	O
this	DT	O
mutation	NN	O
may	MD	O
be	VB	O
particularly	RB	O
deleterious	JJ	O
to	TO	O
the	DT	O
magnocellular	JJ	O
neuron	NN	O
.	.	O

.	.	O

Reversal	NN	O
of	IN	O
severe	JJ	O
hypertrophic	JJ	B-Disease
cardiomyopathy	NN	I-Disease
and	CC	O
excellent	JJ	O
neuropsychologic	JJ	O
outcome	NN	O
in	IN	O
very-long-chain	JJ	B-Disease
acyl-coenzyme	NN	I-Disease
A	NN	I-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

Very-long-chain	JJ	B-Disease
acyl-coenzyme	NN	I-Disease
A	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
VLCAD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
a	DT	O
disorder	NN	O
of	IN	O
fatty	JJ	O
acid	NN	O
beta	NN	O
oxidation	NN	O
that	WDT	O
reportedly	RB	O
has	VBZ	O
high	JJ	O
rates	NNS	O
of	IN	O
morbidity	NN	O
and	CC	O
mortality	NN	O
.	.	O

We	PRP	O
describe	VBP	O
the	DT	O
outcome	NN	O
of	IN	O
a	DT	O
5-year-old	JJ	O
girl	NN	O
with	IN	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
who	WP	O
was	VBD	O
first	RB	O
seen	VBN	O
at	IN	O
5	CD	O
months	NNS	O
of	IN	O
age	NN	O
with	IN	O
severe	JJ	O
hypertrophic	JJ	B-Disease
cardiomyopathy	NN	I-Disease
,	,	O
hepatomegaly	RB	B-Disease
,	,	O
encephalopathy	NN	B-Disease
,	,	O
and	CC	O
hypotonia	NN	B-Disease
.	.	O

Biochemical	JJ	O
studies	NNS	O
indicated	VBD	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
stable	JJ	O
yet	RB	O
inactive	JJ	O
enzyme	NN	O
.	.	O

Molecular	JJ	O
genetic	JJ	O
analysis	NN	O
of	IN	O
her	PRP$	O
VLCAD	NN	O
gene	NN	O
revealed	VBD	O
a	DT	O
T1372C	NN	O
(	-LRB-	O
F458L	NN	O
)	-RRB-	O
missense	NN	O
mutation	NN	O
and	CC	O
a	DT	O
1668	CD	O
ACAG	NNP	O
1669	CD	O
splice	NN	O
site	NN	O
mutation	NN	O
.	.	O

After	IN	O
initial	JJ	O
treatment	NN	O
with	IN	O
intravenous	JJ	O
glucose	NN	O
and	CC	O
carnitine	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
thrived	VBN	O
on	IN	O
a	DT	O
low-fat	JJ	O
diet	NN	O
supplemented	VBN	O
with	IN	O
medium-chain	JJ	O
triglyceride	NN	O
oil	NN	O
and	CC	O
carnitine	NN	O
and	CC	O
avoidance	NN	O
of	IN	O
fasting	NN	O
.	.	O

Her	PRP$	O
ventricular	JJ	O
hypertrophy	NN	O
resolved	VBD	O
significantly	RB	O
over	IN	O
1	CD	O
year	NN	O
,	,	O
and	CC	O
cognitively	RB	O
,	,	O
she	PRP	O
is	VBZ	O
in	IN	O
the	DT	O
superior	JJ	O
range	NN	O
for	IN	O
age	NN	O
.	.	O

Clinical	JJ	O
recognition	NN	O
of	IN	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
important	JJ	O
because	IN	O
it	PRP	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
few	JJ	O
directly	RB	O
treatable	JJ	O
causes	NNS	O
of	IN	O
cardiomyopathy	NN	B-Disease
in	IN	O
children	NNS	O
.	.	O

.	.	O

Mutations	NNS	O
of	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
detected	VBN	O
in	IN	O
Japanese	JJ	O
ataxia-telangiectasia	NN	B-Disease
patients	NNS	O
:	:	O
possible	JJ	O
preponderance	NN	O
of	IN	O
the	DT	O
two	CD	O
founder	NN	O
mutations	NNS	O
4612del165	NN	O
and	CC	O
7883del5	NN	O
.	.	O

The	DT	O
ATM	NNP	O
(	-LRB-	O
A-T	NN	O
,	,	O
mutated	VBN	O
)	-RRB-	O
gene	NN	O
on	IN	O
human	JJ	O
chromosome	NN	O
11q22	NN	O
.	.	O

3	CD	O
has	VBZ	O
recently	RB	O
been	VBN	O
identified	VBN	O
as	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
human	JJ	O
recessive	JJ	B-Disease
disease	NN	I-Disease
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
define	VB	O
the	DT	O
types	NNS	O
of	IN	O
disease-causing	JJ	O
ATM	NNP	O
mutations	NNS	O
in	IN	O
Japanese	JJ	O
A-T	NN	B-Disease
patients	NNS	O
as	RB	O
well	RB	O
as	IN	O
to	TO	O
look	VB	O
for	IN	O
possible	JJ	O
mutational	JJ	O
hotspots	NNS	O
,	,	O
reverse-transcribed	JJ	O
RNA	NN	O
derived	VBN	O
from	IN	O
ten	CD	O
patients	NNS	O
belonging	VBG	O
to	TO	O
eight	CD	O
unrelated	JJ	O
Japanese	JJ	O
A-T	NN	B-Disease
families	NNS	O
was	VBD	O
analyzed	VBN	O
for	IN	O
mutations	NNS	O
by	IN	O
the	DT	O
restriction	NN	O
endonuclease	NN	O
fingerprinting	NN	O
method	NN	O
.	.	O

As	IN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
by	IN	O
others	NNS	O
,	,	O
mutations	NNS	O
that	WDT	O
lead	VBP	O
to	TO	O
exon	NN	O
skipping	VBG	O
or	CC	O
premature	JJ	O
protein	NN	O
truncation	NN	O
were	VBD	O
also	RB	O
predominant	JJ	O
in	IN	O
our	PRP$	O
mutants	NNS	O
.	.	O

Six	CD	O
different	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
on	IN	O
12	CD	O
of	IN	O
the	DT	O
16	CD	O
alleles	NNS	O
examined	VBN	O
.	.	O

Four	CD	O
were	VBD	O
deletions	NNS	O
involving	VBG	O
a	DT	O
loss	NN	O
of	IN	O
a	DT	O
single	JJ	O
exon	NN	O
exon	NN	O
7	CD	O
,	,	O
exon	NN	O
16	CD	O
,	,	O
exon	NN	O
33	CD	O
or	CC	O
exon	NN	O
35	CD	O
.	.	O

The	DT	O
others	NNS	O
were	VBD	O
minute	JJ	O
deletions	NNS	O
,	,	O
4649delA	NN	O
in	IN	O
exon	NN	O
33	CD	O
and	CC	O
7883del5	CD	O
in	IN	O
exon	NN	O
55	CD	O
.	.	O

The	DT	O
mutations	NNS	O
4612del165	NN	O
and	CC	O
7883del5	NN	O
were	VBD	O
found	VBN	O
in	IN	O
more	JJR	O
than	IN	O
two	CD	O
unrelated	JJ	O
families	NNS	O
;	:	O
44	CD	O
%	NN	O
(	-LRB-	O
7	CD	O
of	IN	O
16	CD	O
)	-RRB-	O
of	IN	O
the	DT	O
mutant	JJ	O
alleles	NNS	O
had	VBD	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
.	.	O

The	DT	O
4612del165	NN	O
mutations	NNS	O
in	IN	O
three	CD	O
different	JJ	O
families	NNS	O
were	VBD	O
all	DT	O
ascribed	VBN	O
to	TO	O
the	DT	O
same	JJ	O
T	NN	O
--	:	O
>	JJR	O
A	DT	O
substitution	NN	O
at	IN	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
in	IN	O
intron	NN	O
33	CD	O
.	.	O

Microsatellite	NN	O
genotyping	VBG	O
around	IN	O
the	DT	O
ATM	NNP	O
locus	NN	O
also	RB	O
indicated	VBD	O
that	IN	O
a	DT	O
common	JJ	O
haplotype	NN	O
was	VBD	O
shared	VBN	O
by	IN	O
the	DT	O
mutant	JJ	O
alleles	NNS	O
in	IN	O
both	DT	O
mutations	NNS	O
.	.	O

This	DT	O
suggests	VBZ	O
that	IN	O
these	DT	O
two	CD	O
founder	NN	O
mutations	NNS	O
may	MD	O
be	VB	O
predominant	JJ	O
among	IN	O
Japanese	JJ	O
ATM	NNP	O
mutant	NN	O
alleles	NNS	O
.	.	O

Down-regulation	NN	O
of	IN	O
transmembrane	JJ	O
carbonic	JJ	O
anhydrases	NNS	O
in	IN	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
cell	NN	O
lines	NNS	O
by	IN	O
wild-type	JJ	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
transgenes	NNS	O
.	.	O

To	TO	O
discover	VB	O
genes	NNS	O
involved	VBN	O
in	IN	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
(	-LRB-	O
VHL	NN	B-Disease
)	-RRB-	O
-	:	O
mediated	VBN	O
carcinogenesis	NN	O
,	,	O
we	PRP	O
used	VBD	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
cell	NN	O
lines	NNS	O
stably	RB	O
transfected	VBN	O
with	IN	O
wild-type	JJ	O
VHL-expressing	JJ	O
transgenes	NNS	O
.	.	O

Large-scale	JJ	O
RNA	NN	O
differential	JJ	O
display	NN	O
technology	NN	O
applied	VBD	O
to	TO	O
these	DT	O
cell	NN	O
lines	NNS	O
identified	VBD	O
several	JJ	O
differentially	RB	O
expressed	VBN	O
genes	NNS	O
,	,	O
including	VBG	O
an	DT	O
alpha	NN	O
carbonic	JJ	O
anhydrase	NN	O
gene	NN	O
,	,	O
termed	VBN	O
CA12	NN	O
.	.	O

The	DT	O
deduced	VBN	O
protein	NN	O
sequence	NN	O
was	VBD	O
classified	VBN	O
as	IN	O
a	DT	O
one-pass	JJ	O
transmembrane	NN	O
CA	NNP	O
possessing	VBG	O
an	DT	O
apparently	RB	O
intact	JJ	O
catalytic	JJ	O
domain	NN	O
in	IN	O
the	DT	O
extracellular	JJ	O
CA	NNP	O
module	NN	O
.	.	O

Reintroduced	VBN	O
wild-type	JJ	O
VHL	NN	B-Disease
strongly	RB	O
inhibited	VBD	O
the	DT	O
overexpression	NN	O
of	IN	O
the	DT	O
CA12	NN	O
gene	NN	O
in	IN	O
the	DT	O
parental	JJ	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
cell	NN	O
lines	NNS	O
.	.	O

Similar	JJ	O
results	NNS	O
were	VBD	O
obtained	VBN	O
with	IN	O
CA9	NN	O
,	,	O
encoding	VBG	O
another	DT	O
transmembrane	NN	O
CA	NNP	O
with	IN	O
an	DT	O
intact	JJ	O
catalytic	JJ	O
domain	NN	O
.	.	O

Although	IN	O
both	DT	O
domains	NNS	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
protein	NN	O
contribute	VBP	O
to	TO	O
regulation	NN	O
of	IN	O
CA12	NN	O
expression	NN	O
,	,	O
the	DT	O
elongin	NN	O
binding	NN	O
domain	NN	O
alone	RB	O
could	MD	O
effectively	RB	O
regulate	VB	O
CA9	NN	O
expression	NN	O
.	.	O

We	PRP	O
mapped	VBD	O
CA12	NN	O
and	CC	O
CA9	NN	O
loci	NNS	O
to	TO	O
chromosome	NN	O
bands	NNS	O
15q22	NN	O
and	CC	O
17q21	NN	O
.	.	O

2	CD	O
respectively	RB	O
,	,	O
regions	NNS	O
prone	JJ	O
to	TO	O
amplification	NN	O
in	IN	O
some	DT	O
human	JJ	O
cancers	NNS	B-Disease
.	.	O

Additional	JJ	O
experiments	NNS	O
are	VBP	O
needed	VBN	O
to	TO	O
define	VB	O
the	DT	O
role	NN	O
of	IN	O
CA	NNP	O
IX	CD	O
and	CC	O
CA	NNP	O
XII	NNP	O
enzymes	NNS	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
pH	NN	O
in	IN	O
the	DT	O
extracellular	JJ	O
microenvironment	NN	O
and	CC	O
its	PRP$	O
potential	JJ	O
impact	NN	O
on	IN	O
cancer	NN	B-Disease
cell	NN	O
growth	NN	O
.	.	O

A	DT	O
novel	JJ	O
common	JJ	O
missense	NN	O
mutation	NN	O
G301C	NN	O
in	IN	O
the	DT	O
N-acetylgalactosamine-6-sulfate	NN	O
sulfatase	NN	O
gene	NN	O
in	IN	O
mucopolysaccharidosis	NN	B-Disease
IVA	NNP	I-Disease
.	.	O

Mucopolysaccharidosis	NNP	B-Disease
IVA	NNP	I-Disease
(	-LRB-	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
lysosomal	JJ	I-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
in	IN	O
N-acetylgalactosamine-6-sulfate	NN	O
sulfatase	NN	O
(	-LRB-	O
GALNS	NN	O
)	-RRB-	O
.	.	O

In	IN	O
previous	JJ	O
studies	NNS	O
,	,	O
we	PRP	O
have	VBP	O
found	VBN	O
two	CD	O
common	JJ	O
mutations	NNS	O
in	IN	O
Caucasians	NNPS	O
and	CC	O
Japanese	NNPS	O
,	,	O
respectively	RB	O
.	.	O

To	TO	O
characterize	VB	O
the	DT	O
mutational	JJ	O
spectrum	NN	O
in	IN	O
various	JJ	O
ethnic	JJ	O
groups	NNS	O
,	,	O
mutations	NNS	O
in	IN	O
the	DT	O
GALNS	NN	O
gene	NN	O
in	IN	O
Colombian	JJ	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
patients	NNS	O
were	VBD	O
investigated	VBN	O
,	,	O
and	CC	O
genetic	JJ	O
backgrounds	NNS	O
were	VBD	O
extensively	RB	O
analyzed	VBN	O
to	TO	O
identify	VB	O
racial	JJ	O
origin	NN	O
,	,	O
based	VBN	O
on	IN	O
mitochondrial	JJ	O
DNA	NN	O
(	-LRB-	O
mtDNA	NN	O
)	-RRB-	O
lineages	NNS	O
.	.	O

Three	CD	O
novel	JJ	O
missense	NN	O
mutations	NNS	O
never	RB	O
identified	VBN	O
previously	RB	O
in	IN	O
other	JJ	O
populations	NNS	O
and	CC	O
found	VBN	O
in	IN	O
16	CD	O
out	IN	O
of	IN	O
19	CD	O
Colombian	JJ	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
unrelated	JJ	O
alleles	NNS	O
account	VBP	O
for	IN	O
84	CD	O
.	.	O

2	CD	O
%	NN	O
of	IN	O
the	DT	O
alleles	NNS	O
in	IN	O
this	DT	O
study	NN	O
.	.	O

The	DT	O
G301C	NN	O
and	CC	O
S162F	NN	O
mutations	NNS	O
account	VBP	O
for	IN	O
68	CD	O
.	.	O

4	CD	O
%	NN	O
and	CC	O
10	CD	O
.	.	O

5	CD	O
%	NN	O
of	IN	O
mutations	NNS	O
,	,	O
respectively	RB	O
,	,	O
whereas	IN	O
the	DT	O
remaining	VBG	O
F69V	NN	O
is	VBZ	O
limited	VBN	O
to	TO	O
a	DT	O
single	JJ	O
allele	NN	O
.	.	O

The	DT	O
skewed	JJ	O
prevalence	NN	O
of	IN	O
G301C	NN	O
in	IN	O
only	RB	O
Colombian	JJ	O
patients	NNS	O
and	CC	O
haplotype	NN	O
analysis	NN	O
by	IN	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
GALNS	NN	O
gene	NN	O
suggest	VBP	O
that	IN	O
G301C	NN	O
originated	VBD	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
.	.	O

Investigation	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
background	NN	O
by	IN	O
means	NNS	O
of	IN	O
mtDNA	NN	O
lineages	NNS	O
indicate	VBP	O
that	IN	O
all	PDT	O
our	PRP$	O
patients	NNS	O
are	VBP	O
probably	RB	O
of	IN	O
native	JJ	O
American	JJ	O
descent	NN	O

W474C	NN	O
amino	NN	O
acid	NN	O
substitution	NN	O
affects	VBZ	O
early	JJ	O
processing	NN	O
of	IN	O
the	DT	O
alpha-subunit	NN	O
of	IN	O
beta-hexosaminidase	NN	O
A	NN	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
subacute	JJ	O
G	NN	B-Disease
(	-LRB-	I-Disease
M2	NN	I-Disease
)	-RRB-	I-Disease
gangliosidosis	NN	I-Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
,	,	O
encoding	VBG	O
the	DT	O
alpha-subunit	NN	O
of	IN	O
beta-hexosaminidase	NN	O
A	NN	O
(	-LRB-	O
Hex	NN	O
A	NN	O
)	-RRB-	O
,	,	O
that	WDT	O
abolish	VBP	O
Hex	NN	O
A	NN	O
enzyme	NN	O
activity	NN	O
cause	VBP	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
fatal	JJ	O
infantile	JJ	B-Disease
form	NN	I-Disease
of	IN	I-Disease
G	NN	I-Disease
(	-LRB-	I-Disease
M2	NN	I-Disease
)	-RRB-	I-Disease
gangliosidosis	NN	I-Disease
,	,	I-Disease
Type	NN	I-Disease
1	CD	I-Disease
.	.	O

Less	RBR	O
severe	JJ	O
,	,	O
subacute	JJ	O
(	-LRB-	O
juvenile-onset	JJ	O
)	-RRB-	O
and	CC	O
chronic	JJ	O
(	-LRB-	O
adult-onset	JJ	O
)	-RRB-	O
variants	NNS	O
are	VBP	O
characterized	VBN	O
by	IN	O
a	DT	O
broad	JJ	O
spectrum	NN	O
of	IN	O
clinical	JJ	O
manifestations	NNS	O
and	CC	O
are	VBP	O
associated	VBN	O
with	IN	O
residual	JJ	O
levels	NNS	O
of	IN	O
Hex	NNP	O
A	NNP	O
enzyme	NN	O
activity	NN	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
1422	CD	O
G	NN	O
--	:	O
>	JJR	O
C	NN	O
(	-LRB-	O
amino	NN	O
acid	NN	O
W474C	NN	O
)	-RRB-	O
substitution	NN	O
in	IN	O
the	DT	O
first	JJ	O
position	NN	O
of	IN	O
exon	NN	O
13	CD	O
of	IN	O
HEXA	NN	O
of	IN	O
a	DT	O
non-Jewish	JJ	O
proband	NN	O
who	WP	O
manifested	VBD	O
a	DT	O
subacute	JJ	O
variant	NN	O
of	IN	O
G	NN	B-Disease
(	-LRB-	I-Disease
M2	NN	I-Disease
)	-RRB-	I-Disease
gangliosidosis	NN	I-Disease
.	.	O

On	IN	O
the	DT	O
second	JJ	O
maternally	RB	O
inherited	VBN	O
allele	NN	O
,	,	O
we	PRP	O
identified	VBD	O
the	DT	O
common	JJ	O
infantile	JJ	O
disease-causing	JJ	O
4-bp	JJ	O
insertion	NN	O
,	,	O
+	CC	O
TATC	NNP	O
1278	CD	O
,	,	O
in	IN	O
exon	NN	O
11	CD	O
.	.	O

Pulse-chase	JJ	O
analysis	NN	O
using	VBG	O
proband	NN	O
fibroblasts	NNS	O
revealed	VBD	O
that	IN	O
the	DT	O
W474C-containing	JJ	O
alpha-subunit	NN	O
precursor	NN	O
was	VBD	O
normally	RB	O
synthesized	VBN	O
,	,	O
but	CC	O
not	RB	O
phosphorylated	VBN	O
or	CC	O
secreted	VBN	O
,	,	O
and	CC	O
the	DT	O
mature	JJ	O
lysosomal	JJ	O
alpha-subunit	NN	O
was	VBD	O
not	RB	O
detected	VBN	O
.	.	O

When	WRB	O
the	DT	O
W474C-containing	JJ	O
alpha-subunit	NN	O
was	VBD	O
transiently	RB	O
co-expressed	VBN	O
with	IN	O
the	DT	O
beta-subunit	NN	O
to	TO	O
produce	VB	O
Hex	NN	O
A	NN	O
(	-LRB-	O
alphabeta	NN	O
)	-RRB-	O
in	IN	O
COS-7	NN	O
cells	NNS	O
,	,	O
the	DT	O
mature	JJ	O
alpha-subunit	NN	O
was	VBD	O
present	JJ	O
,	,	O
but	CC	O
its	PRP$	O
level	NN	O
was	VBD	O
much	RB	O
lower	JJR	O
than	IN	O
that	DT	O
from	IN	O
normal	JJ	O
alpha-subunit	NN	O
transfections	NNS	O
,	,	O
although	IN	O
higher	JJR	O
than	IN	O
in	IN	O
those	DT	O
cells	NNS	O
transfected	VBN	O
with	IN	O
an	DT	O
alpha-subunit	NN	O
associated	VBN	O
with	IN	O
infantile	JJ	O
TSD	NNP	B-Disease
.	.	O

Furthermore	RB	O
,	,	O
the	DT	O
precursor	NN	O
level	NN	O
of	IN	O
the	DT	O
W474C	NN	O
alpha-subunit	NN	O
was	VBD	O
found	VBN	O
to	TO	O
accumulate	VB	O
in	IN	O
comparison	NN	O
to	TO	O
the	DT	O
normal	JJ	O
alpha-subunit	NN	O
precursor	NN	O
levels	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
1422	CD	O
G	NN	O
--	:	O
>	JJR	O
C	NN	O
mutation	NN	O
is	VBZ	O
the	DT	O
cause	NN	O
of	IN	O
Hex	NNP	B-Disease
A	NNP	I-Disease
enzyme	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
the	DT	O
proband	NN	O
.	.	O

The	DT	O
resulting	VBG	O
W474C	NN	O
substitution	NN	O
clearly	RB	O
interferes	VBZ	O
with	IN	O
alpha-subunit	NN	O
processing	NN	O
,	,	O
but	CC	O
because	IN	O
the	DT	O
base	NN	O
substitution	NN	O
falls	VBZ	O
at	IN	O
the	DT	O
first	JJ	O
position	NN	O
of	IN	O
exon	NN	O
13	CD	O
,	,	O
aberrant	JJ	O
splicing	NN	O
may	MD	O
also	RB	O
contribute	VB	O
to	TO	O
Hex	NNP	B-Disease
A	NNP	I-Disease
deficiency	NN	I-Disease
in	IN	O
this	DT	O
proband	NN	O
.	.	O

.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
protein	NN	O
kinase	NN	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
modulation	NN	O
of	IN	O
the	DT	O
Ca2	NN	O
+	CC	O
homeostasis	NN	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
cells	NNS	O
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
most	RBS	O
prevalent	JJ	O
muscular	JJ	B-Disease
disorder	NN	I-Disease
in	IN	O
adults	NNS	O
,	,	O
is	VBZ	O
caused	VBN	O
by	IN	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n-repeat	NN	O
expansion	NN	O
in	IN	O
a	DT	O
gene	NN	O
encoding	VBG	O
a	DT	O
protein	NN	O
kinase	NN	O
(	-LRB-	O
DM	NN	B-Disease
protein	NN	O
kinase	NN	O
;	:	O
DMPK	NN	O
)	-RRB-	O
and	CC	O
involves	VBZ	O
changes	NNS	O
in	IN	O
cytoarchitecture	NN	O
and	CC	O
ion	NN	O
homeostasis	NN	O
.	.	O

To	TO	O
obtain	VB	O
clues	NNS	O
to	TO	O
the	DT	O
normal	JJ	O
biological	JJ	O
role	NN	O
of	IN	O
DMPK	NNP	O
in	IN	O
cellular	JJ	O
ion	NN	O
homeostasis	NN	O
,	,	O
we	PRP	O
have	VBP	O
compared	VBN	O
the	DT	O
resting	VBG	O
[	-LRB-	O
Ca2	NN	O
+	CC	O
]	-RRB-	O
i	FW	O
,	,	O
the	DT	O
amplitude	NN	O
and	CC	O
shape	NN	O
of	IN	O
depolarization-induced	JJ	O
Ca2	NN	O
+	CC	O
transients	NNS	O
,	,	O
and	CC	O
the	DT	O
content	NN	O
of	IN	O
ATP-driven	JJ	O
ion	NN	O
pumps	NNS	O
in	IN	O
cultured	VBN	O
skeletal	JJ	O
muscle	NN	O
cells	NNS	O
of	IN	O
wild-type	JJ	O
and	CC	O
DMPK	NN	O
[	-LRB-	O
-	:	O
/	:	O
-	:	O
]	-RRB-	O
knockout	JJ	O
mice	NNS	O
.	.	O

In	IN	O
vitro-differentiated	JJ	O
DMPK	NN	O
[	-LRB-	O
-	:	O
/	:	O
-	:	O
]	-RRB-	O
myotubes	NNS	O
exhibit	VBP	O
a	DT	O
higher	JJR	O
resting	VBG	O
[	-LRB-	O
Ca2	NN	O
+	CC	O
]	-RRB-	O
i	FW	O
than	IN	O
do	VBP	O
wild-type	JJ	O
myotubes	NNS	O
because	IN	O
of	IN	O
an	DT	O
altered	JJ	O
open	JJ	O
probability	NN	O
of	IN	O
voltage-dependent	JJ	O
l-type	JJ	O
Ca2	NN	O
+	CC	O
and	CC	O
Na	NN	O
+	CC	O
channels	NNS	O
.	.	O

The	DT	O
mutant	JJ	O
myotubes	NNS	O
exhibit	VBP	O
smaller	JJR	O
and	CC	O
slower	JJR	O
Ca2	NN	O
+	CC	O
responses	NNS	O
upon	IN	O
triggering	VBG	O
by	IN	O
acetylcholine	NN	O
or	CC	O
high	JJ	O
external	JJ	O
K	NN	O
+	CC	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
observed	VBD	O
that	IN	O
these	DT	O
Ca2	NN	O
+	CC	O
transients	NNS	O
partially	RB	O
result	VBP	O
from	IN	O
an	DT	O
influx	NN	O
of	IN	O
extracellular	JJ	O
Ca2	NN	O
+	CC	O
through	IN	O
the	DT	O
l-type	JJ	O
Ca2	NN	O
+	CC	O
channel	NN	O
.	.	O

Neither	CC	O
the	DT	O
content	NN	O
nor	CC	O
the	DT	O
activity	NN	O
of	IN	O
Na	NN	O
+	CC	O
/	:	O
K	NN	O
+	CC	O
ATPase	NN	O
and	CC	O
sarcoplasmic	JJ	O
reticulum	NN	O
Ca2	NN	O
+	CC	O
-	:	O
ATPase	NN	O
are	VBP	O
affected	VBN	O
by	IN	O
DMPK	NN	O
absence	NN	O
.	.	O

In	IN	O
conclusion	NN	O
,	,	O
our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
DMPK	NN	O
is	VBZ	O
involved	VBN	O
in	IN	O
modulating	VBG	O
the	DT	O
initial	JJ	O
events	NNS	O
of	IN	O
excitation-contraction	JJ	O
coupling	NN	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
.	.	O

.	.	O

Insertional	JJ	O
mutation	NN	O
by	IN	O
transposable	JJ	O
element	NN	O
,	,	O
L1	NN	O
,	,	O
in	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
results	VBZ	O
in	IN	O
X-linked	JJ	B-Disease
dilated	JJ	I-Disease
cardiomyopathy	NN	I-Disease
.	.	O

X-linked	JJ	B-Disease
dilated	JJ	I-Disease
cardiomyopathy	NN	I-Disease
(	-LRB-	O
XLDCM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
clinical	JJ	O
phenotype	NN	O
of	IN	O
dystrophinopathy	NN	B-Disease
which	WDT	O
is	VBZ	O
characterized	VBN	O
by	IN	O
preferential	JJ	O
myocardial	JJ	B-Disease
involvement	NN	I-Disease
without	IN	O
any	DT	O
overt	JJ	O
clinical	JJ	O
signs	NNS	O
of	IN	O
skeletal	JJ	B-Disease
myopathy	NN	I-Disease
.	.	O

To	TO	O
date	NN	O
,	,	O
several	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
gene	NN	O
,	,	O
DMD	NNP	O
,	,	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
XLDCM	NN	B-Disease
,	,	O
but	CC	O
a	DT	O
pathogenic	JJ	O
correlation	NN	O
of	IN	O
these	DT	O
cardiospecific	JJ	O
mutations	NNS	O
in	IN	O
DMD	NN	O
with	IN	O
the	DT	O
XLDCM	NNP	B-Disease
phenotype	NN	O
has	VBZ	O
remained	VBN	O
to	TO	O
be	VB	O
elucidated	VBN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
unique	JJ	O
de	FW	O
novo	FW	O
L1	NN	O
insertion	NN	O
in	IN	O
the	DT	O
muscle	NN	O
exon	NN	O
1	CD	O
in	IN	O
DMD	NNP	O
in	IN	O
three	CD	O
XLDCM	NN	B-Disease
patients	NNS	O
from	IN	O
two	CD	O
unrelated	JJ	O
Japanese	JJ	O
families	NNS	O
.	.	O

The	DT	O
insertion	NN	O
was	VBD	O
a	DT	O
5-truncated	JJ	O
form	NN	O
of	IN	O
human	JJ	O
L1	NN	O
inversely	RB	O
integrated	VBN	O
in	IN	O
the	DT	O
5-untranslated	JJ	O
region	NN	O
in	IN	O
the	DT	O
muscle	NN	O
exon	NN	O
1	CD	O
,	,	O
which	WDT	O
affected	VBD	O
the	DT	O
transcription	NN	O
or	CC	O
the	DT	O
stability	NN	O
of	IN	O
the	DT	O
muscle	NN	O
form	NN	O
of	IN	O
dystrophin	NN	O
transcripts	NNS	O
but	CC	O
not	RB	O
that	DT	O
of	IN	O
the	DT	O
brain	NN	O
or	CC	O
Purkinje	NN	O
cell	NN	O
form	NN	O
,	,	O
probably	RB	O
due	JJ	O
to	TO	O
its	PRP$	O
unique	JJ	O
site	NN	O
of	IN	O
integration	NN	O
.	.	O

We	PRP	O
speculate	VBP	O
that	IN	O
this	DT	O
insertion	NN	O
of	IN	O
an	DT	O
L1	NN	O
sequence	NN	O
in	IN	O
DMD	NNP	O
is	VBZ	O
responsible	JJ	O
for	IN	O
some	DT	O
of	IN	O
the	DT	O
population	NN	O
of	IN	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
XLDCM	NN	B-Disease
.	.	O

.	.	O

Genetic	JJ	O
heterogeneity	NN	O
of	IN	O
Saethre-Chotzen	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
due	JJ	O
to	TO	O
TWIST	NN	O
and	CC	O
FGFR	NN	O
mutations	NNS	O
.	.	O

Thirty-two	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
features	NNS	O
of	IN	O
Saethre-Chotzen	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
a	DT	O
common	JJ	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
condition	NN	I-Disease
of	IN	O
craniosynostosis	NN	B-Disease
and	CC	O
limb	NN	B-Disease
anomalies	NNS	I-Disease
,	,	O
were	VBD	O
screened	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
TWIST	NN	O
,	,	O
FGFR2	NN	O
,	,	O
and	CC	O
FGFR3	NN	O
.	.	O

Nine	CD	O
novel	JJ	O
and	CC	O
three	CD	O
recurrent	JJ	O
TWIST	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
12	CD	O
families	NNS	O
.	.	O

Seven	CD	O
families	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
FGFR3	NN	O
P250R	NN	O
mutation	NN	O
,	,	O
and	CC	O
one	CD	O
individual	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
an	DT	O
FGFR2	NN	O
VV269-270	NN	O
deletion	NN	O
.	.	O

To	TO	O
date	NN	O
,	,	O
our	PRP$	O
detection	NN	O
rate	NN	O
for	IN	O
TWIST	NN	O
or	CC	O
FGFR	NN	O
mutations	NNS	O
is	VBZ	O
68	CD	O
%	NN	O
in	IN	O
our	PRP$	O
Saethre-Chotzen	JJ	B-Disease
syndrome	NN	I-Disease
patients	NNS	O
,	,	O
including	VBG	O
our	PRP$	O
five	CD	O
patients	NNS	O
elsewhere	RB	O
reported	VBN	O
with	IN	O
TWIST	NN	O
mutations	NNS	O
.	.	O

More	JJR	O
than	IN	O
35	CD	O
different	JJ	O
TWIST	NN	O
mutations	NNS	O
are	VBP	O
now	RB	O
known	VBN	O
in	IN	O
the	DT	O
literature	NN	O
.	.	O

The	DT	O
most	RBS	O
common	JJ	O
phenotypic	JJ	O
features	NNS	O
,	,	O
present	JJ	O
in	IN	O
more	JJR	O
than	IN	O
a	DT	O
third	JJ	O
of	IN	O
our	PRP$	O
patients	NNS	O
with	IN	O
TWIST	NN	O
mutations	NNS	O
,	,	O
are	VBP	O
coronal	JJ	B-Disease
synostosis	NNS	I-Disease
,	,	O
brachycephaly	RB	B-Disease
,	,	O
low	JJ	B-Disease
frontal	JJ	I-Disease
hairline	NN	I-Disease
,	,	O
facial	JJ	B-Disease
asymmetry	NN	I-Disease
,	,	O
ptosis	NN	B-Disease
,	,	O
hypertelorism	NN	B-Disease
,	,	O
broad	JJ	B-Disease
great	JJ	I-Disease
toes	NNS	I-Disease
,	,	O
and	CC	O
clinodactyly	RB	B-Disease
.	.	O

Significant	JJ	O
intra	NN	O
-	:	O
and	CC	O
interfamilial	JJ	O
phenotypic	JJ	O
variability	NN	O
is	VBZ	O
present	JJ	O
for	IN	O
either	CC	O
TWIST	NN	O
mutations	NNS	O
or	CC	O
FGFR	NN	O
mutations	NNS	O
.	.	O

The	DT	O
overlap	VBP	O
in	IN	O
clinical	JJ	O
features	NNS	O
and	CC	O
the	DT	O
presence	NN	O
,	,	O
in	IN	O
the	DT	O
same	JJ	O
genes	NNS	O
,	,	O
of	IN	O
mutations	NNS	O
for	IN	O
more	JJR	O
than	IN	O
one	CD	O
craniosynostotic	JJ	B-Disease
condition-such	NN	O
as	IN	O
Saethre-Chotzen	NNP	B-Disease
,	,	I-Disease
Crouzon	NNP	I-Disease
,	,	I-Disease
and	CC	I-Disease
Pfeiffer	NNP	I-Disease
syndromes-support	VBP	O
the	DT	O
hypothesis	NN	O
that	IN	O
TWIST	NN	O
and	CC	O
FGFRs	NNS	O
are	VBP	O
components	NNS	O
of	IN	O
the	DT	O
same	JJ	O
molecular	JJ	O
pathway	NN	O
involved	VBN	O
in	IN	O
the	DT	O
modulation	NN	O
of	IN	O
craniofacial	NN	O
and	CC	O
limb	NN	O
development	NN	O
in	IN	O
humans	NNS	O
.	.	O

.	.	O

Frequent	JJ	O
inactivation	NN	O
of	IN	O
PTEN/MMAC1	NN	O
in	IN	O
primary	JJ	O
prostate	NN	B-Disease
cancer	NN	I-Disease
.	.	O

Sporadic	JJ	B-Disease
prostate	NN	I-Disease
carcinoma	NN	I-Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
male	NN	B-Disease
cancer	NN	I-Disease
in	IN	O
the	DT	O
Western	JJ	O
world	NN	O
,	,	O
yet	RB	O
many	JJ	O
of	IN	O
the	DT	O
major	JJ	O
genetic	JJ	O
events	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
progression	NN	O
of	IN	O
this	DT	O
often	RB	O
fatal	JJ	O
cancer	NN	B-Disease
remain	VBP	O
to	TO	O
be	VB	O
elucidated	VBN	O
.	.	O

Numerous	JJ	O
cytogenetic	JJ	O
and	CC	O
allelotype	JJ	O
studies	NNS	O
have	VBP	O
reported	VBN	O
frequent	JJ	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
on	IN	O
chromosomal	JJ	O
arm	NN	O
10q	CD	O
in	IN	O
sporadic	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
.	.	O

Deletion	NN	O
mapping	NN	O
studies	NNS	O
have	VBP	O
unambiguously	RB	O
identified	VBN	O
a	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
10q23	NN	O
to	TO	O
be	VB	O
the	DT	O
minimal	JJ	O
area	NN	O
of	IN	O
loss	NN	O
.	.	O

A	DT	O
new	JJ	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
,	,	O
PTEN/MMAC1	NN	O
,	,	O
was	VBD	O
isolated	VBN	O
recently	RB	O
at	IN	O
this	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
10q23	NN	O
and	CC	O
found	VBN	O
to	TO	O
be	VB	O
inactivated	VBN	O
by	IN	O
mutation	NN	O
in	IN	O
three	CD	O
prostate	NN	B-Disease
cancer	NN	I-Disease
cell	NN	O
lines	NNS	O
.	.	O

We	PRP	O
screened	VBD	O
80	CD	O
prostate	NN	B-Disease
tumors	NNS	I-Disease
by	IN	O
microsatellite	NN	O
analysis	NN	O
and	CC	O
found	VBD	O
chromosome	NN	O
10q23	NN	O
to	TO	O
be	VB	O
deleted	VBN	O
in	IN	O
23	CD	O
cases	NNS	O
.	.	O

We	PRP	O
then	RB	O
proceeded	VBD	O
with	IN	O
sequence	NN	O
analysis	NN	O
of	IN	O
the	DT	O
entire	JJ	O
PTEN/MMAC1	NN	O
coding	VBG	O
region	NN	O
and	CC	O
tested	VBN	O
for	IN	O
homozygous	JJ	O
deletion	NN	O
with	IN	O
new	JJ	O
intragenic	JJ	O
markers	NNS	O
in	IN	O
these	DT	O
23	CD	O
cases	NNS	O
with	IN	O
10q23	NN	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
the	DT	O
second	JJ	O
mutational	JJ	O
event	NN	O
in	IN	O
10	CD	O
(	-LRB-	O
43	CD	O
%	NN	O
)	-RRB-	O
tumors	NNS	B-Disease
establishes	VBZ	O
PTEN/MMAC1	NN	O
as	IN	O
a	DT	O
main	JJ	O
inactivation	NN	O
target	NN	O
of	IN	O
10q	JJ	O
loss	NN	O
in	IN	O
sporadic	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
.	.	O

.	.	O

Molecular	JJ	O
heterogeneity	NN	O
in	IN	O
mucopolysaccharidosis	NN	B-Disease
IVA	NNP	I-Disease
in	IN	O
Australia	NNP	O
and	CC	O
Northern	NNP	O
Ireland	NNP	O
:	:	O
nine	CD	O
novel	JJ	O
mutations	NNS	O
including	VBG	O
T312S	NN	O
,	,	O
a	DT	O
common	JJ	O
allele	NN	O
that	WDT	O
confers	VBZ	O
a	DT	O
mild	JJ	O
phenotype	NN	O
.	.	O

Mucopolysaccharidosis	NNP	B-Disease
IVA	NNP	I-Disease
(	-LRB-	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
lysosomal	JJ	I-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
in	IN	O
N-acetylgalactosamine-6-sulfate	NN	O
sulfatase	NN	O
(	-LRB-	O
GALNS	NN	O
)	-RRB-	O
.	.	O

Previous	JJ	O
studies	NNS	O
of	IN	O
patients	NNS	O
from	IN	O
a	DT	O
British-Irish	JJ	O
population	NN	O
showed	VBD	O
that	IN	O
the	DT	O
I113F	NN	O
mutation	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
single	JJ	O
mutation	NN	O
among	IN	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
patients	NNS	O
and	CC	O
produces	VBZ	O
a	DT	O
severe	JJ	O
clinical	JJ	O
phenotype	NN	O
.	.	O

We	PRP	O
studied	VBD	O
mutations	NNS	O
in	IN	O
the	DT	O
GALNS	NN	O
gene	NN	O
from	IN	O
23	CD	O
additional	JJ	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
patients	NNS	O
(	-LRB-	O
15	CD	O
from	IN	O
Australia	NNP	O
,	,	O
8	CD	O
from	IN	O
Northern	JJ	O
Ireland	NNP	O
)	-RRB-	O
,	,	O
with	IN	O
various	JJ	O
clinical	JJ	O
phenotypes	NNS	O
(	-LRB-	O
severe	JJ	O
,	,	O
16	CD	O
cases	NNS	O
;	:	O
intermediate	JJ	O
,	,	O
4	CD	O
cases	NNS	O
;	:	O
mild	JJ	O
,	,	O
3	CD	O
cases	NNS	O
)	-RRB-	O
.	.	O

We	PRP	O
found	VBD	O
two	CD	O
common	JJ	O
mutations	NNS	O
that	WDT	O
together	RB	O
accounted	VBD	O
for	IN	O
32	CD	O
%	NN	O
of	IN	O
the	DT	O
44	CD	O
unrelated	JJ	O
alleles	NNS	O
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

One	CD	O
is	VBZ	O
the	DT	O
T312S	NN	O
mutation	NN	O
,	,	O
a	DT	O
novel	JJ	O
mutation	NN	O
found	VBD	O
exclusively	RB	O
in	IN	O
milder	JJ	O
patients	NNS	O
.	.	O

The	DT	O
other	JJ	O
is	VBZ	O
the	DT	O
previously	RB	O
described	VBN	O
I113F	NN	O
that	WDT	O
produces	VBZ	O
a	DT	O
severe	JJ	O
phenotype	NN	O
.	.	O

The	DT	O
I113F	NN	O
and	CC	O
T312S	NN	O
mutations	NNS	O
accounted	VBD	O
for	IN	O
8	CD	O
(	-LRB-	O
18	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
6	CD	O
(	-LRB-	O
14	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
44	CD	O
unrelated	JJ	O
alleles	NNS	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
relatively	RB	O
high	JJ	O
residual	JJ	O
GALNS	NN	O
activity	NN	O
seen	VBN	O
when	WRB	O
the	DT	O
T312S	NN	O
mutant	JJ	O
cDNA	NN	O
is	VBZ	O
overexpressed	VBN	O
in	IN	O
mutant	JJ	O
cells	NNS	O
provides	VBZ	O
an	DT	O
explanation	NN	O
for	IN	O
the	DT	O
mild	JJ	O
phenotype	NN	O
in	IN	O
patients	NNS	O
with	IN	O
this	DT	O
mutation	NN	O
.	.	O

The	DT	O
distribution	NN	O
and	CC	O
relative	JJ	O
frequencies	NNS	O
of	IN	O
the	DT	O
I113F	NN	O
and	CC	O
T312S	NN	O
mutations	NNS	O
in	IN	O
Australia	NNP	O
corresponded	VBD	O
to	TO	O
those	DT	O
observed	VBN	O
in	IN	O
Northern	JJ	O
Ireland	NNP	O
and	CC	O
are	VBP	O
unique	JJ	O
to	TO	O
these	DT	O
two	CD	O
populations	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
both	CC	O
mutations	NNS	O
were	VBD	O
probably	RB	O
introduced	VBN	O
to	TO	O
Australia	NNP	O
by	IN	O
Irish	NNP	O
migrants	NNS	O
during	IN	O
the	DT	O
19th	JJ	O
century	NN	O
.	.	O

Haplotype	NN	O
analysis	NN	O
using	VBG	O
6	CD	O
RFLPs	NNS	O
provides	VBZ	O
additional	JJ	O
data	NNS	O
that	IN	O
the	DT	O
I113F	NN	O
mutation	NN	O
originated	VBD	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
.	.	O

The	DT	O
other	JJ	O
9	CD	O
novel	JJ	O
mutations	NNS	O
identified	VBN	O
in	IN	O
these	DT	O
23	CD	O
patients	NNS	O
were	VBD	O
each	DT	O
limited	VBN	O
to	TO	O
a	DT	O
single	JJ	O
family	NN	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
for	IN	O
extensive	JJ	O
allelic	JJ	O
heterogeneity	NN	O
in	IN	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
in	IN	O
British-Irish	JJ	O
patients	NNS	O
and	CC	O
provide	VBP	O
evidence	NN	O
for	IN	O
their	PRP$	O
transmission	NN	O
to	TO	O
Australia	NNP	O
by	IN	O
British-Irish	NNP	O
migrants	NNS	O
.	.	O

.	.	O

Further	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
major	JJ	O
ancient	JJ	O
mutation	NN	O
underlying	VBG	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
from	IN	O
linkage	NN	O
disequilibrium	NN	O
studies	NNS	O
in	IN	O
the	DT	O
Japanese	JJ	O
population	NN	O
.	.	O

The	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
mutation	NN	O
is	VBZ	O
an	DT	O
unstable	JJ	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
,	,	O
present	JJ	O
at	IN	O
a	DT	O
copy	NN	O
number	NN	O
of	IN	O
5-37	CD	O
repeats	NNS	O
on	IN	O
normal	JJ	O
chromosomes	NNS	O
but	CC	O
amplified	VBD	O
to	TO	O
50-3000	CD	O
copies	NNS	O
on	IN	O
DM	NN	B-Disease
chromosomes	NNS	O
.	.	O

Previous	JJ	O
findings	NNS	O
in	IN	O
Caucasian	JJ	O
populations	NNS	O
of	IN	O
a	DT	O
DM	NN	B-Disease
founder	NN	O
chromosome	NN	O
raise	VB	O
a	DT	O
question	NN	O
about	IN	O
the	DT	O
molecular	JJ	O
events	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
expansion	NN	O
mutation	NN	O
.	.	O

To	TO	O
investigate	VB	O
whether	IN	O
a	DT	O
founder	NN	O
chromosome	NN	O
for	IN	O
the	DT	O
DM	NN	B-Disease
mutation	NN	O
exists	VBZ	O
in	IN	O
the	DT	O
Japanese	JJ	O
population	NN	O
,	,	O
we	PRP	O
genotyped	VBD	O
families	NNS	O
using	VBG	O
polymorphic	JJ	O
markers	NNS	O
near	IN	O
the	DT	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
region	NN	O
and	CC	O
constructed	VBN	O
haplotypes	NNS	O
.	.	O

Six	CD	O
different	JJ	O
haplotypes	NNS	O
were	VBD	O
found	VBN	O
and	CC	O
DM	NN	B-Disease
alleles	NNS	O
were	VBD	O
always	RB	O
haplotype	NN	O
A.	NN	O
To	TO	O
find	VB	O
an	DT	O
origin	NN	O
of	IN	O
the	DT	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
mutation	NN	O
and	CC	O
to	TO	O
investigate	VB	O
the	DT	O
mechanism	NN	O
of	IN	O
the	DT	O
expansion	NN	O
mutation	NN	O
in	IN	O
the	DT	O
Japanese	JJ	O
population	NN	O
we	PRP	O
have	VBP	O
studied	VBN	O
90	CD	O
Japanese	JJ	O
DM	NN	B-Disease
families	NNS	O
comprising	VBG	O
190	CD	O
affected	VBN	O
and	CC	O
130	CD	O
unaffected	JJ	O
members	NNS	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
few	JJ	O
common	JJ	O
ancestral	JJ	O
mutations	NNS	O
in	IN	O
both	DT	O
Caucasian	JJ	O
and	CC	O
Japanese	JJ	O
populations	NNS	O
have	VBP	O
originated	VBN	O
by	IN	O
expansion	NN	O
of	IN	O
an	DT	O
ancestral	JJ	O
n	NN	O
=	JJ	O
5	CD	O
repeat	NN	O
to	TO	O
n	NN	O
=	JJ	O
19-37	CD	O
copies	NNS	O
.	.	O

These	DT	O
data	NNS	O
support	VBP	O
multistep	JJ	O
models	NNS	O
of	IN	O
triplet	NN	O
repeat	NN	O
expansion	NN	O
that	WDT	O
have	VBP	O
been	VBN	O
proposed	VBN	O
for	IN	O
both	DT	O
DM	NN	B-Disease
and	CC	O
Friedreichs	NNS	B-Disease
ataxia	NN	I-Disease
.	.	O

.	.	O

Prevalence	NN	O
of	IN	O
p16	NN	O
and	CC	O
CDK4	NN	O
germline	NN	O
mutations	NNS	O
in	IN	O
48	CD	O
melanoma-prone	JJ	O
families	NNS	O
in	IN	O
France	NNP	O
.	.	O

The	DT	O
French	JJ	O
Familial	JJ	B-Disease
Melanoma	NN	I-Disease
Study	NNP	O
Group	NNP	O
.	.	O

Germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
p16	NN	O
and	CC	O
CDK4	NN	O
genes	NNS	O
have	VBP	O
been	VBN	O
reported	VBN	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
melanoma	NN	B-Disease
pedigrees	NNS	O
,	,	O
but	CC	O
their	PRP$	O
prevalence	NN	O
is	VBZ	O
not	RB	O
well	RB	O
known	VBN	O
.	.	O

We	PRP	O
searched	VBD	O
for	IN	O
such	JJ	O
germline	NN	O
mutations	NNS	O
in	IN	O
48	CD	O
French	JJ	O
melanoma-prone	JJ	O
families	NNS	O
selected	VBN	O
according	VBG	O
to	TO	O
two	CD	O
major	JJ	O
criteria	NNS	O
families	NNS	O
with	IN	O
at	IN	O
least	JJS	O
three	CD	O
affected	VBN	O
members	NNS	O
(	-LRB-	O
n	NN	O
=	JJ	O
20	CD	O
)	-RRB-	O
or	CC	O
families	NNS	O
with	IN	O
two	CD	O
affected	VBD	O
members	NNS	O
,	,	O
one	CD	O
of	IN	O
them	PRP	O
affected	VBD	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
50	CD	O
(	-LRB-	O
n	NN	O
=	JJ	O
28	CD	O
)	-RRB-	O
,	,	O
and	CC	O
one	CD	O
additional	JJ	O
minor	JJ	O
criterion	NN	O
.	.	O

Sixteen	CD	O
different	JJ	O
p16	NN	O
germline	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
21	CD	O
families	NNS	O
,	,	O
while	IN	O
one	CD	O
germline	NN	O
mutation	NN	O
,	,	O
Arg24His	NN	O
,	,	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
CDK4	NN	O
gene	NN	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
p16	NN	O
gene	NN	O
mutation	NN	O
in	IN	O
our	PRP$	O
sample	NN	O
(	-LRB-	O
44	CD	O
%	NN	O
)	-RRB-	O
is	VBZ	O
among	IN	O
the	DT	O
highest	JJS	O
rates	NNS	O
yet	RB	O
reported	VBN	O
and	CC	O
the	DT	O
CDK4	NN	O
mutation	NN	O
is	VBZ	O
the	DT	O
second	JJ	O
mutation	NN	O
detected	VBN	O
in	IN	O
this	DT	O
gene	NN	O
worldwide	RB	O
.	.	O

In	IN	O
summary	NN	O
,	,	O
our	PRP$	O
results	NNS	O
show	VBP	O
frequent	JJ	O
involvement	NN	O
of	IN	O
the	DT	O
p16	NN	O
gene	NN	O
in	IN	O
familial	JJ	B-Disease
melanoma	NN	I-Disease
and	CC	O
confirm	VBP	O
the	DT	O
role	NN	O
of	IN	O
the	DT	O
CDK4	NN	O
gene	NN	O
as	IN	O
a	DT	O
melanoma-predisposing	JJ	O
gene	NN	O
.	.	O

.	.	O

Systematic	JJ	O
analysis	NN	O
of	IN	O
coproporphyrinogen	NN	O
oxidase	NN	O
gene	NN	O
defects	NNS	O
in	IN	O
hereditary	JJ	B-Disease
coproporphyria	NN	I-Disease
and	CC	O
mutation	NN	O
update	VBP	O
.	.	O

Hereditary	JJ	B-Disease
coproporphyria	NN	I-Disease
(	-LRB-	O
HC	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
acute	JJ	O
hepatic	JJ	B-Disease
porphyria	NN	I-Disease
with	IN	O
autosomal	JJ	O
dominant	JJ	O
inheritance	NN	O
caused	VBN	O
by	IN	O
deficient	JJ	B-Disease
activity	NN	I-Disease
of	IN	I-Disease
coproporphyrinogen	NN	I-Disease
III	CD	I-Disease
oxidase	NN	I-Disease
(	-LRB-	O
CPO	NN	O
)	-RRB-	O
.	.	O

Clinical	JJ	O
manifestations	NNS	O
of	IN	O
the	DT	O
disease	NN	O
are	VBP	O
characterized	VBN	O
by	IN	O
acute	JJ	O
attacks	NNS	O
of	IN	O
neurological	JJ	B-Disease
dysfunction	NN	I-Disease
often	RB	O
precipitated	VBN	O
by	IN	O
drugs	NNS	O
,	,	O
fasting	NN	O
,	,	O
cyclical	JJ	O
hormonal	JJ	O
changes	NNS	O
,	,	O
or	CC	O
infectious	JJ	B-Disease
diseases	NNS	I-Disease
.	.	O

Skin	NN	O
photosensitivity	NN	O
may	MD	O
also	RB	O
be	VB	O
present	JJ	O
.	.	O

The	DT	O
seven	CD	O
exons	NNS	O
,	,	O
the	DT	O
exon/intron	NN	O
boundaries	NNS	O
and	CC	O
part	NN	O
of	IN	O
3	CD	O
noncoding	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
CPO	NN	O
gene	NN	O
were	VBD	O
systematically	RB	O
analyzed	VBN	O
by	IN	O
an	DT	O
exon-by-exon	JJ	O
denaturing	VBG	O
gradient	NN	O
gel	NN	O
electrophoresis	NN	O
(	-LRB-	O
DGGE	NN	O
)	-RRB-	O
strategy	NN	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
in	IN	O
seven	CD	O
unrelated	JJ	O
heterozygous	JJ	O
HC	NN	B-Disease
patients	NNS	O
from	IN	O
France	NNP	O
,	,	O
Holland	NNP	O
,	,	O
and	CC	O
Czech	NNP	O
Republic	NNP	O
.	.	O

Seven	CD	O
novel	JJ	O
mutations	NNS	O
and	CC	O
two	CD	O
new	JJ	O
polymorphisms	NNS	O
were	VBD	O
detected	VBN	O
.	.	O

Among	IN	O
these	DT	O
mutations	NNS	O
two	CD	O
are	VBP	O
missense	NN	O
(	-LRB-	O
G197W	NN	O
,	,	O
W427R	NN	O
)	-RRB-	O
,	,	O
two	CD	O
are	VBP	O
nonsense	NN	O
(	-LRB-	O
Q306X	NN	O
,	,	O
Q385X	NN	O
)	-RRB-	O
,	,	O
two	CD	O
are	VBP	O
small	JJ	O
deletions	NNS	O
(	-LRB-	O
662de14bp	NN	O
;	:	O
1168del3bp	JJ	O
removing	VBG	O
a	DT	O
glycine	NN	O
at	IN	O
position	NN	O
390	CD	O
)	-RRB-	O
,	,	O
and	CC	O
one	CD	O
is	VBZ	O
a	DT	O
splicing	NN	O
mutation	NN	O
(	-LRB-	O
IVS1-15c	NN	O
--	:	O
>	JJR	O
g	NN	O
)	-RRB-	O
which	WDT	O
creates	VBZ	O
a	DT	O
new	JJ	O
acceptor	NN	O
splice	NN	O
site	NN	O
.	.	O

The	DT	O
pathological	JJ	O
significance	NN	O
of	IN	O
the	DT	O
point	NN	O
mutations	NNS	O
G197W	NN	O
,	,	O
W427R	NN	O
,	,	O
and	CC	O
the	DT	O
in-frame	RB	O
deletion	NN	O
390delGly	NN	O
were	VBD	O
assessed	VBN	O
by	IN	O
their	PRP$	O
respective	JJ	O
expression	NN	O
in	IN	O
a	DT	O
prokaryotic	JJ	O
system	NN	O
using	VBG	O
site-directed	JJ	O
mutagenesis	NN	O
.	.	O

These	DT	O
mutations	NNS	O
resulted	VBD	O
in	IN	O
the	DT	O
absence	NN	O
or	CC	O
a	DT	O
dramatic	JJ	O
decrease	NN	O
of	IN	O
CPO	NN	O
activity	NN	O
.	.	O

The	DT	O
two	CD	O
polymorphisms	NNS	O
were	VBD	O
localized	JJ	O
in	IN	O
noncoding	JJ	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
1	CD	O
)	-RRB-	O
a	DT	O
C/G	NN	O
polymorphism	NN	O
in	IN	O
the	DT	O
promotor	NN	O
region	NN	O
,	,	O
142	CD	O
bp	NN	O
upstream	RB	O
from	IN	O
the	DT	O
transcriptional	JJ	O
initiation	NN	O
site	NN	O
(	-LRB-	O
-142	CD	O
C/G	NN	O
)	-RRB-	O
,	,	O
and	CC	O
2	LS	O
)	-RRB-	O
a	DT	O
6	CD	O
bp	NN	O
deletion	NN	O
polymorphism	NN	O
in	IN	O
the	DT	O
3	CD	O
noncoding	JJ	O
part	NN	O
of	IN	O
the	DT	O
CPO	NN	O
gene	NN	O
,	,	O
574	CD	O
bp	NN	O
downstream	JJ	O
of	IN	O
the	DT	O
last	JJ	O
base	NN	O
of	IN	O
the	DT	O
normal	JJ	O
termination	NN	O
codon	NN	O
(	-LRB-	O
+	CC	O
574	CD	O
delATTCTT	NN	O
)	-RRB-	O
.	.	O

Five	CD	O
intragenic	JJ	O
dimorphisms	NNS	O
are	VBP	O
now	RB	O
well	RB	O
characterized	VBN	O
and	CC	O
the	DT	O
high	JJ	O
degree	NN	O
of	IN	O
allelic	JJ	O
heterogeneity	NN	O
in	IN	O
HC	NN	B-Disease
is	VBZ	O
demonstrated	VBN	O
with	IN	O
seven	CD	O
new	JJ	O
different	JJ	O
mutations	NNS	O
making	VBG	O
a	DT	O
total	NN	O
of	IN	O
nineteen	CD	O
CPO	NN	O
gene	NN	B-Disease
defects	NNS	I-Disease
reported	VBD	O
so	RB	O
far	RB	O
.	.	O

.	.	O

The	DT	O
haptoglobin-gene	JJ	O
deletion	NN	O
responsible	JJ	O
for	IN	O
anhaptoglobinemia	NN	B-Disease
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
an	DT	O
allelic	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
haptoglobin	NN	O
(	-LRB-	O
Hp	NN	O
)	-RRB-	O
gene	NN	O
from	IN	O
an	DT	O
individual	JJ	O
with	IN	O
anhaptoglobinemia	NN	B-Disease
.	.	O

The	DT	O
Hp	NN	O
gene	NN	O
cluster	NN	O
consists	VBZ	O
of	IN	O
coding	VBG	O
regions	NNS	O
of	IN	O
the	DT	O
alpha	NN	O
chain	NN	O
and	CC	O
beta	NN	O
chain	NN	O
of	IN	O
the	DT	O
haptoglobin	NN	O
gene	NN	O
(	-LRB-	O
Hp	NN	O
)	-RRB-	O
and	CC	O
of	IN	O
the	DT	O
alpha	NN	O
chain	NN	O
and	CC	O
beta	NN	O
chain	NN	O
of	IN	O
the	DT	O
haptoglobin-related	JJ	O
gene	NN	O
(	-LRB-	O
Hpr	NN	O
)	-RRB-	O
,	,	O
in	IN	O
tandem	JJ	O
from	IN	O
the	DT	O
5	CD	O
side	NN	O
.	.	O

Southern	NN	O
blot	NN	O
and	CC	O
PCR	NN	O
analyses	NNS	O
have	VBP	O
indicated	VBN	O
that	IN	O
the	DT	O
individual	JJ	O
with	IN	O
anhaptoglobinemia	NN	B-Disease
was	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
gene	NN	O
deletion	NN	O
and	CC	O
that	IN	O
the	DT	O
gene	NN	O
deletion	NN	O
was	VBD	O
included	VBN	O
at	IN	O
least	JJS	O
from	IN	O
the	DT	O
promoter	NN	O
region	NN	O
of	IN	O
Hp	NNP	O
to	TO	O
Hpr	NNP	O
alpha	NN	O
but	CC	O
not	RB	O
to	TO	O
Hpr	NNP	O
beta	NN	O
(	-LRB-	O
Hpdel	NN	O
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
found	VBD	O
seven	CD	O
individuals	NNS	O
with	IN	O
hypohaptoglobinemia	NN	B-Disease
in	IN	O
three	CD	O
families	NNS	O
,	,	O
and	CC	O
the	DT	O
genotypes	NNS	O
of	IN	O
six	CD	O
of	IN	O
the	DT	O
seven	CD	O
individuals	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
Hp2/Hpdel	NN	O
.	.	O

The	DT	O
phenotypes	NNS	O
and	CC	O
genotypes	NNS	O
in	IN	O
one	CD	O
of	IN	O
these	DT	O
three	CD	O
families	NNS	O
showed	VBD	O
the	DT	O
father	NN	O
to	TO	O
be	VB	O
hypohaptoglobinemic	JJ	B-Disease
(	-LRB-	O
Hp2	NN	O
)	-RRB-	O
and	CC	O
Hp2/Hpdel	NN	O
,	,	O
the	DT	O
mother	NN	O
to	TO	O
be	VB	O
Hp2-1	NN	O
and	CC	O
Hp1/Hp2	NN	O
,	,	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
children	NNS	O
to	TO	O
be	VB	O
hypohaptoglobinemic	JJ	B-Disease
(	-LRB-	O
Hp2	NN	O
)	-RRB-	O
and	CC	O
Hp2/Hpdel	NN	O
,	,	O
and	CC	O
the	DT	O
other	JJ	O
child	NN	O
to	TO	O
be	VB	O
Hp1	NN	O
and	CC	O
Hp1/Hpdel	NN	O
,	,	O
showing	VBG	O
an	DT	O
anomalous	JJ	O
inheritance	NN	O
of	IN	O
Hp	NN	O
phenotypes	NNS	O
in	IN	O
the	DT	O
child	NN	O
with	IN	O
Hp1	NN	O
.	.	O

The	DT	O
Hp2/Hpdel	NN	O
individuals	NNS	O
had	VBD	O
an	DT	O
extremely	RB	O
low	JJ	O
level	NN	O
of	IN	O
Hp	NN	O
(	-LRB-	O
mean	NN	O
+	CC	O
/	:	O
-	:	O
SD	NN	O
=	JJ	O
0	CD	O
.	.	O

049	CD	O
+	CC	O
/	:	O
-0	CD	O
.	.	O

043	CD	O
mg/ml	NN	O
;	:	O
n	NN	O
=	JJ	O
6	CD	O
)	-RRB-	O
,	,	O
compared	VBN	O
with	IN	O
the	DT	O
level	NN	O
(	-LRB-	O
1	CD	O
.	.	O

64	CD	O
+	CC	O
/	:	O
-1	CD	O
.	.	O

07	CD	O
mg/ml	NN	O
)	-RRB-	O
obtained	VBN	O
from	IN	O
52	CD	O
healthy	JJ	O
volunteers	NNS	O
having	VBG	O
phenotype	NN	O
Hp2	NN	O
,	,	O
whereas	IN	O
the	DT	O
serum	NN	O
Hp	NN	O
level	NN	O
of	IN	O
an	DT	O
individual	JJ	O
with	IN	O
Hp1/Hpdel	NN	O
was	VBD	O
0	CD	O
.	.	O

50	CD	O
mg/ml	NN	O
,	,	O
which	WDT	O
was	VBD	O
approximately	RB	O
half	PDT	O
the	DT	O
level	NN	O
of	IN	O
Hp	NNP	O
in	IN	O
control	NN	O
sera	NNS	O
from	IN	O
the	DT	O
Hp1	NN	O
phenotype	NN	O
(	-LRB-	O
1	CD	O
.	.	O

26	CD	O
+	CC	O
/	:	O
-0	CD	O
.	.	O

33	CD	O
mg/ml	NN	O
;	:	O
n	NN	O
=	JJ	O
9	CD	O
)	-RRB-	O
,	,	O
showing	VBG	O
a	DT	O
gene-dosage	JJ	O
effect	NN	O
.	.	O

The	DT	O
other	JJ	O
allele	NN	O
(	-LRB-	O
Hp2	NN	O
)	-RRB-	O
of	IN	O
individuals	NNS	O
with	IN	O
Hp2/Hpdel	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
,	,	O
in	IN	O
all	DT	O
exons	NNS	O
,	,	O
no	DT	O
mutation	NN	O
,	,	O
by	IN	O
DNA	NN	O
sequencing	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
the	DT	O
mechanism	NN	O
of	IN	O
anhaptoglobinemia	NN	B-Disease
and	CC	O
the	DT	O
mechanism	NN	O
of	IN	O
anomalous	JJ	O
inheritance	NN	O
of	IN	O
Hp	NN	O
phenotypes	NNS	O
were	VBD	O
well	RB	O
explained	VBN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
mechanism	NN	O
of	IN	O
hypohaptoglobinemia	NN	B-Disease
remains	VBZ	O
unknown	JJ	O

Genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
attenuated	VBN	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
.	.	O

Germ-line	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
tumor	NN	B-Disease
suppressor	NN	O
APC	NN	O
are	VBP	O
implicated	VBN	O
in	IN	O
attenuated	VBN	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
AAPC	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
variant	NN	O
of	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
.	.	O

AAPC	NNP	B-Disease
is	VBZ	O
recognized	VBN	O
by	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
<	JJR	O
100	CD	O
colonic	JJ	B-Disease
adenomas	NNS	I-Disease
and	CC	O
a	DT	O
later	JJ	O
onset	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
(	-LRB-	O
age	NN	O
>	JJR	O
40	CD	O
years	NNS	O
)	-RRB-	O
.	.	O

The	DT	O
aim	NN	O
of	IN	O
this	DT	O
study	NN	O
was	VBD	O
to	TO	O
assess	VB	O
genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
AAPC	NNP	B-Disease
families	NNS	O
.	.	O

By	IN	O
protein-truncation	JJ	O
test	NN	O
(	-LRB-	O
PTT	NN	O
)	-RRB-	O
assay	NN	O
,	,	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
was	VBD	O
screened	VBN	O
in	IN	O
affected	JJ	O
individuals	NNS	O
from	IN	O
11	CD	O
AAPC	NN	B-Disease
kindreds	NNS	O
,	,	O
and	CC	O
their	PRP$	O
phenotypic	JJ	O
differences	NNS	O
were	VBD	O
examined	VBN	O
.	.	O

Five	CD	O
novel	JJ	O
germ-line	NN	O
APC	NN	B-Disease
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
seven	CD	O
kindreds	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
located	VBN	O
in	IN	O
three	CD	O
different	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
at	IN	O
the	DT	O
5	CD	O
end	NN	O
spanning	VBG	O
exons	NNS	O
4	CD	O
and	CC	O
5	CD	O
,	,	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
within	IN	O
exon	NN	O
9	CD	O
,	,	O
and	CC	O
(	-LRB-	O
3	LS	O
)	-RRB-	O
at	IN	O
the	DT	O
3	CD	O
distal	JJ	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Variability	NN	O
in	IN	O
the	DT	O
number	NN	O
of	IN	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
was	VBD	O
most	RBS	O
apparent	JJ	O
in	IN	O
individuals	NNS	O
with	IN	O
mutations	NNS	O
in	IN	O
region	NN	O
1	CD	O
,	,	O
and	CC	O
upper-gastrointestinal	JJ	O
manifestations	NNS	O
were	VBD	O
more	RBR	O
severe	JJ	O
in	IN	O
them	PRP	O
.	.	O

In	IN	O
individuals	NNS	O
with	IN	O
mutations	NNS	O
in	IN	O
either	CC	O
region	NN	O
2	CD	O
or	CC	O
region	NN	O
3	CD	O
,	,	O
the	DT	O
average	JJ	O
number	NN	O
of	IN	O
adenomas	NNS	B-Disease
tended	VBD	O
to	TO	O
be	VB	O
lower	JJR	O
than	IN	O
those	DT	O
in	IN	O
individuals	NNS	O
with	IN	O
mutations	NNS	O
in	IN	O
region	NN	O
1	CD	O
,	,	O
although	IN	O
age	NN	O
at	IN	O
diagnosis	NN	O
was	VBD	O
similar	JJ	O
.	.	O

In	IN	O
all	DT	O
AAPC	NNP	B-Disease
kindreds	NNS	O
,	,	O
a	DT	O
predominance	NN	O
of	IN	O
right-sided	JJ	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
and	CC	O
rectal	JJ	B-Disease
polyp	NN	I-Disease
sparing	NN	O
was	VBD	O
observed	VBN	O
.	.	O

No	DT	O
desmoid	JJ	B-Disease
tumors	NNS	I-Disease
were	VBD	O
found	VBN	O
in	IN	O
these	DT	O
kindreds	NNS	O
.	.	O

Our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
,	,	O
in	IN	O
AAPC	NNP	B-Disease
families	NNS	O
,	,	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
mutation	NN	O
may	MD	O
partially	RB	O
predict	VB	O
specific	JJ	O
phenotypic	JJ	O
expression	NN	O
.	.	O

This	DT	O
should	MD	O
help	VB	O
in	IN	O
the	DT	O
design	NN	O
of	IN	O
tailored	VBN	O
clinical-management	JJ	O
protocols	NNS	O
in	IN	O
this	DT	O
subset	NN	O
of	IN	O
FAP	NN	B-Disease
patients	NNS	O
.	.	O

.	.	O

The	DT	O
APC	NN	B-Disease
variants	NNS	O
I1307K	NN	O
and	CC	O
E1317Q	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
,	,	O
but	CC	O
not	RB	O
always	RB	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
.	.	O

Classical	JJ	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
high-penetrance	JJ	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disease	NN	I-Disease
that	WDT	O
predisposes	VBZ	O
to	TO	O
hundreds	NNS	O
or	CC	O
thousands	NNS	O
of	IN	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
and	CC	I-Disease
carcinoma	NN	I-Disease
and	CC	O
that	IN	O
results	VBZ	O
from	IN	O
truncating	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
.	.	O

A	DT	O
variant	NN	O
of	IN	O
FAP	NN	B-Disease
is	VBZ	O
attenuated	VBN	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
,	,	O
which	WDT	O
results	VBZ	O
from	IN	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
5	CD	O
and	CC	O
3	CD	O
regions	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
.	.	O

Attenuated	VBN	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
patients	NNS	O
have	VBP	O
"	''	O
multiple	JJ	O
"	''	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
(	-LRB-	O
typically	RB	O
fewer	JJR	O
than	IN	O
100	CD	O
)	-RRB-	O
without	IN	O
the	DT	O
florid	JJ	O
phenotype	NN	O
of	IN	O
classical	JJ	O
FAP	NN	B-Disease
.	.	O

Another	DT	O
group	NN	O
of	IN	O
patients	NNS	O
with	IN	O
multiple	JJ	O
adenomas	NNS	B-Disease
has	VBZ	O
no	DT	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
,	,	O
and	CC	O
their	PRP$	O
phenotype	NN	O
probably	RB	O
results	VBZ	O
from	IN	O
variation	NN	O
at	IN	O
a	DT	O
locus	NN	O
,	,	O
or	CC	O
loci	NNS	O
,	,	O
elsewhere	RB	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O

Recently	RB	O
,	,	O
however	RB	O
,	,	O
a	DT	O
missense	NN	O
variant	NN	O
of	IN	O
APC	NN	B-Disease
(	-LRB-	O
I1307K	NN	O
)	-RRB-	O
was	VBD	O
described	VBN	O
that	IN	O
confers	VBZ	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
,	,	O
including	VBG	O
multiple	JJ	O
adenomas	NNS	B-Disease
,	,	O
in	IN	O
Ashkenazim	NNP	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
a	DT	O
set	NN	O
of	IN	O
164	CD	O
patients	NNS	O
with	IN	O
multiple	JJ	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
and/or	CC	I-Disease
carcinoma	NN	I-Disease
and	CC	O
analyzed	VBN	O
codons	NNS	O
1263-1377	CD	O
(	-LRB-	O
exon	NN	O
15G	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
for	IN	O
germ-line	NN	O
variants	NNS	O
.	.	O

Three	CD	O
patients	NNS	O
with	IN	O
the	DT	O
I1307K	NN	O
allele	NN	O
were	VBD	O
detected	VBN	O
,	,	O
each	DT	O
of	IN	O
Ashkenazi	NNP	O
descent	NN	O
.	.	O

Four	CD	O
patients	NNS	O
had	VBD	O
a	DT	O
germ-line	NN	O
E1317Q	NN	O
missense	NN	O
variant	NN	O
of	IN	O
APC	NN	O
that	WDT	O
was	VBD	O
not	RB	O
present	JJ	O
in	IN	O
controls	NNS	O
;	:	O
one	CD	O
of	IN	O
these	DT	O
individuals	NNS	O
had	VBD	O
an	DT	O
unusually	RB	O
large	JJ	O
number	NN	O
of	IN	O
metaplastic	JJ	B-Disease
polyps	NNS	I-Disease
of	IN	I-Disease
the	DT	I-Disease
colorectum	NN	I-Disease
.	.	O

There	EX	O
is	VBZ	O
increasing	VBG	O
evidence	NN	O
that	IN	O
there	EX	O
exist	VBP	O
germ-line	NN	O
variants	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
that	WDT	O
predispose	VBP	O
to	TO	O
the	DT	O
development	NN	O
of	IN	O
multiple	JJ	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
and	CC	I-Disease
carcinoma	NN	I-Disease
,	,	O
but	CC	O
without	IN	O
the	DT	O
florid	JJ	O
phenotype	NN	O
of	IN	O
classical	JJ	O
FAP	NN	B-Disease
,	,	O
and	CC	O
possibly	RB	O
with	IN	O
importance	NN	O
for	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
risk	NN	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

.	.	O

The	DT	O
hemochromatosis	NN	B-Disease
845	CD	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
and	CC	O
187	CD	O
C	NN	O
--	:	O
>	JJR	O
G	NN	O
mutations	NNS	O
:	:	O
prevalence	NN	O
in	IN	O
non-Caucasian	JJ	O
populations	NNS	O
.	.	O

Hemochromatosis	NNP	B-Disease
,	,	O
the	DT	O
inherited	VBN	B-Disease
disorder	NN	I-Disease
of	IN	I-Disease
iron	NN	I-Disease
metabolism	NN	I-Disease
,	,	O
leads	VBZ	O
,	,	O
if	IN	O
untreated	JJ	O
,	,	O
to	TO	O
progressive	JJ	O
iron	NN	B-Disease
overload	NN	I-Disease
and	CC	O
premature	JJ	B-Disease
death	NN	I-Disease
.	.	O

The	DT	O
hemochromatosis	NN	B-Disease
gene	NN	O
,	,	O
HFE	NN	O
,	,	O
recently	RB	O
has	VBZ	O
been	VBN	O
identified	VBN	O
,	,	O
and	CC	O
characterization	NN	O
of	IN	O
this	DT	O
gene	NN	O
has	VBZ	O
shown	VBN	O
that	IN	O
it	PRP	O
contains	VBZ	O
two	CD	O
mutations	NNS	O
that	WDT	O
result	VBP	O
in	IN	O
amino	NN	O
acid	NN	O
substitutions-cDNA	NN	O
nucleotides	NNS	O
845	CD	O
G	NN	O
--	:	O
>	JJR	O
A	NN	O
(	-LRB-	O
C282Y	NN	O
)	-RRB-	O
and	CC	O
187	CD	O
C	NN	O
--	:	O
>	JJR	O
G	NN	O
(	-LRB-	O
H63D	NN	O
)	-RRB-	O
.	.	O

Although	IN	O
hemochromatosis	NN	B-Disease
is	VBZ	O
common	JJ	O
in	IN	O
Caucasians	NNPS	O
,	,	O
affecting	VBG	O
>	JJR	O
=	JJ	O
1/300	CD	O
individuals	NNS	O
of	IN	O
northern	JJ	O
European	JJ	O
origin	NN	O
,	,	O
it	PRP	O
has	VBZ	O
not	RB	O
been	VBN	O
recognized	VBN	O
in	IN	O
other	JJ	O
populations	NNS	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
used	VBD	O
PCR	NN	O
and	CC	O
restriction-enzyme	JJ	O
digestion	NN	O
to	TO	O
analyze	VB	O
the	DT	O
frequency	NN	O
of	IN	O
the	DT	O
845	CD	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
and	CC	O
187	CD	O
C	NN	O
--	:	O
>	JJR	O
G	NN	O
mutations	NNS	O
in	IN	O
HLA-typed	JJ	O
samples	NNS	O
from	IN	O
non-Caucasian	JJ	O
populations	NNS	O
,	,	O
comprising	VBG	O
Australian	JJ	O
Aboriginal	NNP	O
,	,	O
Chinese	NNP	O
,	,	O
and	CC	O
Pacific	NNP	O
Islanders	NNPS	O
.	.	O

Results	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
845	CD	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
mutation	NN	O
was	VBD	O
present	JJ	O
in	IN	O
these	DT	O
populations	NNS	O
(	-LRB-	O
allele	NN	O
frequency	NN	O
0	CD	O
.	.	O

32	CD	O
%	NN	O
)	-RRB-	O
,	,	O
and	CC	O
,	,	O
furthermore	RB	O
,	,	O
it	PRP	O
was	VBD	O
always	RB	O
seen	VBN	O
in	IN	O
conjunction	NN	O
with	IN	O
HLA	NN	O
haplotypes	NNS	O
common	JJ	O
in	IN	O
Caucasians	NNPS	O
,	,	O
suggesting	VBG	O
that	IN	O
845	CD	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
may	MD	O
have	VB	O
been	VBN	O
introduced	VBN	O
into	IN	O
these	DT	O
populations	NNS	O
by	IN	O
Caucasian	JJ	O
admixture	NN	O
.	.	O

187	CD	O
C	NN	O
--	:	O
>	JJR	O
G	NN	O
was	VBD	O
present	JJ	O
at	IN	O
an	DT	O
allele	NN	O
frequency	NN	O
of	IN	O
2	CD	O
.	.	O

68	CD	O
%	NN	O
in	IN	O
the	DT	O
two	CD	O
populations	NNS	O
analyzed	VBN	O
(	-LRB-	O
Australian	JJ	O
Aboriginal	JJ	O
and	CC	O
Chinese	JJ	O
)	-RRB-	O
.	.	O

In	IN	O
the	DT	O
Australian	JJ	O
Aboriginal	JJ	O
samples	NNS	O
,	,	O
187	CD	O
C	NN	O
--	:	O
>	JJR	O
G	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
HLA	NN	O
haplotypes	NNS	O
common	JJ	O
in	IN	O
Caucasians	NNPS	O
,	,	O
suggesting	VBG	O
that	IN	O
it	PRP	O
was	VBD	O
introduced	VBN	O
by	IN	O
recent	JJ	O
admixture	NN	O
.	.	O

In	IN	O
the	DT	O
Chinese	JJ	O
samples	NNS	O
analyzed	VBN	O
,	,	O
187	CD	O
C	NN	O
--	:	O
>	JJR	O
G	NN	O
was	VBD	O
present	JJ	O
in	IN	O
association	NN	O
with	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
HLA	NN	O
haplotypes	NNS	O
,	,	O
showing	VBG	O
this	DT	O
mutation	NN	O
to	TO	O
be	VB	O
widespread	JJ	O
and	CC	O
likely	JJ	O
to	TO	O
predate	VB	O
the	DT	O
more	RBR	O
genetically	RB	O
restricted	JJ	O
845	CD	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
mutation	NN	O
.	.	O

BRCA1	NN	O
required	VBN	O
for	IN	O
transcription-coupled	JJ	O
repair	NN	O
of	IN	O
oxidative	JJ	O
DNA	NN	O
damage	NN	O
.	.	O

The	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
susceptibility	NN	O
gene	NN	O
BRCA1	NN	O
encodes	VBZ	O
a	DT	O
zinc	NN	O
finger	NN	O
protein	NN	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

Association	NNP	O
of	IN	O
the	DT	O
BRCA1	NN	O
protein	NN	O
with	IN	O
the	DT	O
DNA	NN	O
repair	NN	O
protein	NN	O
Rad51	NN	O
and	CC	O
changes	NNS	O
in	IN	O
the	DT	O
phosphorylation	NN	O
and	CC	O
cellular	JJ	O
localization	NN	O
of	IN	O
the	DT	O
protein	NN	O
after	IN	O
exposure	NN	O
to	TO	O
DNA-damaging	JJ	O
agents	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
role	NN	O
for	IN	O
BRCA1	NN	O
in	IN	O
DNA	NN	O
repair	NN	O
.	.	O

Here	RB	O
,	,	O
it	PRP	O
is	VBZ	O
shown	VBN	O
that	IN	O
mouse	NN	O
embryonic	JJ	O
stem	NN	O
cells	NNS	O
deficient	JJ	B-Disease
in	IN	I-Disease
BRCA1	NN	I-Disease
are	VBP	O
defective	JJ	O
in	IN	O
the	DT	O
ability	NN	O
to	TO	O
carry	VB	O
out	RP	O
transcription-coupled	JJ	O
repair	NN	O
of	IN	O
oxidative	JJ	O
DNA	NN	O
damage	NN	O
,	,	O
and	CC	O
are	VBP	O
hypersensitive	JJ	O
to	TO	O
ionizing	VBG	O
radiation	NN	O
and	CC	O
hydrogen	NN	O
peroxide	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NN	O
participates	VBZ	O
,	,	O
directly	RB	O
or	CC	O
indirectly	RB	O
,	,	O
in	IN	O
transcription-coupled	JJ	O
repair	NN	O
of	IN	O
oxidative	JJ	O
DNA	NN	O
damage	NN	O
.	.	O

.	.	O

A	DT	O
mouse	NN	O
model	NN	O
of	IN	O
severe	JJ	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
:	:	O
defects	NNS	O
in	IN	O
hemostasis	NN	O
and	CC	O
thrombosis	NN	B-Disease
.	.	O

von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	I-Disease
(	-LRB-	I-Disease
vWf	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
causes	VBZ	O
severe	JJ	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
in	IN	O
humans	NNS	O
.	.	O

We	PRP	O
generated	VBD	O
a	DT	O
mouse	NN	O
model	NN	O
for	IN	O
this	DT	O
disease	NN	O
by	IN	O
using	VBG	O
gene	NN	O
targeting	NN	O
.	.	O

vWf-deficient	JJ	B-Disease
mice	NNS	O
appeared	VBD	O
normal	JJ	O
at	IN	O
birth	NN	O
;	:	O
they	PRP	O
were	VBD	O
viable	JJ	O
and	CC	O
fertile	JJ	O
.	.	O

Neither	DT	O
vWf	NN	O
nor	CC	O
vWf	NN	O
propolypeptide	NN	O
(	-LRB-	O
von	NN	B-Disease
Willebrand	NN	I-Disease
antigen	NN	O
II	CD	O
)	-RRB-	O
were	VBD	O
detectable	JJ	O
in	IN	O
plasma	NN	O
,	,	O
platelets	NNS	O
,	,	O
or	CC	O
endothelial	JJ	O
cells	NNS	O
of	IN	O
the	DT	O
homozygous	JJ	O
mutant	JJ	O
mice	NNS	O
.	.	O

The	DT	O
mutant	JJ	O
mice	NNS	O
exhibited	VBD	O
defects	NNS	O
in	IN	O
hemostasis	NN	O
with	IN	O
a	DT	O
highly	RB	O
prolonged	JJ	O
bleeding	NN	O
time	NN	O
and	CC	O
spontaneous	JJ	O
bleeding	NN	O
events	NNS	O
in	IN	O
approximately	RB	O
10	CD	O
%	NN	O
of	IN	O
neonates	NNS	O
.	.	O

As	IN	O
in	IN	O
the	DT	O
human	JJ	O
disease	NN	O
,	,	O
the	DT	O
factor	NN	O
VIII	CD	O
level	NN	O
in	IN	O
these	DT	O
mice	NNS	O
was	VBD	O
reduced	VBN	O
strongly	RB	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
the	DT	O
lack	NN	O
of	IN	O
protection	NN	O
provided	VBN	O
by	IN	O
vWf	NN	O
.	.	O

Defective	JJ	O
thrombosis	NN	B-Disease
in	IN	O
mutant	JJ	O
mice	NNS	O
was	VBD	O
also	RB	O
evident	JJ	O
in	IN	O
an	DT	O
in	FW	O
vivo	FW	O
model	NN	O
of	IN	O
vascular	JJ	B-Disease
injury	NN	I-Disease
.	.	O

In	IN	O
this	DT	O
model	NN	O
,	,	O
the	DT	O
exteriorized	JJ	O
mesentery	NN	O
was	VBD	O
superfused	VBN	O
with	IN	O
ferric	JJ	O
chloride	NN	O
and	CC	O
the	DT	O
accumulation	NN	O
of	IN	O
fluorescently	RB	O
labeled	VBN	O
platelets	NNS	O
was	VBD	O
observed	VBN	O
by	IN	O
intravital	JJ	O
microscopy	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
these	DT	O
mice	NNS	O
very	RB	O
closely	RB	O
mimic	VB	O
severe	JJ	O
human	JJ	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
and	CC	O
will	MD	O
be	VB	O
very	RB	O
useful	JJ	O
for	IN	O
investigating	VBG	O
the	DT	O
role	NN	O
of	IN	O
vWf	NN	O
in	IN	O
normal	JJ	O
physiology	NN	O
and	CC	O
in	IN	O
disease	NN	O
models	NNS	O
.	.	O

.	.	O

The	DT	O
von	NNP	B-Disease
Hippel-Lindau	NNP	I-Disease
tumor	NN	I-Disease
suppressor	NN	O
gene	NN	O
is	VBZ	O
required	VBN	O
for	IN	O
cell	NN	O
cycle	NN	O
exit	NN	O
upon	IN	O
serum	NN	O
withdrawal	NN	O
.	.	O

The	DT	O
inactivation	NN	O
of	IN	O
the	DT	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
(	-LRB-	I-Disease
VHL	NN	I-Disease
)	-RRB-	I-Disease
tumor	NN	I-Disease
suppressor	NN	O
gene	NN	O
predisposes	VBZ	O
affected	VBN	O
individuals	NNS	O
to	TO	O
the	DT	O
human	JJ	O
VHL	NN	B-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
sporadic	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinomas	NNS	I-Disease
(	-LRB-	O
RCC	NN	B-Disease
)	-RRB-	O
and	CC	O
brain	NN	B-Disease
hemangioblastomas	NNS	I-Disease
.	.	O

VHL-negative	JJ	O
786-0	CD	O
RCC	NN	B-Disease
cells	NNS	O
are	VBP	O
tumorigenic	JJ	O
in	IN	O
nude	JJ	O
mice	NNS	O
which	WDT	O
is	VBZ	O
suppressed	VBN	O
by	IN	O
the	DT	O
reintroduction	NN	O
of	IN	O
VHL	NN	B-Disease
.	.	O

Remarkably	RB	O
,	,	O
this	DT	O
occurs	VBZ	O
without	IN	O
affecting	VBG	O
the	DT	O
growth	NN	O
rate	NN	O
and	CC	O
cell	NN	O
cycle	NN	O
profile	NN	O
of	IN	O
these	DT	O
cells	NNS	O
in	IN	O
culture	NN	O
.	.	O

The	DT	O
786-0	CD	O
cell	NN	O
line	NN	O
,	,	O
like	IN	O
many	JJ	O
cancer	NN	B-Disease
cells	NNS	O
,	,	O
fails	VBZ	O
to	TO	O
exit	VB	O
the	DT	O
cell	NN	O
cycle	NN	O
upon	IN	O
serum	NN	O
withdrawal	NN	O
.	.	O

Here	RB	O
,	,	O
it	PRP	O
is	VBZ	O
shown	VBN	O
that	IN	O
reintroduction	NN	O
of	IN	O
the	DT	O
wild-type	JJ	O
VHL	NN	B-Disease
gene	NN	O
restores	VBZ	O
the	DT	O
ability	NN	O
of	IN	O
VHL-negative	JJ	O
RCC	NN	B-Disease
cancer	NN	I-Disease
cells	NNS	O
to	TO	O
exit	VB	O
the	DT	O
cell	NN	O
cycle	NN	O
and	CC	O
enter	VB	O
G0/quiescence	NN	O
in	IN	O
low	JJ	O
serum	NN	O
.	.	O

Both	DT	O
VHL-positive	JJ	O
and	CC	O
VHL-negative	JJ	O
RCC	NN	B-Disease
cells	NNS	O
exit	VBP	O
the	DT	O
cell	NN	O
cycle	NN	O
by	IN	O
contact	NN	O
inhibition	NN	O
.	.	O

The	DT	O
cyclin-dependent	JJ	O
kinase	NN	O
inhibitor	NN	O
,	,	O
p27	NN	O
,	,	O
accumulates	VBZ	O
upon	IN	O
serum	NN	O
withdrawal	NN	O
,	,	O
only	RB	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
VHL	NN	B-Disease
,	,	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
the	DT	O
stabilization	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
the	DT	O
loss	NN	O
of	IN	O
wild-type	JJ	O
VHL	NN	B-Disease
gene	NN	O
results	VBZ	O
in	IN	O
a	DT	O
specific	JJ	O
cellular	JJ	O
defect	NN	O
in	IN	O
serum-dependent	JJ	O
growth	NN	O
control	NN	O
,	,	O
which	WDT	O
may	MD	O
initiate	VB	O
tumor	NN	B-Disease
formation	NN	O
.	.	O

This	DT	O
is	VBZ	O
corrected	VBN	O
by	IN	O
the	DT	O
reintroduction	NN	O
of	IN	O
wild-type	JJ	O
VHL	NN	B-Disease
,	,	O
implicating	VBG	O
VHL	NN	B-Disease
as	IN	O
the	DT	O
first	JJ	O
tumor	NN	B-Disease
suppressor	NN	O
involved	VBN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
cell	NN	O
cycle	NN	O
exit	NN	O
,	,	O
which	WDT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
its	PRP$	O
gatekeeper	NN	O
function	NN	O
in	IN	O
the	DT	O
kidney	NN	O
.	.	O

.	.	O

Nonsense	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
4	CD	O
of	IN	O
human	JJ	O
complement	NN	O
C9	NN	O
gene	NN	O
is	VBZ	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
Japanese	JJ	O
complement	NN	B-Disease
C9	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
ninth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
human	JJ	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C9	NN	O
)	-RRB-	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
complement	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Japan	NNP	O
but	CC	O
is	VBZ	O
rare	JJ	O
in	IN	O
other	JJ	O
countries	NNS	O
.	.	O

We	PRP	O
studied	VBD	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
C9	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
four	CD	O
Japanese	JJ	O
C9-deficient	JJ	B-Disease
patients	NNS	O
who	WP	O
had	VBD	O
suffered	VBN	O
from	IN	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
amplified	VBN	O
C9	NN	O
cDNA	NN	O
and	CC	O
DNA	NN	O
revealed	VBD	O
a	DT	O
nonsense	NN	O
substitution	NN	O
(	-LRB-	O
CGA	NN	O
--	:	O
>	JJR	O
TGA	NN	O
)	-RRB-	O
at	IN	O
codon	NN	O
95	CD	O
in	IN	O
exon	NN	O
4	CD	O
in	IN	O
the	DT	O
four	CD	O
C9-deficient	JJ	B-Disease
individuals	NNS	O
.	.	O

An	DT	O
allele-specific	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
system	NN	O
designed	VBN	O
to	TO	O
detect	VB	O
exclusively	RB	O
only	RB	O
one	CD	O
of	IN	O
the	DT	O
normal	JJ	O
and	CC	O
mutant	JJ	O
alleles	NNS	O
indicated	VBD	O
that	IN	O
all	PDT	O
the	DT	O
four	CD	O
patients	NNS	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
in	IN	O
exon	NN	O
4	CD	O
and	CC	O
that	IN	O
the	DT	O
parents	NNS	O
of	IN	O
patient	NN	O
2	CD	O
were	VBD	O
heterozygous	JJ	O
.	.	O

The	DT	O
common	JJ	O
mutation	NN	O
at	IN	O
codon	NN	O
95	CD	O
in	IN	O
exon	NN	O
4	CD	O
might	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
most	JJS	O
Japanese	JJ	O
C9	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

Human	JJ	B-Disease
complement	NN	I-Disease
factor	NN	I-Disease
H	NN	I-Disease
deficiency	NN	I-Disease
associated	VBN	O
with	IN	O
hemolytic	JJ	B-Disease
uremic	JJ	I-Disease
syndrome	NN	I-Disease
.	.	O

This	DT	O
study	NN	O
reports	VBZ	O
on	IN	O
six	CD	O
cases	NNS	O
of	IN	O
deficiency	NN	B-Disease
in	IN	I-Disease
the	DT	I-Disease
human	JJ	I-Disease
complement	NN	I-Disease
regulatory	JJ	I-Disease
protein	NN	I-Disease
Factor	NN	I-Disease
H	NN	I-Disease
(	-LRB-	O
FH	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
an	DT	O
acute	JJ	B-Disease
renal	JJ	I-Disease
disease	NN	I-Disease
.	.	O

Five	CD	O
of	IN	O
the	DT	O
cases	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
children	NNS	O
presenting	VBG	O
with	IN	O
idiopathic	JJ	O
hemolytic	JJ	B-Disease
uremic	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
HUS	NN	B-Disease
)	-RRB-	O
.	.	O

Two	CD	O
of	IN	O
the	DT	O
children	NNS	O
exhibited	VBD	O
a	DT	O
homozygous	JJ	O
deficiency	NN	O
characterized	VBN	O
by	IN	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
150-kD	JJ	O
form	NN	O
of	IN	O
Factor	NN	O
H	NN	O
and	CC	O
the	DT	O
presence	NN	O
,	,	O
upon	IN	O
immunoblotting	NN	O
,	,	O
of	IN	O
the	DT	O
42-kD	JJ	O
Factor	NN	O
H-like	JJ	O
protein	NN	O
1	CD	O
(	-LRB-	O
FHL-1	NN	O
)	-RRB-	O
and	CC	O
other	JJ	O
FH-related	JJ	O
protein	NN	O
(	-LRB-	O
FHR	NN	O
)	-RRB-	O
bands	NNS	O
.	.	O

Southern	NN	O
blot	NN	O
and	CC	O
PCR	NN	O
analysis	NN	O
of	IN	O
DNA	NN	O
of	IN	O
one	CD	O
patient	NN	O
with	IN	O
homozygous	JJ	O
deficiency	NN	O
ruled	VBD	O
out	RP	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
large	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
FH	NN	O
gene	NN	O
as	IN	O
the	DT	O
underlying	VBG	O
defect	NN	O
for	IN	O
the	DT	O
deficiency	NN	O
.	.	O

The	DT	O
other	JJ	O
four	CD	O
children	NNS	O
presented	VBN	O
with	IN	O
heterozygous	JJ	O
deficiency	NN	O
and	CC	O
exhibited	VBD	O
a	DT	O
normal	JJ	O
immunoblotting	NN	O
pattern	NN	O
of	IN	O
proteins	NNS	O
of	IN	O
the	DT	O
FH	NN	O
family	NN	O
.	.	O

Factor	NN	B-Disease
H	NN	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
the	DT	O
only	JJ	O
complement	NN	B-Disease
deficiency	NN	I-Disease
associated	VBN	O
with	IN	O
HUS	NN	B-Disease
.	.	O

These	DT	O
observations	NNS	O
suggest	VBP	O
a	DT	O
role	NN	O
for	IN	O
FH	NN	O
and/or	CC	O
FH	NN	O
receptors	NNS	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
idiopathic	JJ	O
HUS	NN	B-Disease
.	.	O

.	.	O

Cell	NN	O
cycle-dependent	JJ	O
colocalization	NN	O
of	IN	O
BARD1	NN	O
and	CC	O
BRCA1	NN	O
proteins	NNS	O
in	IN	O
discrete	JJ	O
nuclear	JJ	O
domains	NNS	O
.	.	O

Germ-line	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
predispose	VB	O
women	NNS	O
to	TO	O
early-onset	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
by	IN	O
compromising	VBG	O
the	DT	O
genes	NNS	O
presumptive	JJ	O
function	NN	O
as	IN	O
a	DT	O
tumor	NN	B-Disease
suppressor	NN	O
.	.	O

Although	IN	O
the	DT	O
biochemical	JJ	O
properties	NNS	O
of	IN	O
BRCA1	NN	O
polypeptides	NNS	O
are	VBP	O
not	RB	O
understood	VBN	O
,	,	O
their	PRP$	O
expression	NN	O
pattern	NN	O
and	CC	O
subcellular	JJ	O
localization	NN	O
suggest	VBP	O
a	DT	O
role	NN	O
in	IN	O
cell-cycle	JJ	O
regulation	NN	O
.	.	O

When	WRB	O
resting	VBG	O
cells	NNS	O
are	VBP	O
induced	VBN	O
to	TO	O
proliferate	VB	O
,	,	O
the	DT	O
steady-state	JJ	O
levels	NNS	O
of	IN	O
BRCA1	NN	O
increase	NN	O
in	IN	O
late	JJ	O
G1	NN	O
and	CC	O
reach	VB	O
a	DT	O
maximum	NN	O
during	IN	O
S	NN	O
phase	NN	O
.	.	O

Moreover	RB	O
,	,	O
in	IN	O
S	NN	O
phase	NN	O
cells	NNS	O
,	,	O
BRCA1	NN	O
polypeptides	NNS	O
are	VBP	O
hyperphosphorylated	VBN	O
and	CC	O
accumulate	VBP	O
into	IN	O
discrete	JJ	O
subnuclear	JJ	O
foci	NNS	O
termed	VBN	O
"	''	O
BRCA1	NN	O
nuclear	JJ	O
dots	NNS	O
.	.	O
"	''	O

BRCA1	NN	O
associates	NNS	O
in	FW	O
vivo	FW	O
with	IN	O
a	DT	O
structurally	RB	O
related	JJ	O
protein	NN	O
termed	VBN	O
BARD1	NN	O
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
steady-state	JJ	O
levels	NNS	O
of	IN	O
BARD1	NN	O
,	,	O
unlike	IN	O
those	DT	O
of	IN	O
BRCA1	NN	O
,	,	O
remain	VBP	O
relatively	RB	O
constant	JJ	O
during	IN	O
cell	NN	O
cycle	NN	O
progression	NN	O
.	.	O

However	RB	O
,	,	O
immunostaining	NN	O
revealed	VBD	O
that	IN	O
BARD1	NN	O
resides	VBZ	O
within	IN	O
BRCA1	NN	O
nuclear	JJ	O
dots	NNS	O
during	IN	O
S	NN	O
phase	NN	O
of	IN	O
the	DT	O
cell	NN	O
cycle	NN	O
,	,	O
but	CC	O
not	RB	O
during	IN	O
the	DT	O
G1	NN	O
phase	NN	O
.	.	O

Nevertheless	RB	O
,	,	O
BARD1	NN	O
polypeptides	NNS	O
are	VBP	O
found	VBN	O
exclusively	RB	O
in	IN	O
the	DT	O
nuclear	JJ	O
fractions	NNS	O
of	IN	O
both	DT	O
G1	NN	O
-	:	O
and	CC	O
S-phase	NN	O
cells	NNS	O
.	.	O

Therefore	RB	O
,	,	O
progression	NN	O
to	TO	O
S	NN	O
phase	NN	O
is	VBZ	O
accompanied	VBN	O
by	IN	O
the	DT	O
aggregation	NN	O
of	IN	O
nuclear	JJ	O
BARD1	NN	O
polypeptides	NNS	O
into	IN	O
BRCA1	NN	O
nuclear	JJ	O
dots	NNS	O
.	.	O

This	DT	O
cell	NN	O
cycle-dependent	JJ	O
colocalization	NN	O
of	IN	O
BARD1	NN	O
and	CC	O
BRCA1	NN	O
indicates	VBZ	O
a	DT	O
role	NN	O
for	IN	O
BARD1	NN	O
in	IN	O
BRCA1-mediated	JJ	O
tumor	NN	B-Disease
suppression	NN	O
.	.	O

Genetic	JJ	O
basis	NN	O
and	CC	O
molecular	JJ	O
mechanism	NN	O
for	IN	O
idiopathic	JJ	B-Disease
ventricular	JJ	I-Disease
fibrillation	NN	I-Disease
.	.	O

Ventricular	JJ	B-Disease
fibrillation	NN	I-Disease
causes	VBZ	O
more	JJR	O
than	IN	O
300	CD	O
,	,	O
000	CD	O
sudden	JJ	O
deaths	NNS	O
each	DT	O
year	NN	O
in	IN	O
the	DT	O
USA	NN	O
alone	RB	O
.	.	O

In	IN	O
approximately	RB	O
5-12	CD	O
%	NN	O
of	IN	O
these	DT	O
cases	NNS	O
,	,	O
there	EX	O
are	VBP	O
no	DT	O
demonstrable	JJ	O
cardiac	JJ	O
or	CC	O
non-cardiac	JJ	O
causes	NNS	O
to	TO	O
account	VB	O
for	IN	O
the	DT	O
episode	NN	O
,	,	O
which	WDT	O
is	VBZ	O
therefore	RB	O
classified	VBN	O
as	IN	O
idiopathic	JJ	B-Disease
ventricular	JJ	I-Disease
fibrillation	NN	I-Disease
(	-LRB-	O
IVF	NN	B-Disease
)	-RRB-	O
.	.	O

A	DT	O
distinct	JJ	O
group	NN	O
of	IN	O
IVF	NN	B-Disease
patients	NNS	O
has	VBZ	O
been	VBN	O
found	VBN	O
to	TO	O
present	VB	O
with	IN	O
a	DT	O
characteristic	JJ	O
electrocardiographic	JJ	O
pattern	NN	O
.	.	O

Because	IN	O
of	IN	O
the	DT	O
small	JJ	O
size	NN	O
of	IN	O
most	JJS	O
pedigrees	NNS	O
and	CC	O
the	DT	O
high	JJ	O
incidence	NN	O
of	IN	O
sudden	JJ	B-Disease
death	NN	I-Disease
,	,	O
however	RB	O
,	,	O
molecular	JJ	O
genetic	JJ	O
studies	NNS	O
of	IN	O
IVF	NN	B-Disease
have	VBP	O
not	RB	O
yet	RB	O
been	VBN	O
done	VBN	O
.	.	O

Because	IN	O
IVF	NN	B-Disease
causes	VBZ	O
cardiac	JJ	O
rhythm	NN	O
disturbance	NN	O
,	,	O
we	PRP	O
investigated	VBD	O
whether	IN	O
malfunction	NN	O
of	IN	O
ion	NN	O
channels	NNS	O
could	MD	O
cause	VB	O
the	DT	O
disorder	NN	O
by	IN	O
studying	VBG	O
mutations	NNS	O
in	IN	O
the	DT	O
cardiac	JJ	O
sodium	NN	O
channel	NN	O
gene	NN	O
SCN5A	NN	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
identified	VBN	O
a	DT	O
missense	NN	O
mutation	NN	O
,	,	O
a	DT	O
splice-donor	NN	O
mutation	NN	O
,	,	O
and	CC	O
a	DT	O
frameshift	NN	O
mutation	NN	O
in	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
SCN5A	NN	O
in	IN	O
three	CD	O
IVF	NN	B-Disease
families	NNS	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
sodium	NN	O
channels	NNS	O
with	IN	O
the	DT	O
missense	NN	O
mutation	NN	O
recover	VB	O
from	IN	O
inactivation	NN	O
more	RBR	O
rapidly	RB	O
than	IN	O
normal	JJ	O
and	CC	O
that	IN	O
the	DT	O
frameshift	NN	O
mutation	NN	O
causes	VBZ	O
the	DT	O
sodium	NN	O
channel	NN	O
to	TO	O
be	VB	O
non-functional	JJ	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
mutations	NNS	O
in	IN	O
cardiac	JJ	O
ion-channel	JJ	O
genes	NNS	O
contribute	VBP	O
to	TO	O
the	DT	O
risk	NN	O
of	IN	O
developing	VBG	O
IVF	NNP	B-Disease
.	.	O

.	.	O

Prevalence	NN	O
of	IN	O
the	DT	O
I1307K	NN	O
APC	NN	B-Disease
gene	NN	O
variant	NN	O
in	IN	O
Israeli	JJ	O
Jews	NNS	O
of	IN	O
differing	VBG	O
ethnic	JJ	O
origin	NN	O
and	CC	O
risk	NN	O
for	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

BACKGROUND	NN	O
&	CC	O
AIMS	NNS	O
Israeli	JJ	O
Jews	NNPS	O
of	IN	O
European	JJ	O
birth	NN	O
,	,	O
i.	NNP	O
e.	NNP	O
,	,	O
Ashkenazim	NNP	O
,	,	O
have	VBP	O
the	DT	O
highest	JJS	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
incidence	NN	O
of	IN	O
any	DT	O
Israeli	JJ	O
ethnic	JJ	O
group	NN	O
.	.	O

The	DT	O
I1307K	NN	O
APC	NN	B-Disease
gene	NN	O
variant	NN	O
was	VBD	O
found	VBN	O
in	IN	O
6	CD	O
.	.	O

1	CD	O
%	NN	O
of	IN	O
American	JJ	O
Jews	NNPS	O
,	,	O
28	CD	O
%	NN	O
of	IN	O
their	PRP$	O
familial	JJ	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
cases	NNS	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
non-Jews	NNS	O
.	.	O

We	PRP	O
assessed	VBD	O
the	DT	O
I1307K	NN	O
prevalence	NN	O
in	IN	O
Israeli	JJ	O
Jews	NNS	O
of	IN	O
differing	VBG	O
ethnic	JJ	O
origin	NN	O
and	CC	O
risk	NN	O
for	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

METHODS	NNS	O
DNA	NN	O
samples	NNS	O
from	IN	O
500	CD	O
unrelated	JJ	O
Jews	NNS	O
of	IN	O
European	JJ	O
or	CC	O
non-European	JJ	O
origin	NN	O
,	,	O
with	IN	O
or	CC	O
without	IN	O
a	DT	O
personal	JJ	O
and/or	CC	O
family	NN	O
history	NN	O
of	IN	O
neoplasia	NN	B-Disease
,	,	O
were	VBD	O
examined	VBN	O
for	IN	O
the	DT	O
I1307K	NN	O
variant	NN	O
by	IN	O
the	DT	O
allele-specific	JJ	O
oligonucleotide	NN	O
(	-LRB-	O
ASO	NN	O
)	-RRB-	O
method	NN	O
.	.	O

RESULTS	NNS	O
In	IN	O
persons	NNS	O
at	IN	O
average	JJ	O
risk	NN	O
for	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
,	,	O
I1307K	NN	O
was	VBD	O
found	VBN	O
in	IN	O
5	CD	O
.	.	O

0	CD	O
%	NN	O
of	IN	O
120	CD	O
European	JJ	O
and	CC	O
1	CD	O
.	.	O

6	CD	O
%	NN	O
of	IN	O
188	CD	O
non-European	JJ	O
Jews	NNS	O
(	-LRB-	O
P	NN	O
=	JJ	O
0	CD	O
.	.	O

08	NN	O
)	-RRB-	O
.	.	O

It	PRP	O
occurred	VBD	O
in	IN	O
15	CD	O
.	.	O

4	CD	O
%	NN	O
of	IN	O
52	CD	O
Ashkenazi	NNP	O
Israelis	NNPS	O
with	IN	O
familial	JJ	O
cancer	NN	B-Disease
(	-LRB-	O
P	NN	O
=	JJ	O
0	CD	O
.	.	O

02	NN	O
)	-RRB-	O
and	CC	O
was	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
51	CD	O
non-European	JJ	O
Jews	NNS	O
at	IN	O
increased	VBN	O
cancer	NN	B-Disease
risk	NN	O
.	.	O

Colorectal	JJ	B-Disease
neoplasia	NN	I-Disease
occurred	VBD	O
personally	RB	O
or	CC	O
in	IN	O
the	DT	O
families	NNS	O
of	IN	O
13	CD	O
of	IN	O
20	CD	O
Ashkenazi	NN	O
I1307K	NN	O
carriers	NNS	O
,	,	O
8	CD	O
of	IN	O
whom	WP	O
also	RB	O
had	VBD	O
a	DT	O
personal	JJ	O
or	CC	O
family	NN	O
history	NN	O
of	IN	O
noncolonic	JJ	O
neoplasia	NN	B-Disease
.	.	O

CONCLUSIONS	NNS	O
The	DT	O
I1307K	NN	O
APC	NN	O
variant	NN	O
may	MD	O
represent	VB	O
a	DT	O
susceptibility	NN	O
gene	NN	O
for	IN	O
colorectal	JJ	B-Disease
,	,	I-Disease
or	CC	I-Disease
other	JJ	I-Disease
,	,	I-Disease
cancers	NNS	I-Disease
in	IN	O
Ashkenazi	NNP	O
Jews	NNPS	O
,	,	O
and	CC	O
partially	RB	O
explains	VBZ	O
the	DT	O
higher	JJR	O
incidence	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
in	IN	O
European	JJ	O
Israelis	NNPS	O
.	.	O

Susceptibility	NN	O
to	TO	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
in	IN	O
twins	NNS	O
:	:	O
the	DT	O
role	NN	O
of	IN	O
genes	NNS	O
,	,	O
HLA	NN	O
,	,	O
and	CC	O
the	DT	O
environment	NN	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
determine	VB	O
the	DT	O
relative	JJ	O
effects	NNS	O
of	IN	O
genetic	JJ	O
and	CC	O
environmental	JJ	O
factors	NNS	O
in	IN	O
susceptibility	NN	O
to	TO	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
.	.	O

METHODS	NNS	O
Twins	NNS	O
with	IN	O
AS	JJ	B-Disease
were	VBD	O
identified	VBN	O
from	IN	O
the	DT	O
Royal	NNP	O
National	NNP	O
Hospital	NNP	O
for	IN	O
Rheumatic	JJ	B-Disease
Diseases	NNS	I-Disease
database	NN	O
.	.	O

Clinical	JJ	O
and	CC	O
radiographic	JJ	O
examinations	NNS	O
were	VBD	O
performed	VBN	O
to	TO	O
establish	VB	O
diagnoses	NNS	O
,	,	O
and	CC	O
disease	NN	O
severity	NN	O
was	VBD	O
assessed	VBN	O
using	VBG	O
a	DT	O
combination	NN	O
of	IN	O
validated	VBN	O
scoring	VBG	O
systems	NNS	O
.	.	O

HLA	NN	O
typing	NN	O
for	IN	O
HLA-B27	NN	O
,	,	O
HLA-B60	NN	O
,	,	O
and	CC	O
HLA-DR1	NN	O
was	VBD	O
performed	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
with	IN	O
sequence-specific	JJ	O
primers	NNS	O
,	,	O
and	CC	O
zygosity	NN	O
was	VBD	O
assessed	VBN	O
using	VBG	O
microsatellite	NN	O
markers	NNS	O
.	.	O

Genetic	JJ	O
and	CC	O
environmental	JJ	O
variance	NN	O
components	NNS	O
were	VBD	O
assessed	VBN	O
with	IN	O
the	DT	O
program	NN	O
Mx	NN	O
,	,	O
using	VBG	O
data	NNS	O
from	IN	O
this	DT	O
and	CC	O
previous	JJ	O
studies	NNS	O
of	IN	O
twins	NNS	O
with	IN	O
AS	JJ	B-Disease
.	.	O

RESULTS	NNS	O
Six	CD	O
of	IN	O
8	CD	O
monozygotic	JJ	O
(	-LRB-	O
MZ	JJ	O
)	-RRB-	O
twin	JJ	O
pairs	NNS	O
were	VBD	O
disease	NN	O
concordant	JJ	O
,	,	O
compared	VBN	O
with	IN	O
4	CD	O
of	IN	O
15	CD	O
B27-positive	JJ	O
dizygotic	JJ	O
(	-LRB-	O
DZ	NN	O
)	-RRB-	O
twin	NN	O
pairs	NNS	O
(	-LRB-	O
27	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
4	CD	O
of	IN	O
32	CD	O
DZ	NN	O
twin	NN	O
pairs	NNS	O
overall	JJ	O
(	-LRB-	O
12	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
.	.	O

Nonsignificant	JJ	O
increases	NNS	O
in	IN	O
similarity	NN	O
with	IN	O
regard	NN	O
to	TO	O
age	NN	O
at	IN	O
disease	NN	O
onset	NN	O
and	CC	O
all	DT	O
of	IN	O
the	DT	O
disease	NN	O
severity	NN	O
scores	NNS	O
assessed	VBN	O
were	VBD	O
noted	VBN	O
in	IN	O
disease-concordant	JJ	O
MZ	JJ	O
twins	NNS	O
compared	VBN	O
with	IN	O
concordant	JJ	O
DZ	NN	O
twins	NNS	O
.	.	O

HLA-B27	NN	O
and	CC	O
B60	NN	O
were	VBD	O
associated	VBN	O
with	IN	O
the	DT	O
disease	NN	O
in	IN	O
probands	NNS	O
,	,	O
and	CC	O
the	DT	O
rate	NN	O
of	IN	O
disease	NN	O
concordance	NN	O
was	VBD	O
significantly	RB	O
increased	VBN	O
among	IN	O
DZ	NN	O
twin	NN	O
pairs	NNS	O
in	IN	O
which	WDT	O
the	DT	O
co-twin	NN	O
was	VBD	O
positive	JJ	O
for	IN	O
both	DT	O
B27	NN	O
and	CC	O
DR1	NN	O
.	.	O

Additive	JJ	O
genetic	JJ	O
effects	NNS	O
were	VBD	O
estimated	VBN	O
to	TO	O
contribute	VB	O
97	CD	O
%	NN	O
of	IN	O
the	DT	O
population	NN	O
variance	NN	O
.	.	O

CONCLUSION	NN	O
Susceptibility	NN	O
to	TO	O
AS	JJ	B-Disease
is	VBZ	O
largely	RB	O
genetically	RB	O
determined	VBN	O
,	,	O
and	CC	O
the	DT	O
environmental	JJ	O
trigger	NN	O
for	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
probably	RB	O
ubiquitous	JJ	O
.	.	O

HLA-B27	NN	O
accounts	NNS	O
for	IN	O
a	DT	O
minority	NN	O
of	IN	O
the	DT	O
overall	JJ	O
genetic	JJ	O
susceptibility	NN	O
to	TO	O
AS	JJ	B-Disease
.	.	O

The	DT	O
APCI1307K	NN	O
allele	NN	O
and	CC	O
cancer	NN	B-Disease
risk	NN	O
in	IN	O
a	DT	O
community-based	JJ	O
study	NN	O
of	IN	O
Ashkenazi	NNP	O
Jews	NNPS	O
.	.	O

Mutations	NNS	O
in	IN	O
APC	NN	O
are	VBP	O
classically	RB	O
associated	VBN	O
with	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
highly	RB	O
penetrant	JJ	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
multiple	JJ	O
intestinal	JJ	O
polyps	NNS	B-Disease
and	CC	O
,	,	O
without	IN	O
surgical	JJ	O
intervention	NN	O
,	,	O
the	DT	O
development	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
(	-LRB-	O
CRC	NN	B-Disease
)	-RRB-	O
.	.	O

APC	NN	B-Disease
is	VBZ	O
a	DT	O
tumour-suppressor	JJ	O
gene	NN	O
,	,	O
and	CC	O
somatic	JJ	O
loss	NN	O
occurs	VBZ	O
in	IN	O
tumours	NNS	B-Disease
.	.	O

The	DT	O
germline	NN	O
T-to-A	NN	O
transversion	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
APC	NN	O
I1307K	NN	O
allele	NN	O
converts	VBZ	O
the	DT	O
wild-type	JJ	O
sequence	NN	O
to	TO	O
a	DT	O
homopolymer	NN	O
tract	NN	O
(	-LRB-	O
A8	NN	O
)	-RRB-	O
that	WDT	O
is	VBZ	O
genetically	RB	O
unstable	JJ	O
and	CC	O
prone	JJ	O
to	TO	O
somatic	JJ	O
mutation	NN	O
.	.	O

The	DT	O
I1307K	NN	O
allele	NN	O
was	VBD	O
found	VBN	O
in	IN	O
6	CD	O
.	.	O

1	CD	O
%	NN	O
of	IN	O
unselected	JJ	O
Ashkenazi	NNP	O
Jews	NNPS	O
and	CC	O
higher	JJR	O
proportions	NNS	O
of	IN	O
Ashkenazim	NN	O
with	IN	O
family	NN	O
or	CC	O
personal	JJ	O
histories	NNS	O
of	IN	O
CRC	NN	B-Disease
(	-LRB-	O
ref	NN	O
.	.	O

2	LS	O
)	-RRB-	O
.	.	O

To	TO	O
evaluate	VB	O
the	DT	O
role	NN	O
of	IN	O
I1307K	NN	O
in	IN	O
cancer	NN	B-Disease
,	,	O
we	PRP	O
genotyped	VBD	O
5	CD	O
,	,	O
081	CD	O
Ashkenazi	JJ	O
volunteers	NNS	O
in	IN	O
a	DT	O
community	NN	O
survey	NN	O
.	.	O

Risk	NN	O
of	IN	O
developing	VBG	O
colorectal	JJ	B-Disease
,	,	I-Disease
breast	NN	I-Disease
and	CC	I-Disease
other	JJ	I-Disease
cancers	NNS	I-Disease
were	VBD	O
compared	VBN	O
between	IN	O
genotyped	JJ	O
I1307K	NN	O
carriers	NNS	O
and	CC	O
non-carriers	NNS	O
and	CC	O
their	PRP$	O
first-degree	JJ	O
relatives	NNS	O
.	.	O

The	DT	O
hemochromatosis	NN	B-Disease
gene	NN	O
product	NN	O
complexes	NNS	O
with	IN	O
the	DT	O
transferrin	NN	O
receptor	NN	O
and	CC	O
lowers	VBZ	O
its	PRP$	O
affinity	NN	O
for	IN	O
ligand	NN	O
binding	NN	O
.	.	O

We	PRP	O
recently	RB	O
reported	VBD	O
the	DT	O
positional	JJ	O
cloning	NN	O
of	IN	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
called	VBN	O
HFE	NNP	O
.	.	O

The	DT	O
gene	NN	O
product	NN	O
,	,	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	NN	O
class	NN	O
I-like	JJ	O
family	NN	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
mutation	NN	O
,	,	O
Cys-282	NN	O
--	:	O
>	JJR	O
Tyr	NN	O
(	-LRB-	O
C282Y	NN	O
)	-RRB-	O
,	,	O
in	IN	O
85	CD	O
%	NN	O
of	IN	O
patient	NN	O
chromosomes	NNS	O
.	.	O

This	DT	O
mutation	NN	O
eliminates	VBZ	O
the	DT	O
ability	NN	O
of	IN	O
HFE	NN	O
to	TO	O
associate	VB	O
with	IN	O
beta2-microglobulin	NN	O
(	-LRB-	O
beta2m	NN	O
)	-RRB-	O
and	CC	O
prevents	VBZ	O
cell-surface	JJ	O
expression	NN	O
.	.	O

A	DT	O
second	JJ	O
mutation	NN	O
that	WDT	O
has	VBZ	O
no	DT	O
effect	NN	O
on	IN	O
beta2m	NN	O
association	NN	O
,	,	O
H63D	NN	O
,	,	O
was	VBD	O
found	VBN	O
in	IN	O
eight	CD	O
out	IN	O
of	IN	O
nine	CD	O
patients	NNS	O
heterozygous	JJ	O
for	IN	O
the	DT	O
C282Y	NN	O
mutant	NN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
we	PRP	O
demonstrate	VBP	O
in	IN	O
cultured	VBN	O
293	CD	O
cells	NNS	O
overexpressing	VBG	O
wild-type	JJ	O
or	CC	O
mutant	JJ	O
HFE	NN	O
proteins	NNS	O
that	WDT	O
both	CC	O
the	DT	O
wild-type	JJ	O
and	CC	O
H63D	NN	O
HFE	NN	O
proteins	NNS	O
form	VBP	O
stable	JJ	O
complexes	NNS	O
with	IN	O
the	DT	O
transferrin	NN	O
receptor	NN	O
(	-LRB-	O
TfR	NN	O
)	-RRB-	O
.	.	O

The	DT	O
C282Y	NN	O
mutation	NN	O
nearly	RB	O
completely	RB	O
prevents	VBZ	O
the	DT	O
association	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
HFE	NN	O
protein	NN	O
with	IN	O
the	DT	O
TfR	NN	O
.	.	O

Studies	NNS	O
on	IN	O
cell-associated	JJ	O
transferrin	NN	O
at	IN	O
37	CD	O
degrees	NNS	O
C	NN	O
suggest	VBP	O
that	IN	O
the	DT	O
overexpressed	JJ	O
wild-type	JJ	O
HFE	NN	O
protein	NN	O
decreases	VBZ	O
the	DT	O
affinity	NN	O
of	IN	O
the	DT	O
TfR	NN	O
for	IN	O
transferrin	NN	O
.	.	O

The	DT	O
overexpressed	JJ	O
H63D	NN	O
protein	NN	O
does	VBZ	O
not	RB	O
have	VB	O
this	DT	O
effect	NN	O
,	,	O
providing	VBG	O
the	DT	O
first	JJ	O
direct	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
functional	JJ	O
consequence	NN	O
of	IN	O
the	DT	O
H63D	NN	O
mutation	NN	O
.	.	O

Addition	NN	O
of	IN	O
soluble	JJ	O
wild-type	JJ	O
HFE/beta2m	NN	O
heterodimers	NNS	O
to	TO	O
cultured	VBN	O
cells	NNS	O
also	RB	O
decreased	VBD	O
the	DT	O
apparent	JJ	O
affinity	NN	O
of	IN	O
the	DT	O
TfR	NN	O
for	IN	O
its	PRP$	O
ligand	NN	O
under	IN	O
steady-state	JJ	O
conditions	NNS	O
,	,	O
both	CC	O
in	IN	O
293	CD	O
cells	NNS	O
and	CC	O
in	IN	O
HeLa	NN	O
cells	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
at	IN	O
4	CD	O
degrees	NNS	O
C	NN	O
,	,	O
the	DT	O
added	VBN	O
soluble	JJ	O
complex	NN	O
of	IN	O
HFE/beta2m	NN	O
inhibited	VBD	O
binding	NN	O
of	IN	O
transferrin	NN	O
to	TO	O
HeLa	NN	O
cell	NN	O
TfR	NN	O
in	IN	O
a	DT	O
concentration-dependent	JJ	O
manner	NN	O
.	.	O

Scatchard	NN	O
plots	NNS	O
of	IN	O
these	DT	O
data	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
added	VBN	O
heterodimer	NN	O
substantially	RB	O
reduced	VBD	O
the	DT	O
affinity	NN	O
of	IN	O
TfR	NN	O
for	IN	O
transferrin	NN	O
.	.	O

These	DT	O
results	NNS	O
establish	VBP	O
a	DT	O
molecular	JJ	O
link	NN	O
between	IN	O
HFE	NN	O
and	CC	O
a	DT	O
key	JJ	O
protein	NN	O
involved	VBN	O
in	IN	O
iron	NN	O
transport	NN	O
,	,	O
the	DT	O
TfR	NN	O
,	,	O
and	CC	O
raise	VB	O
the	DT	O
possibility	NN	O
that	IN	O
alterations	NNS	O
in	IN	O
this	DT	O
regulatory	JJ	O
mechanism	NN	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
.	.	O

.	.	O

Cycloheximide	NN	O
facilitates	VBZ	O
the	DT	O
identification	NN	O
of	IN	O
aberrant	JJ	O
transcripts	NNS	O
resulting	VBG	O
from	IN	O
a	DT	O
novel	JJ	O
splice-site	NN	O
mutation	NN	O
in	IN	O
COL17A1	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
generalized	VBN	O
atrophic	JJ	B-Disease
benign	JJ	I-Disease
epidermolysis	NN	I-Disease
bullosa	NN	I-Disease
.	.	O

Patients	NNS	O
with	IN	O
generalized	VBN	O
atrophic	JJ	B-Disease
benign	JJ	I-Disease
epidermolysis	NN	I-Disease
bullosa	NN	I-Disease
often	RB	O
show	VBP	O
decreased	VBN	O
expression	NN	O
of	IN	O
type	NN	O
XVII	CD	O
collagen	NN	O
,	,	O
a	DT	O
transmembrane	JJ	O
hemidesmosomal	JJ	O
protein	NN	O
encoded	VBN	O
by	IN	O
COL17A1	NN	O
.	.	O

This	DT	O
report	NN	O
documents	NNS	O
a	DT	O
novel	JJ	O
splice-site	NN	O
mutation	NN	O
in	IN	O
COL17A1	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
generalized	VBN	O
atrophic	JJ	B-Disease
benign	JJ	I-Disease
epidermolysis	NN	I-Disease
bullosa	NN	I-Disease
,	,	O
and	CC	O
applies	VBZ	O
a	DT	O
new	JJ	O
methodology	NN	O
to	TO	O
define	VB	O
and	CC	O
characterize	VB	O
the	DT	O
resulting	VBG	O
mRNA	NN	O
splice	NN	O
variants	NNS	O
.	.	O

Mutational	JJ	O
analysis	NN	O
of	IN	O
COL17A1	NN	O
identified	VBD	O
a	DT	O
maternally	RB	O
inherited	VBN	O
G-to-T	JJ	O
transversion	NN	O
at	IN	O
the	DT	O
-1	CD	O
position	NN	O
of	IN	O
exon	NN	O
32	CD	O
.	.	O

This	DT	O
acceptor	NN	O
splice-site	NN	O
mutation	NN	O
led	VBD	O
to	TO	O
the	DT	O
formation	NN	O
of	IN	O
aberrant	JJ	O
transcripts	NNS	O
present	JJ	O
at	IN	O
extremely	RB	O
low	JJ	O
levels	NNS	O
.	.	O

Based	VBN	O
on	IN	O
our	PRP$	O
recent	JJ	O
finding	NN	O
that	IN	O
cycloheximide	NN	O
stabilized	VBD	O
mutant	JJ	O
COL17A1	NN	O
transcripts	NNS	O
in	IN	O
keratinocytes	NNS	O
homozygous	JJ	O
for	IN	O
a	DT	O
frameshift	NN	O
mutation	NN	O
,	,	O
the	DT	O
effects	NNS	O
of	IN	O
the	DT	O
splice-site	NN	O
mutation	NN	O
on	IN	O
splicing	NN	O
of	IN	O
COL17A1	NN	O
transcripts	NNS	O
were	VBD	O
determined	VBN	O
using	VBG	O
reverse	JJ	O
transcriptase	NN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
of	IN	O
total	JJ	O
RNA	NN	O
from	IN	O
keratinocytes	NNS	O
incubated	VBN	O
for	IN	O
2	CD	O
.	.	O

5	CD	O
h	NN	O
in	IN	O
the	DT	O
presence	NN	O
or	CC	O
absence	NN	O
of	IN	O
10	CD	O
microg	NN	O
cycloheximide	NN	O
per	IN	O
ml	NN	O
.	.	O

Using	VBG	O
this	DT	O
approach	NN	O
,	,	O
an	DT	O
abnormally	RB	O
spliced	VBN	O
transcript	NN	O
was	VBD	O
identified	VBN	O
that	WDT	O
contains	VBZ	O
an	DT	O
extra	JJ	O
264	CD	O
bases	NNS	O
upstream	RB	O
from	IN	O
exon	NN	O
32	CD	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
27	CD	O
bp	NN	O
downstream	RB	O
from	IN	O
the	DT	O
cryptic	JJ	O
splice	NN	O
site	NN	O
.	.	O

Three	CD	O
other	JJ	O
splice	NN	O
variants	NNS	O
,	,	O
including	VBG	O
one	CD	O
derived	VBN	O
from	IN	O
the	DT	O
skipping	VBG	O
of	IN	O
exon	NN	O
32	CD	O
,	,	O
were	VBD	O
also	RB	O
identified	VBN	O
.	.	O

These	DT	O
results	NNS	O
indicate	VBP	O
the	DT	O
usefulness	NN	O
of	IN	O
cycloheximide	NN	O
treatment	NN	O
in	IN	O
evaluating	VBG	O
the	DT	O
abnormal	JJ	O
processing	NN	O
of	IN	O
mRNA	NN	O
due	JJ	O
to	TO	O
splice-site	JJ	O
mutations	NNS	O
,	,	O
because	IN	O
(	-LRB-	O
i	LS	O
)	-RRB-	O
aberrant	JJ	O
splicing	NN	O
often	RB	O
generates	VBZ	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
,	,	O
(	-LRB-	O
ii	LS	O
)	-RRB-	O
transcripts	NNS	O
with	IN	O
premature	JJ	O
termination	NN	O
codons	NNS	O
can	MD	O
occur	VB	O
at	IN	O
low	JJ	O
or	CC	O
undetectable	JJ	O
levels	NNS	O
due	JJ	O
to	TO	O
nonsense-mediated	JJ	O
mRNA	NN	O
decay	NN	O
,	,	O
and	CC	O
(	-LRB-	O
iii	LS	O
)	-RRB-	O
the	DT	O
levels	NNS	O
of	IN	O
these	DT	O
transcripts	NNS	O
can	MD	O
be	VB	O
increased	VBN	O
by	IN	O
cycloheximide	NN	O
.	.	O

The	DT	O
DMPK	NN	O
gene	NN	O
of	IN	O
severely	RB	O
affected	VBN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
patients	NNS	O
is	VBZ	O
hypermethylated	VBN	O
proximal	JJ	O
to	TO	O
the	DT	O
largely	RB	O
expanded	VBN	O
CTG	NNP	O
repeat	NN	O
.	.	O

Using	VBG	O
methylation-sensitive	JJ	O
restriction	NN	O
enzymes	NNS	O
,	,	O
we	PRP	O
characterized	VBD	O
the	DT	O
methylation	NN	O
pattern	NN	O
on	IN	O
the	DT	O
5	CD	O
side	NN	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
DMPK	NN	O
gene	NN	O
of	IN	O
normal	JJ	O
individuals	NNS	O
and	CC	O
of	IN	O
patients	NNS	O
affected	VBN	O
with	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
showing	VBG	O
expansions	NNS	O
of	IN	O
the	DT	O
repetitive	JJ	O
sequence	NN	O
.	.	O

The	DT	O
gene	NN	O
segment	NN	O
analyzed	VBD	O
corresponds	VBZ	O
to	TO	O
the	DT	O
genomic	JJ	O
SacI-HindIII	NN	O
fragment	NN	O
carrying	VBG	O
exons	NNS	O
11-15	CD	O
.	.	O

There	EX	O
is	VBZ	O
constitutive	JJ	O
methylation	NN	O
in	IN	O
intron	NN	O
12	CD	O
at	IN	O
restriction	NN	O
sites	NNS	O
of	IN	O
SacII	NN	O
and	CC	O
HhaI	NN	O
,	,	O
localized	JJ	O
1	CD	O
,	,	O
159-1	CD	O
,	,	O
232	CD	O
bp	NN	O
upstream	JJ	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
,	,	O
whereas	IN	O
most	JJS	O
,	,	O
if	IN	O
not	RB	O
all	DT	O
,	,	O
of	IN	O
the	DT	O
other	JJ	O
sites	NNS	O
of	IN	O
SacII	NN	O
,	,	O
HhaI	NN	O
,	,	O
and	CC	O
HpaII	NN	O
in	IN	O
this	DT	O
region	NN	O
are	VBP	O
unmethylated	VBN	O
,	,	O
in	IN	O
normal	JJ	O
individuals	NNS	O
and	CC	O
most	JJS	O
of	IN	O
the	DT	O
patients	NNS	O
.	.	O

In	IN	O
a	DT	O
number	NN	O
of	IN	O
young	JJ	O
and	CC	O
severely	RB	O
affected	VBN	O
patients	NNS	O
,	,	O
however	RB	O
,	,	O
complete	JJ	O
methylation	NN	O
of	IN	O
these	DT	O
restriction	NN	O
sites	NNS	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
mutated	VBN	O
allele	NN	O
.	.	O

In	IN	O
most	JJS	O
of	IN	O
these	DT	O
patients	NNS	O
,	,	O
the	DT	O
onset	NN	O
of	IN	O
the	DT	O
disease	NN	O
was	VBD	O
congenital	JJ	O
.	.	O

Preliminary	JJ	O
in	FW	O
vivo	FW	O
footprinting	NN	O
data	NNS	O
gave	VBD	O
evidence	NN	O
for	IN	O
protein-DNA	JJ	O
contact	NN	O
in	IN	O
normal	JJ	O
genes	NNS	O
at	IN	O
an	DT	O
Sp1	NN	O
consensus	NN	O
binding	NN	O
site	NN	O
upstream	JJ	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
and	CC	O
for	IN	O
a	DT	O
significant	JJ	O
reduction	NN	O
of	IN	O
this	DT	O
interaction	NN	O
in	IN	O
cells	NNS	O
with	IN	O
a	DT	O
hypermethylated	VBN	O
DMPK	NN	O
gene	NN	O
.	.	O

.	.	O

Progression	NN	O
of	IN	O
somatic	JJ	O
CTG	NNP	O
repeat	NN	O
length	NN	O
heterogeneity	NN	O
in	IN	O
the	DT	O
blood	NN	O
cells	NNS	O
of	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
patients	NNS	O
.	.	O

The	DT	O
genetic	JJ	O
basis	NN	O
of	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
the	DT	O
expansion	NN	O
of	IN	O
an	DT	O
unstable	JJ	O
CTG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
34	CD	O
UTR	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
protein	NN	O
kinase	NN	O
gene	NN	O
on	IN	O
chromosome	NN	O
19	CD	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
principal	JJ	O
features	NNS	O
of	IN	O
the	DT	O
DM	NN	B-Disease
mutation	NN	O
is	VBZ	O
an	DT	O
extraordinarily	RB	O
high	JJ	O
level	NN	O
of	IN	O
somatic	JJ	O
mosaicism	NN	O
,	,	O
due	JJ	O
to	TO	O
an	DT	O
extremely	RB	O
high	JJ	O
degree	NN	O
of	IN	O
somatic	JJ	O
instability	NN	O
both	CC	O
within	IN	O
and	CC	O
between	IN	O
different	JJ	O
tissues	NNS	O
.	.	O

This	DT	O
instability	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
biased	VBN	O
towards	IN	O
further	JJ	O
expansion	NN	O
and	CC	O
continuous	JJ	O
throughout	IN	O
the	DT	O
life	NN	O
of	IN	O
an	DT	O
individual	JJ	O
,	,	O
features	NNS	O
that	WDT	O
could	MD	O
be	VB	O
associated	VBN	O
with	IN	O
the	DT	O
progressive	JJ	O
nature	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

Although	IN	O
increasing	VBG	O
measured	VBN	O
allele	NN	O
size	NN	O
between	IN	O
patients	NNS	O
clearly	RB	O
correlates	VBZ	O
with	IN	O
an	DT	O
increased	VBN	O
severity	NN	O
of	IN	O
symptoms	NNS	O
and	CC	O
an	DT	O
earlier	JJR	O
age	NN	O
of	IN	O
onset	NN	O
,	,	O
this	DT	O
correlation	NN	O
is	VBZ	O
not	RB	O
precise	JJ	O
and	CC	O
measured	VBN	O
allele	NN	O
length	NN	O
can	MD	O
not	RB	O
be	VB	O
used	VBN	O
as	IN	O
an	DT	O
accurate	JJ	O
predictor	NN	O
of	IN	O
age	NN	O
of	IN	O
onset	NN	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
further	RB	O
characterize	VB	O
the	DT	O
dynamics	NNS	O
of	IN	O
DM	NN	B-Disease
CTG	NN	O
repeat	NN	O
somatic	JJ	O
instability	NN	O
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
repeat	NN	O
length	NN	O
changes	NNS	O
over	IN	O
time	NN	O
in	IN	O
111	CD	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
patients	NNS	O
with	IN	O
varying	VBG	O
clinical	JJ	O
severity	NN	O
and	CC	O
CTG	NN	O
repeat	NN	O
size	NN	O
over	IN	O
time	NN	O
intervals	NNS	O
of	IN	O
1-7	CD	O
years	NNS	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
a	DT	O
direct	JJ	O
progression	NN	O
of	IN	O
the	DT	O
size	NN	O
heterogeneity	NN	O
over	IN	O
time	NN	O
related	JJ	O
to	TO	O
initial	JJ	O
CTG	NNP	O
repeat	NN	O
size	NN	O
and	CC	O
the	DT	O
time	NN	O
interval	NN	O
and	CC	O
always	RB	O
biased	VBN	O
towards	IN	O
further	JJ	O
expansion	NN	O
.	.	O

Attempts	NNS	O
to	TO	O
mathematically	RB	O
model	VB	O
the	DT	O
dynamics	NNS	O
have	VBP	O
proved	VBN	O
only	RB	O
partially	RB	O
successful	JJ	O
suggesting	VBG	O
that	IN	O
individual	JJ	O
specific	JJ	O
genetic	JJ	O
and/or	CC	O
environmental	JJ	O
factors	NNS	O
also	RB	O
play	VBP	O
a	DT	O
role	NN	O
in	IN	O
somatic	JJ	O
mosaicism	NN	O
.	.	O

.	.	O

Inherited	VBN	B-Disease
colorectal	JJ	I-Disease
polyposis	NN	I-Disease
and	CC	O
cancer	NN	B-Disease
risk	NN	O
of	IN	O
the	DT	O
APC	NN	O
I1307K	NN	O
polymorphism	NN	O
.	.	O

Germ-line	NN	O
and	CC	O
somatic	JJ	O
truncating	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
are	VBP	O
thought	VBN	O
to	TO	O
initiate	VB	O
colorectal	JJ	B-Disease
tumor	NN	I-Disease
formation	NN	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
syndrome	NN	I-Disease
and	CC	O
sporadic	JJ	O
colorectal	JJ	O
carcinogenesis	NN	O
,	,	O
respectively	RB	O
.	.	O

Recently	RB	O
,	,	O
an	DT	O
isoleucine	NN	O
--	:	O
>	JJR	O
lysine	NN	O
polymorphism	NN	O
at	IN	O
codon	NN	O
1307	CD	O
(	-LRB-	O
I1307K	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
in	IN	O
6	CD	O
%	NN	O
-7	CD	O
%	NN	O
of	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
population	NN	O
.	.	O

To	TO	O
assess	VB	O
the	DT	O
risk	NN	O
of	IN	O
this	DT	O
common	JJ	O
APC	NN	B-Disease
allelic	JJ	O
variant	NN	O
in	IN	O
colorectal	JJ	O
carcinogenesis	NN	O
,	,	O
we	PRP	O
have	VBP	O
analyzed	VBN	O
a	DT	O
large	JJ	O
cohort	NN	O
of	IN	O
unselected	JJ	O
Ashkenazi	NNP	O
Jewish	JJ	O
subjects	NNS	O
with	IN	O
adenomatous	JJ	B-Disease
polyps	NNS	I-Disease
and	CC	O
.	.	O

or	CC	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
,	,	I-Disease
for	IN	O
the	DT	O
APC	NN	O
I1307K	NN	O
polymorphism	NN	O
.	.	O

The	DT	O
APC	NN	O
I1307K	NN	O
allele	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
48	CD	O
(	-LRB-	O
10	CD	O
.	.	O

1	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
476	CD	O
patients	NNS	O
.	.	O

Compared	VBN	O
with	IN	O
the	DT	O
frequency	NN	O
in	IN	O
two	CD	O
separate	JJ	O
population	NN	O
control	NN	O
groups	NNS	O
,	,	O
the	DT	O
APC	NN	O
I1307K	NN	O
allele	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
an	DT	O
estimated	VBN	O
relative	JJ	O
risk	NN	O
of	IN	O
1	CD	O
.	.	O

5-1	CD	O
.	.	O

7	CD	O
for	IN	O
colorectal	JJ	B-Disease
neoplasia	NN	I-Disease
(	-LRB-	O
both	DT	O
P	NN	O
=	JJ	O
.	.	O

01	NN	O
)	-RRB-	O
.	.	O

Furthermore	RB	O
,	,	O
compared	VBN	O
with	IN	O
noncarriers	NNS	O
,	,	O
APC	NN	O
I1307K	NN	O
carriers	NNS	O
had	VBD	O
increased	VBN	O
numbers	NNS	O
of	IN	O
adenomas	NNS	B-Disease
and	CC	O
colorectal	JJ	B-Disease
cancers	NNS	I-Disease
per	IN	O
patient	NN	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

03	NN	O
)	-RRB-	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
younger	JJR	O
age	NN	O
at	IN	O
diagnosis	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
APC	NN	O
I1307K	NN	O
variant	NN	O
leads	VBZ	O
to	TO	O
increased	VBN	O
adenoma	NN	B-Disease
formation	NN	O
and	CC	O
directly	RB	O
contributes	VBZ	O
to	TO	O
3	CD	O
%	NN	O
-4	CD	O
%	NN	O
of	IN	O
all	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
estimated	VBN	O
relative	JJ	O
risk	NN	O
for	IN	O
carriers	NNS	O
may	MD	O
justify	VB	O
specific	JJ	O
clinical	JJ	O
screening	NN	O
for	IN	O
the	DT	O
360	CD	O
,	,	O
000	CD	O
Americans	NNPS	O
expected	VBD	O
to	TO	O
harbor	VB	O
this	DT	O
allele	NN	O
,	,	O
and	CC	O
genetic	JJ	O
testing	NN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
long-term-outcome	JJ	O
studies	NNS	O
may	MD	O
impact	VB	O
significantly	RB	O
on	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
prevention	NN	O
in	IN	O
this	DT	O
population	NN	O
.	.	O

Human	JJ	O
MLH1	NN	O
deficiency	NN	O
predisposes	VBZ	O
to	TO	O
hematological	JJ	B-Disease
malignancy	NN	I-Disease
and	CC	O
neurofibromatosis	NN	B-Disease
type	NN	I-Disease
1	CD	I-Disease
.	.	O

Heterozygous	JJ	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
DNA	NN	O
mismatch	NN	O
repair	NN	O
genes	NNS	O
lead	VBP	O
to	TO	O
hereditary	JJ	B-Disease
nonpolyposis	JJ	I-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
disease	NN	O
susceptibility	NN	O
of	IN	O
individuals	NNS	O
who	WP	O
constitutionally	RB	O
lack	VBP	O
both	CC	O
wild-type	JJ	O
alleles	NNS	O
is	VBZ	O
unknown	JJ	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
three	CD	O
offspring	NN	O
in	IN	O
a	DT	O
hereditary	JJ	B-Disease
nonpolyposis	JJ	I-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
family	NN	O
who	WP	O
developed	VBD	O
hematological	JJ	B-Disease
malignancy	NN	I-Disease
at	IN	O
a	DT	O
very	RB	O
early	JJ	O
age	NN	O
,	,	O
and	CC	O
at	IN	O
least	JJS	O
two	CD	O
of	IN	O
them	PRP	O
displayed	VBD	O
signs	NNS	O
of	IN	O
neurofibromatosis	NN	B-Disease
type	NN	I-Disease
1	CD	I-Disease
(	-LRB-	O
NF1	NN	B-Disease
)	-RRB-	O
.	.	O

DNA	NN	O
sequence	NN	O
analysis	NN	O
and	CC	O
allele-specific	JJ	O
amplification	NN	O
in	IN	O
two	CD	O
siblings	NNS	O
revealed	VBD	O
a	DT	O
homozygous	JJ	O
MLH1	NN	O
mutation	NN	O
(	-LRB-	O
C676T	NN	O
--	:	O
>	JJR	O
Arg226Stop	NN	O
)	-RRB-	O
.	.	O

Thus	RB	O
,	,	O
a	DT	O
homozygous	JJ	O
germ-line	NN	O
MLH1	NN	O
mutation	NN	O
and	CC	O
consequent	JJ	O
mismatch	NN	O
repair	NN	O
deficiency	NN	O
results	VBZ	O
in	IN	O
a	DT	O
mutator	NN	O
phenotype	NN	O
characterized	VBN	O
by	IN	O
leukemia	NN	B-Disease
and/or	CC	O
lymphoma	NN	B-Disease
associated	VBN	O
with	IN	O
neurofibromatosis	NN	B-Disease
type	NN	I-Disease
1	CD	I-Disease
.	.	O

.	.	O

Are	VBP	O
Dp71	NN	O
and	CC	O
Dp140	NN	O
brain	NN	O
dystrophin	NN	O
isoforms	NNS	O
related	VBN	O
to	TO	O
cognitive	JJ	B-Disease
impairment	NN	I-Disease
in	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
?	.	O

Molecular	JJ	O
study	NN	O
and	CC	O
neuropsychological	JJ	O
analysis	NN	O
were	VBD	O
performed	VBN	O
concurrently	RB	O
on	IN	O
49	CD	O
patients	NNS	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
in	IN	O
order	NN	O
to	TO	O
find	VB	O
a	DT	O
molecular	JJ	O
explanation	NN	O
for	IN	O
the	DT	O
cognitive	JJ	B-Disease
impairment	NN	I-Disease
observed	VBN	O
in	IN	O
most	JJS	O
DMD	NNS	B-Disease
patients	NNS	O
.	.	O

Complete	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
dystrophin	NN	O
gene	NN	O
was	VBD	O
performed	VBN	O
to	TO	O
define	VB	O
the	DT	O
localization	NN	O
of	IN	O
deletions	NNS	O
and	CC	O
duplications	NNS	O
in	IN	O
relation	NN	O
to	TO	O
the	DT	O
different	JJ	O
DMD	NNP	B-Disease
promoters	NNS	O
.	.	O

Qualitative	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
Dp71	NN	O
transcript	NN	O
and	CC	O
testing	NN	O
for	IN	O
the	DT	O
specific	JJ	O
first	JJ	O
exon	NN	O
of	IN	O
Dp140	NN	O
were	VBD	O
also	RB	O
carried	VBN	O
out	RP	O
.	.	O

Neuropsychological	JJ	O
analysis	NN	O
assessed	VBN	O
verbal	JJ	O
and	CC	O
visuospatial	JJ	O
intelligence	NN	O
,	,	O
verbal	JJ	O
memory	NN	O
,	,	O
and	CC	O
reading	NN	O
skills	NNS	O
.	.	O

Comparison	NN	O
of	IN	O
molecular	JJ	O
and	CC	O
psychometric	JJ	O
findings	NNS	O
demonstrated	VBD	O
that	IN	O
deletions	NNS	O
and	CC	O
duplications	NNS	O
that	WDT	O
were	VBD	O
localized	JJ	O
in	IN	O
the	DT	O
distal	JJ	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
seemed	VBD	O
to	TO	O
be	VB	O
preferentially	RB	O
associated	VBN	O
with	IN	O
cognitive	JJ	B-Disease
impairment	NN	I-Disease
.	.	O

Two	CD	O
altered	JJ	O
Dp71	NN	O
transcripts	NNS	O
and	CC	O
two	CD	O
deleted	VBN	O
Dp140	NN	O
DNA	NN	O
sequences	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
four	CD	O
patients	NNS	O
with	IN	O
severe	JJ	O
cerebral	JJ	B-Disease
dysfunction	NN	I-Disease
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
some	DT	O
sequences	NNS	O
located	JJ	O
in	IN	O
the	DT	O
distal	JJ	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
and	CC	O
,	,	O
in	IN	O
particular	JJ	O
,	,	O
some	DT	O
DMD	NN	B-Disease
isoforms	NNS	O
expressed	VBN	O
in	IN	O
the	DT	O
brain	NN	O
may	MD	O
be	VB	O
related	VBN	O
to	TO	O
the	DT	O
cognitive	JJ	B-Disease
impairment	NN	I-Disease
associated	VBN	O
with	IN	O
DMD	NN	B-Disease
.	.	O

.	.	O

A	DT	O
genome-wide	JJ	O
search	NN	O
for	IN	O
chromosomal	JJ	O
loci	NNS	O
linked	VBN	O
to	TO	O
mental	JJ	O
health	NN	O
wellness	NN	O
in	IN	O
relatives	NNS	O
at	IN	O
high	JJ	O
risk	NN	O
for	IN	O
bipolar	JJ	B-Disease
affective	JJ	I-Disease
disorder	NN	I-Disease
among	IN	O
the	DT	O
Old	NNP	O
Order	NNP	O
Amish	JJ	O
.	.	O

Bipolar	JJ	B-Disease
affective	JJ	I-Disease
disorder	NN	I-Disease
(	-LRB-	O
BPAD	NN	B-Disease
;	:	O
manic-depressive	NN	B-Disease
illness	NN	I-Disease
)	-RRB-	O
is	VBZ	O
characterized	VBN	O
by	IN	O
episodes	NNS	O
of	IN	O
mania	NN	B-Disease
and/or	CC	O
hypomania	NN	B-Disease
interspersed	VBN	O
with	IN	O
periods	NNS	O
of	IN	O
depression	NN	B-Disease
.	.	O

Compelling	JJ	O
evidence	NN	O
supports	VBZ	O
a	DT	O
significant	JJ	O
genetic	JJ	O
component	NN	O
in	IN	O
the	DT	O
susceptibility	NN	O
to	TO	O
develop	VB	O
BPAD	NNP	B-Disease
.	.	O

To	TO	O
date	NN	O
,	,	O
however	RB	O
,	,	O
linkage	NN	O
studies	NNS	O
have	VBP	O
attempted	VBN	O
only	RB	O
to	TO	O
identify	VB	O
chromosomal	JJ	O
loci	NNS	O
that	WDT	O
cause	VBP	O
or	CC	O
increase	VBP	O
the	DT	O
risk	NN	O
of	IN	O
developing	VBG	O
BPAD	NNP	B-Disease
.	.	O

To	TO	O
determine	VB	O
whether	IN	O
there	EX	O
could	MD	O
be	VB	O
protective	JJ	O
alleles	NNS	O
that	WDT	O
prevent	VBP	O
or	CC	O
reduce	VB	O
the	DT	O
risk	NN	O
of	IN	O
developing	VBG	O
BPAD	NNP	B-Disease
,	,	O
similar	JJ	O
to	TO	O
what	WP	O
is	VBZ	O
observed	VBN	O
in	IN	O
other	JJ	O
genetic	JJ	B-Disease
disorders	NNS	I-Disease
,	,	O
we	PRP	O
used	VBD	O
mental	JJ	O
health	NN	O
wellness	NN	O
(	-LRB-	O
absence	NN	O
of	IN	O
any	DT	O
psychiatric	JJ	B-Disease
disorder	NN	I-Disease
)	-RRB-	O
as	IN	O
the	DT	O
phenotype	NN	O
in	IN	O
our	PRP$	O
genome-wide	JJ	O
linkage	NN	O
scan	VB	O
of	IN	O
several	JJ	O
large	JJ	O
multigeneration	NNP	O
Old	NNP	O
Order	NNP	O
Amish	JJ	O
pedigrees	NNS	O
exhibiting	VBG	O
an	DT	O
extremely	RB	O
high	JJ	O
incidence	NN	O
of	IN	O
BPAD	NN	B-Disease
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
strong	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
locus	NN	O
on	IN	O
chromosome	NN	O
4p	NN	O
at	IN	O
D4S2949	NN	O
(	-LRB-	O
maximum	NN	O
GENEHUNTER-PLUS	NN	O
nonparametric	JJ	O
linkage	NN	O
score	NN	O
=	JJ	O
4	CD	O
.	.	O

05	NN	O
,	,	O
P	NN	O
=	JJ	O
5	CD	O
.	.	O

22	CD	O
x	CC	O
10	CD	O
(	-LRB-	O
-4	CD	O
)	-RRB-	O
;	:	O
SIBPAL	NNP	O
Pempirical	JJ	O
value	NN	O
<	JJR	O
3	CD	O
x	NN	O
10	CD	O
(	-LRB-	O
-5	CD	O
)	-RRB-	O
)	-RRB-	O
and	CC	O
suggestive	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
locus	NN	O
on	IN	O
chromosome	NN	O
4q	NN	O
at	IN	O
D4S397	NN	O
(	-LRB-	O
maximum	NN	O
GENEHUNTER-PLUS	NN	O
nonparametric	JJ	O
linkage	NN	O
score	NN	O
=	JJ	O
3	CD	O
.	.	O

29	CD	O
,	,	O
P	NN	O
=	JJ	O
2	CD	O
.	.	O

57	CD	O
x	CC	O
10	CD	O
(	-LRB-	O
-3	CD	O
)	-RRB-	O
;	:	O
SIBPAL	NNP	O
Pempirical	JJ	O
value	NN	O
<	JJR	O
1	CD	O
x	NN	O
10	CD	O
(	-LRB-	O
-3	CD	O
)	-RRB-	O
)	-RRB-	O
that	WDT	O
are	VBP	O
linked	VBN	O
to	TO	O
mental	JJ	O
health	NN	O
wellness	NN	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
the	DT	O
hypothesis	NN	O
that	IN	O
certain	JJ	O
alleles	NNS	O
could	MD	O
prevent	VB	O
or	CC	O
modify	VB	O
the	DT	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
BPAD	NN	B-Disease
and	CC	O
perhaps	RB	O
other	JJ	O
related	JJ	O
affective	JJ	B-Disease
disorders	NNS	I-Disease
.	.	O

Hereditary	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
fifth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
in	IN	O
man	NN	O
.	.	O

I.	NN	O
Clinical	JJ	O
,	,	O
immunochemical	JJ	O
,	,	O
and	CC	O
family	NN	O
studies	NNS	O
.	.	O

The	DT	O
first	JJ	O
recognized	VBN	O
human	JJ	O
kindred	NN	O
with	IN	O
hereditary	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
fifth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C5	NN	O
)	-RRB-	O
is	VBZ	O
described	VBN	O
.	.	O

The	DT	O
proband	NN	O
,	,	O
a	DT	O
20-year-old	JJ	O
black	JJ	O
female	NN	O
with	IN	O
systemic	JJ	B-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
since	IN	O
age	NN	O
11	CD	O
,	,	O
lacked	VBD	O
serum	NN	O
hemolytic	JJ	O
complement	NN	O
activity	NN	O
,	,	O
even	RB	O
during	IN	O
remission	NN	O
.	.	O

C5	NN	O
was	VBD	O
undetectable	JJ	O
in	IN	O
her	PRP$	O
serum	NN	O
by	IN	O
both	CC	O
immunodiffusion	NN	O
and	CC	O
hemolytic	JJ	O
assays	NNS	O
.	.	O

Other	JJ	O
complement	NN	O
components	NNS	O
were	VBD	O
normal	JJ	O
during	IN	O
remission	NN	O
of	IN	O
lupus	NN	O
,	,	O
but	CC	O
C1	NN	O
,	,	O
C4	NN	O
,	,	O
C2	NN	O
,	,	O
and	CC	O
C3	NN	O
levels	NNS	O
fell	VBD	O
during	IN	O
exacerbations	NNS	O
.	.	O

A	DT	O
younger	JJR	O
half-sister	NN	O
,	,	O
who	WP	O
had	VBD	O
no	DT	O
underlying	VBG	O
disease	NN	O
,	,	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
lack	VB	O
immunochemically	RB	O
detectable	JJ	O
C5	NN	O
.	.	O

By	IN	O
hemolytic	JJ	O
assay	NN	O
,	,	O
she	PRP	O
exhibited	VBD	O
1-2	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
serum	NN	O
C5	NN	O
level	NN	O
and	CC	O
normal	JJ	O
concentrations	NNS	O
of	IN	O
other	JJ	O
complement	NN	O
components	NNS	O
.	.	O

C5	NN	O
levels	NNS	O
of	IN	O
other	JJ	O
family	NN	O
members	NNS	O
were	VBD	O
either	CC	O
normal	JJ	O
or	CC	O
approximately	RB	O
half-normal	JJ	O
,	,	O
consistent	JJ	O
with	IN	O
autosomal	JJ	O
codominant	JJ	O
inheritance	NN	O
of	IN	O
the	DT	O
gene	NN	O
determining	VBG	O
C5	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Normal	JJ	O
hemolytic	JJ	O
titers	NNS	O
were	VBD	O
restored	VBN	O
to	TO	O
both	DT	O
homozygous	JJ	O
C5-deficient	JJ	B-Disease
(	-LRB-	O
C5D	NN	B-Disease
)	-RRB-	O
sera	NN	O
by	IN	O
addition	NN	O
of	IN	O
highly	RB	O
purified	VBN	O
human	JJ	O
C5	NN	O
.	.	O

In	IN	O
specific	JJ	O
C5	NN	O
titrations	NNS	O
,	,	O
however	RB	O
,	,	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
when	WRB	O
limited	JJ	O
amounts	NNS	O
of	IN	O
C5	NN	O
were	VBD	O
assayed	VBN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
low	JJ	O
dilutions	NNS	O
of	IN	O
either	CC	O
C5D	NN	B-Disease
serum	NN	O
,	,	O
curving	VBG	O
rather	RB	O
than	IN	O
linear	JJ	O
dose-response	JJ	O
plots	NNS	O
were	VBD	O
consistently	RB	O
obtained	VBN	O
,	,	O
suggesting	VBG	O
some	DT	O
inhibitory	JJ	O
effect	NN	O
.	.	O

Further	JJ	O
studies	NNS	O
suggested	VBD	O
that	IN	O
low	JJ	O
dilutions	NNS	O
of	IN	O
C5D	NN	B-Disease
serum	NN	O
contain	VBP	O
a	DT	O
factor	NN	O
(	-LRB-	O
or	CC	O
factors	NNS	O
)	-RRB-	O
interfering	VBG	O
at	IN	O
some	DT	O
step	NN	O
in	IN	O
the	DT	O
hemolytic	JJ	O
assay	NN	O
of	IN	O
C5	NN	O
,	,	O
rather	RB	O
than	IN	O
a	DT	O
true	JJ	O
C5	NN	O
inhibitor	NN	O
or	CC	O
inactivator	NN	O
.	.	O

Of	IN	O
clinical	JJ	O
interest	NN	O
are	VBP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
the	DT	O
documentation	NN	O
of	IN	O
membranous	JJ	O
glomerulonephritis	NN	B-Disease
,	,	O
vasculitis	NN	B-Disease
,	,	O
and	CC	O
arthritis	NN	B-Disease
in	IN	O
an	DT	O
individual	JJ	O
lacking	VBG	O
C5	NN	O
(	-LRB-	O
and	CC	O
its	PRP$	O
biologic	JJ	O
functions	NNS	O
)	-RRB-	O
,	,	O
and	CC	O
(	-LRB-	O
b	LS	O
)	-RRB-	O
a	DT	O
remarkable	JJ	O
propensity	NN	O
to	TO	O
bacterial	JJ	B-Disease
infections	NNS	I-Disease
in	IN	O
the	DT	O
proband	NN	O
,	,	O
even	RB	O
during	IN	O
periods	NNS	O
of	IN	O
low-dose	JJ	O
or	CC	O
alternate-day	JJ	O
corticosteroid	NN	O
therapy	NN	O
.	.	O

Other	JJ	O
observations	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
C5D	NN	B-Disease
state	NN	O
is	VBZ	O
compatible	JJ	O
with	IN	O
normal	JJ	O
coagulation	NN	O
function	NN	O
and	CC	O
the	DT	O
capacity	NN	O
to	TO	O
mount	VB	O
a	DT	O
neutrophilic	JJ	O
leukocytosis	NN	O
during	IN	O
pyogenic	JJ	B-Disease
infection	NN	I-Disease
.	.	O

.	.	O

Detection	NN	O
of	IN	O
heterozygous	JJ	O
carriers	NNS	O
of	IN	O
the	DT	O
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
ATM	NNP	O
)	-RRB-	O
gene	NN	O
by	IN	O
G2	NN	O
phase	NN	O
chromosomal	JJ	O
radiosensitivity	NN	O
of	IN	O
peripheral	JJ	O
blood	NN	O
lymphocytes	NNS	O
.	.	O

In	IN	O
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
patients	NNS	O
,	,	O
mutations	NNS	O
in	IN	O
a	DT	O
single	JJ	O
gene	NN	O
,	,	O
ATM	NNP	O
,	,	O
result	VBP	O
in	IN	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
syndrome	NN	I-Disease
that	WDT	O
embraces	VBZ	O
a	DT	O
variety	NN	O
of	IN	O
clinical	JJ	O
features	NNS	O
and	CC	O
manifests	VBZ	O
extreme	JJ	O
radiosensitivity	NN	O
and	CC	O
a	DT	O
strong	JJ	O
pre-disposition	NN	O
to	TO	O
malignancy	NN	B-Disease
.	.	O

Heterozygotes	NNS	O
for	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
have	VBP	O
no	DT	O
clinical	JJ	O
expression	NN	O
of	IN	O
A-T	NN	B-Disease
but	CC	O
may	MD	O
be	VB	O
cancer	NN	B-Disease
prone	JJ	O
with	IN	O
a	DT	O
moderate	JJ	O
increase	NN	O
in	IN	O
in	FW	O
vitro	FW	O
radiosensitivity	NN	O
.	.	O

We	PRP	O
performed	VBD	O
a	DT	O
blind	JJ	O
chromosomal	JJ	O
analysis	NN	O
on	IN	O
G2-phase	JJ	O
lymphocytes	NNS	O
from	IN	O
7	CD	O
unrelated	JJ	O
A-T	NN	B-Disease
patients	NNS	O
,	,	O
13	CD	O
obligate	JJ	O
A-T	NN	B-Disease
heterozygotes	NNS	O
(	-LRB-	O
parents	NNS	O
of	IN	O
the	DT	O
patients	NNS	O
)	-RRB-	O
,	,	O
and	CC	O
14	CD	O
normal	JJ	O
controls	NNS	O
following	VBG	O
X-irradiation	NN	O
with	IN	O
1	CD	O
Gy	NN	O
in	IN	O
order	NN	O
to	TO	O
evaluate	VB	O
this	DT	O
cytogenetic	JJ	O
method	NN	O
as	IN	O
a	DT	O
tool	NN	O
for	IN	O
detection	NN	O
of	IN	O
ATM	NNP	O
carriers	NNS	O
.	.	O

Both	DT	O
A-T	NN	B-Disease
homozygotes	NNS	O
and	CC	O
heterozygotes	NNS	O
showed	VBD	O
significantly	RB	O
increased	VBN	O
levels	NNS	O
of	IN	O
radiation-induced	JJ	O
chromatid	NN	O
damage	NN	O
relative	JJ	O
to	TO	O
that	DT	O
of	IN	O
normal	JJ	O
controls	NNS	O
.	.	O

These	DT	O
results	NNS	O
show	VBP	O
that	IN	O
the	DT	O
G2-phase	NN	O
chromosomal	JJ	O
radiosensitivity	NN	O
assay	NN	O
can	MD	O
be	VB	O
used	VBN	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
A-T	NN	B-Disease
heterozygotes	NNS	O
.	.	O

In	IN	O
combination	NN	O
with	IN	O
molecular	JJ	O
genetic	JJ	O
analyses	NNS	O
,	,	O
this	DT	O
test	NN	O
may	MD	O
be	VB	O
of	IN	O
value	NN	O
in	IN	O
studies	NNS	O
of	IN	O
familial	JJ	B-Disease
and	CC	I-Disease
sporadic	JJ	I-Disease
cancers	NNS	I-Disease
aimed	VBN	O
at	IN	O
determination	NN	O
of	IN	O
the	DT	O
potential	JJ	O
involvement	NN	O
of	IN	O
ATM	NNP	O
mutations	NNS	O
in	IN	O
tumor	NN	B-Disease
risk	NN	O
or	CC	O
development	NN	O
.	.	O

.	.	O

The	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
C6	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
the	DT	O
western	JJ	O
Cape	NNP	O
,	,	O
South	NNP	O
Africa	NNP	O
.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
sixth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
human	JJ	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C6	NN	O
)	-RRB-	O
has	VBZ	O
been	VBN	O
reported	VBN	O
in	IN	O
a	DT	O
number	NN	O
of	IN	O
families	NNS	O
from	IN	O
the	DT	O
western	JJ	O
Cape	NNP	O
,	,	O
South	NNP	O
Africa	NNP	O
.	.	O

Meningococcal	JJ	B-Disease
disease	NN	I-Disease
is	VBZ	O
endemic	JJ	O
in	IN	O
the	DT	O
Cape	NNP	O
and	CC	O
almost	RB	O
all	DT	O
pedigrees	NNS	O
of	IN	O
total	JJ	O
C6	NN	B-Disease
deficiency	NN	I-Disease
(	-LRB-	O
C6Q0	NN	O
)	-RRB-	O
have	VBP	O
been	VBN	O
ascertained	VBN	O
because	IN	O
of	IN	O
recurrent	JJ	O
disease	NN	O
.	.	O

We	PRP	O
have	VBP	O
sequenced	VBN	O
the	DT	O
expressed	VBN	O
exons	NNS	O
of	IN	O
the	DT	O
C6	NN	O
gene	NN	O
from	IN	O
selected	VBN	O
cases	NNS	O
and	CC	O
have	VBP	O
found	VBN	O
three	CD	O
molecular	JJ	O
defects	NNS	O
leading	VBG	O
to	TO	O
total	JJ	O
deficiency	NN	O
879delG	NN	O
,	,	O
which	WDT	O
is	VBZ	O
the	DT	O
common	JJ	O
defect	NN	O
in	IN	O
the	DT	O
Cape	NNP	O
and	CC	O
hitherto	RB	O
unreported	JJ	O
,	,	O
and	CC	O
1195delC	NN	O
and	CC	O
1936delG	NN	O
,	,	O
which	WDT	O
have	VBP	O
been	VBN	O
previously	RB	O
reported	VBN	O
in	IN	O
African-Americans	NNPS	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
the	DT	O
879delG	NN	O
and	CC	O
1195delC	NN	O
defects	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
characteristic	JJ	O
C6/C7	NN	O
region	NN	O
DNA	NN	O
marker	NN	O
haplotypes	NNS	O
,	,	O
although	IN	O
small	JJ	O
variations	NNS	O
were	VBD	O
observed	VBN	O
.	.	O

The	DT	O
1936delG	NN	O
defect	NN	O
was	VBD	O
observed	VBN	O
only	RB	O
once	RB	O
in	IN	O
the	DT	O
Cape	NNP	O
,	,	O
but	CC	O
its	PRP$	O
associated	VBN	O
haplotype	NN	O
could	MD	O
be	VB	O
deduced	VBN	O
.	.	O

The	DT	O
data	NNS	O
from	IN	O
the	DT	O
haplotypes	NNS	O
indicate	VBP	O
that	IN	O
these	DT	O
three	CD	O
molecular	JJ	O
defects	NNS	O
account	VBP	O
for	IN	O
the	DT	O
defects	NNS	O
in	IN	O
all	PDT	O
the	DT	O
38	CD	O
unrelated	JJ	O
C6Q0	NN	O
individuals	NNS	O
we	PRP	O
have	VBP	O
studied	VBN	O
from	IN	O
the	DT	O
Cape	NNP	O
.	.	O

We	PRP	O
have	VBP	O
also	RB	O
observed	VBN	O
the	DT	O
879delG	NN	O
defect	NN	O
in	IN	O
two	CD	O
Dutch	JJ	O
C6-deficient	JJ	B-Disease
kindreds	NNS	O
,	,	O
but	CC	O
the	DT	O
879delG	NN	O
defect	NN	O
in	IN	O
the	DT	O
Cape	NNP	O
probably	RB	O
did	VBD	O
not	RB	O
come	VB	O
from	IN	O
The	DT	O
Netherlands	NNPS	O
.	.	O

.	.	O

The	DT	O
R496H	NN	O
mutation	NN	O
of	IN	O
arylsulfatase	NN	O
A	NN	O
does	VBZ	O
not	RB	O
cause	VB	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
arylsulfatase	NN	I-Disease
A	NN	I-Disease
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
enzyme	NN	O
activity	NN	O
causes	VBZ	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
.	.	O

A	DT	O
number	NN	O
of	IN	O
ARSA	NNP	O
gene	NN	O
mutations	NNS	O
responsible	JJ	O
for	IN	O
MLD	NN	B-Disease
have	VBP	O
been	VBN	O
identified	VBN	O
.	.	O

Recently	RB	O
,	,	O
the	DT	O
R496H	NN	O
mutation	NN	O
of	IN	O
ARSA	NNP	O
was	VBD	O
proposed	VBN	O
to	TO	O
be	VB	O
a	DT	O
cause	NN	O
of	IN	O
MLD	NN	B-Disease
(	-LRB-	O
Draghia	NNP	O
et	FW	O
al.	FW	O
,	,	O
1997	CD	O
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
investigated	VBN	O
the	DT	O
R496H	NN	O
mutation	NN	O
and	CC	O
found	VBD	O
this	DT	O
mutation	NN	O
at	IN	O
a	DT	O
relatively	RB	O
high	JJ	O
frequency	NN	O
in	IN	O
an	DT	O
African	JJ	O
American	JJ	O
population	NN	O
(	-LRB-	O
f	FW	O
=	JJ	O
0	CD	O
.	.	O

09	NN	O
,	,	O
n	NN	O
=	JJ	O
61	CD	O
subjects	NNS	O
)	-RRB-	O
.	.	O

The	DT	O
ARSA	NNP	O
enzyme	NN	O
activity	NN	O
in	IN	O
subjects	NNS	O
with	IN	O
and	CC	O
without	IN	O
the	DT	O
R496H	NN	O
mutation	NN	O
was	VBD	O
determined	VBN	O
and	CC	O
found	VBN	O
to	TO	O
be	VB	O
normal	JJ	O
.	.	O

It	PRP	O
is	VBZ	O
therefore	RB	O
concluded	VBN	O
that	IN	O
the	DT	O
R496H	NN	O
mutation	NN	O
of	IN	O
ARSA	NNP	O
does	VBZ	O
not	RB	O
negatively	RB	O
influence	VB	O
the	DT	O
activity	NN	O
of	IN	O
ARSA	NNP	O
and	CC	O
is	VBZ	O
not	RB	O
a	DT	O
cause	NN	O
of	IN	O
MLD	NN	B-Disease

Piebaldism	NN	B-Disease
with	IN	O
deafness	NN	B-Disease
:	:	O
molecular	JJ	O
evidence	NN	O
for	IN	O
an	DT	O
expanded	VBN	O
syndrome	NN	O
.	.	O

In	IN	O
a	DT	O
South	JJ	O
African	JJ	O
girl	NN	O
of	IN	O
Xhosa	JJ	O
stock	NN	O
with	IN	O
severe	JJ	O
piebaldism	NN	B-Disease
and	CC	O
profound	JJ	O
congenital	JJ	O
sensorineural	JJ	B-Disease
deafness	NN	I-Disease
we	PRP	O
identified	VBD	O
a	DT	O
novel	JJ	O
missense	NN	O
substitution	NN	O
at	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
residue	NN	O
in	IN	O
the	DT	O
intracellular	JJ	O
kinase	NN	O
domain	NN	O
of	IN	O
the	DT	O
KIT	NN	O
proto-oncogene	NN	O
,	,	O
R796G	NN	O
.	.	O

Though	IN	O
auditory	JJ	B-Disease
anomalies	NNS	I-Disease
have	VBP	O
been	VBN	O
observed	VBN	O
in	IN	O
mice	NNS	O
with	IN	O
dominant	JJ	O
white	JJ	O
spotting	VBG	O
(	-LRB-	O
W	NN	O
)	-RRB-	O
due	JJ	O
to	TO	O
KIT	NN	O
mutations	NNS	O
,	,	O
deafness	NN	B-Disease
is	VBZ	O
not	RB	O
typical	JJ	O
in	IN	O
human	JJ	O
piebaldism	NN	B-Disease
.	.	O

Thus	RB	O
,	,	O
the	DT	O
occurrence	NN	O
of	IN	O
sensorineural	JJ	B-Disease
deafness	NN	I-Disease
in	IN	O
this	DT	O
patient	NN	O
extends	VBZ	O
considerably	RB	O
the	DT	O
phenotypic	JJ	O
range	NN	O
of	IN	O
piebaldism	NN	B-Disease
due	JJ	O
to	TO	O
KIT	NN	O
gene	NN	O
mutation	NN	O
in	IN	O
humans	NNS	O
and	CC	O
tightens	VBZ	O
the	DT	O
clinical	JJ	O
similarity	NN	O
between	IN	O
piebaldism	NN	B-Disease
and	CC	O
the	DT	O
various	JJ	O
forms	NNS	O
of	IN	O
Waardenburg	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

.	.	O

Genetic	JJ	O
heterogeneity	NN	O
and	CC	O
penetrance	NN	O
analysis	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
genes	NNS	O
in	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

The	DT	O
Breast	NN	B-Disease
Cancer	NN	I-Disease
Linkage	NN	O
Consortium	NNP	O
.	.	O

The	DT	O
contribution	NN	O
of	IN	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
to	TO	O
inherited	VBN	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
was	VBD	O
assessed	VBN	O
by	IN	O
linkage	NN	O
and	CC	O
mutation	NN	O
analysis	NN	O
in	IN	O
237	CD	O
families	NNS	O
,	,	O
each	DT	O
with	IN	O
at	IN	O
least	JJS	O
four	CD	O
cases	NNS	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
,	,	O
collected	VBN	O
by	IN	O
the	DT	O
Breast	NN	B-Disease
Cancer	NN	I-Disease
Linkage	NN	O
Consortium	NNP	O
.	.	O

Families	NNS	O
were	VBD	O
included	VBN	O
without	IN	O
regard	NN	O
to	TO	O
the	DT	O
occurrence	NN	O
of	IN	O
ovarian	JJ	B-Disease
or	CC	I-Disease
other	JJ	I-Disease
cancers	NNS	I-Disease
.	.	O

Overall	RB	O
,	,	O
disease	NN	O
was	VBD	O
linked	VBN	O
to	TO	O
BRCA1	NN	O
in	IN	O
an	DT	O
estimated	VBN	O
52	CD	O
%	NN	O
of	IN	O
families	NNS	O
,	,	O
to	TO	O
BRCA2	NN	O
in	IN	O
32	CD	O
%	NN	O
of	IN	O
families	NNS	O
,	,	O
and	CC	O
to	TO	O
neither	CC	O
gene	NN	O
in	IN	O
16	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
[	-LRB-	O
CI	NN	O
]	-RRB-	O
6	CD	O
%	NN	O
-28	CD	O
%	NN	O
)	-RRB-	O
,	,	O
suggesting	VBG	O
other	JJ	O
predisposition	NN	O
genes	NNS	O
.	.	O

The	DT	O
majority	NN	O
(	-LRB-	O
81	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
were	VBD	O
due	JJ	O
to	TO	O
BRCA1	NN	O
,	,	O
with	IN	O
most	JJS	O
others	NNS	O
(	-LRB-	O
14	CD	O
%	NN	O
)	-RRB-	O
due	JJ	O
to	TO	O
BRCA2	NN	O
.	.	O

Conversely	RB	O
,	,	O
the	DT	O
majority	NN	O
of	IN	O
families	NNS	O
with	IN	O
male	NN	B-Disease
and	CC	I-Disease
female	JJ	I-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
were	VBD	O
due	JJ	O
to	TO	O
BRCA2	NN	O
(	-LRB-	O
76	CD	O
%	NN	O
)	-RRB-	O
.	.	O

The	DT	O
largest	JJS	O
proportion	NN	O
(	-LRB-	O
67	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
families	NNS	O
due	JJ	O
to	TO	O
other	JJ	O
genes	NNS	O
was	VBD	O
found	VBN	O
in	IN	O
families	NNS	O
with	IN	O
four	CD	O
or	CC	O
five	CD	O
cases	NNS	O
of	IN	O
female	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
only	RB	O
.	.	O

These	DT	O
estimates	NNS	O
were	VBD	O
not	RB	O
substantially	RB	O
affected	VBN	O
either	CC	O
by	IN	O
changing	VBG	O
the	DT	O
assumed	VBN	O
penetrance	NN	O
model	NN	O
for	IN	O
BRCA1	NN	O
or	CC	O
by	IN	O
including	VBG	O
or	CC	O
excluding	VBG	O
BRCA1	NN	O
mutation	NN	O
data	NNS	O
.	.	O

Among	IN	O
those	DT	O
families	NNS	O
with	IN	O
disease	NN	O
due	JJ	O
to	TO	O
BRCA1	NN	O
that	WDT	O
were	VBD	O
tested	VBN	O
by	IN	O
one	CD	O
of	IN	O
the	DT	O
standard	JJ	O
screening	NN	O
methods	NNS	O
,	,	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
or	CC	O
splice	NN	O
sites	NNS	O
in	IN	O
an	DT	O
estimated	VBN	O
63	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
CI	NN	O
51	CD	O
%	NN	O
-77	CD	O
%	NN	O
)	-RRB-	O
.	.	O

The	DT	O
estimated	VBN	O
sensitivity	NN	O
was	VBD	O
identical	JJ	O
for	IN	O
direct	JJ	O
sequencing	NN	O
and	CC	O
other	JJ	O
techniques	NNS	O
.	.	O

The	DT	O
penetrance	NN	O
of	IN	O
BRCA2	NN	O
was	VBD	O
estimated	VBN	O
by	IN	O
maximizing	VBG	O
the	DT	O
LOD	NN	O
score	NN	O
in	IN	O
BRCA2-mutation	JJ	O
families	NNS	O
,	,	O
over	IN	O
all	DT	O
possible	JJ	O
penetrance	NN	O
functions	NNS	O
.	.	O

The	DT	O
estimated	VBN	O
cumulative	JJ	O
risk	NN	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
reached	VBD	O
28	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
CI	NN	O
9	CD	O
%	NN	O
-44	CD	O
%	NN	O
)	-RRB-	O
by	IN	O
age	NN	O
50	CD	O
years	NNS	O
and	CC	O
84	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
CI	NN	O
43	CD	O
%	NN	O
-95	CD	O
%	NN	O
)	-RRB-	O
by	IN	O
age	NN	O
70	CD	O
years	NNS	O
.	.	O

The	DT	O
corresponding	JJ	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
risks	NNS	O
were	VBD	O
0	CD	O
.	.	O

4	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
CI	NN	O
0	CD	O
%	NN	O
-1	CD	O
%	NN	O
)	-RRB-	O
by	IN	O
age	NN	O
50	CD	O
years	NNS	O
and	CC	O
27	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
CI	NN	O
0	CD	O
%	NN	O
-47	CD	O
%	NN	O
)	-RRB-	O
by	IN	O
age	NN	O
70	CD	O
years	NNS	O
.	.	O

The	DT	O
lifetime	NN	O
risk	NN	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
appears	VBZ	O
similar	JJ	O
to	TO	O
the	DT	O
risk	NN	O
in	IN	O
BRCA1	NN	O
carriers	NNS	O
,	,	O
but	CC	O
there	EX	O
was	VBD	O
some	DT	O
suggestion	NN	O
of	IN	O
a	DT	O
lower	JJR	O
risk	NN	O
in	IN	O
BRCA2	NN	O
carriers	NNS	O
<	JJR	O
50	CD	O
years	NNS	O
of	IN	O
age	NN	O
.	.	O

Severe	JJ	O
early-onset	JJ	O
obesity	NN	B-Disease
,	,	O
adrenal	JJ	B-Disease
insufficiency	NN	I-Disease
and	CC	O
red	JJ	O
hair	NN	O
pigmentation	NN	O
caused	VBN	O
by	IN	O
POMC	JJ	O
mutations	NNS	O
in	IN	O
humans	NNS	O
.	.	O

Sequential	JJ	O
cleavage	NN	O
of	IN	O
the	DT	O
precursor	NN	O
protein	NN	O
pre-pro-opiomelanocortin	NN	O
(	-LRB-	O
POMC	JJ	O
)	-RRB-	O
generates	VBZ	O
the	DT	O
melanocortin	NN	O
peptides	NNS	O
adrenocorticotrophin	NN	O
(	-LRB-	O
ACTH	NN	O
)	-RRB-	O
,	,	O
melanocyte-stimulating	JJ	O
hormones	NNS	O
(	-LRB-	O
MSH	NN	O
)	-RRB-	O
alpha	NN	O
,	,	O
beta	NN	O
and	CC	O
gamma	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
opioid-receptor	NN	O
ligand	NN	O
beta-endorphin	NN	O
.	.	O

While	IN	O
a	DT	O
few	JJ	O
cases	NNS	O
of	IN	O
isolated	VBN	O
ACTH	NN	B-Disease
deficiency	NN	I-Disease
have	VBP	O
been	VBN	O
reported	VBN	O
(	-LRB-	O
OMIM	NN	O
201400	CD	O
)	-RRB-	O
,	,	O
an	DT	O
inherited	VBN	O
POMC	JJ	O
defect	NN	O
has	VBZ	O
not	RB	O
been	VBN	O
described	VBN	O
so	RB	O
far	RB	O
.	.	O

Recent	JJ	O
studies	NNS	O
in	IN	O
animal	NN	O
models	NNS	O
elucidated	VBD	O
a	DT	O
central	JJ	O
role	NN	O
of	IN	O
alpha-MSH	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
food	NN	O
intake	NN	O
by	IN	O
activation	NN	O
of	IN	O
the	DT	O
brain	NN	O
melanocortin-4-receptor	NN	O
(	-LRB-	O
MC4-R	NN	O
;	:	O
refs	NNS	O
3-5	CD	O
)	-RRB-	O
and	CC	O
the	DT	O
linkage	NN	O
of	IN	O
human	JJ	O
obesity	NN	B-Disease
to	TO	O
chromosome	NN	O
2	CD	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
the	DT	O
POMC	JJ	O
locus	NN	O
,	,	O
led	VBD	O
to	TO	O
the	DT	O
proposal	NN	O
of	IN	O
an	DT	O
association	NN	O
of	IN	O
POMC	JJ	O
with	IN	O
human	JJ	O
obesity	NN	B-Disease
.	.	O

The	DT	O
dual	JJ	O
role	NN	O
of	IN	O
alpha-MSH	NN	O
in	IN	O
regulating	VBG	O
food	NN	O
intake	NN	O
and	CC	O
influencing	VBG	O
hair	NN	O
pigmentation	NN	O
predicts	VBZ	O
that	IN	O
the	DT	O
phenotype	NN	O
associated	VBN	O
with	IN	O
a	DT	O
defect	NN	O
in	IN	O
POMC	JJ	O
function	NN	O
would	MD	O
include	VB	O
obesity	NN	B-Disease
,	,	O
alteration	NN	O
in	IN	O
pigmentation	NN	O
and	CC	O
ACTH	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

The	DT	O
observation	NN	O
of	IN	O
these	DT	O
symptoms	NNS	O
in	IN	O
two	CD	O
probands	NNS	O
prompted	VBD	O
us	PRP	O
to	TO	O
search	VB	O
for	IN	O
mutations	NNS	O
within	IN	O
their	PRP$	O
POMC	JJ	O
genes	NNS	O
.	.	O

Patient	NN	O
1	CD	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
a	DT	O
compound	NN	O
heterozygote	NN	O
for	IN	O
two	CD	O
mutations	NNS	O
in	IN	O
exon	NN	O
3	CD	O
(	-LRB-	O
G7013T	NN	O
,	,	O
C7133delta	NN	O
)	-RRB-	O
which	WDT	O
interfere	VBP	O
with	IN	O
appropriate	JJ	O
synthesis	NN	O
of	IN	O
ACTH	NN	O
and	CC	O
alpha-MSH	NN	O
.	.	O

Patient	NN	O
2	CD	O
was	VBD	O
homozygous	JJ	O
for	IN	O
a	DT	O
mutation	NN	O
in	IN	O
exon	NN	O
2	CD	O
(	-LRB-	O
C3804A	NN	O
)	-RRB-	O
which	WDT	O
abolishes	VBZ	O
POMC	JJ	O
translation	NN	O
.	.	O

These	DT	O
findings	NNS	O
represent	VBP	O
the	DT	O
first	JJ	O
examples	NNS	O
of	IN	O
a	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
within	IN	O
the	DT	O
POMC	JJ	O
gene	NN	O
and	CC	O
define	VB	O
a	DT	O
new	JJ	O
monogenic	JJ	B-Disease
endocrine	JJ	I-Disease
disorder	NN	I-Disease
resulting	VBG	O
in	IN	O
early-onset	JJ	O
obesity	NN	B-Disease
,	,	O
adrenal	JJ	B-Disease
insufficiency	NN	I-Disease
and	CC	O
red	JJ	O
hair	NN	O
pigmentation	NN	O
.	.	O

.	.	O

The	DT	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
Smad4/Dpc4	NN	O
is	VBZ	O
required	VBN	O
for	IN	O
gastrulation	NN	O
and	CC	O
later	RB	O
for	IN	O
anterior	JJ	O
development	NN	O
of	IN	O
the	DT	O
mouse	NN	O
embryo	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
SMAD4/DPC4	NN	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
,	,	O
a	DT	O
key	JJ	O
signal	NN	O
transducer	NN	O
in	IN	O
most	JJS	O
TGFbeta-related	JJ	O
pathways	NNS	O
,	,	O
are	VBP	O
involved	VBN	O
in	IN	O
50	CD	O
%	NN	O
of	IN	O
pancreatic	JJ	B-Disease
cancers	NNS	I-Disease
.	.	O

Homozygous	JJ	O
Smad4	NN	O
mutant	JJ	O
mice	NNS	O
die	VBP	O
before	IN	O
day	NN	O
7	CD	O
.	.	O

5	CD	O
of	IN	O
embryogenesis	NN	O
.	.	O

Mutant	JJ	O
embryos	NNS	O
have	VBP	O
reduced	VBN	O
size	NN	O
,	,	O
fail	VBP	O
to	TO	O
gastrulate	VB	O
or	CC	O
express	VB	O
a	DT	O
mesodermal	JJ	O
marker	NN	O
,	,	O
and	CC	O
show	VBP	O
abnormal	JJ	O
visceral	JJ	O
endoderm	NN	O
development	NN	O
.	.	O

Growth	NN	B-Disease
retardation	NN	I-Disease
of	IN	O
the	DT	O
Smad4-deficient	JJ	O
embryos	NNS	O
results	VBZ	O
from	IN	O
reduced	VBN	O
cell	NN	O
proliferation	NN	O
rather	RB	O
than	IN	O
increased	VBN	O
apoptosis	NN	O
.	.	O

Aggregation	NN	O
of	IN	O
mutant	JJ	O
Smad4	NN	O
ES	NN	O
cells	NNS	O
with	IN	O
wild-type	JJ	O
tetraploid	JJ	O
morulae	NN	O
rescues	VBZ	O
the	DT	O
gastrulation	NN	B-Disease
defect	NN	I-Disease
.	.	O

These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
Smad4	NN	O
is	VBZ	O
initially	RB	O
required	VBN	O
for	IN	O
the	DT	O
differentiation	NN	O
of	IN	O
the	DT	O
visceral	JJ	O
endoderm	NN	O
and	CC	O
that	IN	O
the	DT	O
gastrulation	NN	B-Disease
defect	NN	I-Disease
in	IN	O
the	DT	O
epiblast	NN	O
is	VBZ	O
secondary	JJ	O
and	CC	O
non-cell	JJ	O
autonomous	JJ	O
.	.	O

Rescued	VBN	O
embryos	NNS	O
show	VBP	O
severe	JJ	O
anterior	JJ	O
truncations	NNS	O
,	,	O
indicating	VBG	O
a	DT	O
second	JJ	O
important	JJ	O
role	NN	O
for	IN	O
Smad4	NN	O
in	IN	O
anterior	JJ	O
patterning	NN	O
during	IN	O
embryogenesis	NN	O
.	.	O

Coincidence	NN	O
of	IN	O
two	CD	O
novel	JJ	O
arylsulfatase	NN	O
A	DT	O
alleles	NNS	O
and	CC	O
mutation	NN	O
459	CD	O
+1	CD	O
G	NN	O
>	JJR	O
A	DT	O
within	IN	O
a	DT	O
family	NN	O
with	IN	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
:	:	O
molecular	JJ	O
basis	NN	O
of	IN	O
phenotypic	JJ	O
heterogeneity	NN	O
.	.	O

In	IN	O
a	DT	O
family	NN	O
with	IN	O
three	CD	O
siblings	NNS	O
,	,	O
one	CD	O
developed	VBD	O
classical	JJ	O
late	JJ	O
infantile	JJ	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
,	,	O
fatal	JJ	O
at	IN	O
age	NN	O
5	CD	O
years	NNS	O
,	,	O
with	IN	O
deficient	JJ	O
arylsulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
activity	NN	O
and	CC	O
increased	VBD	O
galactosylsulfatide	NN	O
(	-LRB-	O
GS	NN	O
)	-RRB-	O
excretion	NN	O
.	.	O

The	DT	O
two	CD	O
other	JJ	O
siblings	NNS	O
,	,	O
apparently	RB	O
healthy	JJ	O
at	IN	O
12	CD	O
(	-LRB-	O
1/2	CD	O
)	-RRB-	O
and	CC	O
15	CD	O
years	NNS	O
,	,	O
respectively	RB	O
,	,	O
and	CC	O
their	PRP$	O
father	NN	O
,	,	O
apparently	RB	O
healthy	JJ	O
as	RB	O
well	RB	O
,	,	O
presented	VBD	O
ARSA	NNP	O
and	CC	O
GS	NN	O
values	NNS	O
within	IN	O
the	DT	O
range	NN	O
of	IN	O
MLD	NN	B-Disease
patients	NNS	O
.	.	O

Mutation	NN	O
screening	NN	O
and	CC	O
sequence	NN	O
analysis	NN	O
disclosed	VBD	O
the	DT	O
involvement	NN	O
of	IN	O
three	CD	O
different	JJ	O
ARSA	NN	O
mutations	NNS	O
being	VBG	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
intrafamilial	JJ	O
phenotypic	JJ	O
heterogeneity	NN	O
.	.	O

The	DT	O
late	JJ	O
infantile	JJ	O
patient	NN	O
inherited	VBN	O
from	IN	O
his	PRP$	O
mother	NN	O
the	DT	O
frequent	JJ	O
0-type	JJ	O
mutation	NN	O
459	CD	O
+	CC	O
1G	CD	O
>	JJR	O
A	DT	O
,	,	O
and	CC	O
from	IN	O
his	PRP$	O
father	NN	O
a	DT	O
novel	JJ	O
,	,	O
single	JJ	O
basepair	NN	O
microdeletion	NN	O
of	IN	O
guanine	NN	O
at	IN	O
nucleotide	NN	O
7	CD	O
in	IN	O
exon	NN	O
1	CD	O
(	-LRB-	O
7delG	NN	O
)	-RRB-	O
.	.	O

The	DT	O
two	CD	O
clinically	RB	O
unaffected	JJ	O
siblings	NNS	O
carried	VBD	O
the	DT	O
maternal	JJ	O
mutation	NN	O
459	CD	O
+	CC	O
1G	CD	O
>	JJR	O
A	DT	O
and	CC	O
,	,	O
on	IN	O
their	PRP$	O
paternal	JJ	O
allele	NN	O
,	,	O
a	DT	O
novel	JJ	O
cytosine	NN	O
to	TO	O
thymidine	NN	O
transition	NN	O
at	IN	O
nucleotide	NN	O
2435	CD	O
in	IN	O
exon	NN	O
8	CD	O
,	,	O
resulting	VBG	O
in	IN	O
substitution	NN	O
of	IN	O
alanine	NN	O
464	CD	O
by	IN	O
valine	NN	O
(	-LRB-	O
A464V	NN	O
)	-RRB-	O
.	.	O

The	DT	O
fathers	NNS	O
genotype	NN	O
thus	RB	O
was	VBD	O
7delG/A464V	NNP	O
.	.	O

Mutation	NN	O
A464V	NN	O
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
18	CD	O
unrelated	JJ	O
MLD	NN	B-Disease
patients	NNS	O
and	CC	O
50	CD	O
controls	NNS	O
.	.	O

A464V	NN	O
,	,	O
although	IN	O
clearly	RB	O
modifying	VBG	O
ARSA	NNP	O
and	CC	O
GS	NN	O
levels	NNS	O
,	,	O
apparently	RB	O
bears	VBZ	O
little	JJ	O
significance	NN	O
for	IN	O
clinical	JJ	O
manifestation	NN	O
of	IN	O
MLD	NN	B-Disease
,	,	O
mimicking	VBG	O
the	DT	O
frequent	JJ	O
ARSA	NN	O
pseudodeficiency	NN	O
allele	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
in	IN	O
certain	JJ	O
genetic	JJ	O
conditions	NNS	O
MLD-like	JJ	O
ARSA	NN	O
and	CC	O
GS	NN	O
values	NNS	O
need	VBP	O
not	RB	O
be	VB	O
paralleled	VBN	O
by	IN	O
clinical	JJ	O
disease	NN	O
,	,	O
a	DT	O
finding	NN	O
with	IN	O
serious	JJ	O
diagnostic	JJ	O
and	CC	O
prognostic	JJ	O
implications	NNS	O
.	.	O

Moreover	RB	O
,	,	O
further	JJ	O
ARSA	NNP	O
alleles	NNS	O
functionally	RB	O
similar	JJ	O
to	TO	O
A464V	NN	O
might	MD	O
exist	VB	O
which	WDT	O
,	,	O
together	RB	O
with	IN	O
0-type	JJ	O
mutations	NNS	O
,	,	O
may	MD	O
cause	VB	O
pathological	JJ	O
ARSA	NNP	O
and	CC	O
GS	NN	O
levels	NNS	O
,	,	O
but	CC	O
not	RB	O
clinical	JJ	O
outbreak	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

.	.	O

Low	JJ	O
levels	NNS	O
of	IN	O
beta	NN	O
hexosaminidase	NN	O
A	NN	O
in	IN	O
healthy	JJ	O
individuals	NNS	O
with	IN	O
apparent	JJ	O
deficiency	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
.	.	O

Appreciable	JJ	O
beta	NN	O
hexosaminidase	NN	O
A	NN	O
(	-LRB-	O
hex	NN	O
A	NN	O
)	-RRB-	O
activity	NN	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
and	CC	O
melanoma	NN	B-Disease
tissue	NN	O
from	IN	O
healthy	JJ	O
individuals	NNS	O
previously	RB	O
reported	VBN	O
as	IN	O
having	VBG	O
deficiency	NN	B-Disease
of	IN	I-Disease
hex	NN	I-Disease
A	NN	I-Disease
activity	NN	O
indistinguishable	JJ	O
from	IN	O
that	DT	O
of	IN	O
patients	NNS	O
with	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
.	.	O

Identification	NN	O
and	CC	O
quantitation	NN	O
of	IN	O
hex	NN	O
A	NN	O
,	,	O
amounting	VBG	O
to	TO	O
3	CD	O
.	.	O

5	CD	O
%	NN	O
-6	CD	O
.	.	O

9	CD	O
%	NN	O
of	IN	O
total	NN	O
beta	NN	O
hexosaminidase	NN	O
activity	NN	O
,	,	O
has	VBZ	O
been	VBN	O
obtained	VBN	O
by	IN	O
cellulose	NN	O
acetate	NN	O
gel	NN	O
electrophoresis	NN	O
,	,	O
DEAE-cellulose	NN	O
ion-exchange	JJ	O
chromatography	NN	O
,	,	O
radial	JJ	O
immunodiffusion	NN	O
,	,	O
and	CC	O
radioimmunoassay	NN	O
.	.	O

Previous	JJ	O
family	NN	O
studies	NNS	O
suggested	VBD	O
that	IN	O
these	DT	O
individuals	NNS	O
may	MD	O
be	VB	O
compound	JJ	O
heterozygotes	NNS	O
for	IN	O
the	DT	O
common	JJ	O
mutant	JJ	O
TSD	NN	B-Disease
gene	NN	O
and	CC	O
a	DT	O
rare	JJ	O
(	-LRB-	O
allelic	JJ	O
)	-RRB-	O
mutant	JJ	O
gene	NN	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
postulated	VBN	O
rate	NN	O
mutant	JJ	O
gene	NN	O
appears	VBZ	O
to	TO	O
code	VB	O
for	IN	O
the	DT	O
expression	NN	O
of	IN	O
low	JJ	O
amounts	NNS	O
of	IN	O
hex	NN	O
A.	NN	O
Heterozygotes	NNP	O
for	IN	O
the	DT	O
rare	JJ	O
mutant	NN	O
may	MD	O
be	VB	O
indistinguishable	JJ	O
from	IN	O
heterozygotes	NNS	O
for	IN	O
the	DT	O
common	JJ	O
TSD	NN	B-Disease
mutant	NN	O
.	.	O

However	RB	O
,	,	O
direct	JJ	O
visualization	NN	O
and	CC	O
quantitation	NN	O
of	IN	O
hex	NN	O
A	NN	O
by	IN	O
the	DT	O
methods	NNS	O
described	VBD	O
may	MD	O
prevent	VB	O
false-positive	JJ	O
prenatal	JJ	O
diagnosis	NN	O
of	IN	O
TSD	NNP	B-Disease
in	IN	O
fetuses	NNS	O
having	VBG	O
the	DT	O
incomplete	JJ	O
hex	NN	B-Disease
A	DT	I-Disease
deficiency	NN	I-Disease
of	IN	O
the	DT	O
type	NN	O
described	VBN	O
in	IN	O
the	DT	O
four	CD	O
healthy	JJ	O
individuals	NNS	O

A	DT	O
mouse	NN	O
model	NN	O
for	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
imprinting-centre	JJ	O
mutations	NNS	O
.	.	O

Imprinting	NN	O
in	IN	O
the	DT	O
15q11-q13	JJ	O
region	NN	O
involves	VBZ	O
an	DT	O
imprinting	VBG	O
centre	NN	O
(	-LRB-	O
IC	NN	O
)	-RRB-	O
,	,	O
mapping	NN	O
in	IN	O
part	NN	O
to	TO	O
the	DT	O
promoter	NN	O
and	CC	O
first	JJ	O
exon	NN	O
of	IN	O
SNRPN	NNP	O
.	.	O

Deletion	NN	O
of	IN	O
this	DT	O
IC	NN	O
abolishes	VBZ	O
local	JJ	O
paternally	RB	O
derived	VBN	O
gene	NN	O
expression	NN	O
and	CC	O
results	VBZ	O
in	IN	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
created	VBN	O
two	CD	O
deletion	NN	O
mutations	NNS	O
in	IN	O
mice	NNS	O
to	TO	O
understand	VB	O
PWS	NNP	B-Disease
and	CC	O
the	DT	O
mechanism	NN	O
of	IN	O
this	DT	O
IC	NN	O
.	.	O

Mice	NNS	O
harbouring	VBG	O
an	DT	O
intragenic	JJ	O
deletion	NN	O
in	IN	O
Snrpn	NNP	O
are	VBP	O
phenotypically	RB	O
normal	JJ	O
,	,	O
suggesting	VBG	O
that	IN	O
mutations	NNS	O
of	IN	O
SNRPN	NNP	O
are	VBP	O
not	RB	O
sufficient	JJ	O
to	TO	O
induce	VB	O
PWS	NN	B-Disease
.	.	O

Mice	NNS	O
with	IN	O
a	DT	O
larger	JJR	O
deletion	NN	O
involving	VBG	O
both	CC	O
Snrpn	NN	O
and	CC	O
the	DT	O
putative	JJ	O
PWS-IC	NN	O
lack	NN	O
expression	NN	O
of	IN	O
the	DT	O
imprinted	JJ	O
genes	NNS	O
Zfp127	NN	O
(	-LRB-	O
mouse	NN	O
homologue	NN	O
of	IN	O
ZNF127	NN	O
)	-RRB-	O
,	,	O
Ndn	NNP	O
and	CC	O
Ipw	NNP	O
,	,	O
and	CC	O
manifest	JJ	O
several	JJ	O
phenotypes	NNS	O
common	JJ	O
to	TO	O
PWS	NN	B-Disease
infants	NNS	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
both	CC	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
IC	NN	O
and	CC	O
its	PRP$	O
role	NN	O
in	IN	O
the	DT	O
coordinate	JJ	O
expression	NN	O
of	IN	O
genes	NNS	O
is	VBZ	O
conserved	VBN	O
between	IN	O
mouse	NN	O
and	CC	O
human	JJ	O
,	,	O
and	CC	O
indicate	VBP	O
that	IN	O
the	DT	O
mouse	NN	O
is	VBZ	O
a	DT	O
suitable	JJ	O
model	NN	O
system	NN	O
in	IN	O
which	WDT	O
to	TO	O
investigate	VB	O
the	DT	O
molecular	JJ	O
mechanisms	NNS	O
of	IN	O
imprinting	VBG	O
in	IN	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
genome	NN	O
.	.	O

.	.	O

A	DT	O
deletion	NN	O
mutation	NN	O
in	IN	O
COL17A1	NN	O
in	IN	O
five	CD	O
Austrian	JJ	O
families	NNS	O
with	IN	O
generalized	VBN	O
atrophic	JJ	B-Disease
benign	JJ	I-Disease
epidermolysis	NN	I-Disease
bullosa	NN	I-Disease
represents	VBZ	O
propagation	NN	O
of	IN	O
an	DT	O
ancestral	JJ	O
allele	NN	O
.	.	O

Patients	NNS	O
with	IN	O
generalized	VBN	O
atrophic	JJ	B-Disease
benign	JJ	I-Disease
epidermolysis	NN	I-Disease
bullosa	NN	I-Disease
,	,	O
a	DT	O
usually	RB	O
nonlethal	JJ	O
form	NN	O
of	IN	O
junctional	JJ	B-Disease
epidermolysis	NN	I-Disease
bullosa	NN	I-Disease
,	,	O
have	VBP	O
generalized	VBN	O
blistering	NN	B-Disease
,	,	O
nail	NN	B-Disease
dystrophy	NN	I-Disease
,	,	O
patchy	JJ	B-Disease
alopecia	NN	I-Disease
,	,	O
and	CC	O
dental	JJ	B-Disease
abnormalities	NNS	I-Disease
.	.	O

Skin	NN	B-Disease
fragility	NN	I-Disease
in	IN	O
most	JJS	O
cases	NNS	O
is	VBZ	O
due	JJ	O
to	TO	O
mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
type	NN	O
XVII	CD	O
collagen	NN	O
(	-LRB-	O
COL17A1	NN	O
)	-RRB-	O
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
reported	VBD	O
five	CD	O
Austrian	JJ	O
families	NNS	O
with	IN	O
generalized	VBN	O
atrophic	JJ	B-Disease
benign	JJ	I-Disease
epidermolysis	NN	I-Disease
bullosa	NN	I-Disease
who	WP	O
share	VBP	O
the	DT	O
same	JJ	O
COL17A1	NN	O
mutation	NN	O
.	.	O

Affected	VBN	O
individuals	NNS	O
in	IN	O
three	CD	O
families	NNS	O
are	VBP	O
homozygous	JJ	O
for	IN	O
4003delTC	NN	O
,	,	O
whereas	IN	O
those	DT	O
in	IN	O
two	CD	O
others	NNS	O
are	VBP	O
compound	JJ	O
heterozygotes	NNS	O
.	.	O

To	TO	O
determine	VB	O
if	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
4003delTC	NN	O
in	IN	O
these	DT	O
unrelated	JJ	O
families	NNS	O
signifies	VBZ	O
propagation	NN	O
of	IN	O
an	DT	O
ancestral	JJ	O
allele	NN	O
or	CC	O
a	DT	O
mutational	JJ	O
hot	JJ	O
spot	NN	O
,	,	O
haplotypes	NNS	O
were	VBD	O
determined	VBN	O
for	IN	O
polymorphisms	NNS	O
both	CC	O
within	IN	O
and	CC	O
flanking	JJ	O
COL17A1	NN	O
.	.	O

Five	CD	O
intragenic	JJ	O
polymorphisms	NNS	O
were	VBD	O
chosen	VBN	O
based	VBN	O
on	IN	O
their	PRP$	O
informativeness	NN	O
.	.	O

One	CD	O
of	IN	O
these	DT	O
,	,	O
not	RB	O
previously	RB	O
reported	VBN	O
,	,	O
was	VBD	O
2988	CD	O
A	DT	O
or	CC	O
C	NN	O
that	WDT	O
introduces	VBZ	O
a	DT	O
new	JJ	O
restriction	NN	O
site	NN	O
for	IN	O
Eco0109	NN	O
I.	NN	O
All	PDT	O
the	DT	O
4003delTC	NN	O
alleles	NNS	O
showed	VBD	O
the	DT	O
same	JJ	O
haplotype	NN	O
for	IN	O
these	DT	O
five	CD	O
polymorphic	JJ	O
markers	NNS	O
.	.	O

Fourteen	CD	O
microsatellite	NN	O
polymorphisms	NNS	O
were	VBD	O
selected	VBN	O
based	VBN	O
on	IN	O
their	PRP$	O
high	JJ	O
heterozygosity	NN	O
and	CC	O
their	PRP$	O
location	NN	O
within	IN	O
10q23-q25	CD	O
near	IN	O
COL17A1	NN	O
.	.	O

Three	CD	O
families	NNS	O
shared	VBN	O
microsatellite	NN	O
polymorphisms	NNS	O
covering	VBG	O
at	IN	O
most	JJS	O
19	CD	O
cM	NN	O
,	,	O
whereas	IN	O
the	DT	O
others	NNS	O
shared	VBD	O
smaller	JJR	O
regions	NNS	O
consistent	JJ	O
with	IN	O
cross-over	JJ	O
events	NNS	O
during	IN	O
passage	NN	O
of	IN	O
this	DT	O
mutation	NN	O
through	IN	O
several	JJ	O
generations	NNS	O
.	.	O

These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
4003delTC	NN	O
occurs	VBZ	O
on	IN	O
a	DT	O
single	JJ	O
ancestral	JJ	O
allele	NN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
a	DT	O
novel	JJ	O
mutation	NN	O
of	IN	O
the	DT	O
CPO	NN	O
gene	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
hereditary	JJ	B-Disease
coproporphyria	NN	I-Disease
family	NN	O
.	.	O

Hereditary	JJ	B-Disease
coproporphyria	NN	I-Disease
(	-LRB-	O
HCP	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disease	NN	I-Disease
characterized	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
coproporphyrinogen	NN	I-Disease
oxidase	NN	I-Disease
(	-LRB-	O
CPO	NN	O
)	-RRB-	O
caused	VBN	O
by	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
CPO	NN	O
gene	NN	O
.	.	O

Only	RB	O
11	CD	O
mutations	NNS	O
of	IN	O
the	DT	O
gene	NN	O
have	VBP	O
been	VBN	O
reported	VBN	O
in	IN	O
HCP	NN	B-Disease
patients	NNS	O
.	.	O

We	PRP	O
report	VBP	O
another	DT	O
mutation	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
family	NN	O
.	.	O

Polymerase	NN	O
chain	NN	O
reaction-single	JJ	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
and	CC	O
direct	JJ	O
sequence	NN	O
analyses	NNS	O
demonstrated	VBD	O
a	DT	O
C	NN	O
to	TO	O
T	NN	O
substitution	NN	O
in	IN	O
exon	NN	O
1	CD	O
of	IN	O
the	DT	O
CPO	NN	O
gene	NN	O
at	IN	O
nucleotide	NN	O
position	NN	O
85	CD	O
,	,	O
which	WDT	O
lies	VBZ	O
in	IN	O
the	DT	O
putative	JJ	O
presequence	NN	O
for	IN	O
targeting	VBG	O
to	TO	O
mitochondria	NN	O
.	.	O

This	DT	O
mutation	NN	O
changes	VBZ	O
the	DT	O
codon	NN	O
for	IN	O
glutamine	NN	O
to	TO	O
a	DT	O
termination	NN	O
codon	NN	O
at	IN	O
amino	NN	O
acid	NN	O
position	NN	O
29	CD	O
.	.	O

MaeI	NN	O
restriction	NN	O
analysis	NN	O
showed	VBD	O
two	CD	O
other	JJ	O
carriers	NNS	O
in	IN	O
the	DT	O
family	NN	O
.	.	O

The	DT	O
C-T	NN	O
mutation	NN	O
is	VBZ	O
located	JJ	O
within	IN	O
a	DT	O
recently	RB	O
proposed	VBN	O
putative	JJ	O
alternative	JJ	O
translation	NN	O
initiation	NN	O
codon	NN	O
(	-LRB-	O
TIC-1	NN	O
)	-RRB-	O
,	,	O
supporting	VBG	O
that	IN	O
TIC-1	NN	O
is	VBZ	O
the	DT	O
real	JJ	O
TIC	NN	O
rather	RB	O
than	IN	O
TIC-2	NN	O
.	.	O

.	.	O

The	DT	O
chromosomal	JJ	O
order	NN	O
of	IN	O
genes	NNS	O
controlling	VBG	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	NN	O
,	,	O
properdin	NN	O
factor	NN	O
B	NN	O
,	,	O
and	CC	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
second	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
.	.	O

The	DT	O
relationship	NN	O
of	IN	O
the	DT	O
genes	NNS	O
coding	VBG	O
for	IN	O
HLA	NN	O
to	TO	O
those	DT	O
coding	VBG	O
for	IN	O
properdin	NN	O
Factor	NN	O
B	NN	O
allotypes	NNS	O
and	CC	O
for	IN	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
second	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C2	NN	O
)	-RRB-	O
was	VBD	O
studied	VBN	O
in	IN	O
families	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
connective	JJ	O
tissue	NN	O
disorders	NNS	O
.	.	O

Patients	NNS	O
were	VBD	O
selected	VBN	O
because	IN	O
they	PRP	O
were	VBD	O
heterozygous	JJ	O
or	CC	O
homozygous	JJ	O
for	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

12	CD	O
families	NNS	O
with	IN	O
15	CD	O
matings	NNS	O
informative	JJ	O
for	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
were	VBD	O
found	VBN	O
.	.	O

Of	IN	O
57	CD	O
informative	JJ	O
meioses	NNS	O
,	,	O
two	CD	O
crossovers	NNS	O
were	VBD	O
noted	VBN	O
between	IN	O
the	DT	O
C2	NN	B-Disease
deficiency	NN	I-Disease
gene	NN	O
and	CC	O
the	DT	O
HLA-B	NN	O
gene	NN	O
,	,	O
with	IN	O
a	DT	O
recombinant	JJ	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

035	CD	O
.	.	O

A	DT	O
lod	NN	O
score	NN	O
of	IN	O
13	CD	O
was	VBD	O
calculated	VBN	O
for	IN	O
linkage	NN	O
between	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
HLA-B	NN	O
at	IN	O
a	DT	O
maximum	NN	O
likelihood	NN	O
value	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

04	NN	O
.	.	O

18	CD	O
families	NNS	O
with	IN	O
21	CD	O
informative	JJ	O
matings	NNS	O
for	IN	O
both	DT	O
properdin	NN	O
Factor	NN	O
B	NN	O
allotype	NN	O
and	CC	O
HLA-B	NN	O
were	VBD	O
found	VBN	O
.	.	O

Of	IN	O
72	CD	O
informative	JJ	O
meioses	NNS	O
,	,	O
three	CD	O
recombinants	NNS	O
were	VBD	O
found	VBN	O
,	,	O
giving	VBG	O
a	DT	O
recombinant	JJ	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

042	CD	O
.	.	O

A	DT	O
lod	NN	O
score	NN	O
of	IN	O
16	CD	O
between	IN	O
HLA-B	NN	O
and	CC	O
Factor	NN	O
B	NN	O
allotypes	NNS	O
was	VBD	O
calculated	VBN	O
at	IN	O
a	DT	O
maximum	NN	O
likelihood	NN	O
value	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

04	NN	O
.	.	O

A	DT	O
crossover	NN	O
was	VBD	O
shown	VBN	O
to	TO	O
have	VB	O
occurred	VBN	O
between	IN	O
genes	NNS	O
for	IN	O
Factor	NN	O
B	NN	O
and	CC	O
HLA-D	NN	O
,	,	O
in	IN	O
which	WDT	O
HLA-D	NN	O
segregared	VBD	O
with	IN	O
HLA-A	NN	O
and	CC	O
B	NN	O
.	.	O

These	DT	O
studies	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
genes	NNS	O
for	IN	O
Factor	NN	O
B	NN	O
and	CC	O
C2	NN	B-Disease
deficiency	NN	I-Disease
are	VBP	O
located	JJ	O
outside	IN	O
those	DT	O
for	IN	O
HLA	NN	O
,	,	O
that	IN	O
the	DT	O
order	NN	O
of	IN	O
genese	NN	O
is	VBZ	O
HLA-A	NN	O
,	,	O
-	:	O
B	NN	O
,	,	O
-	:	O
D	NN	O
,	,	O
Factor	NN	O
B	NN	O
allotype	NN	O
,	,	O
C2	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
that	IN	O
the	DT	O
genes	NNS	O
coding	VBG	O
for	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
Factor	NN	O
B	NN	O
allotypes	NNS	O
are	VBP	O
approximately	RB	O
3	CD	O
--	:	O
5	CD	O
centimorgans	NNS	O
from	IN	O
the	DT	O
HLA-A	NN	O
and	CC	O
HLA-B	NN	O
loci	NNS	O
,	,	O
and	CC	O
that	IN	O
the	DT	O
apparent	JJ	O
lack	NN	O
of	IN	O
recombinants	NNS	O
between	IN	O
the	DT	O
Factor	NN	O
B	NN	O
gene	NN	O
and	CC	O
C2	NN	B-Disease
deficiency	NN	I-Disease
gene	NN	O
suggests	VBZ	O
that	IN	O
these	DT	O
two	CD	O
genes	NNS	O
lie	VBP	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
one	CD	O
another	DT	O
.	.	O

A	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
patients	NNS	O
from	IN	O
a	DT	O
retinoblastoma	NN	B-Disease
pedigree	NN	O
showing	VBG	O
only	RB	O
mild	JJ	O
expression	NN	O
of	IN	O
the	DT	O
tumor	NN	B-Disease
phenotype	NN	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
to	TO	O
study	VB	O
the	DT	O
27	CD	O
exons	NNS	O
of	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
in	IN	O
individuals	NNS	O
from	IN	O
a	DT	O
family	NN	O
showing	VBG	O
mild	JJ	O
expression	NN	O
of	IN	O
the	DT	O
retinoblastoma	NN	B-Disease
phenotype	NN	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
affected	VBD	O
individuals	NNS	O
developed	VBD	O
unilateral	JJ	B-Disease
tumors	NNS	I-Disease
and	CC	O
,	,	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
linkage	NN	O
analysis	NN	O
,	,	O
unaffected	JJ	O
mutation	NN	O
carriers	NNS	O
were	VBD	O
also	RB	O
identified	VBN	O
within	IN	O
the	DT	O
pedigree	NN	O
.	.	O

A	DT	O
single	JJ	O
band	NN	O
shift	NN	O
using	VBG	O
SSCP	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
exon	NN	O
21	CD	O
which	WDT	O
resulted	VBD	O
in	IN	O
a	DT	O
missense	NN	O
mutation	NN	O
converting	VBG	O
a	DT	O
cys	NNS	O
--	:	O
>	JJR	O
arg	NN	O
at	IN	O
nucleotide	NN	O
position	NN	O
28	CD	O
in	IN	O
the	DT	O
exon	NN	O
.	.	O

The	DT	O
mutation	NN	O
destroyed	VBD	O
an	DT	O
NdeI	NN	O
restriction	NN	O
enzyme	NN	O
site	NN	O
.	.	O

Analysis	NN	O
of	IN	O
all	DT	O
family	NN	O
members	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
missense	NN	O
mutation	NN	O
co-segregated	VBN	O
with	IN	O
patients	NNS	O
with	IN	O
tumors	NNS	B-Disease
or	CC	O
who	WP	O
,	,	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
linkage	NN	O
analysis	NN	O
had	VBD	O
been	VBN	O
predicted	VBN	O
to	TO	O
carry	VB	O
the	DT	O
predisposing	NN	O
mutation	NN	O
.	.	O

These	DT	O
observations	NNS	O
point	VBP	O
to	TO	O
another	DT	O
region	NN	O
of	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
where	WRB	O
mutations	NNS	O
only	RB	O
modify	VBP	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
gene	NN	O
and	CC	O
raise	VB	O
important	JJ	O
questions	NNS	O
for	IN	O
genetic	JJ	O
counseling	NN	O
in	IN	O
families	NNS	O
with	IN	O
these	DT	O
distinctive	JJ	O
phenotypes	NNS	O
.	.	O

.	.	O

Complement	NN	B-Disease
C7	NN	I-Disease
deficiency	NN	I-Disease
:	:	O
seven	CD	O
further	JJ	O
molecular	JJ	O
defects	NNS	O
and	CC	O
their	PRP$	O
associated	VBN	O
marker	NN	O
haplotypes	NNS	O
.	.	O

Seven	CD	O
further	JJ	O
molecular	JJ	O
bases	NNS	O
of	IN	O
C7	NN	B-Disease
deficiency	NN	I-Disease
are	VBP	O
described	VBN	O
.	.	O

All	PDT	O
these	DT	O
new	JJ	O
molecular	JJ	O
defects	NNS	O
involve	VBP	O
single-nucleotide	JJ	O
events	NNS	O
,	,	O
deletions	NNS	O
and	CC	O
substitutions	NNS	O
,	,	O
some	DT	O
of	IN	O
which	WDT	O
alter	VBP	O
splice	NN	O
sites	NNS	O
,	,	O
and	CC	O
others	NNS	O
codons	NNS	O
.	.	O

They	PRP	O
are	VBP	O
distributed	VBN	O
along	IN	O
the	DT	O
C7	NN	O
gene	NN	O
,	,	O
but	CC	O
predominantly	RB	O
towards	IN	O
the	DT	O
3	CD	O
end	NN	O
.	.	O

All	DT	O
were	VBD	O
found	VBN	O
in	IN	O
compound	NN	O
heterozygous	JJ	O
individuals	NNS	O
.	.	O

The	DT	O
C6/C7	NN	O
marker	NN	O
haplotypes	NNS	O
associated	VBN	O
with	IN	O
most	JJS	O
C7	NN	B-Disease
defects	NNS	I-Disease
are	VBP	O
tabulated	VBN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
constitutional	JJ	O
WT1	NN	O
mutations	NNS	O
,	,	O
in	IN	O
patients	NNS	O
with	IN	O
isolated	VBN	O
diffuse	JJ	B-Disease
mesangial	JJ	I-Disease
sclerosis	NN	I-Disease
,	,	O
and	CC	O
analysis	NN	O
of	IN	O
genotype/phenotype	JJ	O
correlations	NNS	O
by	IN	O
use	NN	O
of	IN	O
a	DT	O
computerized	JJ	O
mutation	NN	O
database	NN	O
.	.	O

Constitutional	NNP	O
mutations	NNS	O
of	IN	O
the	DT	O
WT1	NN	O
gene	NN	O
,	,	O
encoding	VBG	O
a	DT	O
zinc-finger	JJ	O
transcription	NN	O
factor	NN	O
involved	VBN	O
in	IN	O
renal	JJ	O
and	CC	O
gonadal	JJ	O
development	NN	O
,	,	O
are	VBP	O
found	VBN	O
in	IN	O
most	JJS	O
patients	NNS	O
with	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
DDS	NN	B-Disease
)	-RRB-	O
,	,	O
or	CC	O
diffuse	JJ	B-Disease
mesangial	JJ	I-Disease
sclerosis	NN	I-Disease
(	-LRB-	O
DMS	NN	B-Disease
)	-RRB-	O
associated	VBN	O
with	IN	O
pseudohermaphroditism	NN	B-Disease
and/or	CC	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
(	-LRB-	O
WT	NN	B-Disease
)	-RRB-	O
.	.	O

Most	JJS	O
mutations	NNS	O
in	IN	O
DDS	NN	B-Disease
patients	NNS	O
lie	VBP	O
in	IN	O
exon	NN	O
8	CD	O
or	CC	O
exon	NN	O
9	CD	O
,	,	O
encoding	VBG	O
zinc	NN	O
finger	NN	O
2	CD	O
or	CC	O
zinc	NN	O
finger	NN	O
3	CD	O
,	,	O
respectively	RB	O
,	,	O
with	IN	O
a	DT	O
hot	JJ	O
spot	NN	O
(	-LRB-	O
R394W	NN	O
)	-RRB-	O
in	IN	O
exon	NN	O
9	CD	O
.	.	O

We	PRP	O
analyzed	VBD	O
a	DT	O
series	NN	O
of	IN	O
24	CD	O
patients	NNS	O
,	,	O
10	CD	O
with	IN	O
isolated	VBN	B-Disease
DMS	NN	I-Disease
(	-LRB-	O
IDMS	NN	B-Disease
)	-RRB-	O
,	,	O
10	CD	O
with	IN	O
DDS	NN	B-Disease
,	,	O
and	CC	O
4	CD	O
with	IN	O
urogenital	JJ	B-Disease
abnormalities	NNS	I-Disease
and/or	CC	O
WT	NNP	B-Disease
.	.	O

We	PRP	O
report	VBP	O
WT1	NN	O
heterozygous	JJ	O
mutations	NNS	O
in	IN	O
16	CD	O
patients	NNS	O
,	,	O
4	CD	O
of	IN	O
whom	WP	O
presented	VBN	O
with	IN	O
IDMS	NN	B-Disease
.	.	O

One	CD	O
male	NN	O
and	CC	O
two	CD	O
female	JJ	O
IDMS	NNS	B-Disease
patients	NNS	O
with	IN	O
WT1	NN	O
mutations	NNS	O
underwent	VBD	O
normal	JJ	O
puberty	NN	O
.	.	O

Two	CD	O
mutations	NNS	O
associated	VBN	O
with	IN	O
IDMS	NNS	B-Disease
are	VBP	O
different	JJ	O
from	IN	O
those	DT	O
described	VBN	O
in	IN	O
DDS	NN	B-Disease
patients	NNS	O
.	.	O

No	DT	O
WT1	NN	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
six	CD	O
other	JJ	O
IDMS	NNS	B-Disease
patients	NNS	O
,	,	O
suggesting	VBG	O
genetic	JJ	O
heterogeneity	NN	O
of	IN	O
this	DT	O
disease	NN	O
.	.	O

We	PRP	O
analyzed	VBD	O
genotype/phenotype	JJ	O
correlations	NNS	O
,	,	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
constitution	NN	O
of	IN	O
a	DT	O
WT1	NN	O
mutation	NN	O
database	NN	O
of	IN	O
84	CD	O
germ-line	NN	O
mutations	NNS	O
,	,	O
to	TO	O
compare	VB	O
the	DT	O
distribution	NN	O
and	CC	O
type	NN	O
of	IN	O
mutations	NNS	O
,	,	O
according	VBG	O
to	TO	O
the	DT	O
different	JJ	O
symptoms	NNS	O
.	.	O

This	DT	O
demonstrated	VBD	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
the	DT	O
association	NN	O
between	IN	O
mutations	NNS	O
in	IN	O
exons	NNS	O
8	CD	O
and	CC	O
9	CD	O
and	CC	O
DMS	NN	B-Disease
;	:	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
among	IN	O
patients	NNS	O
with	IN	O
DMS	NN	B-Disease
,	,	O
a	DT	O
higher	JJR	O
frequency	NN	O
of	IN	O
exon	NN	O
8	CD	O
mutations	NNS	O
among	IN	O
46	CD	O
,	,	O
XY	NN	O
patients	NNS	O
with	IN	O
female	JJ	O
phenotype	NN	O
than	IN	O
among	IN	O
46	CD	O
,	,	O
XY	NN	O
patients	NNS	O
with	IN	O
sexual	JJ	O
ambiguity	NN	O
or	CC	O
male	JJ	O
phenotype	NN	O
;	:	O
and	CC	O
(	-LRB-	O
3	LS	O
)	-RRB-	O
statistically	RB	O
significant	JJ	O
evidence	NN	O
that	IN	O
mutations	NNS	O
in	IN	O
exons	NNS	O
8	CD	O
and	CC	O
9	CD	O
preferentially	RB	O
affect	VB	O
amino	NN	O
acids	NNS	O
with	IN	O
different	JJ	O
functions	NNS	O
.	.	O

.	.	O

Paternal	JJ	O
transmission	NN	O
of	IN	O
congenital	JJ	B-Disease
myotonic	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
rare	JJ	O
case	NN	O
of	IN	O
paternally	RB	O
transmitted	VBN	O
congenital	JJ	B-Disease
myotonic	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
proband	NN	O
is	VBZ	O
a	DT	O
23	CD	O
year	NN	O
old	JJ	O
,	,	O
mentally	RB	B-Disease
retarded	JJ	I-Disease
male	NN	O
who	WP	O
suffers	VBZ	O
severe	JJ	O
muscular	JJ	B-Disease
weakness	NN	I-Disease
.	.	O

He	PRP	O
presented	VBD	O
with	IN	O
respiratory	JJ	O
and	CC	O
feeding	VBG	O
difficulties	NNS	O
at	IN	O
birth	NN	O
.	.	O

His	PRP$	O
two	CD	O
sibs	NNS	O
suffer	VBP	O
from	IN	O
childhood	NN	O
onset	NN	O
DM	NN	B-Disease
.	.	O

Their	PRP$	O
late	JJ	O
father	NN	O
had	VBD	O
the	DT	O
adult	JJ	O
type	NN	O
of	IN	O
DM	NN	B-Disease
,	,	O
with	IN	O
onset	NN	O
around	IN	O
30	CD	O
years	NNS	O
.	.	O

Only	RB	O
six	CD	O
other	JJ	O
cases	NNS	O
of	IN	O
paternal	JJ	O
transmission	NN	O
of	IN	O
congenital	JJ	B-Disease
DM	NN	I-Disease
have	VBP	O
been	VBN	O
reported	VBN	O
recently	RB	O
.	.	O

We	PRP	O
review	VBP	O
the	DT	O
sex	NN	O
related	JJ	O
effects	NNS	O
on	IN	O
transmission	NN	O
of	IN	O
congenital	JJ	B-Disease
DM	NN	I-Disease
.	.	O

Decreased	VBN	O
fertility	NN	O
of	IN	O
males	NNS	O
with	IN	O
adult	JJ	O
onset	NN	O
DM	NN	B-Disease
and	CC	O
contraction	NN	O
of	IN	O
the	DT	O
repeat	NN	O
upon	IN	O
male	JJ	O
transmission	NN	O
contribute	VBP	O
to	TO	O
the	DT	O
almost	RB	O
absent	JJ	O
occurrence	NN	O
of	IN	O
paternal	JJ	O
transmission	NN	O
of	IN	O
congenital	JJ	B-Disease
DM	NN	I-Disease
.	.	O

Also	RB	O
the	DT	O
fathers	NNS	O
of	IN	O
the	DT	O
reported	VBN	O
congenitally	RB	O
affected	JJ	O
children	NNS	O
showed	VBD	O
,	,	O
on	IN	O
average	NN	O
,	,	O
shorter	JJR	O
CTG	NNP	O
repeat	NN	O
lengths	NNS	O
and	CC	O
hence	RB	O
less	RBR	O
severe	JJ	O
clinical	JJ	O
symptoms	NNS	O
than	IN	O
the	DT	O
mothers	NNS	O
of	IN	O
children	NNS	O
with	IN	O
congenital	JJ	B-Disease
DM	NN	I-Disease
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
paternal	JJ	O
transmission	NN	O
of	IN	O
congenital	JJ	B-Disease
DM	NN	I-Disease
is	VBZ	O
rare	JJ	O
and	CC	O
preferentially	RB	O
occurs	VBZ	O
with	IN	O
onset	NN	O
of	IN	O
DM	NN	B-Disease
past	JJ	O
30	CD	O
years	NNS	O
in	IN	O
the	DT	O
father	NN	O
.	.	O

.	.	O

Genomic	JJ	O
organization	NN	O
of	IN	O
the	DT	O
UBE3A/E6-AP	NN	O
gene	NN	O
and	CC	O
related	JJ	O
pseudogenes	NNS	O
.	.	O

The	DT	O
UBE3A	NN	O
gene	NN	O
encodes	VBZ	O
the	DT	O
E6-AP	NN	O
ubiquitin-protein	NN	O
ligase	NN	O
and	CC	O
has	VBZ	O
recently	RB	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
mutated	VBN	O
in	IN	O
Angelman	NNP	B-Disease
syndrome	NN	I-Disease
patients	NNS	O
who	WP	O
lack	VBP	O
15q11-q13	JJ	O
deletions	NNS	O
or	CC	O
chromosome	NN	O
15	CD	O
paternal	JJ	O
uniparental	JJ	B-Disease
disomy	NN	I-Disease
.	.	O

Previous	JJ	O
UBE3A	NN	O
cDNA	NN	O
analysis	NN	O
has	VBZ	O
shown	VBN	O
a	DT	O
coding	VBG	O
region	NN	O
of	IN	O
approximately	RB	O
2	CD	O
.	.	O

6	CD	O
kb	NN	O
and	CC	O
a	DT	O
3-untranslated	JJ	O
region	NN	O
(	-LRB-	O
UTR	NN	O
)	-RRB-	O
of	IN	O
<	JJR	O
50	CD	O
bp	NN	O
,	,	O
whereas	IN	O
Northern	NN	O
analysis	NN	O
has	VBZ	O
indicated	VBN	O
mRNA	NN	O
sizes	NNS	O
of	IN	O
5-8	CD	O
kb	NN	O
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
additional	JJ	O
cDNA	NN	O
clones	NNS	O
and	CC	O
provide	VBP	O
evidence	NN	O
for	IN	O
an	DT	O
additional	JJ	O
0	CD	O
.	.	O

5	CD	O
kb	NN	O
of	IN	O
5-UTR	NN	O
and	CC	O
>	JJR	O
2	CD	O
kb	NN	O
of	IN	O
3-UTR	NN	O
.	.	O

We	PRP	O
have	VBP	O
established	VBN	O
the	DT	O
genomic	JJ	O
organization	NN	O
of	IN	O
UBE3A	NN	O
and	CC	O
the	DT	O
sequence	NN	O
of	IN	O
intron-exon	JJ	O
borders	NNS	O
.	.	O

We	PRP	O
have	VBP	O
also	RB	O
mapped	VBN	O
two	CD	O
highly	RB	O
homologous	JJ	O
processed	VBN	O
pseudogenes	NNS	O
,	,	O
UBE3AP1	NN	O
and	CC	O
UBE3AP2	NN	O
,	,	O
to	TO	O
chromosomes	NNS	O
2	CD	O
and	CC	O
21	CD	O
,	,	O
respectively	RB	O
,	,	O
and	CC	O
determined	VBD	O
their	PRP$	O
genomic	JJ	O
organization	NN	O
.	.	O

These	DT	O
results	NNS	O
will	MD	O
form	VB	O
the	DT	O
basis	NN	O
for	IN	O
studies	NNS	O
of	IN	O
mutation	NN	O
and	CC	O
imprinting	VBG	O
of	IN	O
UBE3A	NN	O
.	.	O

Distribution	NN	O
of	IN	O
emerin	NN	O
and	CC	O
lamins	NNS	O
in	IN	O
the	DT	O
heart	NN	O
and	CC	O
implications	NNS	O
for	IN	O
Emery-Dreifuss	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

Emerin	NNP	O
is	VBZ	O
a	DT	O
nuclear	JJ	O
membrane	NN	O
protein	NN	O
which	WDT	O
is	VBZ	O
missing	VBG	O
or	CC	O
defective	JJ	O
in	IN	O
Emery-Dreifuss	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
EDMD	NN	B-Disease
)	-RRB-	O
.	.	O

It	PRP	O
is	VBZ	O
one	CD	O
member	NN	O
of	IN	O
a	DT	O
family	NN	O
of	IN	O
lamina-associated	JJ	O
proteins	NNS	O
which	WDT	O
includes	VBZ	O
LAP1	NN	O
,	,	O
LAP2	NN	O
and	CC	O
lamin	NN	O
B	NN	O
receptor	NN	O
(	-LRB-	O
LBR	NN	O
)	-RRB-	O
.	.	O

A	DT	O
panel	NN	O
of	IN	O
16	CD	O
monoclonal	JJ	O
antibodies	NNS	O
(	-LRB-	O
mAbs	NNS	O
)	-RRB-	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
six	CD	O
specific	JJ	O
sites	NNS	O
throughout	IN	O
the	DT	O
emerin	NN	O
molecule	NN	O
using	VBG	O
phage-displayed	JJ	O
peptide	NN	O
libraries	NNS	O
and	CC	O
has	VBZ	O
been	VBN	O
used	VBN	O
to	TO	O
localize	VB	O
emerin	NN	O
in	IN	O
human	JJ	O
and	CC	O
rabbit	NN	O
heart	NN	O
.	.	O

Several	JJ	O
mAbs	NNS	O
against	IN	O
different	JJ	O
emerin	NN	O
epitopes	NNS	O
did	VBD	O
not	RB	O
recognize	VB	O
intercalated	JJ	O
discs	NNS	O
in	IN	O
the	DT	O
heart	NN	O
,	,	O
though	IN	O
they	PRP	O
recognized	VBD	O
cardiomyocyte	NN	O
nuclei	NNS	O
strongly	RB	O
,	,	O
both	DT	O
at	IN	O
the	DT	O
rim	NN	O
and	CC	O
in	IN	O
intranuclear	JJ	O
spots	NNS	O
or	CC	O
channels	NNS	O
.	.	O

A	DT	O
polyclonal	JJ	O
rabbit	NN	O
antiserum	NN	O
against	IN	O
emerin	NN	O
did	VBD	O
recognize	VB	O
both	CC	O
nuclear	JJ	O
membrane	NN	O
and	CC	O
intercalated	JJ	O
discs	NNS	O
but	CC	O
,	,	O
after	IN	O
affinity	NN	O
purification	NN	O
against	IN	O
a	DT	O
pure-emerin	JJ	O
band	NN	O
on	IN	O
a	DT	O
western	NN	O
blot	NN	O
,	,	O
it	PRP	O
stained	VBD	O
only	RB	O
the	DT	O
nuclear	JJ	O
membrane	NN	O
.	.	O

These	DT	O
results	NNS	O
would	MD	O
not	RB	O
be	VB	O
expected	VBN	O
if	IN	O
immunostaining	NN	O
at	IN	O
intercalated	JJ	O
discs	NNS	O
were	VBD	O
due	JJ	O
to	TO	O
a	DT	O
product	NN	O
of	IN	O
the	DT	O
emerin	NN	O
gene	NN	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
cast	VBD	O
some	DT	O
doubt	NN	O
upon	IN	O
the	DT	O
hypothesis	NN	O
that	IN	O
cardiac	JJ	B-Disease
defects	NNS	I-Disease
in	IN	O
EDMD	NN	B-Disease
are	VBP	O
caused	VBN	O
by	IN	O
absence	NN	O
of	IN	O
emerin	NN	O
from	IN	O
intercalated	JJ	O
discs	NNS	O
.	.	O

Although	IN	O
emerin	NN	O
was	VBD	O
abundant	JJ	O
in	IN	O
the	DT	O
membranes	NNS	O
of	IN	O
cardiomyocyte	NN	O
nuclei	NNS	O
,	,	O
it	PRP	O
was	VBD	O
absent	JJ	O
from	IN	O
many	JJ	O
non-myocyte	JJ	O
cells	NNS	O
in	IN	O
the	DT	O
heart	NN	O
.	.	O

This	DT	O
distribution	NN	O
of	IN	O
emerin	NN	O
was	VBD	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
lamin	NN	O
A	NN	O
,	,	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
an	DT	O
autosomal	JJ	O
form	NN	O
of	IN	O
EDMD	NN	B-Disease
.	.	O

In	IN	O
contrast	NN	O
,	,	O
lamin	NN	O
B1	NN	O
was	VBD	O
absent	JJ	O
from	IN	O
cardiomyocyte	NN	O
nuclei	NNS	O
,	,	O
showing	VBG	O
that	IN	O
lamin	NN	O
B1	NN	O
is	VBZ	O
not	RB	O
essential	JJ	O
for	IN	O
localization	NN	O
of	IN	O
emerin	NN	O
to	TO	O
the	DT	O
nuclear	JJ	O
lamina	NN	O
.	.	O

Lamin	NN	O
B1	NN	O
is	VBZ	O
also	RB	O
almost	RB	O
completely	RB	O
absent	JJ	O
from	IN	O
skeletal	JJ	O
muscle	NN	O
nuclei	NNS	O
.	.	O

In	IN	O
EDMD	NN	B-Disease
,	,	O
the	DT	O
additional	JJ	O
absence	NN	O
of	IN	O
lamin	NN	O
B1	NN	O
from	IN	O
heart	NN	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
nuclei	NNS	O
which	WDT	O
already	RB	O
lack	VBP	O
emerin	NN	O
may	MD	O
offer	VB	O
an	DT	O
alternative	JJ	O
explanation	NN	O
of	IN	O
why	WRB	O
these	DT	O
tissues	NNS	O
are	VBP	O
particularly	RB	O
affected	VBN	O
.	.	O

.	.	O

Localization	NN	O
of	IN	O
human	JJ	O
BRCA1	NN	O
and	CC	O
its	PRP$	O
loss	NN	O
in	IN	O
high-grade	JJ	O
,	,	O
non-inherited	JJ	B-Disease
breast	NN	I-Disease
carcinomas	NNS	I-Disease
.	.	O

Although	IN	O
the	DT	O
link	NN	O
between	IN	O
the	DT	O
BRCA1	NN	O
tumour-suppressor	NN	O
gene	NN	O
and	CC	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
is	VBZ	O
established	VBN	O
,	,	O
the	DT	O
role	NN	O
,	,	O
if	IN	O
any	DT	O
,	,	O
of	IN	O
BRCA1	NN	O
in	IN	O
non-familial	JJ	B-Disease
cancers	NNS	I-Disease
is	VBZ	O
unclear	JJ	O
.	.	O

BRCA1	NN	O
mutations	NNS	O
are	VBP	O
rare	JJ	O
in	IN	O
sporadic	JJ	B-Disease
cancers	NNS	I-Disease
,	,	O
but	CC	O
loss	NN	O
of	IN	O
BRCA1	NN	O
resulting	VBG	O
from	IN	O
reduced	VBN	O
expression	NN	O
or	CC	O
incorrect	JJ	O
subcellular	JJ	O
localization	NN	O
is	VBZ	O
postulated	VBN	O
to	TO	O
be	VB	O
important	JJ	O
in	IN	O
non-familial	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
.	.	O

Epigenetic	JJ	O
loss	NN	O
,	,	O
however	RB	O
,	,	O
has	VBZ	O
not	RB	O
received	VBN	O
general	JJ	O
acceptance	NN	O
due	JJ	O
to	TO	O
controversy	NN	O
regarding	VBG	O
the	DT	O
subcellular	JJ	O
localization	NN	O
of	IN	O
BRCA1	NN	O
proteins	NNS	O
,	,	O
reports	NNS	O
of	IN	O
which	WDT	O
have	VBP	O
ranged	VBN	O
from	IN	O
exclusively	RB	O
nuclear	JJ	O
,	,	O
to	TO	O
conditionally	RB	O
nuclear	JJ	O
,	,	O
to	TO	O
the	DT	O
ER/golgi	NNP	O
,	,	O
to	TO	O
cytoplasmic	JJ	O
invaginations	NNS	O
into	IN	O
the	DT	O
nucleus	NN	O
.	.	O

In	IN	O
an	DT	O
attempt	NN	O
to	TO	O
resolve	VB	O
this	DT	O
issue	NN	O
,	,	O
we	PRP	O
have	VBP	O
comprehensively	RB	O
characterized	VBN	O
19	CD	O
anti-BRCA1	JJ	O
antibodies	NNS	O
.	.	O

These	DT	O
reagents	NNS	O
detect	VBP	O
a	DT	O
220-kD	JJ	O
protein	NN	O
localized	JJ	O
in	IN	O
discrete	JJ	O
nuclear	JJ	O
foci	NNS	O
in	IN	O
all	DT	O
epithelial	JJ	O
cell	NN	O
lines	NNS	O
,	,	O
including	VBG	O
those	DT	O
derived	VBN	O
from	IN	O
breast	NN	B-Disease
malignancies	NNS	I-Disease
.	.	O

Immunohistochemical	JJ	O
staining	NN	O
of	IN	O
human	JJ	O
breast	NN	O
specimens	NNS	O
also	RB	O
revealed	VBD	O
BRCA1	NN	O
nuclear	JJ	O
foci	NNS	O
in	IN	O
benign	JJ	O
breast	NN	O
,	,	O
invasive	JJ	B-Disease
lobular	JJ	I-Disease
cancers	NNS	I-Disease
and	CC	O
low-grade	JJ	B-Disease
ductal	JJ	I-Disease
carcinomas	NNS	I-Disease
.	.	O

Conversely	RB	O
,	,	O
BRCA1	NN	O
expression	NN	O
was	VBD	O
reduced	VBN	O
or	CC	O
undetectable	JJ	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
high-grade	JJ	O
,	,	O
ductal	JJ	B-Disease
carcinomas	NNS	I-Disease
,	,	O
suggesting	VBG	O
that	IN	O
absence	NN	O
of	IN	O
BRCA1	NN	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
pathogenesis	NN	O
of	IN	O
a	DT	O
significant	JJ	O
percentage	NN	O
of	IN	O
sporadic	JJ	B-Disease
breast	NN	I-Disease
cancers	NNS	I-Disease
.	.	O

.	.	O

